selleck_plate,well,Library,Library Well Type,Reagent Vendor,Vendor Reagent ID,Compound SMILES,Molecular Weight,Compound Names,PubChem CIDs,Clinical Phase [100012],Mechanism of Action [100012],Protein Target [100012],Match Type [100012],Screen Positives Count [200001],Screened Count [200001]
3651,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1011,c1(F)ccc(Nc2c3c(cc(O[C@@H]4COCC4)c(NC(=O)C=CCN(C)C)c3)ncn2)cc1Cl,485.9384,Afatinib (BIBW2992),53445376,Launched,EGFR inhibitor,EGFR|ERBB2|ERBB4,canonical SMILES,,35
3651,A04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1888,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@]5([H])[C@]4(C(=O)COC(=O)C)N=C(C)O5)=CC1=O,441.51673,Deflazacort,129010212,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,,35
3651,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1198,N1(C2CCN(C(Oc3ccc(c4c3)nc5c(CN(C5=C6)C(=O)C7=C6[C@@](CC)(O)C(=O)OC7)c4CC)=O)CC2)CCCCC1,586.67802,Irinotecan,6093360,Launched,topoisomerase inhibitor,TOP1|TOP1MT,InChI key,1,35
3651,A06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1941,c1cc(CC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O)ccc1.C(=O)(C=CC(O)=O)O,492.51887,Enalapril Maleate,53395224,,,,,,35
3651,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1274,N1(C(Nc2cccc(Nc3ncc(I)c(NCCCNC(=O)c4sccc4)n3)c2)=O)CCCC1,591.46771,BX-795,10077147,Preclinical,IKK inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,InChI key,2,35
3651,A08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2013,N1c(c2CCC1=O)ccc(Nc3ncc(C(F)(F)F)c(NCc4cccc(S(C)(=O)=O)c4)n3)c2,491.4861,PF-573228,11612883,Preclinical,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB,InChI key,,35
3651,A09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1343,C1([C@@H]2C[C@H]3C(C)(C)C)(C34[C@@]([H])(OC(=O)[C@H]4O)O5)[C@@]5(C(=O)O2)[C@]6(O)[C@@]([H])(OC(=O)[C@@H]6C)[C@H]1O,424.39855,Ginkgolide B,129010213,Phase 3,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,InChI key,,35
3651,A10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2054,c1(ccccc1)C(c2c(C)cccc2)OCCN(C)C.OC(=O)CC(O)(C(O)=O)CC(=O)O,461.50483,Orphenadrine Citrate,83823,,,,,,35
3651,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1389,c1cc2c(nc(S(Cc3ncc(C)c(OC)c3C)=O)[nH]2)cc1OC,345.41605,Omeprazole,4594,Launched,ATPase inhibitor,ATP4A|CLCN2,InChI key,,35
3651,A12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2096,c1(CS(=O)(=O)N2CCCC2)cc3c([nH]cc3CCN(C)C)cc1.C(O)(=O)C(O)CC(=O)O,469.55173,Almotriptan Malate,123607,,,,,1,35
3651,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1544,c1ccc2c(c(C(=O)c3c(I)ccc([N+]([O-])=O)c3)cn2CC4CCCCN4C)c1,503.33284,AM1241,10141893,Preclinical,cannabinoid receptor agonist,CNR1|CNR2,InChI key,,35
3651,A14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2153,c(ncn1[C@H]2[C@@H](O)[C@H](O)[C@@H](C(=O)NCC)O2)(c(N)nc(NCCc3ccc(CCC(=O)O)cc3)n4)c14.Cl,535.9806,CGS 21680 HCl,71297010,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,InChI key,2,35
3651,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1638,c1cc(C(C)C(=O)O)ccc1CC(C)C,206.28082,Ibuprofen,3672,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,35
3651,A16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2217,C1CCN(C2CCN(C(=O)Oc3cc4c(nc5c(CN6C5=CC7=C(COC(=O)[C@]7(O)CC)C6=O)c4CC)cc3)CC2)CC1.Cl.O.O.O,677.1848,Irinotecan HCl Trihydrate,129010214,Launched,topoisomerase inhibitor,TOP1|TOP1MT,InChI key,,35
3651,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1696,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(O)C(CO)=O)=CC1=O,362.4599,Hydrocortisone,129010215,Launched,glucocorticoid receptor agonist,,InChI key,,35
3651,A18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2293,OC(=O)CC(C[N+](C)(C)C)O.[Cl-],197.65983,DL-Carnitine HCl,5970,Phase 3,,,InChI key,,35
3651,A19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1763,OC(=O)C=CC(=O)O.c1cc2c(Sc3c(cccc3)C(N4CCN(CCOCCO)CC4)=N2)cc1.c5cc6c(Sc7c(cccc7)C(N8CCN(CCOCCO)CC8)=N6)cc5,883.08636,Quetiapine Fumarate,441261,,,,,2,35
3651,A20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2327,c1(O)cc2c(C(=O)C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)=C(c4cc(O)c(O)c(O)c4)O2)c(O)c1,464.37629,Myricitrin,5352000,Preclinical,PKC inhibitor,NOS1|PRKCA,InChI key,,35
3651,A21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1829,c(C(=O)C=C(c1[nH]nnn1)O2)(ccc(NC(=O)c3ccc(OCCCCc4ccccc4)cc3)c5)c25,481.50262,Pranlukast,115100,Launched,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,InChI key,3,35
3651,A22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2363,c1(OC)c(OC)c2c(C(=O)C=C(c3ccc(OC)cc3)O2)c(OC)c1OC,372.36859,Tangeretin,68077,Preclinical,cell cycle inhibitor,,InChI key,2,35
3651,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2393,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO,182.17175,Sorbitol,453,Launched,diuretic,,InChI key,,35
3651,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2872,c1c(I)ccc2c1C(=Cc3cc(Br)c(O)c(Br)c3)C(=O)N2,520.94198,GW5074,5034,,,,,4,35
3651,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2450,C1Oc2c(ccc(O)c2)C[C@H]1c3ccc(O)cc3,242.26985,Equol,382975,Launched,estrogen receptor agonist,ESR1|ESR2,InChI key,2,35
3651,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2886,c1(cc(NC(=O)CN(C)C)cc2)c2NC(=O)c3c1cccc3,295.33578,PJ34,4858,Preclinical,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,InChI key,1,35
3651,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2532,O1C(=O)C(O)=C(O)[C@@]1([H])[C@@H](O)COC(=O)CCCCCCCCCCCCCCC,414.53291,L-Ascorbyl 6-palmitate,54679407,,,,,2,35
3651,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2900,c1(nc(C(C)C)sc1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)CC[C@H](Cc4ccccc4)NC(=O)OCc5scnc5,776.02272,Cobicistat (GS-9350),24950485,Launched,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,InChI key,,35
3651,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2585,c1(ccc(Br)cc1)C(c2ncccc2)CCN(C)C.OC(=O)C=CC(=O)O,435.31161,Brompheniramine hydrogen maleate,91495,,,,,1,35
3651,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2910,C1(C)(C)CC(O)CC(C)(C)N1[O],172.24471,Tempol,5395,Phase 2,free radical scavenger,,chemical name,1,35
3651,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2691,c1cc(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c(OC)cc1.Cl.Cl,458.42172,BMY 7378,44275113,Preclinical,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A,InChI key,,35
3651,B12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2919,C(O)(=O)CNC(C1=C(O)c(c2N(Cc3ccccc3)C1=O)cccc2)=O,352.34074,IOX2,54685215,Preclinical,hypoxia inducible factor inhibitor,EGLN1|KDM2A|KDM5C,InChI key,,35
3651,B13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2804,C(NC(c1ccccc1)C)(=O)c2ccccc2N=Cc3c(c4ccc3O)cccc4,394.46508,Sirtinol,6836442,,,,,2,35
3651,B14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2930,c1cc(C#CS(=O)(=O)N)ccc1,181.21168,Pifithrin-?,327653,Preclinical,HSP inhibitor,HSPA1A|TP53,InChI key,2,35
3651,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2819,n1(c2ccc(Cl)cc2Cl)c(c3ccc(I)cc3)c(C)c(C(NN4CCCCC4)=O)n1,555.2388,AM251,2125,Preclinical,cannabinoid receptor antagonist,CNR1|GPR18|GPR55,InChI key,3,35
3651,B16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3038,c1([C@@H]2N(CC(NC(=O)N3P(O)(=O)O)=N3)CCO[C@@H]2O[C@H](C)c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc(F)cc1.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,1004.83372,Fosaprepitant dimeglumine salt,73197500,,,,,,35
3651,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2842,c(ccc(C#C[C@@](COC)(C)O)n1)(C(=O)C(C(=O)NC)=C(N)N2CC)c12,358.39167,SAR131675,71295845,Preclinical,VEGFR inhibitor,FLT4,InChI key,,35
3651,B18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3052,c(C(=C1CCN(Cc2cc(C)cnc2)CC1)c3c(cc(Cl)cc3)CC4)(nccc5)c45.C(O)(=O)C=CC(O)=O,532.0299,Rupatadine Fumarate,3075477,,,,,1,35
3651,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2855,C(NCCCCNC(=S)Nc1cccc(N=C=S)c1)(=S)Nc2cccc(N=C=S)c2,472.673,MRS 2578,16078986,Preclinical,purinergic receptor antagonist,P2RY6,InChI key,,35
3651,B20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3067,C(Nc1ccc(Cl)cc1)(=N)NC(=N)NCCCCCCNC(=N)NC(Nc2ccc(Cl)cc2)=N.Cl.Cl,578.36848,Chlorhexidine HCl,85066607,Launched,membrane integrity inhibitor,,InChI key,4,35
3651,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2863,c1cc2c(nc(N)n2S(=O)(c3ccc(C)cc3)=O)cc1,287.33691,ML130 (Nodinitib-1),1088438,Preclinical,NOD1 inhibitor,,InChI key,1,35
3651,B22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3081,[C@H]1(c2ccc(N(C)C)cc2)C[C@@]3(C)[C@@]([H])(CC[C@@]3(OC(=O)C)C(C)=O)[C@@]4([H])C1=C5C(=CC(=O)CC5)CC4,475.61907,Ulipristal,129010216,Launched,progesterone receptor antagonist,PGR,InChI key,,35
3651,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1014,n1c(c2c(Nc3cc(OC)c(Cl)cc3Cl)c(C#N)c1)cc(OCCCN4CCN(C)CC4)c(OC)c2,530.44616,Bosutinib (SKI-606),5328940,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,InChI key,,34
3651,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1890,s1cc(CSCCNC(NC)=C[N+]([O-])=O)nc1CN(C)C,331.45744,Nizatidine,4513,,,,,,35
3651,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1214,S([O-])(O)(=O)=O.[C@@H](NC(=O)c1c(C)c(N)nc([C@H](CC(=O)N)NC[C@@H](N)C(=O)N)n1)(C(=O)N[C@@H](C)[C@H](O)[C@@H](C)C(=O)N[C@@H](C(=O)NCCc2scc(c3scc(C(=O)NCCC[S+](C)C)n3)n2)[C@H](O)C)C(O[C@H]4O[C@H](CO)[C@H](O)[C@@H](O)[C@@]4([H])O[C@H]5O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]5O)c6c[nH]cn6,1512.62229,Bleomycin Sulfate,129010217,,,,,3,35
3651,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1958,C1(=O)N2[C@]([H])(S(=O)(=O)C(C)(C)[C@]2(C(=O)O)[H])C1,233.24164,Sulbactam,130313,Launched,beta lactamase inhibitor,,InChI key,1,35
3651,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1284,N1(CC(=O)O)c2c(cccc2)CC[C@H](N[C@@H](CCc3ccccc3)C(=O)OCC)C1=O.Cl,460.95046,Benazepril HCl,71296885,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,,35
3651,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2017,c1(cccc([N+]([O-])=O)c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)O[C@H]3CN(Cc4ccccc4)CCC3.Cl,542.02317,Benidipine HCl,71296872,Launched,calcium channel blocker,CACNA1C|CACNA1G,InChI key,,35
3651,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1351,[C@](O)(C1=CC=C[C@H](C)[C@H](O[C@]2([H])O[C@@H](C)[C@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)C(C)=CC[C@]([H])(C[C@@H]4OC5=O)O[C@@]6(CC[C@H](C)[C@@]([H])([C@H](CC)C)O6)C4)([C@]5([H])C=C(C)[C@H]7O)[C@]7([H])OC1,875.09276,Ivermectin,129010219,Launched,benzodiazepine receptor agonist,CHRNA7|GABRB3|GLRA3|P2RX7,chemical name,2,35
3651,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2069,NC(=N)NCCC[C@]([H])(NS(=O)(=O)c1c2c(CC(C)CN2)ccc1)C(=O)N3[C@H](C(O)=O)C[C@H](C)CC3,508.63414,Argatroban,54018892,Launched,thrombin inhibitor,F2,InChI key,,35
3651,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1394,C1(=C2CCN(C)CC2)c3c(cccc3)CCc4c1ccs4.C(O)(=O)C(O)CC(O)=O,429.52917,Pizotifen Malate,168993,,,,,1,35
3651,C12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2099,c1cc(CC[C@@H](C(=O)OCC)N[C@H]2CS[C@H](c3cccs3)CN(CC(=O)O)C2=O)ccc1.Cl,513.06975,Temocapril HCl,129010220,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,1,35
3651,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1578,c1(Cn2c(OCC)nc3c2c(C(=O)O)ccc3)ccc(c4c(c5n[nH]nn5)cccc4)cc1,440.45399,Candesartan,2541,Launched,angiotensin receptor antagonist,AGTR1,InChI key,,35
3651,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2160,c1cccc([C@H](N2[C@@H](CCc3ccc(C(F)(F)F)cc3)c4c(cc(OC)c(OC)c4)CC2)C(=O)NC)c1.Cl,549.02418,Almorexant HCl,129010221,,,,,,35
3651,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1640,c1(SCCC)cc2c(nc(NC(=O)OC)[nH]2)cc1,265.3314,Albendazole,2082,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,InChI key,2,35
3651,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2228,c1(C(=O)N[C@@H](C(C)(C)C)C(N2CCC[C@H]2C(=O)N[C@@H]3[C@@H](OCC)OC(=O)C3)=O)ccc(N)c(Cl)c1,508.99501,VX-765,9892498,Phase 2,caspase inhibitor,CASP1,InChI key,,35
3651,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1703,C(CCC)(CCC)C(=O)[O-].[Na+].C(O)(=O)C(CCC)CCC,310.4047,Divalproex Sodium,23663956,,,,,,35
3651,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2303,c1(C=O)c2c(cc(C)c(c3c(C)cc4c(c(C=O)c(O)c(O)c4C(C)C)c3O)c2O)c(C(C)C)c(O)c1O,518.55439,Gossypol,3503,Phase 2,BCL inhibitor|MCL1 inhibitor,BCL2,InChI key,2,35
3651,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1771,c1cc2c(C(=CCCN(C)C)c3c(ccc(Cl)c3)S2)cc1,315.86022,Chlorprothixene,2729,Launched,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,chemical name,2,35
3651,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2329,c1c(O)c2c(O[C@H](c3ccc(O)cc3)CC2=O)cc1O[C@H]4[C@@H](O[C@H]5[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)[C@@H](O)[C@H](O)[C@@H](CO)O4,580.53458,Naringin,4441,Preclinical,cytochrome P450 inhibitor,SLCO1A2,InChI key,,35
3651,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1832,c1(OC)cc2c(C(Cc3cc(OC)c(OC)cc3)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCc(c5C4Cc6cc(OC)c(OC)cc6)cc(OC)c(OC)c5)CC2)cc1OC.c7c(S(=O)(=O)[O-])cccc7.c8c(S(=O)(=O)[O-])cccc8,1243.47918,Atracurium Besylate,47320,Launched,acetylcholine receptor antagonist,CHRNA2,InChI key,1,35
3651,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2369,c1c(O)c2c(OC(c3ccc(OCCO)c(OCCO)c3)=C(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)O4)C2=O)cc1OCCO,742.67518,Troxerutin,5360237,Launched,antioxidant,,InChI key,,35
3651,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2397,c1cc2c(c[n+]3c(c4c(cc(OC)c(OC)c4)CC3)c2)c(OC)c1OC.[Cl-],387.85667,Palmatine chloride,73442,Preclinical,dopamine synthesis inhibitor,CYP3A4,InChI key,,35
3651,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2874,c1(ccc(NC(=N)N)cc1)C(=O)Oc2ccc(CC(=O)OCC(=O)N(C)C)cc2.S(=O)(=O)(O)C,494.51814,Camostat Mesilate,5284360,Launched,protease inhibitor,PRSS1,InChI key,2,35
3651,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2454,c1c(C)c(NC(=O)C2CCCCN2CCCC)c(C)cc1.Cl,324.88866,Bupivacaine HCl,45114156,Launched,sodium channel blocker,KCNA5|PTGER1|SCN10A|SCN4A,InChI key,2,35
3651,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2890,c1ccc(CNc2nc(Nc3cc4c(NC(=O)C4)cc3)ncc2C(F)(F)F)c(N(S(C)(=O)=O)C)n1,507.4888,PF-562271,11713159,Phase 1,focal adhesion kinase inhibitor,PTK2|PTK2B,InChI key,,35
3651,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2538,CC(Nc1ccccc1)=O,135.16316,Acetanilide,904,Preclinical,hydrogen peroxide decomposition inhibitor,,InChI key,1,35
3651,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2901,c1(F)ccc(CN2C(=O)SN(c3ccc(C)cc3)C2=O)cc1,316.35002,CCG 50014,2733079,Preclinical,G protein signaling inhibitor,RGS4|RGS8,InChI key,,35
3651,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2590,c1(CC)cnc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)cc1,356.43869,Pioglitazone,4829,Launched,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,InChI key,,35
3651,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2911,c1(OC)cc2c(n(CCCN(C)C)cc2C3=C(c4c[nH]c5c4cccc5)C(=O)NC3=O)cc1,442.50963,Go 6983,3499,Preclinical,protein kinase inhibitor,PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ,InChI key,4,35
3651,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2693,c1cc(CN(C)C)ccc1S(=O)(=O)n2cc(C=CC(=O)NO)cc2,349.40476,Resminostat,73028572,Phase 2,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,chemical name,1,35
3651,D12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2921,c1(cnn(C)c1c2ccc(C)cc2)c3nn(C)c4c3c(N5CC[C@H](N6CCCCC6)C5)ncn4,456.58588,PF-4981517,91989794,Preclinical,cytochrome P450 inhibitor,CYP3A4,InChI key,,35
3651,D13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2806,c1(N2CCN(C)CC2)cc(Nc3nn4c(c(c5ccc(S(=O)(C)=O)cc5)ccc4)n3)ccc1,462.56723,CEP-33779,57336812,Preclinical,JAK inhibitor,JAK2,InChI key,1,35
3651,D14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3002,c1cc(N2CCOCC2=O)ccc1N3CC(CNC(=O)c4ccc(Cl)s4)OC3=O,435.88132,Rivaroxaban,6433119,Launched,coagulation factor inhibitor,F10,InChI key,1,35
3651,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2821,[C@@]([H])(C(=O)O)(Cc1c[nH]c2c1cccc2)N3C(=O)c(c4C3=O)cccc4,334.32546,RG108,702558,Preclinical,DNA methyltransferase inhibitor,DNMT1|DNMT3B,InChI key,,35
3651,D16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3042,c(n(C1CCCCC1)cn2)(nc(Oc3cccc4c3cccc4)nc5Nc6ccc(N7CCOCC7)cc6)c25,520.62478,Purmorphamine,5284329,Preclinical,smoothened receptor agonist,SMO,InChI key,,35
3651,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2843,c1(O)c(F)cc(Nc2ncc3c(N(CCC(C)C)C(C)C(=O)N3C)n2)cc1F,391.41502,BI-D1870,25023738,Preclinical,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6,InChI key,1,35
3651,D18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3053,C(N)(NC(C)=C(C(OC(C)C)=O)C1c2cccc([N+]([O-])=O)c2)=C1C(OC3CN(C(c4ccccc4)c5ccccc5)C3)=O,582.64625,Azelnidipine,65948,Launched,calcium channel blocker,CACNA1C,InChI key,,35
3651,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2856,c(ccc(Cl)c1)(sc(S(Nc2ccc(OC)c(N3CCNCC3)c2)(=O)=O)c4C)c14,451.98997,SB271046,5312149,Phase 1,serotonin receptor antagonist,HTR6,InChI key,2,35
3651,D20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3071,C(=O)c1ccc(O)c(OC)c1,152.14732,Vanillin,1183,Preclinical,,ABAT|ALDH5A1,InChI key,,35
3651,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,InChI key,5,35
3651,D22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3083,N1c(c2C=CC1=O)c(O)ccc2[C@@H](O)CNC3Cc(c4C3)cc(CC)c(CC)c4.C(=CC(O)=O)C(O)=O,508.56287,Indacaterol Maleate,66822886,,,,,2,35
3651,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1018,c1c2c(C(N)=C(c3nc4c(cc(N5CCN(C)CC5)cc4)[nH]3)C(=O)N2)c(F)cc1,392.42944,"Dovitinib (TKI-258, CHIR-258)",49830557,Phase 3,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB,InChI key,4,35
3651,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1894,c1(CN(C(CCCC)=O)[C@]([H])(C(O)=O)C(C)C)ccc(c2c(c3n[nH]nn3)cccc2)cc1,435.51875,Valsartan,60846,Launched,angiotensin receptor antagonist,AGTR1,InChI key,1,35
3651,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1216,c1(NS(c2ccccc2OC)(=O)=O)cc3c(NC(=O)N(C)C3)cc1,347.38888,PFI-1 (PF-6405761),71271629,Preclinical,bromodomain inhibitor,BRD4,InChI key,2,35
3651,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1959,c1(ccccc1C(=O)O)Nc2c(C)c(Cl)ccc2,261.70358,Tolfenamic Acid,610479,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,,InChI key,,35
3651,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1293,c1c(C2C(C(=O)OCCOC)=C(C)NC(C)=C2C(=O)OCC=Cc3ccccc3)cc([N+]([O-])=O)cc1,492.52041,Cilnidipine,2752,,,,,1,35
3651,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2020,OC(=O)C=CC(=O)O.c1cc(C[C@H](C)NC[C@@H](O)c2cc(NC=O)c(O)cc2)ccc1OC.c3cc(C[C@H](C)NC[C@@H](O)c4cc(NC=O)c(O)cc4)ccc3OC,804.88188,Formoterol Hemifumarate,443956,,,,,,35
3651,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1353,c1(N2CCN(C(C)=O)CC2)ccc(OC[C@H]3CO[C@@](c4c(Cl)cc(Cl)cc4)(Cn5cncc5)O3)cc1,531.43091,Ketoconazole,5702077,Launched,sterol demethylase inhibitor,AR|CYP19A1|CYP21A2|KCNA10,InChI key,1,35
3651,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2079,c1(OC)cc2c(CN(C([C@@H](N[C@@H](CCc3ccccc3)C(OCC)=O)C)=O)[C@H](C(=O)O)C2)cc1OC.Cl,535.02899,Moexipril HCl,78052518,Launched,angiotensin converting enzyme inhibitor,ACE|ACE2,InChI key,,35
3651,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1432,c1(CS(=O)(=O)NC)cc2c([nH]cc2CCN(C)C)cc1.OC(=O)CCC(=O)O,413.48847,Sumatriptan Succinate,59772,,,,,,35
3651,E12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2102,c1cc2c(CC[C@@H]2NCC#C)cc1.O=S(O)(C)=O,267.34398,Rasagiline Mesylate,10355621,Launched,monoamine oxidase inhibitor,BCL2|MAOB,InChI key,,35
3651,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1604,n1(c(C(=O)OCC2=C(C)OC(=O)O2)c(C(C)(C)O)nc1CCC)Cc3ccc(c4c(c5nn[nH]n5)cccc4)cc3,558.5851,Olmesartan Medoxomil,130881,Launched,angiotensin receptor antagonist,AGTR1,InChI key,1,35
3651,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2163,[nH]1c2c(cc(C(F)(F)F)cc2)nc1CN3CCN(c4c(CC)cncn4)CC3,390.40544,PF-4708671,51371303,Preclinical,ribosomal protein inhibitor,RPS6KB1,InChI key,1,35
3651,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1649,c1c2c([nH]cc2CCN(C)C)ccc1C[C@H]3COC(=O)N3,287.35683,Zolmitriptan,5731,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,InChI key,,35
3651,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2233,c1(OC)cc2c([n-]c(S(=O)Cc3c(C)c(OC)c(C)cn3)n2)cc1.[Na+],367.39788,Esomeprazole Sodium,10959536,,,,,,35
3651,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1716,C1CC(NC(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3cc(Cl)ccc3OC)cc2)CCC1,494.00351,Glyburide,3488,Launched,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,InChI key,1,35
3651,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2304,c(c(CN(C)C)c[nH]1)(cccc2)c12,174.24226,Gramine,6890,Preclinical,norepinephrine reputake inhibitor,,InChI key,,35
3651,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1776,c1cc(C(=C(CCCl)c2ccccc2)c3ccccc3)ccc1OCCN(C)C.OC(=O)CC(O)(C(O)=O)CC(O)=O,598.08313,Toremifene Citrate,56008,,,,,2,35
3651,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2332,c1c(O)c2c(O[C@H](c3cc(O)cc(OC)c3)CC2=O)cc1O[C@H]4[C@@H](O[C@H]5[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)[C@@H](O)[C@H](O)[C@@H](CO)O4,610.56056,Neohesperidin,44134843,Preclinical,,,InChI key,,35
3651,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1845,c1(C)[nH]cnc1CSCCNC(NC)=NC#N,252.33923,Cimetidine,2756,Launched,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,InChI key,,35
3651,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2371,c1cc(CCC(=O)C)cc(OC)c1O,194.22706,Vanillylacetone,31211,Preclinical,,,InChI key,,35
3651,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2411,[C@H]1(O)[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@]3([H])[C@]([H])(CC=C3CO)C(C(OC)=O)=CO2)O[C@@H]1CO,388.36645,Geniposide,129010222,Preclinical,GLP receptor agonist,GLP1R,InChI key,,35
3651,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2875,c1(C(=O)NC2CCN(CCCOC)CC2)cc(Cl)c(N)c3c1OCC3,367.87033,Prucalopride,3052762,Launched,serotonin receptor agonist,HTR4,InChI key,1,35
3651,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2491,c1cc([N+](=O)[O-])cc(C2C(C(OC)=O)=C(C)NC(C)=C2C(OCC)=O)c1,360.36119,Nitrendipine,4507,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CACNG1|KCNN4,InChI key,2,35
3651,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2892,c1(C(Nc2ccc(Cl)c(OC)c2)=O)ncccc1,262.69164,VU 0361737,44191096,Preclinical,glutamate receptor positive allosteric modulator,GRM4,InChI key,2,35
3651,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2550,c1cc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)cc1C.O=C([C@H](O)[C@@H](O)C(=O)O)O,475.57447,Tolterodine tartrate,11691408,,,,,1,35
3651,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2902,n1cnc(c2cnn([C@@H](CC#N)C3CCCC3)c2)c4c1[nH]cc4,306.36502,S-Ruxolitinib (INCB018424),17754772,Preclinical,JAK inhibitor,JAK1|JAK2,InChI key,1,35
3651,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2610,c1cc2c(c(C(=O)O)nn2Cc3ccc(Cl)cc3Cl)cc1,321.1581,Lonidamine,39562,Launched,glucokinase inhibitor,GCK,InChI key,1,35
3651,F10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2912,c1(CNc2ncccc2)ccc(CNc3ncccc3)cc1,290.36232,WZ811,11565518,Preclinical,CC chemokine receptor antagonist,CXCR4,InChI key,,35
3651,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2694,c1cc2c([nH]c3c2C(C)(C)CN(C(=O)c4cc(F)c(F)cc4)C=C3C(OC(C)C)=O)cc1,438.46646,XL335,10026128,Phase 1,FXR agonist,NR1H4,InChI key,,35
3651,F12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2922,c1c(Nc2c3c(cc4c(OCCOCCOCCO4)c3)ncn2)cccc1C#C,391.41983,Icotinib,22024915,Launched,EGFR inhibitor,EGFR,InChI key,1,35
3651,F13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2809,c1(C)nc(C#Cc2ccccc2)ccc1,193.24384,MPEP,3025961,Preclinical,glutamate receptor antagonist,GRM1|GRM4|GRM5,InChI key,1,35
3651,F14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3015,[C@H]1(NC([C@H](N)c2ccc(O)cc2)=O)[C@@]3([H])N([C@@H](C(O)=O)C(C)(C)S3)C1=O,365.40416,Amoxicillin,22791788,Launched,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,InChI key,1,35
3651,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2822,c1(F)cc2c(n(CC(=O)O)c(C)c2Cc3nc4c(cccc4)cc3)cc1,348.37028,OC000459,11462174,Phase 2,CRTH receptor antagonist,PTGDR2,InChI key,,35
3651,F16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3043,c1cc(C(COC2=O)=C2c3ccccc3)ccc1S(=O)(=O)C,314.35566,Rofecoxib,5090,Withdrawn,cyclooxygenase inhibitor,ELN|PTGS2,InChI key,,35
3651,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2845,c1cc2c(NC(=O)C2=Cc3c(C)cc(C)[nH]3)cc1,238.28445,Semaxanib (SU5416),123015,,,,,2,35
3651,F18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3054,c1(CCCN(CC)CCCc2ccccc2)ccccc1.C(C(O)=O)C(O)(C(O)=O)CC(O)=O,473.55859,Alverine Citrate,21718,,,,,1,35
3651,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2857,c(cccc1)(C[C@@H](N[C@]23C)c4c2cccc4)c13,221.297,MK-801 (Dizocilpine),9862634,Preclinical,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,InChI key,1,35
3651,F20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3073,[C@@H]1(O)C[C@]2([H])N(C(=O)[C@]([H])([C@H](O)C)NC(=O)[C@@H](NC(=O)CCCCCCCC[C@H](C)C[C@H](C)CC)C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@]3([H])N(CC[C@@H]3O)C(=O)[C@@]([H])([C@@H](O)CCN)NC(=O)[C@]([H])([C@@H]([C@H](c4ccc(O)cc4)O)O)NC2=O)C1.CC(O)=O.CC(O)=O,1213.41704,Caspofungin Acetate,129010223,,,,,3,35
3651,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2865,c1cc2c(nc(Cl)c(N3CCN(C)CC3)n2)cc1,262.738,VUF 10166,24278976,Preclinical,serotonin receptor antagonist,HTR3A|HTR3B,InChI key,,35
3651,F22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3100,N1C=CC(=O)NC1=S,128.15235,2-Thiouracil,1269845,Preclinical,,,InChI key,1,35
3651,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1061,N1(C(N2CC(=O)NCC2)=O)C(c3ccc(OC)cc3OC(C)C)=NC(c4ccc(Cl)cc4)C1c5ccc(Cl)cc5,581.4896,Nutlin-3,216345,Preclinical,MDM inhibitor,MDM2|TP53,InChI key,,35
3651,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1897,[K+].[I-],166.00277,Potassium Iodide,4875,,,,,,35
3651,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1223,c1c(OC)c2c(C(=O)c3c(c(O)c4c(C[C@@](O)(C(=O)CO)C[C@H]4O[C@]5([H])O[C@@H](C)[C@H](O)[C@@H](N)C5)c3O)C2=O)cc1.Cl,579.98019,Epirubicin HCl,129010225,Launched,topoisomerase inhibitor,CHD1|TOP2A,InChI key,6,35
3651,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1960,c1cc2c(Oc3c(cc(C(C)C(=O)O)cc3)C2)nc1,255.26862,Pranoprofen,4888,Launched,cyclooxygenase inhibitor,,InChI key,,35
3651,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1305,N(C(=S)c1c(nc[nH]1)N2)=C2,152.17705,Mercaptopurine (6-MP),667490,Launched,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,InChI key,,35
3651,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2025,N1(C)C(=O)C=C(NCCCN2CCN(c3c(OC)cccc3)CC2)N(C)C1=O.Cl,423.9369,Urapidil HCl,45114226,Launched,adrenergic receptor antagonist,HTR1A,InChI key,,35
3651,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1357,c1c(C)c(NC(=O)CN(CC)CC)c(C)cc1,234.33728,Lidocaine,3676,Launched,histamine receptor agonist,EGFR|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,35
3651,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2080,CCCC(=O)OCOC(=O)C(C(c1c(Cl)c(Cl)ccc1)C(C(=O)OC)=C(C)N2)=C2C,456.31641,Clevidipine Butyrate,153994,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,InChI key,,35
3651,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1436,c(cccc1)(N(C)S(=O)(=O)c2c(ccc(Cl)c2)C3NCCCCCCC([O-])=O)c13.[Na+],458.93402,Tianeptine sodium,23663953,,,,,,35
3651,G12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2104,c1c(S(=O)(N)=O)cc(C(NC[C@@H]2CCCN2CC)=O)c(OC)c1,341.42581,Levosulpiride,5355,Launched,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,InChI key,,35
3651,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1608,c1[n+](C)cccc1OC(=O)N(C)C.[Br-],261.11572,Pyridostigmine Bromide,7550,Launched,cholinesterase inhibitor,ACHE|BCHE,InChI key,,35
3651,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2168,c1(O)cc2c(OC[C@@]3([H])[C@]2([H])OCCN3CCC)cc1,249.30556,PD128907 HCl,44329754,Preclinical,dopamine receptor agonist,DRD2|DRD3,InChI key,,35
3651,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1654,N1(c2ccccc2)C(=O)C(CCCC)C(=O)N1c3ccccc3,308.3743,Phenylbutazone,4781,Withdrawn,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,InChI key,,35
3651,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2240,c1ccccc1[C@H](c2cc(CO)ccc2OC(=O)C(C)C)CCN(C(C)C)C(C)C.C(C(=O)O)=CC(=O)O,527.64903,Fesoterodine Fumarate,74344602,,,,,1,35
3651,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1727,C1C[C@@]2([H])C(CC[C@]3([H])[C@@]2([H])CC[C@@]4(CC)[C@@]3([H])CC[C@@]4(C#C)O)=CC1=O,312.44582,Levonorgestrel,129009949,Launched,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,AR|ESR1|PGR|SRD5A1,InChI key,,35
3651,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2306,C1C[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@@]2([H])C[C@@H](O)[C@@]4([H])[C@@]3(C)CC[C@H]4[C@@](CCC=C(C)C)(C)O[C@H]5[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H](O)[C@@H](O)[C@H](O)CO6)O5)C(C)(C)[C@H]1O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7,917.1279,Gynostemma Extract,129010227,Preclinical,calcium channel modulator,,InChI key,2,35
3651,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1782,[C@H]1(O)[C@H](O)[C@H](N2C=NC(N)=NC2=O)O[C@@H]1CO,244.20467,Azacitidine,1805,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,InChI key,2,35
3651,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2333,c1(OC)c(OC)c2c(C(=O)C=C(c3ccc(OC)c(OC)c3)O2)c(OC)c1OC,402.39457,Nobiletin,72344,Preclinical,MEK inhibitor,MAP2K1,InChI key,,35
3651,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1854,c1cc(C(n2ccnc2)c3ccc(c4ccccc4)cc3)ccc1,310.39172,Bifonazole,2378,Launched,sterol demethylase inhibitor,CYP2B6,InChI key,1,35
3651,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2372,c1cc2c(Oc3c(cccc3)C2=O)cc1,196.20142,Xanthone,7020,Preclinical,antimalarial agent,,InChI key,,35
3651,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2425,c1(OC)c(O)ccc(C(=O)C)c1,166.1739,Apocynin,2214,Phase 1,NADPH oxidase inhibitor,NOX4,InChI key,1,35
3651,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2876,[C@]1(C)(N[C@]2([H])c3c1cccc3)c4c(cccc4)C2.C(C(=O)O)=CC(=O)O,337.36915,(-)-MK 801 Maleate,129010228,,,,,,35
3651,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2516,c1c(C)c(NC2=NCCCS2)c(C)cc1.Cl,256.79478,Xylazine HCl,21114890,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,InChI key,1,35
3651,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2894,c1c(S(=O)(=O)c2cc(c3nc2)cccc3N4CCNCC4)cccc1,353.43805,SB742457,11256720,Phase 3,serotonin receptor antagonist,HTR6,InChI key,2,35
3651,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2551,C1(=O)N2[C@]([H])(S(=O)(=O)C(C)(C)[C@]2(C(=O)[O-])[H])C1.[Na+],255.22347,Sulbactam sodium,23663973,,,,,1,35
3651,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2903,c1c(Cl)c(Nc2c(CC(=O)O)cc(C)cc2)c(F)cc1,293.72062,Lumiracoxib,151166,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,35
3651,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2625,c1(OC)cc(Nc2nc(Nc3nc4c(OC(C)(C)C(=O)N4COP(=O)(O)O)cc3)c(F)cn2)cc(OC)c1OC,580.4595,Fostamatinib (R788),11671467,Phase 3,SYK inhibitor,RET|SYK,InChI key,1,35
3651,H10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2913,c1(ccc(C)cc1)S(=O)(=O)C=CC#N,207.24896,BAY 11-7082,2301,,,,,,35
3651,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2698,c1c(c2nc(N)nc(C(C)C)c2)c3c(cccc3)c(F)c1,281.32744,RS-127445,196968,Phase 1,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,InChI key,,35
3651,H12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2923,c1(nccc2)c2cccc1NC(=S)NC(C(Cl)(Cl)Cl)NC(=O)C=Cc3ccccc3,479.80988,Salubrinal,2830510,,,,,,35
3651,H13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2812,c1(O)c(c2cc(C)c1c3c(C)cc(c4c3O)c(C(C)C)c(O)c(O)c4C=O)c(C=O)c(O)c(O)c2C(C)C.C(O)(=O)C,578.60635,AT101,227456,,,,,5,35
3651,H14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3033,C1CC[C@@H](C#N)N1C(=O)CNC2(CC(O)(CC3C2)CC4C3)C4,303.3993,Vildagliptin (LAF-237),5251896,Launched,dipeptidyl peptidase inhibitor,DPP4,InChI key,,35
3651,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2824,c1(NC(N)=O)sc(c2ccc(F)cc2)cc1C(N)=O,279.2901,TPCA-1,9903786,Preclinical,IKK inhibitor,IKBKB,InChI key,2,35
3651,H16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3045,N1(CC(N2CCCC2)=O)CCN(C(=O)C=Cc3cc(OC)c(OC)c(OC)c3)CC1.C(=O)(O)C=CC(=O)O,533.57079,Cinepazide maleate,324822,,,,,1,35
3651,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2847,n1(C)c(C(N[C@@H](Cc2cccc(Cl)c2)C(NCC#N)=O)=O)cc(C(C)(C)C)n1,401.88985,Cathepsin Inhibitor 1,56664471,Preclinical,cathepsin inhibitor,CTSB|CTSL|CTSV,InChI key,,35
3651,H18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3057,c1(OCC)n(Cc2ccc(c3ccccc3C4=NC(=O)ON4)cc2)c5c(cccc5C(OCC6=C(C)OC(=O)O6)=O)n1,568.53356,Azilsartan Medoxomil,11238823,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,InChI key,1,35
3651,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2858,c1(O)ccc(CCNc2c(c3nc(c4csc5c4cccc5)n2)ncn3C(C)C)cc1,429.53732,StemRegenin 1 (SR1),46199207,Preclinical,aryl hydrocarbon receptor antagonist,AHR,InChI key,2,35
3651,H20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3075,c1ccc(C)c(C)c1[C@H](C)c2cnc[nH]2,200.27953,Dexmedetomidine,68602,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,InChI key,,35
3651,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2866,N(c1ccc(F)cc1)C(=O)Nc2ccc(S(=O)(=O)N)cc2,309.31608,U-104,310360,Preclinical,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA9,InChI key,,35
3651,H22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3104,c1cccc(OC)c1OCC2SCCN2C(CC(=O)OCC)=O,339.40663,Moguisteine,65935,Phase 2,ATP-sensitive potassium channel inhibitor,,InChI key,,35
3651,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1121,c1c(C(C)(C)C)c(S(=O)(=O)c2ccc(NC(=O)c3cc(Cc4c(C(C)C)cccc4)c(O)c(O)c3O)cc2)ccc1,573.69909,TW-37,11455910,Preclinical,BCL inhibitor,BCL2|BCL2L1|MCL1,InChI key,2,35
3651,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1905,N1C(C)=C(C(OC)=O)C(c2ccccc2Cl)C(C(=O)OCC)=C1COCCN,408.87589,Amlodipine,2162,Launched,calcium channel blocker,CA1|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNA2D3|CACNB1|CACNB2|SMPD1,InChI key,1,35
3651,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1228,c1cc2c(C(=O)c3c(c(O)c4c(C[C@@](O)(C(=O)C)C[C@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c3O)C2=O)cc1.Cl,533.95481,Idarubicin HCl,71296908,Launched,topoisomerase inhibitor,TOP2A,InChI key,5,35
3651,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1972,c1(OCCN(C)C)ccc(C(c2ccccc2)=C(c3ccccc3)CC)cc1.C(O)(=O)CC(O)(C(O)=O)CC(O)=O,563.63807,Tamoxifen Citrate,23672,,,,,1,35
3651,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1319,C1C=C(C)CC[C@@H]2[C@H](OC(=O)C2=C)C=C(C)C1,232.3181,Costunolide,556919,Preclinical,telomerase inhibitor,,chemical name,1,35
3651,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2037,C1CC(OC(=O)OC(C)OC(c2c3c(nc(OCC)n3Cc4ccc(c5ccccc5c6[nH]nnn6)cc4)ccc2)=O)CCC1,610.65966,Candesartan Cilexetil,2540,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,InChI key,,35
3651,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1359,c1c(c2ccccc2c3nnn[nH]3)ccc(Cn4c(CCCC)nc(Cl)c4CO)c1.[K],462.00891,Losartan Potassium (DuP 753),21989751,Launched,angiotensin receptor antagonist,AGTR1,InChI key,1,35
3651,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2081,c1ccc(CC[C@@H](C(OCC)=O)N[C@@H]2C(=O)N3N(CCC[C@@H]3C(=O)O)CCC2)cc1.O,435.51391,Cilazapril Monohydrate,21863027,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,1,35
3651,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1468,C1C(=CC=C2CCC[C@@]3(C)[C@@]2([H])CC[C@@H]3[C@H](C)CCCC(C)C)C(=C)[C@@H](O)C[C@@H]1O,400.63706,Alfacalcidol,129010229,Launched,vitamin D receptor agonist,CYP27B1|VDR,chemical name,2,35
3651,I12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2108,c1(Nc2cccc(C(F)(F)F)c2C)ncccc1C(O)=O.N(C)C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,491.45812,Flunixin Meglumin,6713974,,,,,1,35
3651,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1609,N1C(=S)N(C)C=C1,114.16884,Methimazole,1349907,Launched,antithyroid agent,TPO,InChI key,1,35
3651,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2169,[Ca+2].n1c(C(C)C)c(C=C[C@H](C[C@@H](O)CC(=O)[O-])O)c(c2ccc(F)cc2)nc1N(C)S(=O)(=O)C.n3c(C(C)C)c(C=C[C@H](C[C@@H](O)CC(=O)[O-])O)c(c4ccc(F)cc4)nc3N(C)S(=O)(=O)C,1001.13736,Rosuvastatin Calcium,16413926,,,,,,35
3651,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1657,c1cc(CC[C@H](N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O)C(=O)O)ccc1.O.O,384.42411,Enalaprilat Dihydrate,21585234,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,,35
3651,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2250,c1(O)cc(C(=O)O[C@@H]2Cc3c(cc(O)cc3O)O[C@@H]2c4cc(O)c(O)c(O)c4)cc(O)c1O,458.37171,(-)-Epigallocatechin Gallate,1287,Phase 2/Phase 3,bacterial DNA gyrase inhibitor,ELANE|EP300|FASN|KAT2B|MMP14|MMP2,InChI key,2,35
3651,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1740,c1ccc(OCC(O)CO)c(OC)c1,198.21576,Guaifenesin,3516,Launched,expectorant,,InChI key,1,35
3651,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2313,c1c2c([nH]cc2CO)ccc1,147.17386,Indole-3-carbinol,3712,Phase 2/Phase 3,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,InChI key,,35
3651,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1801,N(C)(C)Cc1oc(CSCCNC(NC)=C[N+]([O-])=O)cc1.Cl,350.86472,Ranitidine,71297063,,,,,1,35
3651,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2336,C(C(=O)NC(=O)N1)=C1C(=O)O,156.09626,Orotic acid (6-Carboxyuracil),967,Phase 2,,DHODH,InChI key,,35
3651,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1856,[C@@H](O)([C@@H](O)C(=O)O)C(=O)O.c1cc(OCC(O)CNC(C)C)ccc1CCOC.c2cc(OCC(O)CNC(C)C)ccc2CCOC,684.81464,Metoprolol Tartrate,6420057,,,,,,35
3651,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2376,[C@@]1(C(=O)O)(C)C[C@]2([H])[C@@](C)(CC[C@]3(C)C2=CC(=O)[C@@]4([H])[C@@]3(C)CC[C@]5([H])[C@@]4(C)CC[C@H](O[C@]6([H])[C@@H](O[C@]7([H])O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@@H](C(=O)O)O6)C5(C)C)CC1.N,839.9626,Ammonium Glycyrrhizinate,129010230,Launched,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,InChI key,,35
3651,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2439,c1(N=C(N)NC2=O)c2ncn1[C@H]3[C@H](O)[C@H](O)[C@H](CO)O3,283.24071,Guanosine,765,Preclinical,,PNP,InChI key,,35
3651,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2882,c1(C(N2CCC(N3CCCC3)CC2)=O)ccc(Nc4nccc(c5sc6c(cccc6)c5)n4)cc1,483.62775,IKK-16 (IKK Inhibitor VII),9549298,Preclinical,IKK inhibitor,IKBKB,InChI key,1,35
3651,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2519,c1(cccc2)c2c(CC(NCC3)=N3)ccc1.Cl,246.7353,Naphazoline HCl,23615857,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A,InChI key,2,35
3651,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2895,c1(C(C)(C)C)cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O,282.38007,Tyrphostin 9,5614,Preclinical,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,InChI key,3,35
3651,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2553,NCC(=O)CCC(=O)O.Cl,167.59079,5-Aminolevulinic acid HCl,45114132,Launched,oxidizing agent,ALAD,InChI key,2,35
3651,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2904,c1c2c(c3C=NNC2=O)c([nH]c3c4cn(C)nc4)cc1NC(=O)[C@H](N)C5CCCCC5,419.47959,PF-477736,23402305,Phase 1,CHK inhibitor,CHEK1|CHEK2,InChI key,1,35
3651,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2637,c1ccc(COc2cc3c([C@H](CC(O)=O)CO3)cc2)cc1c4c(C)cc(OCCCS(=O)(C)=O)cc4C.O.c5ccc(COc6cc7c([C@H](CC(O)=O)CO7)cc6)cc5c8c(C)cc(OCCCS(=O)(C)=O)cc8C,1067.26564,TAK-875,76516068,,,,,2,35
3651,J10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2914,n1c(Nc2c(C)cc(C)cc2C)ccnc1Nc3ccc(C#N)cc3,329.39835,Dapivirine (TMC120),214347,Phase 3,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,InChI key,1,35
3651,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2721,C1(C)=C(C(OC(C)C)=O)C(c2cc([N+]([O-])=O)ccc2)C(C(=O)OC)=C(C#N)N1,385.37065,Nilvadipine,4494,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1S|CACNA2D1|CACNA2D3|CACNB2,InChI key,2,35
3651,J12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2925,c1(C(F)(F)F)cc(CN(c2nn(C)nn2)[C@]3([H])c4c(c(C)cc(C)c4)N(C[C@]5([H])CC[C@@]([H])(C(=O)O)CC5)CCC3)cc(C(F)(F)F)c1,638.64695,Evacetrapib (LY2484595),49836058,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,InChI key,1,35
3651,J13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2813,C(C1CC1)(c2ccc(OCCCc3c[nH]cn3)cc2)=O.C(O)(=O)C=CC(O)=O,386.39847,Ciproxifan,53399088,,,,,1,35
3651,J14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3034,c1(C(Cc2c(C)cc(c3c2)OCO3)=O)sccc1S([N-]c4onc(C)c4Cl)(=O)=O.[Na+],476.88632,Sitaxentan sodium,11477084,,,,,2,35
3651,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2825,c1ccc2c(cccc2CNCc3ccc(OC)cc3)c1.Cl,313.8212,ML133 HCl,129010232,Preclinical,potassium channel blocker,,InChI key,,35
3651,J16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3046,c1(OCC)n(Cc2ccc(c3ccccc3C4=NC(=O)ON4)cc2)c5c(cccc5C(O)=O)n1,456.45009,Azilsartan,9825285,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,InChI key,1,35
3651,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2849,N1(S(c2cccc(O)c2)(=O)=O)CCC[C@@H]1CCN3CCC(C)CC3.Cl,388.95246,SB269970 HCl,73759859,Preclinical,serotonin receptor antagonist,HTR7,InChI key,1,35
3651,J18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3060,c1(C(C)c2c[nH]cn2)cccc(C)c1C.Cl,236.74048,Medetomidine HCl,44377741,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,InChI key,1,35
3651,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2859,c1c(F)c(NC(=O)C2(CC2)C(=O)Nc3ccc(F)cc3)ccc1Oc4ccnc(NC(=O)N5CCC(N6CCN(C)CC6)CC5)c4,633.68818,Golvatinib (E7050),16118392,Phase 2,VEGFR inhibitor,KDR|MET,InChI key,2,35
3651,J20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3076,P(=O)([O-])([O-])C([O-])=O.[Na+].[Na+].[Na+],191.95077,Foscarnet Sodium,44561,,,,,,35
3651,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2867,n1c(c2c(Nc3ccc(O)c(Br)c3)nc1)cc(OC)c(OC)c2,376.20466,WHI-P154,3795,Preclinical,JAK inhibitor,EGFR|JAK1|JAK2|JAK3,InChI key,1,35
3651,J22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3105,c1(cc(F)c2N3CCC(O)CC3)c(N4C=C(C(O)=O)C1=O)c2CCC4C,360.37944,Nadifloxacin,4410,Launched,bacterial DNA gyrase inhibitor,,InChI key,4,35
3651,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1138,c([nH]c(C)c1)(ccc(Oc2c3n(cc(OC[C@H](OC(=O)[C@H](C)N)C)c3C)ncn2)c4F)c14,441.45546,Brivanib Alaninate (BMS-582664),22508903,Phase 3,FGFR inhibitor|VEGFR inhibitor,FGFR3,InChI key,1,35
3651,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1913,c1cc(C(C(N(Cc2ccncc2)CC)=O)CO)ccc1,284.3529,Tropicamide,5593,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,InChI key,,35
3651,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1235,c1c(C(c2ccc(C#N)cc2)n3cncn3)ccc(C#N)c1,285.30273,Letrozole,3902,Launched,aromatase inhibitor,CYP19A1,InChI key,1,35
3651,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1973,C(N1C(O[C@H]2[C@H]1O[C@H](CO)[C@@H]2O)=NC3=N)=C3.Cl,261.66228,Cyclocytidine HCl,19968823,Preclinical,DNA synthesis inhibitor|RNA synthesis inhibitor,,InChI key,,35
3651,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1322,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(O)C(CO)=O)=CC1=O,392.46106,Dexamethasone (DHAP),129010233,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,InChI key,,35
3651,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2041,c1cc(C(=O)CCN2CCCCC2)ccc1OCCCC.Cl,325.87342,Dyclonine HCl,24183034,Launched,sodium channel blocker,SCN10A|SCN5A,InChI key,1,35
3651,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1362,c1(C=CS(=O)(=O)Cc2cc(NCC(=O)[O-])c(OC)cc2)c(OC)cc(OC)cc1OC.[Na+],473.47192,Rigosertib (ON-01910),73265218,,,,,1,35
3651,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2082,C(=O)(OCCN(CC)CC)C(c1ccccc1)c2ccccc2.Cl,347.87894,Adiphenine HCl,23615527,Launched,acetylcholine receptor antagonist,CHRNA1,InChI key,,35
3651,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1469,C1C(=CC=C2CCC[C@@]3(C)[C@@]2([H])CC[C@@]3([H])[C@H](C)CCCC(O)(C)C)C(=C)CC[C@@H]1O,400.63706,Calcifediol,129010234,Launched,vitamin D receptor agonist,VDR,chemical name,2,35
3651,K12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2109,CCOC([C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C(O)=O)CN(C)C2=O)=O,405.44487,Imidapril HCl,3693,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,2,35
3651,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1611,C1(CSc2n(C)nnn2)=C(C(O)=O)N3[C@@]([H])([C@H](NC([C@H](NC(=O)N4CCN(CC)C(=O)C4=O)c5ccc(O)cc5)=O)C3=O)SC1,645.66738,Cefoperazone,70603228,Launched,bacterial cell wall synthesis inhibitor,,InChI key,2,35
3651,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2173,c1cc(c2nc(N)nc(O[C@@H](C(F)(F)F)c3c(n4ccc(C)n4)cc(Cl)cc3)c2)ccc1C[C@H](N)C(=O)OCC.c5cc(C(=O)NCC(=O)O)ccc5,754.1546,Telotristat Etiprate (LX 1606 Hippurate),74434892,,,,,,35
3651,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1675,C1(=O)[C@@H](CCCCCCC(=O)O)[C@@H](CCC(=O)C(F)(F)CCCC)[C@H](O)C1,390.46188,Lubiprostone,73125101,Launched,chloride channel activator,CLCN2,InChI key,,35
3651,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2258,c1(O)cc2c(C=CC(=O)O2)cc1O[C@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3,340.28214,Esculin,5351506,Phase 1,antioxidant,,InChI key,1,35
3651,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1748,C(C)(NC(C)=C(C(=O)OC)C1c2c([N+]([O-])=O)cccc2)=C1C(=O)OCC(C)C,388.41435,Nisoldipine,4499,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNB2,InChI key,1,35
3651,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2316,c(nc[nH]1)(ncnc2NCc3ccco3)c12,215.21135,Kinetin,3830,Launched,cell division inducer,,InChI key,1,35
3651,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1805,CC(=O)OCC[N+](C)(C)C.[Cl-],181.66044,Acetylcholine Chloride,6060,Launched,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,InChI key,,35
3651,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2350,C(c1ccc(O)c(O)c1)(Oc2c(c(O)cc(O)c2)C3=O)=C3O[C@H]4[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]5[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)O4,610.5175,Rutin,5293655,Launched,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,InChI key,1,35
3651,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1865,c1(cccc2)c2S[C@@H](c3ccc(OC)cc3)[C@@H](OC(=O)C)C(=O)N1CCN(C)C.Cl,450.97877,Diltiazem HCl,19882930,Launched,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,InChI key,,35
3651,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2383,[C@@H]1(O)[C@H](CO)O[C@@H](Oc2ccc(CO)cc2)[C@H](O)[C@H]1O,286.27782,Gastrodin,3645183,Phase 2,,,InChI key,,35
3651,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2442,O1[C@H](n2cnc3c2N=CNC3=O)[C@H](O)[C@H](O)[C@H]1CO,268.22608,Inosine,804,Launched,neurotrophic agent,PARP1|PNP,InChI key,2,35
3651,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2883,C(O)(=O)CNC(c1ccc(N)cc1)=O,194.1873,4-Aminohippuric Acid,2148,Preclinical,,SLC22A6,InChI key,1,35
3651,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2521,c1(O)cc([C@H](CNC)O)ccc1O.C(O)(=O)[C@@H]([C@H](C(O)=O)O)O,333.29125,Epinephrine Bitartrate,12309655,,,,,1,35
3651,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2896,c1(O)cc(Nc2c(c3ncn2)ccc(OCc4ccccc4)c3)c(F)cc1C.Cl,411.85656,ZM 323881 HCl,71297145,Preclinical,VEGFR inhibitor,KDR,InChI key,1,35
3651,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2573,c1cc(C(=O)OCCN(C)C)ccc1NCCCC.Cl,300.8242,Tetracaine HCl,18539387,Launched,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,1,35
3651,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2905,c1(Cl)cc2c([nH]c(C(=O)N3CCN(C)CC3)c2)cc1,277.74934,JNJ-7777120,4908365,Preclinical,histamine receptor antagonist,HRH4,InChI key,1,35
3651,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2662,c1ccc(CNC(=O)N2CCC(=O)N3[C@]2([H])CN(Cc4c5c(cccc5)ccc4)C(=O)[C@H]3Cc6ccc(O)cc6)cc1,548.63157,ICG-001,69221911,Preclinical,beta-catenin inhibitor,CTNNB1,InChI key,2,35
3651,L10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2915,c1(C(=O)Nc2ccccc2)c(Cl)ccc([N+]([O-])=O)c1,276.67516,GW9662,644213,Preclinical,PPAR receptor antagonist,NCOA2|PPARG|RXRA,InChI key,,35
3651,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2769,N1c(c2C(N)=C(c3[nH]c4c(ccc(N5CCN(C)CC5)c4)n3)C1=O)cccc2F.CC(O)C(=O)O.CC(O)C(=O)O,572.58532,Dovitinib (TKI-258) Dilactic Acid,118797566,,,,,2,35
3651,L12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2927,c(C(=O)C(=O)N1Cc2ccc(Cl)c(Cl)c2)(cccc3)c13,306.14346,Apoptosis Activator 2,1901244,Preclinical,carboxylesterase inhibitor,BCHE|CES1,InChI key,,35
3651,L13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2816,C(=S)(N)C(C#N)=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,316.46095,Tyrphostin AG 879,6809654,,,,,1,35
3651,L14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3035,c1c(OC)c2c(C(=O)c3c(c(O)c4c(C[C@](C(=O)C)(O)C[C@H]4O[C@]5([H])O[C@@H](C)[C@@H](O)[C@@H](N)C5)c3O)C2=O)cc1.Cl,563.98079,Daunorubicin HCl,129010235,Launched,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,InChI key,3,35
3651,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2828,N1(c2snc(c3ccccc3)n2)CCN(C(Nc4ccccc4)=O)CC1,365.45206,JNJ-1661010,2809273,Preclinical,FAAH inhibitor,FAAH,InChI key,,35
3651,L16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3047,C([N+](CC)(CC)C)COC(=O)c1ccc(NC(=O)c2ccccc2OCCCCCCCC)cc1.[Br-],563.56671,Otilonium Bromide,72092,Launched,acetylcholine receptor antagonist,CACNA1C,InChI key,4,35
3651,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2851,CCS(N1CC(n2ncc(c3ncnc(c34)[nH]cc4)c2)(CC#N)C1)(=O)=O,371.41688,"Baricitinib (LY3009104, INCB028050)",44205240,Phase 3,JAK inhibitor,JAK1|JAK2,InChI key,1,35
3651,L18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3063,c1c(Cl)c(Nc2c(CC(=O)O)cccc2)c(Cl)cc1.N(CC)CC,369.28547,Diclofenac Diethylamine,115087,Launched,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,InChI key,,35
3651,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2860,C(N)CCCCNCC1(CC(CC2C1)CC3C2)C3.Br.Br,412.24668,IEM 1754 dihydrobroMide,129010237,Preclinical,glutamate receptor antagonist,GRIA1,InChI key,,35
3651,L20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3078,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(Cl)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@H](C)[C@@]4(OC(CC)=O)C(=O)COC(CC)=O)=CC1=O,521.04217,Beclomethasone dipropionate,129010238,Launched,glucocorticoid receptor agonist,GPR97|NR3C1,InChI key,,35
3651,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2868,C(#N)c1ccccc1CN2C(=O)N(C)C(=O)C=C2N3C[C@H](N)CCC3,339.39164,Alogliptin,11163584,Launched,dipeptidyl peptidase inhibitor,DPP4,InChI key,,35
3651,L22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3106,S1C[C@@H](C(O)=O)N(C([C@@H]2CCC(=O)N2)=O)C1,244.26758,Pidotimod,114751,Launched,interferon receptor agonist|interleukin receptor agonist,,InChI key,,35
3651,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1148,c1c(C(O[C@@H]2C([C@@]3(C)C(=O)[C@H](O)C(C([C@@]24O)(C)C)=C(C)[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c5ccccc5)C4)[C@]6(OC(=O)C)[C@H](OC6)C[C@@H]3O)=O)cccc1,807.87922,Docetaxel,129010239,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1,InChI key,,35
3651,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1921,c1cc2c(C(=O)C(c3ccccc3)C2=O)cc1,222.2387,Phenindione,4760,Launched,vitamin K antagonist,VKORC1,InChI key,,35
3651,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1252,N(C(=O)c1c(n([C@@H]2C(=C)[C@H](CO)[C@@H](O)C2)cn1)N3)=C3N.O,295.29448,Entecavir Hydrate,21924982,Launched,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,InChI key,,35
3651,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1983,c([nH]cn1)(ncnc2N)c12.Cl,171.58763,Adenine HCl,44305832,Preclinical,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2,InChI key,,35
3651,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1328,c1cc(CC)c2c(c3c([C@](CC)(CC(O)=O)OCC3)[nH]2)c1,287.35354,Etodolac,688461,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2|RXRA,InChI key,,35
3651,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2046,c1(CC)cnc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)cc1.Cl,392.89963,Pioglitazone HCl,44285636,Launched,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,InChI key,1,35
3651,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1374,C1(=O)N2[C@@]([H])([C@H](C)C(S[C@H]3C[C@@H](CNS(=O)(=O)N)NC3)=C2C(O)=O)[C@]1([H])[C@@H](O)C.O,438.51953,Doripenem Hydrate,129010240,Launched,bacterial cell wall synthesis inhibitor,DPEP1,InChI key,4,35
3651,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2085,c1(OC)cc(C(=O)OCC(N(C)C)(CC)c2ccccc2)cc(OC)c1OC,387.46935,Trimebutine,5573,Launched,opioid receptor agonist,OPRD1|OPRK1|OPRM1,InChI key,,35
3651,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1480,[C@H]1(N(C([C@H]2CC[C@H](C)CC2)=O)c3cc(C#CC(C)(C)C)sc3C(=O)O)CC[C@@H](O)CC1,445.61469,"VX-222 (VCH-222, Lomibuvir)",24798764,Phase 2,HCV inhibitor,,InChI key,2,35
3651,M12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2123,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O,180.15588,Dextrose,24749,Launched,,,InChI key,,35
3651,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1619,c1c(C)c(NC(=O)C(C)NCCC)ccc1,220.3107,Prilocaine,4906,Launched,local anesthetic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,35
3651,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2194,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC.c5cc(S(=O)(=O)O)ccc5,628.62866,R406,11984591,,,,,1,35
3651,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1681,c1c(N)ccc(O)c1C(=O)O,153.13538,Mesalamine,4075,Launched,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2,InChI key,,35
3651,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2280,C1[C@](O)(C(O)=O)C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@H](O)[C@@H]1O,354.30871,Chlorogenic Acid,129010242,Launched,antioxidant,SLC37A4,canonical SMILES,,35
3651,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1759,[Ca+2].c1cc2c(nc(C3CC3)c(C=C[C@H](C[C@@H](O)CC(=O)[O-])O)c2c4ccc(F)cc4)cc1.c5cc6c(nc(C7CC7)c(C=C[C@H](C[C@@H](O)CC(=O)[O-])O)c6c8ccc(F)cc8)cc5,880.98364,Pitavastatin Calcium,53394921,,,,,,35
3651,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2317,[C@H]1(O)[C@@H](C)OC(O)[C@H](O)[C@@H]1O.O,182.17176,L-(+)-Rhamnose Monohydrate,16218576,Preclinical,,,InChI key,1,35
3651,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1808,c1ccc([N+](=O)[O-])c(C2C(C(OC)=O)=C(C)NC(C)=C2C(=O)OC)c1,346.33461,Nifedipine,4485,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3,InChI key,,35
3651,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2354,C1CC2[C@](C)(CCCC2(C)C)[C@@H](CCC(O)(C=C)C)[C@@]1(O)C,308.49863,Sclareol,42648440,Preclinical,,,InChI key,1,35
3651,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1880,C(N1CCCCC1)c2cccc(OCCCNC(=O)COC(=O)C)c2.Cl,384.89755,Roxatidine Acetate HCl,45114193,Launched,histamine receptor antagonist,HRH2,InChI key,,35
3651,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2387,C1[C@@H](OC)[C@]2(C3[C@@H]4[C@]5(O)[C@@](O)([C@@H](OC)[C@@]6([H])[C@@H](OC)C5)[C@]2([H])C6)[C@]([H])(C4)[C@](OC(=O)c7ccccc7NC(C)=O)(CN3CC)C1.Br,665.6123,Lappaconite HBr,129010243,Phase 2,sodium channel blocker,,InChI key,1,35
3651,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2443,c1(S(NC(NCCCC)=O)(=O)=O)ccc(C)cc1,270.34792,Tolbutamide,5505,Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,InChI key,1,35
3651,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2884,O1C(C)=CC(=O)NS1(=O)=O.[K],202.2501,Acesulfame Potassium,22245511,Phase 3,,,InChI key,,35
3651,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2524,N1C([O-])=NC(=O)C1(c2ccccc2)c3ccccc3.[Na+],274.2498,Phenytoin sodium,23679632,,,,,1,35
3651,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,InChI key,1,35
3651,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2577,c1cc(NC(=O)C)ccc1OCC,179.21572,Phenacetin,4754,Withdrawn,cyclooxygenase inhibitor,PTGS1,InChI key,1,35
3651,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2906,c1c(c2onc(C)c2NC(=O)OC(C)c3ccccc3Cl)ccc(CSCCC(=O)OC)c1,488.98369,Ki16198,9913405,Preclinical,lipoprotein antagonist,LPA,InChI key,,35
3651,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2672,c1ccc(CNc2nc(Nc3cc4c(NC(=O)C4)cc3)ncc2C(F)(F)F)c(N(S(=O)(C)=O)C)n1.c5cc(S(=O)(=O)O)ccc5,665.66384,PF-00562271,16118986,,,,,,35
3651,N10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2916,c1cc(C(=O)Nc2cccc(NC(=O)CCC)c2)c(Br)cc1,361.23308,ML161,1048267,Preclinical,protease-activated receptor inhibitor,,InChI key,,35
3651,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2774,c(ncc(c1cnn(C)c1)c2)(C=Cc3c(cc(NS(=O)(=O)N(C)C[C@@H]4COCCO4)cc3)C5=O)c25,495.55079,MK-2461,15981080,Phase 1/Phase 2,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,InChI key,1,35
3651,N12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2928,C(Nc1nccc(c2sc(CC)nc2c3cccc(C)c3)c1)(=O)c4ccccc4,399.50803,TAK-715,9952773,Phase 2,p38 MAPK inhibitor,MAPK14,InChI key,1,35
3651,N13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2817,N1(c2cccc(C(F)(F)F)c2)c(c3C=CC1=O)c4c(ccc(c5ccc(N)nc5)c4)nc3,432.3973,Torin 2,51358113,Preclinical,mTOR inhibitor,MTOR,InChI key,3,35
3651,N14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3036,C1[C@@H](OC(=O)[C@H](CC)C)[C@@]2([H])C(C=C[C@H](C)[C@H]2CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C[C@H]1O.[Na+],446.50956,Pravastatin sodium,129010245,,,,,1,35
3651,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2830,[C@H]1(O)[C@H](SC)O[C@H]([C@@H](NC([C@@H]2C[C@@H](CCC)CN2C)=O)C(Cl)C)[C@H](O)[C@@H]1O,424.98301,Clindamycin,2786,Launched,protein synthesis inhibitor,,InChI key,2,35
3651,N16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3048,[C@H]1(c2ccccc2)c(c3CCN1C(O[C@]4([H])C(CCN5C4)CC5)=O)cccc3.C(O)(=O)CCC(O)=O,480.55277,Solifenacin succinate,46782934,,,,,2,35
3651,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2852,[nH]1c(c2c(C3CCN(C)CC3)c1)ccc(O)c2,230.30552,BRL-54443,2438,Preclinical,serotonin receptor agonist,HTR1E|HTR1F,InChI key,2,35
3651,N18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3064,[C@@H]1(O)CC[C@@H](NCc2cc(Br)cc(Br)c2N)CC1.Cl,414.56375,Ambroxol HCl,46864195,Launched,sodium channel blocker,CYP3A4,InChI key,,35
3651,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2861,c1(C#Cc2c(C)n(c3ccc(OC(F)(F)F)cc3)c(C)n2)cc(Cl)ncc1,391.77422,CTEP (RO4956371),11646823,Preclinical,glutamate receptor antagonist,GRM5,InChI key,,35
3651,N20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3079,C1(=C(O)C(=O)c2c(cccc2)C1=O)[C@H]3CC[C@H](c4ccc(Cl)cc4)CC3,366.83745,Atovaquone,74989,Launched,mitochondrial electron transport inhibitor,DHODH,chemical name,,35
3651,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2870,c1(O)cccc(c2cnc(c3n2)nc(N)nc3N)c1,254.2474,TG100713,17751063,Preclinical,PI3K inhibitor,,InChI key,,35
3651,N22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3113,c1nc(C)c(O)c(CO)c1CO.Cl,205.63877,Pyridoxine HCl,21881650,Launched,vitamin B,DDC|PDXK,InChI key,1,35
3651,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1195,c1cc2c(ccc(C3(O)CCn4c3cnc4)c2)cc1C(=O)NC,307.34648,TAK-700 (Orteronel),9883029,,,,,,35
3651,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1933,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](O)[C@@]4(O)C(=O)CO)=CC1=O,394.43388,Triamcinolone,129010247,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,InChI key,,35
3651,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1256,c1c(F)c(Cn2cc(C(N)=O)nn2)c(F)cc1,238.19352,Rufinamide,129228,Launched,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,35
3651,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1994,c1c(C2C(C(=O)OCC)=C(C)NC(C)=C2C(=O)OCC)c(C=CC(OC(C)(C)C)=O)ccc1,455.54331,Lacidipine,68733,,,,,1,35
3651,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1334,c1(F)ccc(CNc2ccc(NC(OCC)=O)c(N)n2)cc1.OC(=O)C=CC(=O)O,420.39164,Flupirtine maleate,53275,,,,,,35
3651,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2051,C(O)(=O)[C@H]1CCCN1C(=O)[C@H](C)CS,217.2853,Captopril,2550,Launched,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9,InChI key,,35
3651,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1385,c1(Cl)cc(C(=O)NCC2CN(Cc3ccc(F)cc3)CCO2)c(OCC)cc1N.OC(=O)CC(O)(C(O)=O)CC(=O)O,614.01642,Mosapride Citrate,119583,,,,,,35
3651,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2092,c1(Cc2c[nH]cn2)c(C)c(C)ccc1.Cl,222.7139,Detomidine HCl,129010248,Launched,adrenergic receptor agonist,ADRA2A,InChI key,,35
3651,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1534,c1(Cl)cc2c([nH]c(C(NCCc3ccc(N4CCCCC4)cc3)=O)c2CC)cc1,409.95161,Org 27569,44828492,Preclinical,cannabinoid receptor modulator,CNR1,InChI key,,35
3651,O12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2124,OC[C@@H](O)[C@H](O)[C@@H](O)C=O,150.1299,Xylose,854,Launched,,,InChI key,,35
3651,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1630,N(C(=O)C(=C1)C(NN1)=N2)=C2,136.11146,Allopurinol,2094,Launched,xanthine oxidase inhibitor,XDH,InChI key,,35
3651,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2199,C(=O)(O)C=CC(=O)O.c1(OC)ccc(C[C@H](C(C)C)C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)cc1OCCCOC.c2(OC)ccc(C[C@H](C(C)C)C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)cc2OCCCOC,1219.5888,Aliskiren Hemifumarate,53394959,,,,,,35
3651,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1683,[Br-].C1(CC(OC(=O)C(CO)c2ccccc2)C3)[N+](C(C)C)(C)C3CC1,412.36109,Ipratropium Bromide,31098,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,InChI key,,35
3651,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2286,N1(C)[C@H](CC(C)C)C(=O)N(C)[C@H](C(C)C)C(=O)N(C)[C@H]([C@@H]([C@H](C)CC=CC)O)C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C1=O,1202.61124,Cyclosporin A,2909,,,,,,35
3651,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1761,c1(C(=O)c2cccs2)ccc(C(C)C(=O)O)cc1,260.30827,Suprofen,5359,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,35
3651,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2321,c1c(CC=C)cc(c2c(O)ccc(CC=C)c2)c(O)c1,266.33432,Magnolol,72300,Preclinical,PPAR receptor agonist,GABRA1|PPARG,InChI key,,35
3651,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1823,[Ca+2].O(c1ccccc1)c2cc(C(C(=O)[O-])C)ccc2.O(c3ccccc3)c4cc(C(C(=O)[O-])C)ccc4,522.60183,Fenoprofen Calcium,64746,,,,,,35
3651,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2358,c1(OC)c(O)ccc(C2C(CO)Oc3c(ccc(C4Oc5c(c(O)cc(O)c5)C(=O)C4O)c3)O2)c1,482.43617,Silymarin,3085830,Launched,,,InChI key,,35
3651,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1885,C(C(=O)OCC)(C(c1c(Cl)c(Cl)ccc1)C(C(=O)OC)=C(C)N2)=C2C,384.25375,Felodipine,3333,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2,InChI key,1,35
3651,O22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2389,c1(O[C@H]2[C@@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@@H](CO)O2)cc(O)c(C(=O)CCc4ccc(O)cc4)c(O)c1,582.55045,Naringin Dihydrochalcone,129010249,Preclinical,cytochrome P450 inhibitor,,InChI key,1,35
3651,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,P03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2449,C1[C@@H](O)[C@@]2(C)[C@@]([H])([C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@@]2(O)C(=O)C[C@](C)(C=C)O3)C(C)(C)C1,410.50115,Forskolin,129010250,Launched,adenylyl cyclase activator,ADCY2|ADCY5|GNAS,InChI key,,35
3651,P04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2885,c(sc(C(N)=O)c1)(cncc2Sc3ccc(C)cc3)c12,300.39857,A-205804,9839311,Preclinical,ICAM1 expression inhibitor,ICAM1|SELE,InChI key,2,35
3651,P05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2526,c1cc2c(C(=O)c3c(c(O)c(O)cc3)C2=O)cc1,240.21092,Alizarin,6293,Preclinical,,,InChI key,3,35
3651,P06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2899,c1cc(C(N)=O)cc(c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,374.31662,GNF-2,5311510,Preclinical,Bcr-Abl kinase inhibitor,ABL1|BCR,InChI key,1,35
3651,P07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2581,c1cc(CC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N2Cc3c(cccc3)C[C@H]2C(=O)O)ccc1.Cl,474.97703,Quinapril HCl,73759669,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,1,35
3651,P08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2907,N1(C=C(C)C=CC1=O)c2ccccc2,185.22184,Pirfenidone,40632,Launched,TGF beta receptor inhibitor,FURIN|TNF,InChI key,,35
3651,P09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2679,c1c(O)c2c(OC(c3ccccc3Cl)=CC2=O)c([C@@]4([H])CCN(C)C[C@H]4O)c1O.Cl,438.30113,Flavopiridol HCl,129010251,Phase 2,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,InChI key,1,35
3651,P10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2918,c1(c2ncn1CC(=O)Nc3ccc(C(C)C)cc3)C(=O)N(C)C(=O)N2C,355.39104,HC-030031,1150897,Phase 1,TRPA1 channel blocker,TRPA1,InChI key,1,35
3651,P11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2782,c1c(C(O)=O)cc(C=Cc2ccc(OCc3c(C(C)C)onc3c4c(Cl)cccc4Cl)cc2Cl)cc1,542.83757,GW4064,44483281,,,,,1,35
3651,P12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2929,C1CC2=C(SC(=N)N2CC(=O)c3ccc(C)cc3)CC1.Br,367.30386,Pifithrin-? (PFT?),44390074,Preclinical,TP53 inhibitor,TP53,InChI key,1,35
3651,P13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2818,c1(NC(=O)C)ccc(C(Nc2ccccc2N)=O)cc1,269.29849,CI994 (Tacedinaline),2746,Phase 3,HDAC inhibitor,HDAC1,InChI key,,35
3651,P14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3037,N1(CCCC(O)=O)CCC(O[C@@H](c2ccc(Cl)cc2)c3ncccc3)CC1.c4cccc(S(=O)(=O)O)c4,547.06283,Bepotastine Besilate,53394973,,,,,1,35
3651,P15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2832,C1C[C@@]2(C)[C@@]([H])(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CCC4=O)C[C@H]1O,290.4403,Epiandrosterone,129010252,Preclinical,steroid,G6PD,InChI key,,35
3651,P16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3051,c1(S(Nc2c(Oc3ccccc3OC)c(OCCO)nc(c4ncccn4)n2)(=O)=O)ccc(C(C)(C)C)cc1.O,569.62933,Bosentan Hydrate,185462,Launched,endothelin receptor antagonist,EDNRA|EDNRB,InChI key,1,35
3651,P17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2854,C(=O)(N1CCOCC1)Cc2c(c3n(C(=O)c4ccc(Cl)cc4)c2C)cc(OC)cc3,426.89271,BML-190,2415,Preclinical,cannabinoid receptor inverse agonist,CNR2,InChI key,,35
3651,P18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3066,c(c1c(O)cc2)(c2C3)[C@@](CCN4CC=C)([C@@]5([H])O1)[C@@](O)(CCC5=O)[C@@H]34.Cl,363.83527,Naloxone HCl,129010253,Launched,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,InChI key,1,35
3651,P19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2862,c1(C(Nc2cccc(Cl)c2)=O)ncccc1,232.66566,VU 0364770,836002,Preclinical,glutamate receptor positive allosteric modulator,GRM4,InChI key,1,35
3651,P20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3080,c1(Oc2c(C)cc(C#N)cc2C)c(Br)c(N)nc(Nc3ccc(C#N)cc3)n1,435.27669,Etravirine (TMC125),193962,Launched,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,InChI key,1,35
3651,P21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2871,C(Nc1ccncc1)(=O)c2cc([N+]([O-])=O)ccc2Cl,277.66321,T0070907,2777391,Preclinical,PPAR receptor antagonist,PPARG,InChI key,,35
3651,P22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3114,OC1=C(O)C(=O)O[C@@H]1[C@H](CO)O,176.12412,Vitamin C,54676860,,,,,,35
3651,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3651,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3116,c1(S(Nc2nccs2)(=O)=O)ccc(N)cc1,255.31665,Sulfathiazole,5340,Launched,dihydropteroate synthase inhibitor,,InChI key,2,34
3652,A04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4045,c1cc(C(c2ccccn2)CCN(C)C)ccc1.C(=O)(O)C=CC(=O)O,356.41556,Pheniramine Maleate,443885,,,,,,34
3652,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3139,C1N(CN(CN2C3)CN13)C2,140.18627,Methenamine,4101,Launched,bacterial DNA inhibitor,,InChI key,1,34
3652,A06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4054,C1C[C@@]2(C)C(C[C@@H](SC(=O)C)[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]45CCC(=O)O5)=CC1=O,416.57347,Spironolactone,129010254,Launched,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,InChI key,3,34
3652,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3154,c1(CN(Cc2ccc(C(C)(C)C)cc2)C)c(c3ccc1)cccc3.Cl,353.92812,Butenafine HCl,123132522,Launched,fungal squalene epoxidase inhibitor,SQLE,InChI key,1,34
3652,A08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4068,c1c([N+]([O-])=O)n(CCS(=O)(=O)CC)c(C)n1,247.27152,Tinidazole,5479,Launched,antiprotozoal agent,,InChI key,,34
3652,A09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3172,c1cc2c(CN3C(=NC(=O)C3)N2)c(Cl)c1Cl.Cl,292.54902,Anagrelide HCl,45114173,Launched,phosphodiesterase inhibitor,PDE3A,InChI key,,34
3652,A10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,InChI key,,34
3652,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3186,c(C(=C1CCN(C)CC1)c2c(cccc2)CC3)(nccc4)c34.C(O)(=O)C=CC(O)=O.C(O)(=O)C=CC(O)=O,522.54639,Azatadine dimaleate,66273,,,,,1,34
3652,A12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,InChI key,1,34
3652,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3202,c1cc2c([nH]c3c2CCN(C[C@@]45[H])[C@]([H])(C(CC)=C4)[C@]3(C(OC)=O)C5)cc1,336.42746,Catharanthine,5458190,Preclinical,tubulin polymerization inhibitor,,InChI key,,34
3652,A14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,,34
3652,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4003,[C@]1([H])(CC[C@H]2[C@H](C)CCC(=O)O)[C@]2(C)CC[C@@]3([H])[C@@]1([H])CC[C@@]4([H])[C@]3(C)CC[C@@H](O)C4,376.57259,Lithocholic acid,129010257,Preclinical,FXR antagonist|vitamin D receptor agonist,GPBAR1|NR1H4|NR1I2|VDR,InChI key,,34
3652,A16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4107,N1(c2ccc(Cl)cc2)c3c(cccc3)N=C4C1=CC(=NC(C)C)C(Nc5ccc(Cl)cc5)=C4,473.39637,Clofazimine,2794,,,,,3,34
3652,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4014,C1(OC(=O)[C@H](CO)c2ccccc2)CC3N(C)C(CC3)C1,289.36941,Hyoscyamine,3661,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,InChI key,,34
3652,A18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,InChI key,,34
3652,A19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4023,c1(ccc(N)cc1)C(=O)OCCN(CC)CC.Cl,272.77104,Procaine HCl,45114093,Launched,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,InChI key,,34
3652,A20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4132,c1cc(OC2OCCCC2)ccc1O,194.22706,Deoxyarbutin,11745519,Preclinical,tyrosinase inhibitor,,InChI key,,34
3652,A21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4037,C1(=O)N(CC)CC(CCN2CCOCC2)C1(c3ccccc3)c4ccccc4.Cl.O,432.98342,Doxapram HCl,129010258,Launched,potassium channel blocker,KCNK3|KCNK9,InChI key,,34
3652,A22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4146,C([C@@H](N)C1=NCC(C(=O)N[C@@H](CC(C)C)C(N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](CC)C)C(N[C@@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)=O)=O)S1)(C)C,1408.66674,Bacitracin,78161633,Launched,bacterial cell wall synthesis inhibitor,A2M|IDE,InChI key,,34
3652,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4161,c1cc(C(=O)O)ccc1,122.12133,Benzoic Acid,243,Launched,food preservative,DAO|HRSP12|PRDX5|RAB9A,InChI key,1,34
3652,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4257,c([nH]nn1)(cc(OC)c(C(=O)NCC2CCCN2CC=C)c3)c13.Cl,351.83118,Alizapride HCl,51371396,Launched,dopamine receptor antagonist,DRD2,InChI key,1,34
3652,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4170,O1c(c2C=CC1=O)cccc2,146.14274,Coumarin,323,Launched,vitamin K antagonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6,InChI key,,34
3652,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4266,c1cnc2c(c(Br)c(NC(NCC3)=N3)cc2)n1.[C@H](C(=O)O)(O)[C@@H](O)C(=O)O,442.22144,Brimonidine Tartrate,11236066,,,,,,34
3652,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4179,N1(S(C)(=O)=O)CCN(C(N[C@@H](c2ccccc2)C(N[C@H]3C(=O)N4[C@@]3([H])SC(C)(C)[C@@H]4C(=O)[O-])=O)=O)C1=O.[Na+],561.56373,Mezlocillin Sodium,129010259,,,,,,34
3652,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4278,c1cc2c(CCC(=O)N2)c(OCC(O)CNC(C)(C)C)c1.Cl,328.8343,Carteolol HCl,18462442,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,InChI key,1,34
3652,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4189,C1C(OC(C(O)c2ccccc2)=O)CC(C)(C)CC1C,276.37066,Cyclandelate,2893,Launched,calcium channel blocker,CACNA2D1|CES1,InChI key,1,34
3652,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4290,[C@H]1(O)C[C@]([H])(O[C@@H]2[C@H](C)O[C@@]([H])(O[C@H]3CC[C@@]4(C)[C@]([H])(CC[C@]5([H])[C@@]4([H])C[C@@H](O)[C@@]6(C)[C@]5(O)CC[C@H]6C7=CC(=O)OC7)C3)C[C@@H]2O)O[C@H](C)[C@H]1O[C@@]8([H])C[C@H](O)[C@H](O)[C@@H](C)O8,780.93845,Digoxin,129010261,,,,,3,34
3652,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4198,c1nc(N)sc1,100.14225,Aminothiazole,2155,Preclinical,cyclin D inhibitor,NOS2,InChI key,,34
3652,B12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4420,Cl.c1c(C(F)(F)F)c2c(c([C@@H]([C@@]3([H])CCCCN3)O)cc(C(F)(F)F)n2)cc1,414.77309,Mefloquine HCl,129010262,,,,,,34
3652,B13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4207,c1cc(OC(C)(C)C(O)=O)ccc1Cl,214.64554,Clofibric Acid,2797,Launched,PPAR receptor agonist,PPARA,InChI key,1,34
3652,B14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4921,c(OCO1)(cc(C=C[N+]([O-])=O)cc2)c12,193.15618,"MNS (3,4-Methylenedioxy-?-nitrostyrene, MDBN)",94945,,,,,3,34
3652,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4217,c1(c(I)cc(C[C@H](N)C([O-])=O)cc1I)Oc2ccc(O)c(I)c2.[Na+],672.95531,Liothyronine Sodium,16760684,,,,,,34
3652,B16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,2,34
3652,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4227,[C@@H]1(CC)[C@H](O[C@@]2([H])[C@H](O)[C@@H](O)[C@H](OC(=O)C(C)C)C(C)(C)O2)C(C)=CC(C)=CC[C@]([H])([C@H](O)C)OC(=O)C(CO[C@@H]3O[C@H](C)[C@@H](OC(c4c(O)c(Cl)c(O)c(Cl)c4CC)=O)[C@H](O)[C@@H]3OC)=CC=CC[C@H](O)C(C)=C1,1058.03916,Fidaxomicin,129010263,Launched,RNA polymerase inhibitor,,chemical name,3,34
3652,B18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7036,c1c(NC(=O)[C@H]2NCCC2)ccc(c3nc(Nc4ccc(N5CCOCC5)cc4)ncc3)c1,444.52881,XL019,57990770,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,InChI key,,34
3652,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4237,c1(OC)cc2c(nccc2)c(NC(C)CCCN)c1.OP(O)(=O)O.OP(O)(=O)O,455.3371,Primaquine Diphosphate,6135,,,,,,34
3652,B20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7051,C(Nc1ccc(C(N2CCOCC2)=O)cc1)(C(=O)N(C)C=C3c4c(C)c(NC(=O)c5ccc(C(C)(C)C)cc5)ccc4)=N3,579.68868,CGI1746,24857323,,,,,1,34
3652,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4247,C(O)(=O)CCC(O)=O.O1c2c(c(N)c(Cl)cc2C(NC3CCN(CCCOC)CC3)=O)CC1,485.95837,Prucalopride Succinat,9870009,,,,,,34
3652,B22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7076,c1cc(S(=O)(N(CC(F)(F)F)c2ccc(C(C(F)(F)F)(O)C(F)(F)F)cc2)=O)ccc1,481.3327,T0901317,447912,Preclinical,LXR agonist,NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB,InChI key,1,34
3652,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3121,c1nc(C)n(CC(O)CCl)c1[N+]([O-])=O,219.6256,Ornidazole,28061,Launched,antiprotozoal agent,,InChI key,1,34
3652,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4046,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4OC(CCC5CCCC5)=O)cc1O,396.56223,Estradiol Cypionate,129010264,,,,,,34
3652,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3140,[C@H]1(CN)C[C@@]1(c2ccccc2)C(=O)N(CC)CC.Cl,282.80892,Milnacipran HCl,71296892,Launched,serotonin norepinephrine reuptake inhibitor (SNRI),GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A4,InChI key,1,34
3652,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4056,[C@@]1([H])(C[C@H](SCC(=O)O[C@H]2[C@@]3(C)[C@@]4([H])[C@](CCC4=O)(CC[C@@H]3C)[C@@H](C)[C@H](O)[C@](C=C)(C)C2)C5)N(C)[C@]5([H])CC1,517.76347,Retapamulin,129010265,Launched,protein synthesis inhibitor,,InChI key,3,34
3652,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3155,N1(C)CCCCC1C(Nc2c(C)cccc2C)=O.Cl,282.80892,Mepivacaine HCl,45114128,Launched,potassium channel blocker|sodium channel blocker,SCN10A,InChI key,,34
3652,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4070,NC(=N)N.Cl,95.53144,Guanidine HCl,21864146,Launched,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,InChI key,,34
3652,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3173,N1(C)C(C)=CC(=O)N1c2ccccc2,188.22578,Antipyrine,2206,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,34
3652,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4079,n1([C@@H]2C[C@H](OCCO)[C@H](O)[C@H]2O)nnc3c1nc(SCCC)nc3N[C@@H]4C[C@@H]4c5ccc(F)c(F)c5,522.56802,Ticagrelor,22052291,Launched,purinergic receptor antagonist,P2RY12,InChI key,,34
3652,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3188,c1cc(C(O)CN)ccc1O.Cl,189.63938,"(+,-)-Octopamine HCl",46864201,Preclinical,trace amine associated receptor agonist,F10|TAAR1,InChI key,,34
3652,C12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4089,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@H](C)[C@@]4(OC(CC)=O)C(=O)CCl)=CC1=O,484.96044,Halobetasol Propionate,129010266,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,InChI key,1,34
3652,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3204,c1(O)cccc(C2(CC)CCCCN(C)C2)c1.Cl,269.81016,Meptazinol HCl,51371442,Launched,opioid receptor agonist,BCHE,InChI key,,34
3652,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4099,c1(OCC(F)(F)F)c(C)c(C[S@@](=O)c2[nH]c3c(cccc3)n2)ncc1,369.36146,Dexlansoprazole,9578005,Launched,ATPase inhibitor,ATP4A|ATP4B,InChI key,,34
3652,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4004,[C@@H](CO)(CC)NCCN[C@H](CO)CC.Cl.Cl,277.23164,Ethambutol HCl,75094265,Launched,bacterial cell wall synthesis inhibitor,,InChI key,,34
3652,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4109,C1Cc2c(cc(Cl)cc2)[C@@H](C)CN1.Cl,232.1495,Lorcaserin HCl,129010267,Launched,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,InChI key,,34
3652,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4015,C1(CCCCC1)NS(=O)(=O)O,179.23732,Cyclamic  acid,7533,Preclinical,,,InChI key,,34
3652,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4120,c1n(CC(SCc2ccc(Cl)cc2)c3ccc(Cl)cc3Cl)ccn1.[N+]([O-])(=O)O,460.76193,Sulconazole Nitrate,65495,Launched,sterol demethylase inhibitor,,InChI key,,34
3652,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4024,[Br-].[C@@]1([H])(C[C@@H](OC(=O)C(O)c2ccccc2)C3)[N+](C)(C)[C@]3([H])CC1,370.28136,Homatropine Methylbromide,10429215,,,,,,34
3652,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4135,c1cc(Cl)c(C(O)CNC(C)C)cc1.Cl,250.16478,Clorprenaline HCl,129010268,Launched,adrenergic receptor agonist,ADRB1|ADRB2,InChI key,,34
3652,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4038,c1(cccc2)c2nc(OCCCC)cc1C(=O)NCCN(CC)CC.Cl,379.9241,Dibucaine HCl,18539389,Launched,sodium channel blocker,CALM1|SCN10A|SCN5A,InChI key,3,34
3652,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4148,c1ccc([C@@H](N)C(=O)N[C@H]2[C@@]3([H])N([C@@H](C(=O)O)C(C)(C)S3)C2=O)cc1.O.O.O,403.45059,Ampicillin Trihydrate,70580489,Launched,bacterial cell wall synthesis inhibitor,,InChI key,,34
3652,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4162,c1cc(OCCOCC[N+](C)(C)Cc2ccccc2)ccc1C(C)(C)CC(C)(C)C.[Cl-],448.08087,Benzethonium Chloride,8478,Launched,sodium channel blocker,SCN10A,InChI key,4,34
3652,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4258,c1(ccc(Cl)cc1Cl)[C@@H]2CSC(=C(C#N)n3cncc3)S2,354.27736,Luliconazole,53394969,Launched,sterol demethylase inhibitor,,chemical name,2,34
3652,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4171,C(CO)[N+](C)(C)C.[Cl-],139.62376,Choline Chloride,6209,,,,,1,34
3652,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4267,c(C(=O)c1c(cccc1OC(C)=O)C2=O)(c(OC(=O)C)cc(C(=O)O)c3)c23,368.29377,Diacerein,26248,Launched,interleukin inhibitor,IL1B,InChI key,4,34
3652,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4181,C(C(=O)OC)(C(c1cccc([N+]([O-])=O)c1)C(C(=O)OCCN(C)Cc2ccccc2)=C(C)N3)=C3C.Cl,515.98589,Nicardipine HCl,22987918,Launched,calcium channel blocker,ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1C|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B,InChI key,3,34
3652,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4279,c1c(Cl)c2c(C(=O)C(=C3O)[C@]([H])(C[C@]4([H])[C@@]3(O)C(=O)C(C(=O)N)=C(O)[C@@H]4N(C)C)[C@H]2O)c(O)c1.Cl,501.31397,Demeclocycline HCl,129010269,,,,,2,34
3652,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4190,n1c(c2c(C(O)=O)cc1c3ccccc3)cccc2,249.26404,Cinchophen,8593,Launched,analgesic agent,,InChI key,,34
3652,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4291,c1(C(=O)N)cc(C(O)CNC(C)CCc2ccccc2)ccc1O.Cl,364.8664,Labetalol HCl,45114126,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2,InChI key,,34
3652,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4199,c1ccc(CN(c2ccccc2)CC3=NCCN3)cc1.Cl,301.8138,Antazoline HCl,49951956,Launched,antihistamine,HRH1,InChI key,,33
3652,D12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4627,c(C(C)(C)CCC1(C)C)(cc(C(C)=Cc2ccc(C(=O)O)cc2)cc3)c13,348.47791,TTNPB (Arotinoid Acid),5602,,,,,,33
3652,D13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4208,c1cc2c(OC(C(=O)O)=CC2=O)cc1,190.15224,Chromocarb,2741,Launched,antispasmodic,,InChI key,1,33
3652,D14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4926,c1(F)cc2c(CC[C@@H](N3C(=S)NC=C3CN)C2)c(F)c1.Cl,331.81174,(R)-Nepicastat HCl,129010270,,,,,1,34
3652,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4219,N1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ncccc3,327.39588,Azaperone,15443,Launched,dopamine receptor antagonist,DRD2|DRD3,InChI key,1,34
3652,D16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7018,c1(S(NC(C)(C)C)(=O)=O)cc(c2cn(c3c(F)c2)nc(N)n3)cnc1,364.39788,CZC24832,42623951,Preclinical,PI3K inhibitor,PIK3CG,InChI key,,34
3652,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4228,[C@](F)([C@]1(C)C(=CC(=O)C=C1)[C@@]([H])(C)C2)([C@](O)([H])C[C@@]3(C)[C@@]4([H])CC[C@@]3(C(=O)C)OC(=O)C)[C@@]24[H],418.49834,Fluorometholone Acetate,129010271,Launched,,NR3C1,InChI key,,34
3652,D18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7037,n1ccc(c2ccc(CC(=O)Nc3ccc(c4cnccc4)cc3)cc2)cc1C,379.45374,Wnt-C59 (C59),57519544,Preclinical,porcupine inhibitor,PORCN,InChI key,2,34
3652,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4238,c1(OC)cc2c([C@@]3([H])N(C)CC2)cc1Oc(c(c45)[C@]([H])(N(C)CC4)Cc(ccc6Oc7cc(ccc7OC)C3)cc6)c8c(OCO8)c5,606.70741,Cepharanthine,12300002,Phase 2,NFkB pathway inhibitor,,InChI key,1,34
3652,D20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7059,c1(OC(F)(F)O2)c2cc(C3(CC3)C(Nc4cc5c(n(C[C@@H](O)CO)c(C(C)(C)CO)c5)cc4F)=O)cc1,520.49758,VX-661,46199801,Phase 3,CFTR channel agonist,CFTR,InChI key,,34
3652,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4248,[Na+].C([O-])(=O)Cc1cccc(C(=O)c2ccc(Br)cc2)c1N,356.1465,Bromfenac Sodium,23693301,,,,,,34
3652,D22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7077,N1(C)[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc2ccccc2)C1=O,588.65589,Cilengitide,21947593,Phase 3,integrin antagonist,ITGAV|ITGB3,InChI key,,34
3652,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3129,c1(N)ncc(Cc2cc(OC)c(OC)c(OC)c2)c(N)n1,290.31772,Trimethoprim,5578,Launched,dihydrofolate reductase inhibitor,DHFR|TYMS,InChI key,1,34
3652,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4047,c1(C(c2ccc(OC(C)=O)cc2)c3ncccc3)ccc(OC(C)=O)cc1,361.39055,Bisacodyl,2391,Launched,laxative,,InChI key,,34
3652,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3144,c1(CCN2C[C@H](C(c3ccccc3)(c4ccccc4)C(N)=O)CC2)cc5c(OCC5)cc1.Br,507.46194,Darifenacin HBr,51371305,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,InChI key,2,34
3652,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4057,c1(S(N)(=O)=O)cc2c(NC(CCl)N(C)S2(=O)=O)cc1Cl,360.23733,Methyclothiazide,4121,Launched,chloride reabsorption inhibitor,CA1|CA2|CA4|SLC12A1|SLC12A3,InChI key,,34
3652,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3160,C1C[C@@]2([H])C(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4(OC(C)=O)C#C)=C[C@H]1OC(C)=O,384.50848,Ethynodiol diacetate,129010272,Launched,,ESR1|PGR,InChI key,,34
3652,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4071,c1c(OC)c2c(O[C@]3(C(OC)=CC(=O)C[C@H]3C)C2=O)c(Cl)c1OC,352.76627,Griseofulvin,129010273,Launched,tubulin polymerization inhibitor,KRT12,InChI key,,34
3652,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3176,c1(CCNC)ncccc1.Cl.Cl,209.11615,Betahistine 2HCl,45114105,Launched,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,InChI key,1,34
3652,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4080,c1(N)nc(N)c2c(nc(N)c(c3ccccc3)n2)n1,253.26264,Triamterene,5546,Launched,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,InChI key,1,34
3652,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3190,OC[C@H]1O[C@@H](n2c(c3nc2)ncnc3NC)[C@H](O)[C@@H]1O,281.26789,N6-methyladenosine (m6A),1869,Preclinical,,,InChI key,,33
3652,E12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4090,c1c(CCN2CCC3(OC(=O)NC3)CC2)cccc1.Cl,296.79244,Fenspiride HCl,45114090,Launched,bronchodilator,,InChI key,,33
3652,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3208,C1(C(O)(c2ccccc2)c3ccccc3)CCN(CCCC(O)c4ccc(C(C)(C)C(=O)O)cc4)CC1.Cl,538.11729,Fexofenadine HCl,45114130,Launched,histamine receptor antagonist,HRH1,InChI key,,33
3652,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4100,c1cc(OCC(O)CNC(C)C)ccc1CCC(=O)OC.Cl,331.83494,Esmolol HCl,45114219,Launched,adrenergic receptor antagonist,ADRB1,InChI key,,34
3652,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4005,Cl.c1cc2c(C(=O)C(=C3O)[C@]([H])([C@@H](O)[C@]4([H])[C@@]3(O)C(=O)C(C(=O)N)=C(O)[C@@H]4N(C)C)[C@@H]2C)c(O)c1,480.89549,Doxycycline HCl,129010274,,,,,4,34
3652,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4110,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4O)cc1OC(=O)c5ccccc5,376.48802,Estradiol Benzoate,129010276,,,,,,34
3652,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4016,[C@@]1(CO)([C@@H](O)C[C@@H](O[C@@H]2O[C@H](C)[C@H](O)[C@@H](O)[C@@H]2O)C3)[C@]3(O)CC[C@]4([H])[C@@]1([C@H](O)C[C@@]5(C)[C@]4(O)CC[C@H]5C6=CC(=O)OC6)[H].O.O.O.O.O.O.O.O,728.7747,Ouabain,129010277,Launched,ATPase inhibitor,ATP1A1,InChI key,1,33
3652,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4122,[C@@H]1(O[C@@H]2O[C@@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O)CC(=O)O[C@H](CC)[C@H](CO[C@@H]3O[C@@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)C=C(C)C=CC(=O)[C@H](C)C[C@@H]1CCN4C[C@H](C)C[C@@H](C)C4,869.133,Tilmicosin,53394823,Launched,bacterial 50S ribosomal subunit inhibitor,,chemical name,1,34
3652,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4025,[C@@H]1(OC(=O)C(O)c2ccccc2)C[C@]3([H])N(C)[C@]([H])(CC3)C1.Br,356.25478,Homatropine Bromide,129010279,Launched,acetylcholine receptor antagonist,,InChI key,1,34
3652,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4136,OC(=O)C(C)c1cc2c(c3c(ccc(Cl)c3)[nH]2)cc1,273.71427,Carprofen,2581,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,1,34
3652,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4039,C1(=NC(=O)C)N(C)N=C(S(=O)(=O)N)S1,236.27201,Methazolamide,4100,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,InChI key,,34
3652,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4149,c1(cccc(CC([O-])=O)c1N)C(=O)c2ccccc2.O.[Na+],295.26573,Amfenac Sodium Monohydrate,23663941,,,,,,34
3652,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4163,c1c(O)c2c([C@H](C)[C@]3([H])C(=C(O)[C@@]4(O)[C@]([H])([C@H](N(C)C)C(O)=C(C(N)=O)C4=O)[C@H]3O)C2=O)cc1.c5c(O)c6c([C@H](C)[C@]7([H])C(=C(O)[C@@]8(O)[C@]([H])([C@H](N(C)C)C(O)=C(C(N)=O)C8=O)[C@H]7O)C6=O)cc5.Cl.O.CCO.Cl,1025.87472,Doxycycline Hyclate,129010280,,,,,4,34
3652,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4259,c(cc(C#N)cc1)(c(CCCCN2CCN(c3ccc4c(cc(C(=O)N)o4)c3)CC2)c[nH]5)c15.Cl,477.98582,Vilazodone HCl,129010281,Launched,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,InChI key,2,34
3652,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4172,[n+]1(CCCCCCCCCCCCCCCC)ccccc1.[Cl-],339.98612,Cetylpyridinium Chloride,31239,Launched,,,InChI key,4,34
3652,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4268,C(O)(=O)c1ccccc1Nc2cccc(C(F)(F)F)c2,281.2299,Flufenamic acid,3371,Preclinical,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,InChI key,1,34
3652,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4182,c1cc(C=NNC(=O)c2ccc(O)cc2)oc1[N+](=O)[O-],275.21695,Nifuroxazide,13764,,,,,2,34
3652,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4280,c1cc(OCC(=O)OCCN(C)C)ccc1Cl.Cl,294.17428,Meclofenoxate (Centrophenoxine) HCl,46864204,Launched,nootropic agent,,InChI key,1,34
3652,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4191,c1ccccc1C(=O)NCCC(=O)O,193.19924,Betamipron,71651,Launched,panipenem uptake inhibitor,,InChI key,,34
3652,F10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4292,c1cc(C(O)(c2ccccc2)CCCN3CCCCC3)ccc1.Cl,345.90612,Diphenidol HCl,51371355,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,InChI key,,34
3652,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4200,c1cc(C(=O)C(C)CN2CCCCC2)ccc1C.Cl,281.82086,Tolperisone HCl,46864202,Launched,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,InChI key,,33
3652,F12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4900,CC(c1ccc(C(NC(Nc2ccc(NC(CCCCN(C)C)=O)cc2)=S)=O)cc1)(C)C,454.62805,Tenovin-6,24772043,Preclinical,SIRT inhibitor,SIRT1|SIRT2|SIRT3,InChI key,2,33
3652,F13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4209,c1(C)cc(O)ccc1Cl,142.58287,Chlorocresol,1732,Launched,ryanodine receptor activator,,InChI key,,33
3652,F14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S5001,n1c(N([C@@H]2[C@@H](C)CCN(C(CC#N)=O)C2)C)c3c([nH]cc3)nc1.C(C(=O)O)C(O)(CC(O)=O)C(=O)O,504.49312,Tofacitinib (CP-690550) Citrate,22280329,,,,,1,34
3652,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4220,n1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c(Oc3c(OC)cccc3)c(OCCO)nc1c4ncccn4,551.61405,Bosentan,104865,Launched,endothelin receptor antagonist,EDNRA|EDNRB,InChI key,1,34
3652,F16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7023,C(C)(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C(N[C@H](C(CF)=O)CC(=O)OC)=O,467.4879,Z-VAD-FMK,5737,,,,,2,34
3652,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4229,c1(C(=O)OCCN(CC)CC)ccc(N)c(OCCCC)c1.Cl,344.87676,Oxybuprocaine HCl,51371368,Launched,local anesthetic,SCN10A,InChI key,,34
3652,F18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7039,c1cc2c(c(Nc3cc(Br)ccc3)ncn2)cc1NC(=O)C=C,369.21532,PD168393,4708,Preclinical,EGFR inhibitor,EGFR|ERBB2|SRC,InChI key,1,34
3652,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4239,C1=Cc2c(cc3c(cco3)c2OC)OC1=O,216.18952,Bergapten,2355,Preclinical,,,InChI key,,34
3652,F20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7060,n1c(N)c2c(n(C(C)(C)C)nc2c3ccc(C)cc3)nc1,281.35555,PP1,1400,Preclinical,src inhibitor,HCK|RET,InChI key,3,34
3652,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4249,c1(C(=O)CC)c(O)cc(O)cc1O,182.1733,Flopropione,3362,Launched,serotonin receptor antagonist,HTR1A,InChI key,,34
3652,F22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7079,c1(C(C)(C)C)ccc(NC(NCCCN(C[C@H]2O[C@@H](n3cc(Br)c4c3ncnc4N)[C@H](O)[C@@H]2O)C(C)C)=O)cc1,618.5657,SGC 0946,76450047,Preclinical,histone lysine methyltransferase inhibitor,,InChI key,1,34
3652,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3130,C1(=O)N[C@@]2([H])[C@]([H])(CS[C@@H]2CCCCC(O)=O)N1,244.31064,Biotin (Vitamin B7),11184136,Launched,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,InChI key,1,34
3652,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4048,C1=CN(C)C(=S)N1C(OCC)=O,186.2315,Carbimazole,31072,Launched,antithyroid agent,TPO,InChI key,,34
3652,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3146,C(N(C)C)CN(Cc1ccccc1)c2ncccc2.Cl,291.81898,Tripelennamine HCl,45114192,Launched,histamine receptor antagonist,HRH1,InChI key,,34
3652,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4059,[Fe](N=O)(C#N)(C#N)(C#N)(C#N)C#N.[Na+].[Na+].[R],261.91764,Sodium Nitroprusside,0,,,,,3,34
3652,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3161,c1n(CC(OCc2csc3c2cccc3Cl)c4ccc(Cl)cc4Cl)ccn1.[R],437.76989,Sertaconazole nitrate,0,,,,,,34
3652,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4072,[N+](C)(C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],418.29431,Decamethonium Bromide,10921,Launched,acetylcholine receptor agonist,ACHE|CHRNA2,InChI key,,34
3652,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3178,S1(=O)(=O)c2c(cc(S(N)(=O)=O)s2)[C@@H](NCC)CN1CCCOC,383.50723,Brinzolamide,3504707,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7,InChI key,,34
3652,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4081,c1cc(S(=O)(=O)[N-]C(=O)C)ccc1N.[Na+],236.22343,Sulfacetamide Sodium,4022878,,,,,,34
3652,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3193,N1(C2SC(C)(C)C1C(O)=O)C(=O)C2NC([C@H](C(O)=O)c3ccsc3)=O.[Na].[Na],430.40688,Ticarcillin sodium,74324902,Launched,lactamase inhibitor,,InChI key,,33
3652,G12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4091,c1(O)ccc(C(O)C(C)N2CCC(Cc3ccccc3)CC2)cc1.c4(O)ccc(C(O)C(C)N5CCC(Cc6ccccc6)CC5)cc4.C(=O)(O)[C@H](O)[C@@H](O)C(=O)O,800.976,Ifenprodil Tartrate,11957579,,,,,,33
3652,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3209,N1(C)C(C)=C(N(C)C)C(=O)N1c2ccccc2,231.29358,Amidopyrine,6009,Launched,analgesic agent,,InChI key,,33
3652,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4101,[C@@H]1(O)[C@@](CO)(O)C[C@H](NC(CO)CO)[C@H](O)[C@H]1O,267.27624,Voglibose,129010282,Launched,glucosidase inhibitor,MGAM,InChI key,,34
3652,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4007,c1(C(=N)N)ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.Cl.Cl,413.34134,Pentamidine,44288881,Launched,anti-pneumocystis agent,TRDMT1,InChI key,1,34
3652,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4111,c1(c2c(C(=O)N[C@H]3[C@H]4N([C@@H](C(O[Na])=O)C(C)(C)S4)C3=O)c(C)on2)c(Cl)cccc1Cl.O,510.32348,Dicloxacillin Sodium,23702387,,,,,,34
3652,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4017,N(CC=C)C(=S)N,116.18472,Allylthiourea,1549517,Preclinical,nitrification inhibitor,,InChI key,,34
3652,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4123,c1(N2CCOCC2)nsnc1OC[C@@H](O)CNC(C)(C)C.C(C(=O)O)=CC(=O)O,432.49181,Timolol Maleate,329565,,,,,,34
3652,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4026,C(c1ccccc1)(c2ccc(Cl)cc2)N3CCN(CCOCCO)CC3.Cl.Cl,447.82616,Hydroxyzine 2HCl,49951526,Launched,antihistamine,HRH1,InChI key,,34
3652,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4138,N1(CCN(CC(O)CO)CC1)c2ccccc2,236.3101,Dropropizine,3169,Launched,antitussive,,InChI key,,34
3652,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4040,[C@@]([H])([C@@]1([H])[C@]([H])([C@]2([H])C(=CC(=O)CC2)CC1)CC3)(CC[C@@]4(O)C#C)[C@]34C,298.41924,Norethindrone,40469488,Launched,progestogen hormone,PGR,InChI key,1,34
3652,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4151,c1(ccc(Cl)c(C(F)(F)F)c1)C2(O)CCN(CCCC(c3ccc(F)cc3)c4ccc(F)cc4)CC2,523.96509,Penfluridol,33630,Launched,T-type calcium channel blocker,CACNA1G,InChI key,2,34
3652,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4164,N1(C)C(=O)c2c(ncn2CC3OCCO3)N(C)C1=O,266.25326,Doxofylline,50942,Launched,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,InChI key,,34
3652,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4260,c(C(C)(C)CCC1(C)C)(ccc(NC(=O)c2ccc(C(=O)O)cc2)c3)c13,351.43879,Tamibarotene,108143,Launched,retinoid receptor agonist,RARA|RARB,InChI key,,34
3652,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4173,C(CCCCCCCC)CCCCCCCO,242.44056,1-Hexadecanol,2682,Launched,,,InChI key,1,34
3652,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4269,c1([C@]2(C(=O)OC)c3c(c4c(cccc4)[nH]3)CN(CC5C2)CC(CC)=C5)cc6c(N(C)[C@]7([H])[C@]6(CC8)[C@]([H])(N89)[C@@](CC)(C=CC9)[C@@H](OC(=O)C)[C@]7(O)C(=O)OC)cc1OC.C(=O)(O)[C@H](O)[C@@H](O)C(=O)O.C(=O)(O)[C@H](O)[C@@H](O)C(=O)O,1079.10594,Vinorelbine Tartrate,129010283,,,,,3,34
3652,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4184,N(C(=O)c1c(n(CCC(CO)CO)cn1)N2)=C2N,253.2578,Penciclovir,4725,Launched,DNA directed DNA polymerase inhibitor,,InChI key,,34
3652,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4282,C1C[C@]2([H])[C@@]([H])(CN(C[C@@H](O)[C@H](CSc3ccccc3)NC(=O)c4cccc(O)c4C)[C@H](C(=O)NC(C)(C)C)C2)CC1.OS(=O)(=O)C,663.88806,Nelfinavir Mesylate,129010285,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,InChI key,1,34
3652,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4192,n1c(c2ccc1C)c(O)c(Cl)cc2Cl,228.07468,Chlorquinaldol,6301,Launched,other antibiotic,,InChI key,1,34
3652,H10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4293,c1cc2c(N(CC(N(C)C)C)c3c(cccc3)S2)cc1.Cl,320.88004,Promethazine HCl,19824879,Launched,histamine receptor antagonist,ADRA1A|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A,InChI key,,34
3652,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4201,c1(S(=O)(=O)C)ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1,358.21326,Florfenicol,5201447,Launched,protein synthesis inhibitor,,InChI key,1,33
3652,H12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4901,C(Nc1ccc(Nc2nccc(c3cccnc3)n2)c(C)c1)(=O)c4cccc(NC(=O)C=CCN(C)C)c4,507.58626,JNK-IN-8,76516568,,,,,3,33
3652,H13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4210,c1(N)ccc(C(OCC)=O)cc1,165.18914,Benzocaine,2337,Launched,sodium channel blocker,SCN10A,InChI key,,33
3652,H14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7000,c1(Nc2ccc(N3CCC(N(C)C)CC3)cc2OC)ncc(Cl)c(Nc4ccccc4P(C)(C)=O)n1,529.01392,AP26113,57390074,Phase 2,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,InChI key,1,34
3652,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4221,c1(C(=O)c2cc(Br)c(O)c(Br)c2)c(CC)oc3c1cccc3,424.08337,Benzbromarone,2333,Launched,chloride channel blocker,ABCC1,InChI key,1,34
3652,H16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7024,c1([N+]([O-])=O)cc2c(C=CS2(=O)=O)cc1,211.1946,Stattic,2779853,Preclinical,,,InChI key,3,34
3652,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4230,c1(c2ccccc2)oc(CCC(O)=O)nc1c3ccccc3,293.3166,Oxaprozin,4614,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,34
3652,H18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7040,c1cc(OCCN2CCN(C(=O)C)CC2)ccc1C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3,519.56248,AZD3514,46893585,Phase 1,androgen receptor modulator,AR,InChI key,,34
3652,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4240,c1cccc(C(OCCN(C)C)(C)c2ncccc2)c1.C(O)(=O)CCC(O)=O,388.45741,Doxylamine Succinate,11224,,,,,,34
3652,H20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7062,N([C@H]1C[C@@H](CCc2[nH]c3c(cc(C(C)(C)C)cc3)n2)C1)(C[C@H]4O[C@@H](n5cnc6c5ncnc6N)[C@H](O)[C@@H]4O)C(C)C,562.70628,EPZ5676,76518457,Phase 1,histone lysine methyltransferase inhibitor,DOT1L,InChI key,1,33
3652,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4250,c1(S(Nc2nnc(OC)cc2)(=O)=O)ccc(N)cc1,280.30297,Sulfamethoxypyridazine,5330,Withdrawn,bacterial antifolate,,InChI key,1,33
3652,H22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7083,c1ccc(Nc2nc(Nc3cc(C)c(C4CCNCC4)cc3OC(C)C)ncc2Cl)c(S(=O)(=O)C(C)C)c1,558.13513,LDK378,57379345,Launched,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B,InChI key,,33
3652,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3132,c1(S(Nc2nccc(C)n2)(=O)=O)ccc(N)cc1,264.30357,Sulfamerazine,5325,Launched,bacterial antifolate,,InChI key,,34
3652,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4049,c1cc(c2c(c3ccc(S(=O)(=O)N)cc3)c(C)on2)ccc1,314.35895,Valdecoxib,119607,Withdrawn,cyclooxygenase inhibitor,CA12|PTGS2,InChI key,,34
3652,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3147,C(N(CC)CC)(=O)C(C#N)=Cc1cc([N+]([O-])=O)c(O)c(O)c1,305.28599,Entacapone,4659568,,,,,,34
3652,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4062,c1([N+]([O-])=O)cnc(COC(=O)N)n1C,200.15212,Ronidazole,5094,Launched,antiprotozoal agent,,InChI key,2,34
3652,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3162,[C@H]1(CO[C@@H]2O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]2OC)C=C(C)C=CC(=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@]3([H])O[C@H](C)[C@@H](O[C@@]4([H])C[C@](O)(C)[C@@H](O)[C@H](C)O4)[C@H](N(C)C)[C@H]3O)[C@@H](C)[C@H](O)CC(=O)O[C@@H]1CC.C(O)(=O)[C@H](O)[C@@H](O)C(O)=O,1066.18692,Tylosin tartrate,129010287,,,,,1,34
3652,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4073,[O-]C(=O)c1ccc(N)cc1O.[Na+],175.11721,Sodium 4-Aminosalicylate,2724368,,,,,,34
3652,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3179,N1([C@]2([H])SC(C)(C)[C@@H]1C([O-])=O)C(=O)[C@H]2NC(C(C([O-])=O)c3ccccc3)=O.[Na+].[Na+],422.36328,Carbenicillin disodium,129010289,,,,,1,34
3652,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4082,C1C=CC=C[C@H](O[C@H]2CC[C@H](N(C)C)[C@H](C)O2)[C@H](C)C[C@H](CC=O)[C@H](O[C@H]3O[C@@H](C)[C@H](O[C@H]4O[C@H](C)[C@@H](O)[C@@](C)(O)C4)[C@@H](N(C)C)[C@@H]3O)[C@H](OC)[C@H](O)CC(=O)O[C@@H]1C,843.05266,Spiramycin,129010290,Launched,bacterial 50S ribosomal subunit inhibitor,,chemical name,1,34
3652,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3195,N1(C2SC(C)(C)C1C(O)=O)C(=O)C2NC([C@H](NC(N3C(=O)NCC3)=O)c4ccccc4)=O.[Na],484.48129,Azlocillin sodium salt,21872803,Launched,bacterial cell wall synthesis inhibitor,,InChI key,,33
3652,I12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4092,Cl.c1cc(OCCCN2CCOCC2)ccc1OCCCC,329.86211,Pramoxine HCl,24183243,Launched,topical anesthetic,,InChI key,1,33
3652,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3600,c1(c(OC)c2c(OCO2)c3)c3C[C@H](C)[C@@H](C)Cc4c1c(OC)c(OC)c(OC)c4,400.46481,Schisandrin B (Sch B),108130,Preclinical,antioxidant,ATR,InChI key,,33
3652,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4102,c1cc(Cn2c(CCCC)ncc2C=C(Cc3cccs3)C(=O)O)ccc1C(O)=O.CS(O)(=O)=O,520.61831,Eprosartan Mesylate,60878,,,,,2,34
3652,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4009,s1cc(CC(Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)=O)nc1N,396.50586,Mirabegron,18319735,Launched,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,InChI key,,34
3652,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4112,C1CCCCC1(O)C(c2ccc(O)cc2)CN(C)C.C(=O)(O)CCC(=O)O,381.46323,Desvenlafaxine Succinate,9800068,,,,,,34
3652,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4019,C(c1cnc(N2CCC[C@H]2CO)nc1NCc3ccc(OC)c(Cl)c3)(=O)NCc4ncccn4,483.95063,Avanafil,18762634,Launched,phosphodiesterase inhibitor,PDE5A,InChI key,,34
3652,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4124,c1(ccccc1)CC2=NCCN2.Cl,196.67662,Tolazoline HCl,23616156,Launched,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2,InChI key,,34
3652,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4027,c(c(C(=O)OCCN1CCCCC1)ccc2)(OC(c3ccccc3)=C(C)C4=O)c24.Cl,427.92053,Flavoxate HCl,51371352,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2,InChI key,,34
3652,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4139,C1N(C)CCN(C(c2ccccc2)c3ccccc3)C1.Cl.Cl,339.30256,Cyclizine 2HCl,129010291,Launched,histamine receptor modulator,HRH1|SULT1E1,InChI key,1,33
3652,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4041,c1(C([O-])=O)c(O)ccc(N=Nc2cc(C(=O)[O-])c(O)cc2)c1.[Na+].[Na+],346.20266,Olsalazine Sodium,54727588,,,,,1,33
3652,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4152,c1(S(=O)(=O)O)cc(O)ccc1O.N(CC)CC,263.31068,Ethamsylate,17506,Launched,haemostatic agent,,InChI key,,33
3652,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4165,c1cc2c(c(OCCCN(C)C)nn2Cc3ccccc3)cc1.Cl,345.86636,Benzydamine HCl,45114153,Launched,prostanoid receptor antagonist,,InChI key,1,34
3652,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4261,c1(c2c(OC)ccc1)C=[N]3[Mn+3]([Cl-])([N](=C4)CC3)([O-]c5c4cccc5OC)[O-]2,416.73756,EUK 134,0,,,,,2,34
3652,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4175,c1(ccc(N)cc1)S(NC(N)=N)(=O)=O,214.2449,Sulfaguanidine,5324,Launched,bacterial antifolate,,InChI key,,34
3652,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4270,N1(CC(=O)N)C(=O)CC(O)C1,158.1552,Oxiracetam,4626,Launched,acetylcholine receptor agonist,,chemical name,1,34
3652,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,s4185,c1(O)c(I)cc(Oc2c(I)cc(CC(=O)O)cc2I)cc1,621.93226,Tiratricol,5803,Launched,thyroid hormone stimulant,THRA|THRB,InChI key,2,34
3652,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4284,Nc1cc(Cl)c(C(=O)OCCN(CC)CC)cc1.Cl,307.2161,Chloroprocaine HCl,129010292,Launched,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3,InChI key,1,34
3652,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4194,C1(N)=Nc2c(nn[nH]2)C(=O)N1,152.11416,Azaguanine-8,8646,Preclinical,purine antagonist,PNP,InChI key,1,34
3652,J10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4294,c1cc(C(=O)NCCN(CC)CC)ccc1N.Cl,271.78628,Procainamide HCl,43822553,Launched,sodium channel blocker,DNMT1|SCN5A,InChI key,,34
3652,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4203,C1OCCN(CC2CN(N=Cc3ccc([N+]([O-])=O)o3)C(=O)O2)C1.Cl,360.75028,Furaltadone HCl,24186667,,,,,,34
3652,J12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,InChI key,2,34
3652,J13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4211,n1c(C=Cc2cccc([C@@H](CCc3ccccc3C(C)(C)O)SCC4(CC([O-])=O)CC4)c2)ccc(c15)ccc(Cl)c5.[Na+],608.16506,Montelukast Sodium,53394937,,,,,1,34
3652,J14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7007,c(ncn1C)(c(F)c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)c3)c13,441.2268,"MEK162 (ARRY-162, ARRY-438162)",10288191,Phase 3,MEK inhibitor,MAP2K1|MAP2K2,InChI key,1,34
3652,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4222,[C@H]([C@@H](NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)c2ccccc2)C3=O)(SC(C)(C)[C@H]4C([O-])=O)N34.[Na+],539.5366,Piperacillin Sodium,23702394,,,,,2,34
3652,J16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7025,C1(CCCCCCCCCCC)=C(O)C(=O)C=C(O)C1=O,294.38594,Embelin,3218,Preclinical,HCV inhibitor|XIAP inhibitor,XIAP,chemical name,1,34
3652,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4231,[C@H]1(Cc2cncn2C)COC(=O)[C@H]1CC.Cl,244.71787,Pilocarpine HCl,22315846,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,InChI key,2,34
3652,J18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7041,c1(C(=O)N2CCN(C)CCC2)cc(c3oc(C=C4c5c(ccc(Cl)c5)NC4=O)cc3)ccc1.Cl,498.40099,CX-6258 HCl,129010293,,,,,4,34
3652,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4242,CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-],364.44748,Cetrimonium Bromide (CTAB),5974,Launched,,,InChI key,3,34
3652,J20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7065,c1(Cl)c(F)c(C(=O)N2CCN(Cc3nc(Nc4sccn4)ccc3)CC2)ccc1,431.91416,MK-8745,11676373,Preclinical,Aurora kinase inhibitor,AURKA,InChI key,1,33
3652,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4251,c(cccc1)(Nc2c(cccc2)S3)c13,199.27156,Phenothiazine,7108,Preclinical,dopamine receptor antagonist,,InChI key,2,33
3652,J22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7085,C(CCS1)(N=C(SCC(=O)Nc2sc3c(ccc(C)c3)n2)N(c4ccccc4)C5=O)=C15,466.59891,IWP-2,2155128,,,,,1,33
3652,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3133,c1cc(S(=O)(=O)Nc2nc(C)cc(C)n2)ccc1N,278.33016,Sulfamethazine,5327,Launched,PABA antagonist,,InChI key,,34
3652,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4050,C([C@H](N)C(=O)OCC(OCN1C2C(C(=O)NC(N)=N2)N=C1)CO)(C)C.Cl,392.83849,Valganciclovir HCl,129010294,,,,,1,34
3652,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3149,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4OC(=O)CCCC)cc1O,356.49837,Estradiol valerate,129010295,Launched,estrogen receptor agonist,ESR1,InChI key,,34
3652,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4063,C1C(=CC=C2CCC[C@@]3(C)[C@@]2([H])CC[C@H]3[C@H](C)CCCC(C)C)C(=C)CC[C@@H]1O,384.63766,Vitamin D3,129010296,,,,,3,34
3652,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3163,C1[C@@H](N(C)[C@@H]2C1)C[C@@H](OC(c3ccccc3)c4ccccc4)C2.CS(O)(=O)=O,403.53496,Benztropine mesylate,238053,Launched,acetylcholine receptor antagonist,CHRM1|HRH1|SLC6A3,InChI key,2,34
3652,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4074,[O-]N=O.[Na+],68.99527,Sodium Nitrite,23668193,,,,,,34
3652,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3181,c1(cc(F)c2)c(N3C=C(C(O)=O)C1=O)c2CCC3C,261.24838,Flumequine,3374,Launched,topoisomerase inhibitor,,InChI key,3,34
3652,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4084,C(c1ccc(F)cc1)(c2ccc(F)cc2)N3CCN(Cc4ccc(OC)c(OC)c4OC)CC3.Cl.Cl,541.45738,Lomerizine HCl,129010297,Launched,calcium channel blocker,CACNA1B|SCN5A,InChI key,4,34
3652,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3196,N1CCC(C(c2ccccc2)(c3ccccc3)O)CC1,267.36544,Azacyclonol,15723,Preclinical,histamine receptor antagonist,HRH1,InChI key,,34
3652,K12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4095,C1(=O)C=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(OC(CCC)=O)C(=O)COC(=O)C)=C1,508.55146,Difluprednate,129010298,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,,34
3652,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3603,[C@@]([C@H](C(C)=C)CC1)([C@]2([H])[C@](C)([C@@]3(C)[C@@]([H])([C@]4(C)[C@]([H])(C(C)(C)[C@@H](O)CC4)CC3)CC2)CC5)([C@]15C(=O)O)[H],456.70031,Betulinic acid,129010299,Phase 1/Phase 2,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,InChI key,1,34
3652,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4104,c1cc(N=NNc2ccc(C(N)=N)cc2)ccc1C(=N)N.OC(=O)CNC(C)=O.OC(=O)CNC(C)=O,515.52235,Diminazene Aceturate,5284544,,,,,1,34
3652,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4010,c1(OCC(O)CNC(C)C)ccc(NC(=O)CCC)cc1C(=O)C.Cl,372.88686,Acebutolol HCl,45114104,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,InChI key,2,34
3652,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4113,C1CCCCC1(O)C(c2ccc(O)cc2)CN(C)C,263.37519,Desvenlafaxine,125017,Launched,serotonin norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,InChI key,1,34
3652,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4020,C(c1ncccc1)(c2ccc(OS([O-])(=O)=O)cc2)c3ccc(OS([O-])(=O)=O)cc3.[Na+].[Na+],481.40726,Sodium Picosulfate,68654,,,,,,34
3652,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4125,C(O[Na])(=O)CCCc1ccccc1,186.18291,Sodium Phenylbutyrate,5258,,,,,,34
3652,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4031,C(O)(c1cccs1)(c2cccs2)C(=O)O[C@@H]3C([H])(CC[N+]4(CCCOc5ccccc5)C3)CC4.[Br-],564.55469,Aclidinium Bromide,11467166,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,InChI key,,34
3652,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4141,c1(C(N)=O)cc([N+](=O)[O-])cc([N+]([O-])=O)c1C,225.15828,Dinitolmide,3092,Launched,,,InChI key,2,33
3652,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4042,c(cccc1)(c(C(=O)N[C@H]2[C@]3([H])N([C@H](C(O[Na])=O)C(C)(C)S3)C2=O)c(OCC)cc4)c14.O,454.47188,Nafcillin Sodium,129010300,,,,,,33
3652,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4155,c(ccc(Cl)c1)(OC(=O)N2)c12,169.56516,Chlorzoxazone,2733,Launched,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4,InChI key,,33
3652,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4166,c1cc(S(=O)(=O)NC(NCCC)=O)ccc1Cl,276.73982,Chlorpropamide,2727,Launched,ATP channel blocker,ABCC8|KCNJ10|KCNJ11,InChI key,,34
3652,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4263,c1(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)[O-])cc2)cc(C)c1.[Na+],363.38274,Efaproxiral Sodium,2725048,,,,,,34
3652,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4176,C(N)(CO)(CO)CO,121.13503,Trometamol,6503,Launched,,AMD1|CANT1|DCN|NEIL1|VEGFA,InChI key,,34
3652,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4274,C1c2c(cccc2O)C[C@@H](N(CCC)CCc3cccs3)C1,315.4729,Rotigotine,57537,Launched,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,InChI key,1,34
3652,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4186,C(C)CCCCCCCCCC[N+](C)(C)CCOc1ccccc1.[Br-],414.4631,Domiphen Bromide,10866,Preclinical,,,InChI key,4,34
3652,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4285,c1cc(C(c2ccccc2)=C(c3ccccc3)CCCl)ccc1OCCO,378.89122,Ospemifene,148127,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,chemical name,2,34
3652,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4195,c1c(Br)c2c(nccc2)c(O)c1Br,302.95009,Broxyquinoline,2453,Phase 1,antiprotozoal agent,,InChI key,1,34
3652,L10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4295,c1c(Cl)c(Nc2c(C(O[Na])=O)cccc2)c(Cl)c(C)c1,318.13047,Meclofenamate Sodium,4038,,,,,,34
3652,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4204,[C@@H]1(O)[C@@]2([H])[C@@]([H])([C@H](O)CO2)OC1,146.14119,Isosorbide,129010301,Launched,nitric oxide stimulant,,InChI key,,34
3652,L12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4904,N1(C(Oc2ccc([N+]([O-])=O)cc2)=O)CCC(C(c3ccc(c4c3)OCO4)(c5ccc(c6c5)OCO6)O)CC1,520.48745,JZL184,25021165,Preclinical,monoacylglucerol lipase inhibitor,MGLL,InChI key,1,34
3652,L13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4213,C1[C@H](C)O[C@@H](O[C@@H]2[C@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@H](C)C(=O)O[C@@H](CC)[C@@](C)(O)C([H])([C@H](C)[C@]4([H])[C@H](C)C[C@@]2(O)C)O[C@H](COCCOC)N4)[C@H](O)[C@H]1N(C)C,835.07372,Dirithromycin,129010302,Launched,bacterial 50S ribosomal subunit inhibitor,,InChI key,2,34
3652,L14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7008,n1c(N)c2c(n(C(C)(C)C)nc2c3ccc(Cl)cc3)nc1,301.77403,PP2,4878,Preclinical,src inhibitor,ABL1|LCK|LYN|RIPK2|SRC,InChI key,3,34
3652,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4223,C1(=O)C[C@H](O)C[C@H](CC[C@H]2[C@@H](C)C=CC([C@@]23[H])=CCC[C@@H]3OC([C@@H](C)CC)=O)O1,390.51306,Mevastatin,129010303,Preclinical,HMGCR inhibitor,HMGCR,InChI key,2,34
3652,L16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7028,c1c(Cl)c2c(C=C([C@@H](Nc3c4c([nH]cn4)ncn3)C)N(c5ccccc5)C2=O)cc1,416.86298,IPI-145 (INK1197),58008990,Phase 3,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,,34
3652,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4232,c1(NC(=O)C)ncc([N+]([O-])=O)s1,187.17649,Nithiamide,8798,Preclinical,bacterial DNA inhibitor,,InChI key,1,34
3652,L18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7048,c1c2c(C3=NNC2=O)c(N[C@H](c4ccc(F)cc4)[C@H]3c5n(C)ncn5)cc1F,380.35086,BMN 673,53345055,Phase 3,PARP inhibitor,PARP2,InChI key,1,34
3652,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4244,c1(O)cc2c([nH]cc2CCN)cc1.Cl,212.67602,Serotonin HCl,44410671,Launched,growth factor receptor activator,DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1,InChI key,1,34
3652,L20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7070,C1CN(c2cc(NCCC(=O)OCC)nc(c3ncccc3)n2)CCc4c1cccc4.Cl,453.96442,GSK J4 HCl,129010304,Preclinical,histone lysine demethylase inhibitor,KDM6A|KDM6B,InChI key,3,33
3652,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4252,ClCCN(CCCl)C.Cl,192.51448,Mechlorethamine HCl,49952039,Launched,DNA inhibitor,,InChI key,2,33
3652,L22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7086,[C@@](C)([C@H](C[C@H]12)C=C1)(C(=O)N(c3ccc(C(Nc4c5c(cccn5)ccc4)=O)cc3)C6=O)[C@@]26[H],423.46324,IWR-1-endo,129010305,,,,,3,33
3652,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3137,C(O)(=O)c1ccccc1O.[Na],161.1105,Sodium salicylate,18943026,Launched,cyclooxygenase inhibitor,AKR1C1|PTGS1|PTGS2,InChI key,,34
3652,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4051,c1(OC)cc2c(cc(CCC(=O)C)cc2)cc1,228.28634,Nabumetone,4409,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,34
3652,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3150,c1(C(OC)=O)scc(C)c1NC(=O)C(NCCC)C.Cl,320.83544,Articaine HCl,51371449,Launched,local anesthetic,,InChI key,1,34
3652,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4064,c1(C(c2ccc(F)cc2)(CCCN(C)C)OC3)c3cc(C#N)cc1.OC(C(O)=O)=O,414.42682,Escitalopram Oxalate,21871605,,,,,,34
3652,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3167,C1CC(=C(C=C[C@@]2(C)[C@@]3([H])CC[C@]2(O)CC=C)[C@]34[H])C(CC4)=CC1=O,310.42994,Altrenogest,76973971,Launched,progestogen hormone,PGR,InChI key,,34
3652,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4076,c1cc2c(cccc2OCC(O)CNC(C)C)cc1.Cl,295.80438,Propranolol HCl,24189499,Launched,adrenergic receptor antagonist,,InChI key,1,34
3652,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3183,C(N(C)C)CC=C1c2c(cccc2)CCc3c1cccc3.Cl,313.86426,Amitriptyline HCl,18415560,Launched,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin norepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,InChI key,2,34
3652,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4085,c1(OC[C@@H](O)CNC(C)C)ccc(CCOCC2CC2)cc1.Cl,343.8887,Levobetaxolol HCl,44264405,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,InChI key,1,34
3652,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3200,C(O)(=O)c1ccc(C(F)(F)F)cc1OC(C)=O,248.15538,Triflusal,9458,Launched,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1,InChI key,,34
3652,M12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4096,c1cc2c(N(C3=CCN(CCCC(c4ccc(F)cc4)=O)CC3)C(=O)N2)cc1,379.42738,Droperidol,3168,Launched,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,InChI key,3,34
3652,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3604,[C@](O1)([C@@H]1[C@@H]2[C@@](C(C)C)(O2)[C@H]3O)([C@]4(C)[C@@]([H])(C5=C(C(=O)OC5)CC4)C6)[C@@]3(O7)[C@@H]67,360.40095,Triptolide (PG490),129010306,Phase 3,RNA polymerase inhibitor,RELA,InChI key,1,34
3652,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4105,c1(cc(C)c(NC(=O)c2cc(I)cc(I)c2[O-])cc1Cl)C(C#N)c3ccc(Cl)cc3.[Na+],685.05553,Closantel Sodium,23683671,,,,,1,34
3652,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4011,C1(OC(C)OC(=O)OCC)=C(C(=O)Nc2ncccc2)N(C)S(=O)(=O)c3c1cccc3,447.46163,Ampiroxicam,2176,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,34
3652,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4114,c1ccc(Oc2c(Cl)cc3c(nc(SC)[nH]3)c2)c(Cl)c1Cl,359.65806,Triclabendazole,50248,Launched,microtubule inhibitor,DNMT1,InChI key,1,34
3652,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4021,c1(cc(O)c(O)c([N+]([O-])=O)c1)C(=O)c2ccc(C)cc2,273.24083,Tolcapone,4659569,Withdrawn,catechol O methyltransferase inhibitor,COMT,InChI key,4,34
3652,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4128,c1(C(=O)NC2CNCCC2)cc(OC)c(OC)c(OC)c1,294.34618,Troxipide,5597,Launched,glucosamine synthetase stimulant,,InChI key,1,34
3652,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4034,C(c1ccccc1)(c2ccccc2)=C3CC[N+](C)(C)CC3.S([O-])(=O)(=O)OC,389.50837,Diphemanil Methylsulfate,6126,,,,,1,34
3652,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4143,c1cnc(C(c2ccccc2)(C(=O)N)CCN(C(C)C)C(C)C)cc1.P(O)(O)(O)=O,437.46964,Pentoxyverine Citrate,30928,,,,,1,34
3652,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4043,N(CCN1)=C1C2CCCc(c23)cccc3.Cl,236.74048,Tetrahydrozoline HCl,44669968,Launched,adrenergic receptor agonist,,InChI key,,34
3652,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4159,c1cc(C(NCCc2ccc(OC(C(O)=O)(C)C)cc2)=O)ccc1Cl,361.8194,Bezafibrate,39042,Launched,PPAR receptor agonist,PPARA|PPARD|PPARG,InChI key,,34
3652,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4167,n1c(NC2CC2)nc(N)nc1N,166.1838,Cyromazine,47866,Launched,,,InChI key,,34
3652,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4264,c1cc(OC(C)(C)C(=O)OCCOC(=O)c2cnccc2)ccc1Cl,363.79221,Etofibrate,65777,Launched,PPAR receptor agonist,PPARA,InChI key,,34
3652,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4177,N1C(=O)NC=CC1=O,112.08675,Uracil,1174,Launched,,DPYD|UCKL1,InChI key,1,34
3652,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4276,c(sc(CC)c1)(n2c(nnc2C)CN=C3c4c(Cl)cccc4)c13,342.84579,Etizolam,3307,Launched,benzodiazepine receptor agonist,GABRA1,InChI key,1,34
3652,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4187,C(Nc1ccccc1)(=O)c2ccccc2O,213.23193,Salicylanilide,6872,Preclinical,other antibiotic,,InChI key,3,34
3652,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4286,[C@H]1(O)NC(=O)[C@@H](N2C(=O)[C@H]([C@H](O)C)NC(=O)[C@H]([C@H](O)[C@@H](O)c3ccc(O)cc3)NC(=O)[C@@H](N4C(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(c5ccc(c6ccc(c7ccc(OCCCCC)cc7)cc6)cc5)=O)C[C@H]1O)C[C@@H](O)C4)[C@@H](O)[C@@H](C)C2,1140.23691,Anidulafungin (LY303366),15224271,,,,,3,34
3652,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4196,c1cc2c(nc3c(cc(OCC)cc3)c2N)cc1N.OC(C)C(=O)O.O,361.39231,Ethacridine lactate monohydrate,165457,,,,,2,34
3652,N10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4297,[C@H]1(O)[C@H](O)[C@H](CC(C)=CC(=O)OCCCCCCCCC(=O)O)OC[C@]1([H])C[C@H]2[C@]([C@@H](C)[C@@H](O)C)([H])O2,500.62216,Mupirocin,129010307,Launched,isoleucyl-tRNA synthetase inhibitor,,chemical name,1,34
3652,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4205,c1cc2c(c3c(cccc3)s2)cc1,184.25692,Dibenzothiophene,3023,Preclinical,,,InChI key,1,34
3652,N12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4907,c1(c2ccsc2)sc(C(N)=O)c(N)c1,224.30261,SC-514,2807869,Preclinical,IKK inhibitor|SYK inhibitor,IKBKB,InChI key,2,34
3652,N13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4214,[C@H]1(Cl)[C@H](CO)O[C@H](O[C@@]2(CCl)[C@H](O)[C@H](O)[C@@H](CCl)O2)[C@H](O)[C@H]1O,397.63346,Sucralose,126543516,Launched,,,InChI key,1,34
3652,N14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7010,s1c(NC(=O)[C@@H]2CCCN2C(=O)[C@H](C3CCCCC3)NC(=O)[C@H](C)NC)c(c4ccccc4)nn1,498.64085,GDC-0152,66720910,Phase 1,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,InChI key,2,34
3652,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4224,[C@@H](O)(CO)[C@@H](O)CO,122.1198,Erythritol,8998,Launched,,,InChI key,1,34
3652,N16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7029,c1cc2c(C(Cc3cc(C(=O)N4CCC(OC)CC4)c(F)cc3)=NNC2=O)cc1,395.42678,AZD2461,44199317,Phase 1,PARP inhibitor,,InChI key,,34
3652,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4233,c(ccc(Cl)c1)(oc(N)n2)c12,168.5804,Zoxazolamine,6103,Phase 2,myorelaxant,,InChI key,,34
3652,N18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7049,N(C(=O)c1sc(C)nc1)[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc2ccccc2)C(=O)C3(C)CO3,532.60918,Oprozomib (ONX 0912),16718034,Phase 1/Phase 2,proteasome inhibitor,,InChI key,1,34
3652,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4245,[C@@]1([H])([C@@H](O)CO)OC(=O)C(O)C1O.[Na],201.12976,Sodium ascorbate,129010308,Launched,,,InChI key,,34
3652,N20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7071,[C@]1([H])([C@@]2([H])N(C)CCc3c2cc4c(OCO4)c3)OC(=O)c5c1ccc6c5OCO6,367.35207,(+)-Bicuculline,10237,,,,,,34
3652,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4253,N(C(N)=NC1)(c2c(cccc2)Cc3c4cccc3)C14.[H]Cl,285.77134,Epinastine HCl,157313,Launched,histamine receptor antagonist,ADRA1A|ADRA2A|HRH1|HRH2|HTR2A|HTR7,InChI key,,34
3652,N22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7087,c1(N2C[C@@H](C(NC3CCCCC3)=O)CC[C@H]2C)cc(c4ccc5c([nH]nc5N)c4)nc(NC)n1,462.59045,GSK2334470,75151153,,,,,,34
3652,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3138,C1(=S)NC(C)=CC(=O)N1,142.17894,Methylthiouracil,667493,Launched,,,InChI key,,34
3652,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4053,c(cccc1)([C@H](NC)CC[C@H]2c3cc(Cl)c(Cl)cc3)c12.Cl,342.69052,Sertraline HCl,22222722,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,InChI key,1,34
3652,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3151,c1(S(NC(NC2CCCCC2)=O)(=O)=O)ccc(CCN3C(=O)C(C)(C)c(c4C3=O)ccc(OC)c4)cc1,527.63241,Gliquidone,91610,Launched,sulfonylurea,ABCC8|KCNJ10|KCNJ8,InChI key,,34
3652,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4065,c1c(Cl)c(C=NNC(=N)N)c(Cl)cc1.CC(=O)O,291.13387,Guanabenz Acetate,6852405,,,,,1,34
3652,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3170,N1([C@]2([H])SC(C)(C)[C@@H]1C([O-])=O)C(=O)[C@H]2NC(=O)[C@H](N)c3ccccc3.[Na+],371.38658,Ampicillin sodium,129010309,,,,,1,34
3652,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4077,c1c(O)ccc(OC)c1,124.13721,Mequinol,9015,Launched,,TYR,InChI key,1,34
3652,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3185,O=C(c1cc(O)c(O)cc1)CNC.Cl,217.64947,Adrenalone HCl,49956213,Launched,adrenergic receptor agonist,ADRA1A,InChI key,1,34
3652,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4086,C1(N2CCN(C)CC2)=Nc3c(cccc3)Oc4c1cc(Cl)cc4.C(C(=O)O)CC(=O)O,445.89605,Loxapine Succinate,71399,,,,,2,34
3652,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3201,c1c(c2ccc1C(F)(F)F)N(CCCN3CCN(C)CC3)c(c4S2)cccc4.Cl.Cl,480.41744,Trifluoperazine 2HCl,45114123,Launched,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,InChI key,2,34
3652,O12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4097,C1C[C@]2(C)C(C=C[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4(C(C)=O)[H])=CC1=O,312.44582,Dydrogesterone,20056532,Launched,progesterone receptor agonist,PGR,InChI key,,34
3652,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4000,c(c1[nH]c2)(c2C[C@]3([H])[C@]4([H])C[C@H](CSC)CN3CCC)c4ccc1.CS(=O)(=O)O,410.5938,Pergolide mesylate,88740857,Withdrawn,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,InChI key,2,34
3652,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4106,c1(cc(C)c(NC(=O)c2cc(I)cc(I)c2O)cc1Cl)C(C#N)c3ccc(Cl)cc3,663.07369,Closantel,42574,Launched,chitinase inhibitor|NFkB pathway inhibitor,,InChI key,3,34
3652,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4012,C1NCCC(=C2c3c(cccn3)CCc4c2ccc(Cl)c4)C1,310.82056,Desloratadine,124087,Launched,histamine receptor antagonist,HRH1,InChI key,1,34
3652,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4116,CC(C)CC(=O)N,101.14694,Isovaleramide,10930,Phase 2,alcohol dehydrogenase inhibitor,,InChI key,2,34
3652,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4022,c1cc(C(O)=O)ccc1S(=O)(=O)N(CCC)CCC,285.35926,Probenecid,4911,Launched,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,InChI key,,34
3652,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4131,c1cc(N2CCN(C[C@@H](O)CO)CC2)ccc1,236.3101,Levodropropizine,3169,Launched,antitussive,,InChI key,,34
3652,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4035,[C@](C)([C@@H]([C@H](C)C=C[C@H](C)C(C)C)CC1)(CCCC2=CC=C3C[C@H](O)CCC3=C)[C@@]12[H],396.64836,Vitamin D2,129010310,,,,,1,34
3652,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4144,c1c(C)[n+](Cc2c(N)nc(CCC)nc2)ccc1.Cl.[Cl-],315.2414,Amprolium HCl,44278258,Launched,thiamine uptake blocker,,InChI key,2,34
3652,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4044,c1cc(SC(F)(F)F)ccc1Oc2ccc(N3C(=O)NC(=O)N(C)C3=O)cc2C,425.38166,Toltrazuril,68591,Launched,antiprotozoal agent,,InChI key,2,34
3652,O22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4160,N([C@@H](C([O-])=O)C(C)(C)S1)(C(=O)[C@H]2NC(=O)Cc3ccccc3)[C@]12[H].[Na+],356.37195,Penicillin G Sodium,129010311,,,,,1,34
3652,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,P03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4169,c1(NC(=O)C(C#N)=C(O)C)ccc(C(F)(F)F)cc1,270.20726,Teriflunomide,54677977,Launched,dihydroorotate dehydrogenase inhibitor,DHODH,chemical name,3,34
3652,P04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4265,c1(cnccc1)C(=O)NCC(C)NC(=O)c2cnccc2,284.31314,Nicaraven,71234,Phase 3,free radical scavenger,,InChI key,1,34
3652,P05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4178,C(C(=O)C(C)(C)C)(Oc1ccc(Cl)cc1)n2cncc2,292.76067,Climbazole,37907,Launched,enzyme inducer,,InChI key,1,34
3652,P06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4277,c1(OC(N(C)C)=O)cc(C(O)CNC(C)(C)C)cc(OC(=O)N(C)C)c1.Cl,403.90089,Bambuterol HCl,51371393,Launched,adrenergic receptor agonist,ADRB2|BCHE,InChI key,2,34
3652,P07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4188,C(Oc1ccccc1C(O)=O)(=O)c2ccccc2O,258.2262,Sasapyrine,5161,Launched,NFkB pathway inhibitor,PTGS1|PTGS2,InChI key,,34
3652,P08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4288,c1(N(CCCl)CCCl)ccc(CCCC(=O)O)cc1,304.21216,Chloroambucil,2708,Launched,DNA inhibitor,,InChI key,1,34
3652,P09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4197,C1(=O)NC(=O)CC(C)(CC)C1,155.19432,Bemegride,2310,Launched,chemoreceptor agonist,GABRA1,InChI key,1,34
3652,P10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4299,c1cc2c(C(O)=C(CC3=C(O)c4c(cccc4)OC3=O)C(=O)O2)cc1,336.29497,Dicoumarol,54676038,Launched,NADPH inhibitor,CRYZ|NQO1|VKORC1,InChI key,,34
3652,P11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4206,C(N)CS.Cl,113.60962,Cysteamine HCl,18759463,Launched,tissue transglutaminase inhibitor,NPY2R|SST,canonical SMILES,1,34
3652,P12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4908,c1(nc2c(cc(O)cc2)c3CC)c3CN4C1=CC5=C(COC(=O)[C@]5(O)CC)C4=O,392.4046,SN-38,104842,Launched,topoisomerase inhibitor,TOP1,InChI key,1,34
3652,P13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4216,[C@]([H])(C(=O)CC1)([C@@]2(C)[C@H](OC(=O)CSC(C)(CNC(=O)[C@H](N)C(C)C)C)C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)[C@@]13CC[C@H]2C.Cl,601.28092,Valnemulin HCl,129010312,Launched,bacterial 50S ribosomal subunit inhibitor,,InChI key,2,34
3652,P14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7015,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](O)C[C@H]1Cc2c3c(cc(F)cc3)[nH]c2c4c(C[C@H]5N(C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C[C@@H](O)C5)c6c(cc(F)cc6)[nH]4)CC,806.94084,Birinapant,75299860,Phase 2,XIAP inhibitor,BIRC2|XIAP,InChI key,1,34
3652,P15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4225,c1(OCC(N)C)c(C)cccc1C.Cl,215.71972,Mexiletine HCl,45114163,Launched,sodium channel blocker,AHR|SCN4A|SCN5A,InChI key,1,34
3652,P16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7033,n1c(N)c(c(c2ccc(N(C(Cc3nc(C)ccc3)=O)CC4)c4c2F)cn5C)c5nc1,416.45084,GSK2656157,53469059,Preclinical,PERK inhibitor,,InChI key,1,34
3652,P17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4235,c1ccc(N=Nc2ccc(N)nc2N)cc1.Cl,249.69947,Phenazopyridine HCl,45114084,,,,,1,34
3652,P18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7050,c1c(N2CCOC[C@H]2C)nc(c3c4c([nH]cc4)ccc3)nc1C5(CC5)S(=O)(=O)C,412.50525,AZ20,75184787,Preclinical,ATR kinase inhibitor,ATR|MTOR,InChI key,,34
3652,P19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4246,Cl.c1cc([C@H]2C[C@@H]2N)ccc1,169.65128,Tranylcypromine (2-PCPA) HCl,44296125,Launched,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,InChI key,,34
3652,P20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7072,[C@H](NC)(C(=O)O)CC(=O)O,147.12925,NMDA (N-Methyl-D-aspartic acid),4376,Preclinical,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,InChI key,1,34
3652,P21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4255,c1(NC(C)CCCN(CC)CC)c2c(cc(Cl)cc2)nc3c1cc(OC)cc3.Cl.Cl,472.87868,Quinacrine 2HCl,44325495,Launched,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B|PLA2G4A|PLA2G6|PLCL1,InChI key,3,34
3652,P22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7088,C1CN(C2CCN(C(c3ccc(C(N4CCC(N5CCCC5)CC4)=O)c(Nc6ccccc6)c3)=O)CC2)CC1,529.71611,UNC1215,57339144,Preclinical,L3MBTL antagonist,L3MBTL3,InChI key,1,34
3652,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3652,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7090,C(N[C@@H](Cc1ccc(c2cn(c3n2)cccc3[C@@H](O)C)cc1)CNC(=O)CN(C)C)(=O)c4ccc(OC(C)C)c(Cl)c4,592.12821,GSK923295,56644302,Phase 1,centromere associated protein inhibitor,CENPE,InChI key,1,32
3653,A04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7251,c1(C(F)(F)F)cc(c2nn(C=CC(=O)N3CC(F)(F)C3)cn2)cc(C(F)(F)F)c1,426.26402,KPT-276,77992924,Preclinical,exportin antagonist,XPO1,chemical name,1,32
3653,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7099,c1(N2CC[C@]3(O)C2=Nc4c(cc(C)cc4)C3=O)ccccc1,292.33183,(-)-Blebbistatin,5287792,Preclinical,ATPase inhibitor,,InChI key,1,32
3653,A06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7263,c1cc2c(c(Sc3ccc(Cl)cc3)c(C)n2CC(O)=O)c(NC(=O)C)c1,388.86787,AZD1981,11292191,Phase 2,CRTH receptor antagonist,PTGDR2,InChI key,,32
3653,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7114,C1CC(COc2c(N=O)c(N)nc(N)n2)CCC1,251.28498,NU6027,398148,Preclinical,CDK inhibitor,CCNA2|CDK2,InChI key,,32
3653,A08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7279,c1cc2c(nc(N3CCN(C(=O)c4c(n5nccn5)ccc(C)c4)[C@H](C)CC3)o2)cc1Cl,450.92072,Suvorexant (MK-4305),57505028,Launched,orexin receptor antagonist,HCRTR1|HCRTR2,InChI key,,32
3653,A09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7129,N1C(=O)C(=Cc2ccc([N+]([O-])=O)o2)C(=O)N1c3ccc(C(OCC)=O)cc3,371.30101,PYR-41,2856906,Preclinical,ubiquitin activating enzyme inhibitor,,chemical name,2,32
3653,A10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7293,c1c(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3ccc(Br)cc3Cl)cc2)nc1C,584.89365,ZCL278,1791111,Preclinical,CDC inhibitor,CDC42,InChI key,1,32
3653,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7139,c1cc(C=C2SC(=S)N(c3cc(C(F)(F)F)ccc3)C2=O)ccc1C(=O)O,409.4021,CFTRinh-172,504670,,,,,,32
3653,A12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7310,c(cccc1)(c2c(cc(NC(=O)C(C)(C)C)cc2)C(=O)C3=O)c13,307.34318,SF1670,9926586,,,,,2,32
3653,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7149,c1nc(C(C)=NNC(=S)N2CCC2)ccc1,234.32066,NSC 319726,3003931,Preclinical,p53 activator,,canonical SMILES,1,32
3653,A14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,InChI key,2,32
3653,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7167,c1ccn2c(c(OC)c(C)c2C(c3cc(C(=O)O[Na])c(N)cc3)=O)c1,346.31246,SSR128129E,68853159,Preclinical,,,chemical name,3,32
3653,A16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7340,c1c(Cl)c(c2nc(N)nc(SCCCC(=O)N)n2)c3c(c4ccc3)c1COC4,415.89651,CH5138303,25066238,,,,,2,32
3653,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7193,C1C(=O)Nc2c(nccc2)c3c1c4c(ccc(Br)c4)[nH]3,328.16339,1-Azakenpaullone,6538897,Preclinical,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,InChI key,2,32
3653,A18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7364,CN(c1ccc(c2cccc(NC(N(C)C)=O)c2)cc1)C,283.36814,Atglistatin,71699712,Preclinical,adipose triglyceride lipase inhibitor,,InChI key,1,32
3653,A19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7209,c1(c2ccccc2)cc3c([nH]cc3c4ccc(C(O)=O)c(C5CCCC5)c4)nc1,382.45437,GSK650394,25022668,Preclinical,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2,InChI key,1,32
3653,A20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7378,c1c(S(=O)(=O)F)ccc(CCN)c1.Cl,239.69484,AEBSF HCl,51371124,,,,,1,32
3653,A21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7229,c1(NC(=O)C=Cc2cn(CC=Cc3ccccc3)nc2)c(N)cc(F)cc1,362.40016,RGFP966,68294530,Preclinical,HDAC inhibitor,HDAC3,chemical name,1,32
3653,A22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7399,CC(NC1=C(C(=O)CC(C)(C)C1)C2c3ccc([N+]([O-])=O)cc3)=C2C(OC4CCCCC4)=O,438.51609,FLI-06,3103157,Preclinical,notch signaling inhibitor,,InChI key,2,32
3653,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7430,c1cc(Oc2ccc(S(=O)(=O)CC3CS3)cc2)ccc1,306.39985,SB-3CT,9883002,,,,,,32
3653,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,InChI key,1,32
3653,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7448,[Ru]1(Cl)(OC(=O)CN1)(C=O)(C=O)C=O.[R],296.62784,CORM-3,0,,,,,1,32
3653,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8042,n1c(N)c(Cc2cc(OC)c(OCc3ccc(OC)cc3)cc2)cnc1N,366.41367,GW2580,11617559,Preclinical,cFMS kinase inhibitor,CSF1R,InChI key,,32
3653,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7461,c1ccc(Nc2ncnc(c3c(OC)cccc3)c2)cc1CS(=O)(=O)N,370.42551,LDC000067,25104564,,,,,,32
3653,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8057,c1c2nc(Nc3cc(c(OCCN4CCCC4)cc3)COCC=CCOCc5cc2ccc5)nc1,472.57867,Pacritinib (SB1518),73354318,Phase 3,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,canonical SMILES,1,32
3653,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7489,c1cc(Cl)ccc1CN(C=O)C(c2c3c(cc(Cl)cc3)[nH]c2C(=O)OCC)C(NC(C)(C)C)=O,504.40557,YH239-EE,56943013,,,,,,32
3653,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8077,c1(Cl)c(Cl)ccc(N2C(=O)C(Cl)=C(N3CCOCC3)C2=O)c1,361.60773,RI-1,1074953,Preclinical,,RAD51,InChI key,1,32
3653,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7505,CC(Oc1cc(c2cnn(C3CCNCC3)c2)cnc1N)c4c(Cl)c(F)ccc4Cl,450.33668,(S)-crizotinib,11597571,Preclinical,MTH1 inhibitor,NUDT1,InChI key,,32
3653,B12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7520,C1(=O)C2=C(CCC2)N(CC(=O)N(CCN(CC)CC)Cc3ccc(c4ccc(C(F)(F)F)cc4)cc3)C(SCc5ccc(F)cc5)=N1,666.77113,Darapladib (SB-480848),9939609,Phase 3,phospholipase inhibitor,PLA2G7,InChI key,2,32
3653,B14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7546,c1ccc(c2ccc(CC(=O)N(C)c3nc(C)c(S(N)(=O)=O)s3)cc2)nc1,402.49051,Pritelivir (BAY 57-1293),491941,Phase 2,helicase primase inhibitor,,InChI key,1,32
3653,B16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7635,N1(CCCCC2(C(NCC(F)(F)F)=O)c3c(cccc3)c4c2cccc4)CCC(NC(=O)c5ccccc5c6ccc(C(F)(F)F)cc6)CC1,693.72039,Lomitapide,9853053,Launched,microsomal trigylceride transfer protein inhibitor,MTTP,InChI key,2,32
3653,B18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8007,c1(C(Nc2ccccc2)=O)nc(c3ccc(S(C)(=O)=O)cc3)cnc1N,368.40964,VE-821,51000408,Preclinical,ATR kinase inhibitor,ATR,InChI key,1,32
3653,B20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8021,c1(C)cc(C)c(Sc2c(N3CCNCC3)cccc2)cc1.Br,379.35762,Vortioxetine (Lu AA21004) HBr,129010315,Launched,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,InChI key,,32
3653,B22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7091,[C@H]1(C)[C@]2(O)O[C@H](C[C@H](OC)C(C)=CC=CC=C[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)C(C)=C[C@@H](C)C(=O)C[C@@H]([C@H](C)C[C@H]3C[C@@H](OC)[C@@H](n4cnnn4)CC3)OC(=O)[C@@]5([H])N(CCCC5)C(=O)C2=O)CC1,966.20996,Zotarolimus(ABT-578),129010316,,,,,,32
3653,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7252,c1(C(F)(F)F)cc(c2nn(C=CC(NNc3nccnc3)=O)cn2)cc(C(F)(F)F)c1,443.30595,KPT-330,77987108,Phase 2/Phase 3,exportin antagonist,XPO1,canonical SMILES,1,32
3653,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7102,n1c(N)c(c2onc(c3ccc(CNC)cc3)c2)nc(c4ccc(S(C(C)C)(=O)=O)cc4)c1,463.55199,VE-822,59472121,Phase 2,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG,InChI key,1,32
3653,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7265,C1CCC(C(NC(c2ccc(F)cc2)c3ccc(F)cc3)=O)(NC(=O)[C@H](CCCNC(=N)N)NC(C(CC)(CC)NC(C(C)C)=O)=O)C1,669.80486,MM-102,76192067,Preclinical,WDR5/MLL interaction inhibitor,,InChI key,1,32
3653,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7115,c1(C(F)(F)F)ccc(c2cc(Oc3c4c(sc(NC(=O)C)n4)ccc3)ncn2)cc1,430.40302,AMG-517,16007367,Phase 1,TRPV antagonist,TRPV1,InChI key,,32
3653,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7280,C(=O)(C(=O)Nc1ncc(Cl)cc1)N[C@H]2CC[C@@H](C(=O)N(C)C)C[C@@H]2NC(=O)c3sc4c(CCN(C)C4)n3,548.0575,Edoxaban,11635624,Launched,coagulation factor inhibitor,F10,InChI key,1,32
3653,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7130,c1(SC#N)cc(SC#N)c(N)nc1N,223.2781,PR-619,2817763,Preclinical,DUB inhibitor,,InChI key,4,32
3653,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7295,c1(OC)cc2c(C(=O)NC(c3cc(C)c(OCCO)c(C)c3)=N2)c(OC)c1,370.39907,RVX-208,24871506,Phase 3,apolipoprotein expression enhancer,BRD3,InChI key,,32
3653,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7140,c1(Cl)c(Cl)c2c(C(=O)CC2=O)c(Cl)c1Cl,283.92298,TCID,2729042,Preclinical,,,InChI key,3,32
3653,C12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7316,c1ccc(CNC(=O)c2ccc(c3nc(CS(=O)(=O)c4ccc(C)cc4)c(C)o3)cc2)cn1,461.53281,STF-118804,20916937,Preclinical,NAMPT inhibitor,NAMPT,InChI key,1,32
3653,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7152,Cc1cc(c2oc(C=C3C(=O)N(c4ccc(C(O)=O)cc4)N=C3C)cc2)c([N+]([O-])=O)cc1C,445.42416,C646,2871948,Preclinical,histone acetyltransferase inhibitor,EP300,chemical name,1,32
3653,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7329,c1ccc(Oc2ccc(CNC(=O)c3nc(c4cc(Br)c(O)c(Br)c4)no3)cc2)cc1,545.18019,IOWH032,44241539,Phase 2,CFTR channel antagonist,CFTR,InChI key,1,32
3653,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7172,N(C(=O)CN1CCOCC1)[C@@H](C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)[C@]4(C)CO4,580.6719,ONX-0914 (PR-957),129010317,Preclinical,proteasome inhibitor,,InChI key,2,32
3653,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7351,c1(NCCCc2ccccc2)ccc(C)cc1N,240.3434,JSH-23,16760588,Preclinical,NFkB pathway inhibitor,RELA,InChI key,,32
3653,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7194,c1c(C)c(C#Cc2cnc3c(cn[nH]3)c2)cc(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)c1.CS(O)(=O)=O.CS(O)(=O)=O,724.7708,GZD824,71519689,Preclinical,Bcr-Abl kinase inhibitor,ABL1|BCR,InChI key,3,32
3653,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7365,c1cc(C(=O)c2ccc(OCC(NC3CCN(Cc4ccccc4)CC3)=O)cc2)ccc1,428.52281,AdipoRon,16307093,Preclinical,adiponectin receptor agonist,ADIPOR1|ADIPOR2,InChI key,,32
3653,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7213,[C@H]1(CO)O[C@@]2([H])[C@]([H])(N=C(NCC)S2)[C@@H](O)[C@@H]1O,248.29934,Thiamet G,129010318,Preclinical,GLCNAC phosphotransferase inhibitor,MGEA5,InChI key,2,32
3653,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7379,c1c(O)c2c([C@H](C)[C@]3([H])C(=C(O)[C@@]4(O)[C@]([H])([C@H](N(C)C)C(O)=C(C(N)=O)C4=O)[C@H]3O)C2=O)cc1.c5c(O)c6c([C@H](C)[C@]7([H])C(=C(O)[C@@]8(O)[C@]([H])([C@H](N(C)C)C(O)=C(C(N)=O)C8=O)[C@H]7O)C6=O)cc5.Cl.O.CCO.Cl,1025.87472,E-64,129010280,,,,,1,32
3653,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7233,c1c(c2cc(NC(OCC)=O)c3n(c(C)nn3)n2)cc(NS(=O)(=O)C)c(C)c1,404.44349,Bromosporine,72943187,Preclinical,bromodomain inhibitor,,InChI key,1,32
3653,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7414,C(OCCc1ccccc1)(=O)C=Cc2ccc(O)c(O)c2,284.30654,Caffeic Acid Phenethyl Ester,108042,,,,,,32
3653,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7434,c1cc2c(cc(C[C@H](NC(=O)C(CC(=O)NO)CC(C)C)C(=O)N[C@@H](C)C(=O)NCCN)cc2)cc1,499.60247,TAPI-1,75641285,,,,,,32
3653,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,InChI key,1,32
3653,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7449,c1cc([N+]([O-])=O)c2c(cc(C(O)=O)[nH]2)c1,206.15494,CRT0044876,81409,Preclinical,,,InChI key,1,32
3653,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8043,c1c2c(c3C(=O)N(CCCCCC(=O)NO)C2=O)c(ccc3)cc1,326.34652,Scriptaid,5186,Preclinical,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,InChI key,1,32
3653,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7462,c1cc(OCC(=O)N(C(C)C)Cc2onc(c3cnccc3)n2)ccc1CCC,394.46683,PI-1840,56945245,,,,,,32
3653,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8058,c1ccc(C(Oc2c(c(O)cc(O)c2[C@@H]3CCN(C)[C@H]3CO)C4=O)=C4)c(Cl)c1.Cl,438.30113,P276-00,129010319,Phase 2,CDK inhibitor,CDK1|CDK4|CDK9,InChI key,2,32
3653,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7490,c1cc2c(c3C(=O)N(CCCSc4nnc(c5ccncc5)n4c6ccc(OC)cc6)C2=O)c(ccc3)c1,521.58962,WIKI4,2984337,Preclinical,Wnt pathway inhibitor|tankyrase inhibitor,TNKS2,InChI key,,32
3653,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,InChI key,3,32
3653,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7508,C1Cc2c(sc(NC(=O)c3c4c(cccc4)ccc3)c2C#N)CC1,332.41883,JNK Inhibitor IX,766949,,,,,1,32
3653,D12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7523,C1N(c2ccc(Nc3c4n(ccn4)cc(c5ccc6c([nH]nc6)c5)n3)cc2)CCOC1,411.45914,GS-9973,59473233,Phase 2,syk inhibitor,SYK,InChI key,1,32
3653,D14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7565,c1(OC)c(N(c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2)C(Oc5c(C)cccc5C)=O)ccc(OC)c1,568.66604,WH-4-023,11844351,,,,,1,32
3653,D16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8000,c1cc(C(=O)NC(=S)Nc2ccc(NC(=O)C)cc2)ccc1C(C)(C)C,369.48051,Tenovin-1,1013376,Preclinical,SIRT inhibitor|TP53 activator,SIRT1,InChI key,1,32
3653,D18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8009,c1(ccc(O)c(O)c1)C=C(C#N)C#N,186.16684,AG-18,2052,Preclinical,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,InChI key,,32
3653,D20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8022,[C@H]1(CO)O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@@H]4COCC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,450.90927,Empagliflozin (BI 10773),73151030,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,InChI key,1,32
3653,D22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7092,c1c(n2c(C)c(C=NN3CCN(Cc4ccccc4)CC3)c(C)n2)cccc1,373.49397,SANT-1,1356208,,,,,,32
3653,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7253,c1nc(N)c(C(Nc2cccnc2)=O)nc1c3ccc(S(N4CCN(C)CC4)(=O)=O)cc3,453.51741,AZD2858,10138980,Preclinical,glycogen synthase kinase inhibitor,GSK3B,InChI key,3,32
3653,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7104,c1c(C=C2SC(=O)NC2=O)c(N3CCC[C@@H](N)C3)c(c4ccccc4)cc1,379.47533,AZD1208,75081564,Phase 1,Pim kinase inhibitor,PIM1|PIM2|PIM3,chemical name,,32
3653,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7266,n1cc(C2[C@]3([H])[C@]([H])(C=CC3)c4c(c(F)cc(F)c4)N2)ccc1,284.30326,Golgicide A,129010097,Preclinical,ARF inhibitor,GBF1,InChI key,1,32
3653,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7120,c1cc2c(ncn2[C@H]3[C@@H](O)[C@H](O)C(CO)=C3)c(N)n1,262.26455,3-Deazaneplanocin A (DZNeP),358177,Preclinical,histone lysine methyltransferase inhibitor,EZH2,InChI key,,32
3653,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7282,CN1CCC(NC(C(NOC2=C3C(Oc4ccc([N+]([O-])=O)cc4)=CC(=O)C=C3O)=C2)=O)CC1,454.43267,NMS-E973,66759715,Preclinical,HSP inhibitor,,chemical name,3,32
3653,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7132,c1c([N+]([O-])=O)c(Sc2c(Cl)c(Cl)ccc2)sc1C(C)=O,348.22487,P5091 (P005091),2819993,Preclinical,ubiquitin specific protease inhibitor,USP7,InChI key,,32
3653,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7297,c1c(c2c3c(cccc3)n(C)c2)nc(Nc4cc(NC(=O)C=C)c(N(C)CCN(C)C)cc4OC)nc1,499.60731,AZD9291,71496458,Launched,EGFR inhibitor,EGFR,InChI key,,32
3653,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7142,Cc1ccc(S(c2oc([N+]([O-])=O)cc2)(=O)=O)cc1,267.25786,NSC697923,394449,Preclinical,ubiquitin-conjugating enzyme inhibitor,UBE2N,InChI key,2,32
3653,E12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7317,n1cc(Cl)c(Oc2cccc(NC(=O)CC)c2)nc1Nc3ccc(N4CCN(C)CC4)cc3OC,496.98915,WZ4003,72200024,Preclinical,AMPK inhibitor,NUAK1|NUAK2,InChI key,2,32
3653,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7153,c1cc(C=C2SC(=S)NC2=O)ccc1CC,249.35184,10058-F4,2844975,,,,,1,32
3653,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7330,c1(Cl)ccc(SCC(=O)N2CCC(C(=O)NCCSSCCN(C)C)CC2)cc1.C(C(O)=O)(F)(F)F,590.14244,6H05,86208069,,,,,1,32
3653,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7173,c1(F)c(Nc2cccc(NC(=O)C=C)c2)nc(Nc3ccc(OCCOC)cc3)nc1,423.44018,AVL-292,59174488,Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,InChI key,1,32
3653,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7353,C(CN(C(C)C)C[C@H]1O[C@@H](n2ccc3c2ncnc3N)[C@H](O)[C@@H]1O)CNC(=O)Nc4ccc(C(C)(C)C)cc4,539.66964,EPZ004777,76450046,Preclinical,histone lysine methyltransferase inhibitor,DOT1L,InChI key,1,32
3653,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7195,c1cc(c2csc(NC(=O)NCc3cc(O)ccc3)n2)ccn1,326.37295,RKI-1447,60138149,Preclinical,rho associated kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2,InChI key,1,32
3653,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7367,n1cc(C(F)(F)F)c(NC)nc1Nc2c(C)nn(C(C)(C)C#N)c2,339.31894,GNE-0877,69093374,,,,,,32
3653,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7214,c(cc(Nc1ccc(F)cc1F)cc2)(CCc3c(cc(OC[C@H](O)CO)cc3)C4=O)c24,425.42464,Skepinone-L,75110012,Preclinical,p38 MAPK inhibitor,MAPK14,InChI key,,32
3653,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7380,C(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C([H])=O)CCCNC(=N)N)CC(C)C)NC(=O)C)(C)C.[R],426.55351,Leupeptin Hemisulfate,0,,,,,,32
3653,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7234,c1nc2c(c(C(=O)O)ccc2O)cc1,189.16748,IOX1,459617,Preclinical,histone demethylase inhibitor,EGLN1|KDM3A|KDM4C|KDM6B,InChI key,,32
3653,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7417,Cl.Cl.n1c(N(C)C)c2c(n([C@@H]3O[C@@H](CO)[C@H](NC(=O)[C@@H](N)Cc4ccc(OC)cc4)[C@@H]3O)cn2)nc1,544.43143,Puromycin 2HCl,75094266,,,,,2,32
3653,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7435,c1nc(NC(=O)NCc2ccc(OC)cc2)sc1[N+]([O-])=O,308.31307,AR-A014418,448014,Preclinical,glycogen synthase kinase inhibitor,GSK3B,InChI key,2,32
3653,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8035,c1nc(C(=O)Nc2ccc(S(Nc3ccccc3Cl)(=O)=O)c(Cl)c2)ccc1,422.28511,VU 0364439,46934289,Preclinical,glutamate receptor positive allosteric modulator,GRM4,InChI key,1,32
3653,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7450,CC(Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1)=O,282.33702,FH1(BRD-K4477),94990,Preclinical,hepatocyte function enhancer,,InChI key,1,32
3653,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8044,c1(C)cc2c(nc(NCCN)c3n2c(C)cn3)cc1,255.31828,BMS-345541,9813758,Preclinical,IKK inhibitor,CHUK|IKBKB,InChI key,,32
3653,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7467,C1N(C(c2c(c3c(c4ccc3)cccc4)cn(Cc5n(Cc6ccc(Br)cc6)cnc5)c2)=O)CCOC1,555.46498,LB42708,10099206,Preclinical,farnesyltransferase inhibitor,,InChI key,2,32
3653,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8059,N1(C(=O)N2CCNC(=O)C2)[C@@H](c3ccc(Cl)cc3)[C@H](c4ccc(Cl)cc4)N=C1c5c(OC(C)C)cc(OC)cc5,581.4896,Nutlin-3a,216345,,,,,1,32
3653,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7493,C(=O)(c1ccccc1)Nc2nc(c3ccc(C)cc3C)cs2,308.39743,INH1,959043,Preclinical,Hec1 inhibitor,NDC80,InChI key,,32
3653,F10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,InChI key,,32
3653,F12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7525,C1N(c2cc(OCC)c(Nc3ncc4c(N(C)c5c(cccc5)C(=O)N4C)n3)cc2)CCC(O)C1,474.55479,XMD8-92,46843772,Preclinical,MAP kinase inhibitor,DCLK2|MAPK7|PLK4|TNK1,InChI key,,32
3653,F14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7566,C1(=O)N(C)C(=O)C(NCCc2ccc(F)cc2)=C1c3c(C)[nH]c4c3cccc4,377.4115,IM-12,25209788,,,,,2,32
3653,F16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8001,c1cc(N(c2ncc(C(NCCCCCCC(=O)NO)=O)cn2)c3ccccc3)ccc1,433.50287,Rocilinostat (ACY-1215),53340666,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,InChI key,,32
3653,F18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8010,C(O)(=O)C=CC(O)=O.C(#N)c1cc(CN2CCC(Nc3ncnc4c3cc(Cl)s4)CC2)ccc1F,517.96034,PRX-08066 Maleic acid,75306359,,,,,1,32
3653,F20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8023,c(CCCC1)(sc(NC(=O)c2ccc(OC)c(OC)c2)c3C(N)=O)c13,360.42739,TCS 359,1048845,Preclinical,FLT3 inhibitor,FLT3,InChI key,1,32
3653,F22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7093,S(c1c(c2ccc1O)cccc2)Sc3c(c4ccc3O)cccc4,350.45396,IPA-3,521106,Preclinical,p21 activated kinase inhibitor,PAK1,InChI key,,32
3653,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7255,c1(OC(F)(F)F)c(Nc2ncc3c(c4c(c(C(=O)N)nn4CCO)CC3)n2)cc(N5CCN(C)CC5)cc1,532.51818,NMS-P937 (NMS1286937),49792852,Phase 1,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,InChI key,2,32
3653,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7106,c([nH]cc1c2nc(Nc3ccc(N4CCC(N)CC4)cc3OC)ncc2Cl)(cccc5)c15,448.94789,AZD3463,56599293,Preclinical,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R,InChI key,1,32
3653,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7269,C1(=O)N(C)C2C(C=NC(Nc3cc(SC)ccc3)=N2)C=C1c4c(Cl)cccc4Cl,445.36481,PD173955,77058641,,,,,1,32
3653,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7122,c1(N(C2CC3)C3CC(NC(c4c(C)cc(C(=O)N)c(N[C@H](C)CC)c4)=O)C2)ccc(C(C5CC5)=O)cn1,503.63578,XL888,121595951,Phase 1,HSP inhibitor,,InChI key,3,32
3653,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7284,c1(C(F)(F)F)c(Nc2cc(NC(C=C)=O)ccc2)nc(Nc3ccc(N4CCN(C(=O)C)CC4)cc3OC)nc1,555.55152,CO-1686 (AVL-301),57335384,Phase 3,EGFR inhibitor,EGFR,InChI key,1,32
3653,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7133,c1c([N+]([O-])=O)c(Sc2c(F)cc(F)cc2)sc1C(C)=O,315.31568,P22077,46931953,Preclinical,ubiquitin specific protease inhibitor,USP7,InChI key,,32
3653,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7300,c1(cc(NC(=O)CN(C)C)cc2)c2NC(=O)c3c1cccc3.Cl,331.79672,PJ34 HCl,129010320,Preclinical,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,InChI key,,32
3653,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7143,c1(c2cc(C)ncc2)ncc(CC(=O)Nc3ncc(c4nccnc4)cc3)cc1C,396.44449,LGK-974,46926973,Phase 2,porcupine inhibitor,PORCN,InChI key,,32
3653,G12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7319,c1(NCCCN2CCOCC2)nccc(Nc3cc(c4cc3)c(c5n4CC)cccc5)n1,430.54529,EHop-016,51031035,Preclinical,Ras GTPase inhibitor,RAC1|RAC3,InChI key,1,32
3653,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7155,ONC(=O)[C@@H](CSc1cccs1)[C@H](CC(C)C)C(=O)N[C@H](Cc2ccccc2)C(NC)=O,477.63993,Batimastat (BB-94),2299,Phase 3,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,InChI key,1,32
3653,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7332,c1(Cl)cc(OC)c(NCC(=O)N2CCC(NS(=O)(=O)C=C)CC2)cc1I,513.77811,K-Ras(G12C) inhibitor 9,71761630,,,,,,32
3653,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7176,c1(csc(Nc2ccc(O)cc2)n1)c3ccc(Cl)cc3,302.77864,SKI II,753704,Preclinical,sphingosine kinase inhibitor,SPHK1,InChI key,,32
3653,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7355,c(ccc(Cl)c1)(C(=O)N(Nc2ccccc2)C([C@@H](CC#C)N(CCCN)C(c3c(F)c(Cl)ccc3)=O)=N4)c14,552.42686,ARQ 621,57695476,Phase 1,kinesin-like spindle protein inhibitor,KIF11,InChI key,2,32
3653,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7198,c1cc2c(NC(=C3c4c(cc(Br)cc4)NC3=O)C2=NO)cc1,356.17349,BIO,24906282,,,,,3,32
3653,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7368,n1cc(C(F)(F)F)c(NC)nc1Nc2cnn([C@@H]3[C@H](F)CN(C4COC4)CC3)c2Cl,449.83361,GNE-9605,69281791,,,,,,32
3653,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7215,c1(C(=O)NC2CC2)cc(c3ncc(C(=O)NCC(C)(C)C)cc3)c(C)c(F)c1,383.45914,Losmapimod (GW856553X),11552706,Phase 3,p38 MAPK inhibitor,MAPK14,InChI key,,32
3653,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7382,c1cc2c(c(C[C@H](NC(=O)[C@H](CC(C)C)NP(=O)(O)O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C(O)=O)c[nH]2)cc1.[Na][Na],589.48346,Phosphoramidon Disodium Salt,121595956,,,,,1,32
3653,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7237,C1C(N)C1c2ccc(c3cccc(O)c3)cc2,225.2857,OG-L002,53354794,Preclinical,histone lysine demethylase inhibitor,KDM1A,InChI key,,32
3653,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7421,c1c(Nc2[nH]nc(c23)ncnc3N)ccc(F)c1,244.22776,CGP 57380,11644425,Preclinical,MAP kinase inhibitor,AURKB|LCK|MKNK1|MKNK2|SGK1,InChI key,1,32
3653,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,InChI key,3,32
3653,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8036,c1(C(=O)C=Cc2ccc(O)c(O)c2)ccc(O)cc1O,272.25277,Butein,2483,Preclinical,EGFR inhibitor|src inhibitor,ACE,chemical name,,32
3653,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7451,Cc1ccc(Cl)cc1N(S(C)(=O)=O)CC(Nc2c(F)cccc2F)=O,388.8167,FPH1 (BRD-6125),2210370,Preclinical,hepatocyte function enhancer,,InChI key,1,32
3653,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8047,c1(O)ccc(C=NNC(c2cc3c(cccc3)cc2O)=O)cc1O,322.31475,Dynasore,6739924,Preclinical,dynamin inhibitor,DNM1|DNM1L|DNM2,chemical name,1,32
3653,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7470,c1cnc(C=NNC(N)=S)c(N)c1,195.24486,Triapine,3006315,Phase 2,ribonucleotide reductase inhibitor,RRM1|RRM2,chemical name,,32
3653,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8061,c1(O)cc2c(cc(C)c(c3c(C)cc4c(cc(O)c(O)c4C(NC[C@@H](c5ccccc5)C)=O)c3O)c2O)c(C(NC[C@@H](c6ccccc6)C)=O)c1O,700.7756,Sabutoclax,44224066,,,,,4,32
3653,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7494,c1(C)cc(C)c(c2nc(NC(=O)c3ccccc3)sc2)c(C)c1,322.42402,INH6,7918451,,,,,1,32
3653,H10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7513,CN1C(=O)N(Cc2cc(F)ccc2C#N)C(N3CC(N)CCC3)=CC1=O,357.3821,Trelagliptin,11360300,Launched,dipeptidyl peptidase inhibitor,DPP4,InChI key,1,32
3653,H12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7526,C(NCCO)(=O)c1cccc(c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,418.36918,GNF-5,44129660,,,,,,32
3653,H14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7587,c1(NC(c2nonc2N)=NO)cc(Cl)c(F)cc1,271.63558,INCB024360,53434622,Phase 2,"indoleamine 2,3-dioxygenase inhibitor",IDO1,InChI key,1,32
3653,H16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8002,c1c(C(O)=O)c2c(n(Cc3c(C)c(C(F)(F)F)ccc3)c(C)n2)cc1N4CCOCC4,433.42358,GSK2636771,56949517,Phase 2,PI3K inhibitor,PIK3CB,InChI key,,32
3653,H18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8014,C(O)(CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1)=O,347.40704,GW9508,11595431,Preclinical,free fatty acid receptor agonist|G protein-coupled receptor agonist,FFAR1|FFAR4,InChI key,,32
3653,H20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8024,n1c(c2ncc1c3ccccc3)cc(OC)c(OC)c2,266.29456,Tyrphostin AG 1296,2049,Preclinical,FLT3 inhibitor,FLT3,InChI key,,32
3653,H22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7094,c(scc1)(c(Nc2n[nH]c3c2CN(C(N[C@@H](c4ccccc4)CN(C)C)=O)C3(C)C)nc(C)n5)c15,490.6237,PF-3758309,90461900,Phase 1,p21 activated kinase inhibitor,PAK4,InChI key,1,32
3653,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7256,c1cc2c(nc(CCc3ccc(OC)c(Cl)c3)n2C[C@@H](N4CCOCC4)C)cc1c5c(C)onc5C,509.03961,SGC-CBP30,101043110,Preclinical,bromodomain inhibitor,CREBBP|EP300,InChI key,,32
3653,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7108,CC(n1nc(c2c(F)c(NS(C)(=O)=O)cc(Cl)c2)c(c3ccnc(NCC(NC(OC)=O)C)n3)c1)C,540.01068,LGX818,70311789,Phase 3,RAF inhibitor,BRAF,InChI key,3,32
3653,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7270,c1c(C(F)(F)F)cc(NC(=O)c2ccncc2)c(N3CCCCC3)c1,349.35022,SRPIN340,2797577,Preclinical,serine arginine protein kinase inhibitor,SRPK1|SRPK2,InChI key,,32
3653,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7124,c1n2c(c(NNC(c3nccnc3)=O)nc4c2ccc(F)c4)cc1,322.29654,SC144,400169,Preclinical,P glycoprotein inhibitor,,InChI key,4,32
3653,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7285,c1c(n2c(COc3cc(C)c(c4ccc(S(C)(=O)=O)cc4)cc3)nnc2SC5CCCC5)cncc1,520.66621,NMS-873,71521142,Preclinical,ATPase inhibitor,VCP,InChI key,,32
3653,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7134,c1cc(n2c(C)cc(C(=O)CN3CCCC3)c2C)ccc1F,300.37054,IU1,675434,Preclinical,ubiquitin C-terminal hydrolase inhibitor,USP14,InChI key,1,32
3653,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7301,C(CCS1)(N=C(SCC(=O)Nc2ccc(c3ccccc3)cn2)N(c4ccccc4)C5=O)=C15,472.58189,IWP-L6,71601111,Preclinical,porcupine inhibitor,PORCN,InChI key,,32
3653,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7145,c1cc2c(c(c3ncc(CN4CCOCC4)cc3)c(O)[nH]2)cc1C#N,334.37181,AZD1080,49830844,Phase 1,glycogen synthase kinase inhibitor,GSK3A|GSK3B,InChI key,2,32
3653,I12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7320,c1(cc(OC)cc2)c2SC(=CC(=O)C)N1CC,249.32869,TG003,647991,,,,,,32
3653,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7157,c1cc2c([nH]cc2C[C@H](NC([C@H](CC(C)C)CC(NO)=O)=O)C(NC)=O)cc1,388.46072,"Ilomastat (GM6001, Galardin)",3498,Phase 3,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,InChI key,,32
3653,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7333,c1cc(OCC(=O)N2CCC(NC(=O)CCCS)CC2)c(Cl)cc1Cl,405.33917,K-Ras(G12C) inhibitor 6,71815954,Preclinical,K-ras inhibitor,,InChI key,,32
3653,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7177,c1cc(S(=O)(=O)Cc2cc(C)cc(OCc3ccc(CN4CCC[C@@H]4CO)cc3)c2)ccc1,465.60433,PF-543,77147233,,,,,3,32
3653,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7356,c1c(NS(c2ccccc2)(=O)=O)cc(c3ccc4n(c(C(OCC)=O)cn4)c3)cn1,422.45701,HS-173,52936849,,,,,1,32
3653,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7199,c1cc2c(c(NCc3ccccc3)nc(NCc4ccccc4)n2)cc1,340.421,DBeQ,676352,Preclinical,ATPase inhibitor,CASP3,InChI key,1,32
3653,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7369,C1SC(NN=C(C(O)=O)Cc2c(N(O)O)cccc2)=NC1c3ccc(Cl)c(Cl)c3,455.31503,4EGI-1,129010321,Preclinical,protein synthesis inhibitor,EIF4E,chemical name,2,32
3653,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7217,c1cc(C(=O)Nc2ncc3c(cc[nH]3)c2)ccc1,237.25663,OAC1,789882,Preclinical,Oct activator,,InChI key,1,32
3653,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7383,OC(=O)C(=O)O.C1SC(=N2)N(C[C@@H]2c3ccc(Br)cc3)C1,373.22232,(-)-p-Bromotetramisole Oxalate,112477,,,,,,32
3653,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7241,C1C(NS(c2ccc(c3ccsc3)c(NC(Nc4cc(C(F)(F)F)ccc4)=O)c2)(=O)=O)C1,481.51112,AGI-6780,71299339,Preclinical,isocitrate dehydrogenase inhibitor,IDH2,InChI key,,32
3653,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7422,c1(ccnc2)c2cccc1S(=O)(=O)N(C)[C@@H](Cc3ccc(OS(=O)(=O)c4cccc5c4ccnc5)cc3)C(=O)N6CCN(c7ccccc7)CC6,721.8444,KN-62,3838,,,,,,32
3653,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7437,c1ccc(C=CC(NC(NC(Nc2ccc(Cl)cc2)=S)C(Cl)(Cl)Cl)=O)cc1,463.2082,Sal003,2829966,,,,,,32
3653,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8037,c1cc2c([nH]cc2CC3C(=O)N(C)C(=S)N3)cc1,259.32682,Necrostatin-1,2828334,Preclinical,RIPK inhibitor,RIPK1,InChI key,1,32
3653,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7452,c1cc(OC)c(NC(=S)Nc2cn(CC)nc2C(=O)N)cc1Cl,353.82714,FPH2 (BRD-9424),2208391,,,,,1,32
3653,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8048,c1cc(C2=C(CN3CCN(c4ccc(C(NS(=O)(=O)c5cc([N+]([O-])=O)c(NCC6CCOCC6)cc5)=O)c(Oc7cc8c([nH]cc8)nc7)c4)CC3)CCC(C)(C)C2)ccc1Cl,868.4392,ABT-199 (GDC-0199),49846579,Launched,BCL inhibitor,BCL2,InChI key,2,32
3653,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7473,CCCCN(C(Nc1ccccc1)=O)Cc2ccc(C(NO)=O)cc2,341.40422,Nexturastat A,71462653,Preclinical,HDAC inhibitor,HDAC1|HDAC6,InChI key,1,32
3653,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8065,N1(C(=O)N2CCNC(=O)C2)[C@H](c3ccc(Cl)cc3)[C@@H](c4ccc(Cl)cc4)N=C1c5c(OC(C)C)cc(OC)cc5,581.4896,Nutlin-3b,216345,,,,,,32
3653,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7497,Cc1[nH]c(c2c1CCNC(c3sccc3)=O)cccc2,284.37604,CK-636,588963,Preclinical,actin related protein inhibitor,ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5,InChI key,1,32
3653,J10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7515,C1C(c2ccccc2)=NOC1CC(O)=O,205.20994,VGX-1027,10798271,Phase 1,tumor necrosis factor receptor antagonist,TLR4,InChI key,1,32
3653,J12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7528,c1(C(F)(F)F)c(NCC)nc(Nc2c(OC)cc(C(=O)N3CCOCC3)c(F)c2)nc1,443.39535,GNE-7915,58539171,,,,,1,32
3653,J14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7589,c1c(n2c(c3ccc(n4ccnc4)cc3)ccc2CCC(=O)O)c(C)cc(C(=O)N)c1,414.45647,N6022,44623946,Phase 1/Phase 2,alcohol dehydrogenase inhibitor,ADH5,InChI key,1,32
3653,J16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8003,N(c1cc(Cl)ccc1OC)C(Nc2c(c3nc(C)c2)cccc3)=O,341.79153,PQ 401,9549305,Preclinical,IGF-1 inhibitor,IGF1R,InChI key,1,32
3653,J18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8015,N(c1cccc(Oc2c(c3ncn2)cc(OC)c(OC)c3)c1)C(Nc4cc(C(C)(C)C(F)(F)F)on4)=O,517.45718,CEP-32496,56846693,Phase 1/Phase 2,RAF inhibitor,BRAF|RAF1,InChI key,1,32
3653,J20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8025,c1c(C(F)(F)F)ccc(S(=O)(CCNC(=O)c2ccc(Cl)cc2)=O)n1,392.78058,GSK3787,2800647,Preclinical,PPAR receptor antagonist,PPARD,InChI key,1,32
3653,J22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7096,c1(CCC(Nc2nc3c(cc(Cl)cc3)s2)=O)ccc(OC)c(OC)c1,376.85718,KY02111,8582409,Preclinical,Wnt pathway inhibitor,DKK1,InChI key,,32
3653,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7257,c1ccc(NC(=O)C=C)cc1Nc2nc(Nc3ccc(Oc4cc(C(=O)NC)ncc4)cc3)ncc2F,499.49638,CNX-774,59174579,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,InChI key,1,32
3653,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,,,32
3653,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7272,c1(O)c(C=O)c2c(C(C)=CC(=O)O2)cc1,204.17882,4?8C,12934390,Preclinical,IRE1 inhibitor,ERN1,InChI key,,32
3653,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7125,c1(C(F)(F)F)cc(c2nn(C=CC(OC(C)C)=O)cn2)cc(OC)c1,355.31174,KPT-185,66996657,Preclinical,exportin antagonist,XPO1,chemical name,1,32
3653,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7289,c1cc(C(=O)C=Cc2nc3c(cccc3)cc2)ccn1,260.28998,PFK15,74395294,Phase 1,phosphofructokinase inhibitor,PFKFB3,canonical SMILES,,32
3653,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7135,c1(Cl)cc2c(N(Cc3c(Cl)ccc(Cl)c3)C(=O)C2=NOC(C)=O)cc1,397.63983,LDN-57444,24906255,Preclinical,ubiquitin C-terminal hydrolase inhibitor,,chemical name,,32
3653,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7303,n1c(Nc2c(C)cc(C=CC#N)cc2C)ccnc1Nc3ccc(C#N)cc3,366.41852,Rilpivirine,3006171,Launched,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A,chemical name,,32
3653,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7146,CC(Oc1ccc(c2cnc3n(ncc3c4c(c5ncc4)cccc5)c2)cc1)C,380.44179,DMH1,50997747,Preclinical,ALK tyrosine kinase receptor inhibitor,ACVR1,InChI key,,32
3653,K12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7324,c1(c2nc(C(F)(F)F)on2)cc(C(=O)NCC3(c4scc(c5ccccc5)n4)CCOCC3)ccc1,514.51944,TMP269,53344908,,,,,,32
3653,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7158,c1(CN2CCN(CC)CC2)cnc(Nc3ncc(F)c(c4cc5c(nc(C)n5C(C)C)c(F)c4)n3)cc1.CS(O)(=O)=O,602.69904,LY2835219,71576678,Phase 3,CDK inhibitor,CDK4|CDK6,InChI key,3,32
3653,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7336,c1(I)cc(C(O)=O)c(NC(=O)[C@@H](NCc2ccccc2)Cc3ccccc3)cc1,500.32891,CW069,121595950,,,,,,32
3653,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7185,C1CCC(NC(=O)C(c2ccccc2C)N(c3cccc(F)c3)C(=O)Cn4c(C)ncc4)CC1,462.55904,AGI-5198,56645356,Preclinical,isocitrate dehydrogenase inhibitor,IDH1,InChI key,1,32
3653,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7357,c1ccc(CNc2nc(Nc3cc(CC(=O)N4)c4cc3)ncc2C(F)(F)F)c(N(S(C)(=O)=O)C)n1.Cl,543.94974,PF-562271 HCl,129010322,Phase 1,focal adhesion kinase inhibitor,PTK2|PTK2B,InChI key,,32
3653,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7206,c1(C(F)(F)F)c(Nc2cc(NC(=O)C=C)ccc2)nc(Nc3ccc(NC4CN(CCF)C4)cc3OC)nc1,545.53189,CNX-2006,56968072,Preclinical,EGFR inhibitor,EGFR,InChI key,2,32
3653,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7370,c1ccc(C(N(c2ccc(C(O)=O)cc2)C(=O)C3=Cc4oc(c5ccc([N+]([O-])=O)cc5)cc4)=C3)cc1,478.45232,4E1RCat,6617612,Preclinical,protein synthesis inhibitor,EIF4E|EIF4G1,chemical name,2,32
3653,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7218,C(N(c1cc(C(F)(F)F)ccc1)C(=O)C(C(=O)NCc2ccc(S(=O)(=O)C)cn2)=C3)=C3c4n(C)ncc4,531.5069,Alvelestat (AZD9668),75731913,,,,,,32
3653,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7391,[C@@H](NC(=O)OCc1ccccc1)(C(=O)NC(C)C(=O)CF)Cc2ccccc2,386.41672,Z-FA-FMK,122019,,,,,1,32
3653,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7242,c1c2c(C(=O)N(c3ccccc3OCC)C(C(N4CCN(C(=O)COc5ccc(Cl)cc5)CC4)C)=N2)ccc1,547.04454,Erastin,11214940,Preclinical,ion channel antagonist,VDAC2,InChI key,,32
3653,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7423,c1(ccccc1CN(C)CC=Cc2ccc(Cl)cc2)N(CCO)S(=O)(=O)c3ccc(OC)cc3.P(OO)(=O)=O.[H],599.03264,KN-93 Phosphate,129010323,,,,,2,32
3653,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7438,CC(NC(CCC(Nc(c1C2=O)cccc1)=N2)=O)c3ccccc3,321.37306,ME0328,51147633,Preclinical,PARP inhibitor,PARP3,InChI key,,32
3653,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,InChI key,1,32
3653,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7458,CCNC(C(NNC1=C2C(=O)C=C(O)C(Cl)=C2)=C1c3ccc(OC)cc3)=O,387.81692,VER-49009,49830986,Preclinical,HSP inhibitor,HSP90AA1,chemical name,3,32
3653,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8050,c1c2c(c3c(COC(=O)N3c4ccc(C(C)(C)C#N)cc4)cn2)cc(c5cc6c(cccc6)nc5)c1,470.52128,ETP-46464,72199292,Preclinical,ATR kinase inhibitor,,InChI key,1,32
3653,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7482,O1C=C(OCCCCCSc2c3c(cc(C(F)(F)F)cc3)ncc2)C(=O)C=C1CN4CCOCC4.Cl.Cl,581.47496,EHT 1864,129010324,,,,,,32
3653,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8072,c1cc(C(=O)NC(C)CCC)cc(Cl)c1Cl,260.1596,NSC 405020,346721,Preclinical,matrix metalloprotease inhibitor,MMP1,InChI key,,32
3653,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7499,c1c(NN=C(C#N)C(=O)c2noc(C(C)(C)C)c2)cccc1Cl,330.76889,ESI-09,2744921,Preclinical,EPAC inhibitor,RAPGEF3|RAPGEF4,chemical name,1,32
3653,L10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7516,Cc1n(c2ccc(Cl)cc2)ncc1C(Nc3ccc(N4CCC(N5CCOCC5)CC4)c(C#N)c3)=O,505.01115,Y-320,22227931,Preclinical,interleukin inhibitor,IL17A,InChI key,,32
3653,L12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7529,c1(c2ncc(C)c(NCc3ccc(n4ccnn4)cc3)n2)ccccc1C(C)C,384.47686,ML323,60167849,Preclinical,ubiquitin specific protease inhibitor,USP1,InChI key,,32
3653,L14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7595,c1ccccc1CCNC(=O)CCCNC(=O)OCC,278.34678,Santacruzamate A (CAY10683),72946782,,,,,1,32
3653,L16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8004,C(c1ccc(c2c1)cccc2)(=O)CCN(Cc3ccccc3)C(C)C.Cl,367.91164,ZM 39923 HCl,44369814,Preclinical,JAK inhibitor,JAK1|JAK3,InChI key,1,32
3653,L18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8016,N(C)Cc1cc(c2ccccc2F)n(S(c3cccnc3)(=O)=O)c1.C(O)(=O)C=CC(O)=O,461.4634,TAK-438,66618705,,,,,1,32
3653,L20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8028,c1cc2c(ncc(C(=O)Nc3cc(OC)c(OC)cc3C(=O)Nc4ccc(CCN5CCc6c(cc(OC)c(OC)c6)C5)cc4)c2)cc1,646.73152,Tariquidar,148201,Phase 3,P glycoprotein inhibitor,ABCB1,InChI key,1,32
3653,L22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7097,n1c(c2cc(F)ccc2[C@H]3Cc4c(c(C)nc(N)n4)C(=O)N3)cccc1OC,379.38762,HSP990 (NVP-HSP990),16226182,Phase 1,HSP inhibitor,HSP90AA1|HSP90AB1,InChI key,2,32
3653,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7258,Cc1sc(Sc2c(c3ncn2)cc(OC)c(OC)c3)nn1,320.38997,SKLB1002,71461003,Preclinical,VEGFR inhibitor,KDR,InChI key,2,32
3653,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7111,c1ccc2c(c3n(cnc3)C2CC(O)C4CCCCC4)c1,282.38008,NLG919,66558287,Phase 1,"indoleamine 2,3-dioxygenase inhibitor",IDO1,InChI key,,32
3653,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7273,n1c(N2CCC(c3nc(C(=O)Nc4[nH]c5c(ccc(C(=O)c6ccccc6)c5)n4)cs3)CC2)c7c(ccs7)nc1,565.66862,SC75741,23661638,,,,,2,32
3653,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7127,c1cc(CN2CC3=C(N(Cc4ccccc4C)C(=N5)N(CC5)C3=O)CC2)ccc1,386.48943,TIC10,336423,Phase 2,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,InChI key,1,32
3653,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7291,c(nc(NC(=O)C1CC1)s2)(ccc(Oc3ccc(F)c(NC(=O)Cc4cc(C(F)(F)F)ccc4)c3)c5C#N)c25,554.51543,TAK-632,46209401,Preclinical,RAF inhibitor,BRAF,InChI key,2,32
3653,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7136,c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c3ccccc3)C(Cl)(Cl)Cl)cc([N+]([O-])=O)c1F,555.83642,CGK 733,6605258,Preclinical,ATM kinase inhibitor|ATR kinase inhibitor,ATM|ATR,InChI key,,32
3653,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7304,c1(C)sc2c(C(c3ccc(Cl)cc3)=N[C@@H](CC(N)=O)c4n2c(C)nn4)c1C,399.89711,CPI-203,19704953,Preclinical,bromodomain inhibitor,BRD4,InChI key,,32
3653,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7147,C1NCCN(c2ccc(c3cnc4n(ncc4c5cccc(c56)nccc6)c3)cc2)C1,406.48238,LDN-212854,60182388,Preclinical,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2,InChI key,,32
3653,M12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7325,n1c(N[C@H]2CC[C@H](O)CC2)c(C(=O)NCc3ccc(n4ccnc4)cc3)cnc1NCCCC,463.57522,UNC2881,71721525,,,,,,32
3653,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7162,N(c(c1C(=O)N2c3cc(OC)c(Cl)cc3Cl)cccc1)=C2S,353.22309,Mdivi-1,3825829,Preclinical,dynamin inhibitor,DNM1,InChI key,1,32
3653,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7337,C1CC(c2ccc(CN(c3ccc(C(=O)O)cc3)C(CN(C)S(=O)(=O)c4c(F)c(F)c(F)c(F)c4F)=O)cc2)CCC1,610.59209,SH-4-54,72188643,,,,,1,32
3653,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,InChI key,,32
3653,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7359,n1c(N)c(c2cc(OC)c(OC)c(OC)c2)cc(c3cc(O)ccc3)c1,352.3838,K02288,46173038,Preclinical,bone morphogenic protein inhibitor,BMP1,InChI key,,32
3653,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,InChI key,6,32
3653,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7372,Cc1nc(n2c1c3nc(Nc4c(Br)cc(OC)cc4Br)sc3)nccc2,495.19101,PTC-209,1117196,Preclinical,BMI-1 inhibitor,,InChI key,2,32
3653,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7223,n1c(c2ccc1c3c[nH]nc3c4nc(C)ccc4)cccn2,287.31862,RepSox,449054,Preclinical,TGF beta receptor inhibitor,TGFBR1,InChI key,2,32
3653,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7392,CC(CCNC(C(NC(C1OC1C(O)=O)=O)CC(C)C)=O)C,314.37734,Loxistatin Acid (E-64C),3188,Preclinical,cysteine peptidase inhibitor,CTSB,InChI key,,32
3653,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7243,c1(NC2CCCCC2)c(N)cc(C(=O)OCC)cc1,262.34738,Ferrostatin-1 (Fer-1),4068248,Preclinical,ferroptosis inhibitor,,InChI key,,32
3653,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7424,c1cc2c(c(C=C(C(=O)O)S)c[nH]2)cc1F,237.25012,PD 151746,4704,,,,,2,32
3653,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7440,CN(C(c1n(C2CCCC2)c(c3c1)nc(Nc4ccc(N5CCNCC5)cn4)nc3)=O)C,434.5373,LEE011,44631912,Phase 3,CDK inhibitor,CDK4|CDK6,InChI key,,32
3653,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,InChI key,2,32
3653,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7459,n1oc(c2c(O)cc(O)c(Cl)c2)c(c3ccc(OC)cc3)c1C(=O)NCC,388.80168,VER-50589,53394038,,,,,,32
3653,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8051,c1(Br)cnc(OCCOc2ncnc(NS(=O)(NCCC)=O)c2c3ccc(Br)cc3)nc1,588.27289,Macitentan,16004692,Launched,endothelin receptor antagonist,EDNRA|EDNRB,InChI key,2,32
3653,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7484,c1c(Cl)cc(S(=O)(=O)Nc2ccc([N+]([O-])=O)cc2C)c(Cl)c1,361.20049,FH535,3463933,,,,,2,32
3653,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8073,c1ncc(n2c(C)cc(C=C3C(=O)NC(=S)S3)c2C)cc1,315.41321,Optovin,2890284,,,,,2,32
3653,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7500,c1c(C)cc(C)c(S(n2c(C)cc(C)c2)(=O)=O)c1C,277.38185,HJC0350,22200891,,,,,,32
3653,N10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7517,CC(O)(C(F)(F)F)C(Nc1ccc(S(c2ccc(C(N(C)C)=O)cc2)(=O)=O)cc1Cl)=O,478.86982,AZD7545,9805105,Phase 1,pyruvate dehydrogenase kinase inhibitor,PDK1,InChI key,,32
3653,N12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7534,c1(ccccc1OCCOc2ccccc2N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C)N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,764.684,BAPTA-AM,2293,,,,,,32
3653,N14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7597,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(N[C@@H](C(c3ccccc3)c4ccccc4)C(=O)NCCCCCCNC([C@H](C(c5ccccc5)c6ccccc6)NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)NC)=O)=O,1205.57344,BV-6,74081524,,,,,4,32
3653,N16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8005,S1C(=Cc2cccc(C(F)(F)F)c2)C(=O)NC1=O,273.23104,SMI-4a,2864586,,,,,,32
3653,N18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8019,N1(c2ncnc3c2cc[nH]3)CCC(N)(C(N[C@H](c4ccc(Cl)cc4)CCO)=O)CC1,428.9152,AZD5363,42602260,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,InChI key,,32
3653,N20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8029,c1(cc(Cl)nc(SCC(=O)O)n1)Nc2cccc(C)c2C,323.79785,WY-14643 (Pirinixic Acid),5694,Preclinical,PPAR receptor agonist,PPARA,InChI key,1,32
3653,N22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7098,N1(C(C(c2ccccc2)c3ccccc3)=O)Cc4c(n(Cc5ccc(N(C)C)c(C)c5)cn4)C[C@H]1C(=O)O,508.61077,PD123319,4701,Phase 1,angiotensin antagonist,AGTR2,InChI key,,32
3653,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7261,c1cc2c(C(=O)C(=O)C3=C2OC(C)(C)CC3)cc1,242.26986,Beta-Lapachone,3885,Phase 2,topoisomerase inhibitor,TOP1,InChI key,,32
3653,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7113,[C@@H]1(CO)[C@H](O)[C@H](O)[C@H](N2C=CC=NC2=O)O1,228.20198,Zebularine,328839,Preclinical,DNA methyltransferase inhibitor,CDA|DNMT1,InChI key,,32
3653,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7276,n1c2c(cccc2)c(Nc3ccc(C(=O)Nc4ccc(Nc5cc(C)nc(N)n5)cc4)cc3)cc1,461.51782,SGI-1027,24858111,Preclinical,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B,InChI key,,32
3653,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7128,C1OCCC(N(c2cc(c3ccc(CN4CCOCC4)cc3)cc(C(=O)NCC5=C(C)C=C(C)NC5=O)c2C)CC)C1,572.73755,EPZ-6438,66558664,Phase 2,histone lysine methyltransferase inhibitor,EZH2,InChI key,1,32
3653,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7292,c1(C)ccc(C(NCCCCCC(=O)Nc2c(N)cccc2)=O)cc1,339.4314,RG2833 (RGFP109),56654642,Phase 1,HDAC inhibitor,HDAC1|HDAC3,InChI key,,32
3653,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7138,c1cc2c(c(c3ccccc3)nc(Nc4ccc(C(=O)Nc5cc(CNC)ccc5C)cc4)n2)cc1,473.56827,BMS-833923,57662985,Phase 2,smoothened receptor antagonist,SMO,InChI key,1,32
3653,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7307,c1cc2c(CCN2C(Cc3cc(C(F)(F)F)ccc3)=O)cc1c4cn(C)c5c4c(N)ncn5,451.4437,GSK2606414,53469448,Preclinical,protein kinase inhibitor,EIF2AK3|MYLK2,InChI key,1,32
3653,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7148,COc1ccc(c2cnc3n(ncc3c4cccc(c45)nccc5)c2)cc1,352.38864,ML347,44577753,Preclinical,serine/threonine kinase inhibitor,GSG2,InChI key,,32
3653,O12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7326,C(NS(=O)(c1ccc(Br)s1)=O)(=O)c2ccc(Cl)cc2Cl,415.11024,Tasisulam,10160238,Phase 3,apoptosis stimulant,,InChI key,,32
3653,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7165,c1cc(c2cc(C(NCC(C(=O)NC(C)=C3)=C3CCC)=O)c4c(n(C(C)C)nc4)c2)cnc1N5CCN(C(C)C)CC5,569.74022,UNC1999,72551585,Preclinical,histone lysine methyltransferase inhibitor,EZH2,InChI key,1,32
3653,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7338,c1cc2c(n(C)cc2c3ccnc(Nc4c(OC)cc(N5CCN(C)CC5)cc4)n3)cn1,429.51747,AZ191,72716071,Preclinical,DYRK inhibitor,DYRK1B,InChI key,1,32
3653,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7192,n1c(N)c2c(OCCN(c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)C2=O)nc1,396.43965,PF-04620110,46926360,Phase 1,diacylglycerol O acyltransferase inhibitor,DGAT1,InChI key,1,32
3653,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7360,Cc1c2c(n(c3C(CC(Nc4ccc(O)cc4)=O)N=C2c5ccc(Cl)cc5)c(C)nn3)sc1C,491.99247,OTX015,19704956,Phase 1/Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,chemical name,,32
3653,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7208,c1cccc2c1n(CCCN(C)C)cc2C3=C(c4c(c5[nH]c4)cccc5)C(=O)NC3=O,412.48366,GF109203X,2396,Preclinical,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,InChI key,3,32
3653,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7373,C1CN(C2CCN(C(c3cncc(Br)c3)=O)CC2)CC1,338.2428,UNC669,46931242,Preclinical,L3MBTL antagonist,L3MBTL1,InChI key,1,32
3653,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7224,c1cc2c(n([C@H](COc3ccc(c4nc5c(cccc5)n4Cc6ccccc6)cc3)C7CCNCC7)c(c8ccccc8)n2)cc1,603.75468,Deltarasin,73292903,,,,,,32
3653,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7393,CCOC(C1OC1C(NC(C(NCCC(C)C)=O)CC(C)C)=O)=O,342.43049,Aloxistatin,3189,Phase 3,protease inhibitor,CTSG,InChI key,1,32
3653,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7248,c1(C(=O)NC2CCN(C)CC2)ccc(Nc3ncc4c(N(C5CCCC5)CC(F)(F)C(=O)N4C)n3)c(OC)c1,543.6087,Ro3280,25015677,,,,,1,32
3653,O22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7429,n1n(c2ccc(NC(CCl)=O)cc2)c(c3ccc(Cl)c(Cl)c3)nc1OCCOC,455.72227,MI-2 (MALT1 inhibitor),45942672,,,,,2,32
3653,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7447,c1cc2c([nH]c(c3ccc(C(C)(C)C)cc3)n2)cc1,250.33821,ZLN005,899323,Preclinical,,,InChI key,2,32
3653,P04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8040,N(CC)C(Nc1ccc(c2nc(N3CCOC[C@@H]3C)c4c(CN(C5COC5)CC4)n2)cc1)=O,452.54927,GDC-0349,60154901,Phase 1,Pim kinase inhibitor,PIK3CA,InChI key,1,32
3653,P05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7460,c1ccc(S(c2ccc([N+]([O-])=O)c(OC(c3ccc(Cl)cc3)=O)c2)(=O)=O)cc1,417.81967,BTB06584,2799764,Preclinical,ATPase inhibitor,ATP5F1,InChI key,3,32
3653,P06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8056,n1c(N)nc(OCc2scc(Br)c2)c3c1nc[nH]3,326.17242,Lomeguatrib,3025944,Phase 2,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,InChI key,,32
3653,P07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7488,Cc1cc(N2CCOCC2)ccc1Nc3nc(NC4CCCCC4)c5c(nc[nH]5)n3,407.51196,MPI-0479605,46909588,Preclinical,mitotic kinase inhibitor,TTK,InChI key,,32
3653,P08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,InChI key,,32
3653,P09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,,2,32
3653,P10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7518,c(N(c1nccs1)C=C(C(O)=O)C2=O)(nc(N3C[C@H](OC)[C@@H](NC)C3)cc4)c24,401.43955,Voreloxin (SNS-595),18969086,Phase 3,topoisomerase inhibitor,TOP2A,InChI key,3,32
3653,P12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7539,c1(OC)cc(Br)c(Nc2scc(c3c(C)nc4n3cccn4)n2)c(Br)c1.Br,576.10295,PTC-209 HBr,129010325,Preclinical,BMI-1 inhibitor,,InChI key,3,32
3653,P14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7605,c1c(c2ccc(CN3CCS(=O)(=O)CC3)cc2)n4c(nc(NC(=O)C5CC5)n4)cc1,425.50402,Filgotinib (GLPG0634),49831257,Phase 2,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,InChI key,,32
3653,P16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8006,n1c(c2c(NC3CCN(Cc4ccccc4)CC3)nc1N5CCCN(C)CC5)cc(OC)c(OC)c2.Cl.Cl.Cl,600.02313,BIX 01294,51371252,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,InChI key,1,32
3653,P18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8020,n1c(C)c(CSc2ccc(OCC(O)=O)c(C)c2)sc1c3ccc(C(F)(F)F)c(F)c3,471.48819,GW0742,9934458,Preclinical,PPAR receptor agonist,PPARD,InChI key,,32
3653,P20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8031,n1c(c2c(N)cc1C)ccc(Nc3cc(C)nc(NC(C)CCCN(CC)CC)n3)c2.Cl.Cl.Cl,530.96441,NSC 23766,71297115,Preclinical,Ras GTPase inhibitor,,InChI key,,32
3653,P22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3653,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1001,c1c(C(CCC(C)(C)C2)=C2CN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(N[C@@H](CSc6ccccc6)CCN7CCOCC7)c(S(=O)(=O)C(F)(F)F)c5)cc4)CC3)ccc(Cl)c1,974.6127,ABT-263 (Navitoclax),25059310,Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,InChI key,1,32
3654,A04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1107,c1([C@@H](OC)C(=O)N2Cc3c([nH]nc3NC(c4ccc(N5CCN(C)CC5)cc4)=O)C2)ccccc1,474.55479,Danusertib (PHA-739358),21874004,Phase 2,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,InChI key,3,32
3654,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1010,c1cc2c(NC(=O)C2=C(Nc3ccc(N(C(=O)CN4CCN(C)CC4)C)cc3)c5ccccc5)cc1C(=O)OC,539.62481,Nintedanib (BIBF 1120),56965894,Launched,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,canonical SMILES,4,32
3654,A06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1116,n1cc2c(N(C3CCCC3)C(=O)C(C(=O)C)=C2C)nc1Nc4ccc(N5CCNCC5)cn4.Cl,483.9937,Palbociclib (PD-0332991) HCl,129010326,Launched,CDK inhibitor,CDK4|CDK6,InChI key,,32
3654,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1025,c1(OC)cc2c(c(Nc3cc(Cl)c(F)cc3)ncn2)cc1OCCCN4CCOCC4,446.90236,Gefitinib (ZD1839),123631,Launched,EGFR inhibitor,EGFR,InChI key,1,32
3654,A08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1130,c1cc2c(C(=O)C3=C([N](Cc4cnccn4)=C(C)N3CCOC)C2=O)cc1.[Br-],443.29385,YM155 (Sepantronium Bromide),11178236,,,,,3,32
3654,A09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1035,c1cc(Nc2nc(N(C)c3cc4c(c(C)n(C)n4)cc3)ccn2)cc(S(=O)(N)=O)c1C.Cl,473.97896,Pazopanib HCl (GW786034 HCl),123132495,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,InChI key,3,32
3654,A10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1142,C(NCCN(C)C)(C1=O)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)C=C(C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2)C(=O)C2=C1.Cl,653.20646,17-DMAG (Alvespimycin) HCl,129010327,Phase 2,HSP inhibitor,HSP90AA1,canonical SMILES,1,32
3654,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1044,[C@H]1(OC)[C@@H](OC(=O)C(C)(CO)CO)CC[C@@H](C[C@@H](C)[C@H]2OC(=O)[C@@]3([H])N(CCCC3)C(=O)C(=O)[C@](O)(O[C@@]4([H])C[C@H](OC)C(C)=CC=CC=C[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)C(C)=C[C@@H](C)C(=O)C2)[C@H](C)CC4)C1,1030.28708,"Temsirolimus (CCI-779, NSC 683864)",129010328,Launched,mTOR inhibitor,MTOR,canonical SMILES,,32
3654,A12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1154,c(scc1)(c(NCCc2cnc(NC(=O)Nc3cccc(Cl)c3)s2)ncn4)c14.CS(O)(=O)=O,527.03995,SNS-314 Mesylate,24995523,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,InChI key,3,32
3654,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1055,c1cc2c(n(C3CCN(Cc4ccccn4)CC3)cc2C5=C(c6cn(C)c7c6cccc7)C(=O)NC5=O)cc1,515.60496,Enzastaurin (LY317615),176167,Phase 3,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,InChI key,2,32
3654,A14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,InChI key,2,32
3654,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1068,c1(c2cnn(C3CCNCC3)c2)cnc(N)c(O[C@H](C)c4c(Cl)c(F)ccc4Cl)c1,450.33668,Crizotinib (PF-02341066),11597571,Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,InChI key,2,32
3654,A16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1172,c1cccc2c1c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]2,328.4103,JNJ-26854165 (Serdemetan),11609586,Phase 1,MDM inhibitor,MDM2,InChI key,3,32
3654,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1078,c1(c2cc3c(C=CN4C3=NNC4=O)nc2c5ccc(C6(N)CCC6)cc5)ccccc1.Cl.Cl,480.38902,MK-2206 2HCl,56965964,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,InChI key,2,32
3654,A18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1181,c1(C=Cc2ccccc2)nc(N3CCN(C)CC3)cc(Nc4cc(C)[nH]n4)n1,375.4701,ENMD-2076,49831008,Phase 2,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,chemical name,2,32
3654,A19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,InChI key,1,32
3654,A20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1193,C1(=O)c(c2C(=O)N1C3CCC(=O)NC3=O)cccc2,258.2295,Thalidomide,5426,Launched,tumor necrosis factor production inhibitor,CRBN|FGFR2|NFKB1|ORM1|ORM2|PTGS2|TNF,InChI key,,32
3654,A21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1098,c1([nH]c2c(c3cc(F)c2)c1CCNC3=O)c4ccc(CNC)cc4.P(O)(O)(O)=O,421.3593,"Rucaparib (AG-014699,PF-01367338)",9931953,,,,,2,32
3654,A22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1204,c1c2c(c(CCNC(C)=O)c[nH]2)cc(OC)c1,232.27834,Melatonin,896,Launched,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,InChI key,,32
3654,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1213,n1c(OC)c2c(n([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)cn2)nc1N,297.2673,Nelarabine,248862,Launched,DNA synthesis inhibitor|T cell inhibitor,POLA1,InChI key,,32
3654,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1393,[C@@H]1(C)O[C@@H](O[C@@]2([H])C[C@](O)(C(=O)CO)Cc3c2c(O)c4c(C(=O)c5c(c(OC)ccc5)C4=O)c3O)C[C@H](N)[C@@H]1O[C@@H]6CCCCO6,627.63568,Pirarubicin,24840378,Launched,topoisomerase inhibitor,TOP2A,InChI key,2,32
3654,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1226,n1c(N2CCOCC2)c3c(nc(c4ccc(OC)c(CO)c4)cc3)nc1N5C[C@H](C)O[C@H](C)C5,465.54473,KU-0063794,25262967,Preclinical,mTOR inhibitor,MTOR,InChI key,,32
3654,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1407,c1ccc(CCC(C=C[C@H]2[C@H](O)C[C@H](O)[C@@H]2CC=CCCCC(NCC)=O)O)cc1,415.56557,Bimatoprost,53393954,Launched,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,chemical name,,32
3654,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1243,C(NCCc1c(c2ccc1)cc(OC)cc2)(=O)C,243.30098,Agomelatine,82148,Launched,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,InChI key,,32
3654,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1431,c1(S(=O)(=O)N2CCN(C)CC2)cc(C(NC(=O)c3c4c(CCC)nn3C)=N4)c(OCC)cc1.C(C(C(=O)O)(O)CC(=O)O)C(=O)O,666.69992,Sildenafil Citrate,62853,,,,,,32
3654,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1257,c1(N2C=NN([C@@H](CC)[C@@H](O)C)C2=O)ccc(N3CCN(c4ccc(OC[C@H]5C[C@](Cn6cncn6)(c7c(F)cc(F)cc7)OC5)cc4)CC3)cc1,700.77738,Posaconazole,129010329,Launched,sterol demethylase inhibitor,CYP3A4,InChI key,1,32
3654,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1453,c1c([C@@](N)(c2ccc3c(C(c4cccc(Cl)c4)=CC(=O)N3C)c2)c5n(C)cnc5)ccc(Cl)c1,489.39577,Tipifarnib,159324,Phase 3,farnesyltransferase inhibitor,FNTA|FNTB,InChI key,,32
3654,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1271,[C@@H]1(N[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)C(CO)=C2)[C@H](C)O[C@H](O[C@@H]3[C@H](CO)O[C@H](O[C@@H]4[C@H](CO)O[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]1O,645.60482,Acarbose,4432690,Launched,glucosidase inhibitor,AMY2A|GAA|MGAM|SI,InChI key,,32
3654,B12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1462,C(O)(=O)c1ccccc1N[C@@H](C(C(N2C=C3C)=NC(N4CCOCC4)=CC2=O)=C3)C,408.45035,AZD6482,10364098,Phase 1,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,1,32
3654,B13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1287,c1c(C(O)=O)cc(NCCCC)c(Oc2ccccc2)c1S(N)(=O)=O,364.4161,Bumetanide,2471,Launched,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,InChI key,,32
3654,B14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1476,c1(c2c(c3nc(C)ccc3)nc(C(C)(C)C)[nH]2)cc4c(nccn4)cc1,343.42493,SB525334,9967941,Preclinical,TGF beta receptor inhibitor,TGFBR1,InChI key,1,32
3654,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1302,C1CN(CCCl)P(=O)(NCCCl)OC1,261.08596,Ifosfamide,3690,Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,InChI key,,32
3654,B16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1487,[nH]1c2c(CN(C(=O)C3CCN(C)CC3)C2(C)C)c(NC(=O)CC(C)C)n1,361.48174,PHA-793887,46191454,Phase 1,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,InChI key,1,32
3654,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1336,c1(C(F)(F)F)ccc(C(=NOCCN)CCCCOC)cc1.C(=CC(O)=O)C(O)=O,434.4068,Fluvoxamine maleate,43725,,,,,,32
3654,B18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1502,c1ccc([C@@H](N)C(=O)N[C@H]2[C@@]3([H])N(C(C(O)=O)=C(C)CS3)C2=O)cc1,347.38887,Cephalexin,22817051,Launched,bacterial cell wall synthesis inhibitor,,InChI key,,32
3654,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1363,c1c(Oc2cc(F)c(NC(=O)Nc3c(F)cc(F)cc3)cc2)c4c(cc(OC)c(OC)c4)nc1,469.41262,Ki8751,11317348,Preclinical,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,InChI key,2,32
3654,B20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1519,c1(Cl)c(N2CCN(CC(=O)Nc3nccs3)CC2)c4c([nH]c(c5ccc(N(C)C)cc5)n4)nc1,497.0156,CCT129202,16202152,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,InChI key,1,32
3654,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1379,C(O)(=O)C=C(C)C=CC=C(C)C=CC(C(C)(C)CCC1)=C1C,300.43512,Isotretinoin,5538,Launched,retinoid receptor agonist,RARA|RARB|RARG,chemical name,1,32
3654,B22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1531,c1cc2c(NC(=O)C2=C(c3ccccc3)Nc4cccc(CN(C)C)c4)cc1C(=O)N(C)C,440.53681,BIX 02189,73265217,Preclinical,MEK inhibitor,MAP2K5|MAPK7,canonical SMILES,1,32
3654,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1002,c1c(C(NS(=O)(=O)c2cc([N+]([O-])=O)c(N[C@H](CCN(C)C)CSc3ccccc3)cc2)=O)ccc(N4CCN(Cc5ccccc5c6ccc(Cl)cc6)CC4)c1,813.4269,ABT-737,46228957,Phase 1/Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,InChI key,1,32
3654,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1109,c1(C(=O)NC2CCN(C)CC2)cc(OC)c(Nc3nc4c(N(C)C(=O)[C@@H](CC)N4C5CCCC5)cn3)cc1,521.65435,BI 2536,11577250,Phase 2,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,InChI key,1,32
3654,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1012,c1(N2CCOCC2)cc3c(nc(C(C(=O)NC=C4)=C4NC[C@@H](O)c5cc(Cl)ccc5)[nH]3)c(C)c1,479.95863,BMS-536924,49830981,Preclinical,IGF-1 inhibitor,AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB,InChI key,2,32
3654,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1117,[C@H]1(O)[C@@H](n2cc3c(c4N(C)N=C3N)c2ncn4)O[C@H](CO)[C@H]1O,320.30393,Triciribine,290486,Phase 1/Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,InChI key,,32
3654,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1026,c1(NC(c2ccc(CN3CCN(C)CC3)cc2)=O)cc(Nc4nc(c5cnccc5)ccn4)c(C)cc1.OS(=O)(=O)C,589.7084,Imatinib Mesylate (STI571),123596,Launched,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,InChI key,1,32
3654,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1132,c1c(C(N)=O)cc(N)cc1,136.15122,INO-1001,1645,Phase 2,PARP inhibitor,PARP1,InChI key,,32
3654,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1036,c1c(C(NOC[C@@H](CO)O)=O)c(Nc2c(F)cc(I)cc2)c(F)c(F)c1,482.19303,PD0325901,10206158,Phase 2,MEK inhibitor,MAP2K1,InChI key,,32
3654,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1143,c1(O)cc(C=C(C#N)C(=O)NCc2ccccc2)ccc1O,294.30466,AG-490 (Tyrphostin B42),2390,,,,,,32
3654,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1045,c1cc(C(=O)[C@H](C)C=C(C)C=CC(=O)NO)ccc1N(C)C,302.36818,Trichostatin A (TSA),5562,,,,,2,32
3654,C12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1155,c1(C)ccc(S(=O)(=O)OCC(=O)Nc2cc(O)c(C(=O)O)cc2)cc1,365.35779,S3I-201,252682,Preclinical,STAT inhibitor,STAT3,InChI key,1,32
3654,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1056,C1OC[C@@H](COC(=O)Nc2c(C)c3n(ncnc3Nc4ccc5c(cnn5Cc6cccc(F)c6)c4)c2)NC1.Cl,567.01442,AC480 (BMS-599626),129010330,Phase 1,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4,InChI key,2,32
3654,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1165,c1cc(S(Nc2cccnc2Nc3ccc(O)cc3)(=O)=O)ccc1OC,371.41027,ABT-751 (E7010),3035714,Phase 2,tubulin polymerization inhibitor,TUBB,InChI key,1,32
3654,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1069,c1(O)c(c2onc(C(NCC)=O)c2c3ccc(CN4CCOCC4)cc3)cc(C(C)C)c(O)c1,465.54143,AUY922 (NVP-AUY922),53401173,Phase 2,HSP inhibitor,HSP90AA1|HSP90AB1,InChI key,,32
3654,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1173,c1(N2CCN(C)CC2)ccc(Nc3nc(Oc4cccc(NC(=O)C=C)c4)c(Cl)cn3)c(OC)c1,494.97327,WZ4002,44607530,Preclinical,EGFR inhibitor,EGFR|ERBB2,InChI key,2,32
3654,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1080,c1(Cl)cc(N(S(=O)(=O)c2ccc3c(C(=Cc4c(C)c(C(=O)N5CCN(C)CC5)c(C)[nH]4)C(=O)N3)c2)C)ccc1,568.08689,SU11274,53396327,Preclinical,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MET,canonical SMILES,5,32
3654,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1183,[C@@H]1(OC(=O)N2Cc3c(cccc3F)C2)C[C@@H]4N(C(=O)[C@@H](NC(=O)OC(C)(C)C)CCCCCC=C[C@H]5[C@](C5)(C(=O)NS(C6CC6)(=O)=O)NC4=O)C1,731.83124,Danoprevir (ITMN-191),129010331,Phase 2,HCV inhibitor,,canonical SMILES,,32
3654,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1091,c1cc2c(nc(c3ccccc3)cc2)cc1c4nc([C@@H]5C[C@@](O)(C)C5)n6c4c(N)ncc6,421.49372,OSI-906 (Linsitinib),11640390,Phase 3,IGF-1 inhibitor,IGF1R|INSR|INSRR,InChI key,1,32
3654,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1194,c(cc(OCCCCCCC(=O)NO)c(OC)c1)(c(Nc2cccc(C#C)c2)ncn3)c13,434.48763,CUDC-101,24756910,Phase 1,EGFR inhibitor,EGFR|ERBB2,InChI key,,32
3654,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1100,c1cc2c(C(c3c(F)cccc3F)=NCc4c2nc(Nc5ccc(C(O)=O)cc5)nc4)cc1Cl,476.862,MLN8054,11712649,Phase 1,Aurora kinase inhibitor,AURKA,InChI key,1,32
3654,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1205,c1cc2n(c(C=NN(C)S(=O)(=O)c3cc([N+]([O-])=O)ccc3C)cn2)cc1Br.Cl,488.74339,PIK-75,129010332,,,,,,32
3654,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1218,n1c(N)c2c(n([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)cn2)nc1Cl,303.67744,Clofarabine,354624,Launched,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,InChI key,,32
3654,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1396,c1(O)ccc(C=Cc2cc(O)cc(O)c2)cc1,228.24328,Resveratrol,5056,,,,,,32
3654,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1227,c1(O)cc2c(c(C(=O)c3ccc(OCCN4CCCCC4)cc3)c(c5ccc(O)cc5)s2)cc1.Cl,510.04421,Raloxifene HCl,16639408,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,InChI key,,32
3654,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1408,c1cc(N2C(=O)O[C@@H](CNC(=O)C)C2)cc(F)c1N3CCOCC3,337.3461,Linezolid,3929,Launched,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,InChI key,2,32
3654,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1244,c1cc2c(oc3c2ncnc3N4CCN(C(NCc5cc6c(OCO6)cc5)=S)CC4)cc1,447.50953,Amuvatinib (MP-470),11282283,Phase 2,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,InChI key,1,32
3654,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1437,c1(Cl)c(NC2=NCCN2)c3c(nsn3)cc1.Cl,290.17226,Tizanidine HCl,51371300,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH,InChI key,3,32
3654,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1258,C(=O)(C1CC1)C(N2Cc3c(sc(OC(C)=O)c3)CC2)c4ccccc4F,373.4411,Prasugrel,6918456,Launched,purinergic receptor antagonist,P2RY12,InChI key,,32
3654,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1454,c1(N2CCN(C)CC2)ccc(C(Nc3n[nH]c4c3CN(C(Nc5c(CC)cccc5CC)=O)C4)=O)cc1,501.62319,PHA-680632,11249084,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,InChI key,,32
3654,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1275,N1(C(Nc2cccc(Nc3ncc(Br)c(NCCc4[nH]cnc4)n3)c2)=O)CCCC1,471.35362,BX-912,11754511,Preclinical,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,InChI key,1,32
3654,D12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1465,c1(F)cc2c(N(C3CC3)C=C(C(=O)O)C2=O)c(OC)c1N4C[C@@]5([H])[C@]([H])(NCCC5)C4.Cl,437.8923,Moxifloxacin HCl,45114218,Launched,bacterial DNA gyrase inhibitor,TOP2A,InChI key,5,32
3654,D13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1288,O1CC2=C(C=C3N(Cc4c3nc5c(cccc5)c4)C2=O)[C@@](O)(CC)C1=O,348.35203,Camptothecin,24360,Phase 3,topoisomerase inhibitor,TOP1,InChI key,1,32
3654,D14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1478,C1[C@@H](C)[C@H](C[C@H](O)C)O[C@]2(O[C@@H]3[C@@]([H])(C)[C@@H](OC(=O)C=C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@](O)([H])[C@H](C)C(=O)[C@@](O)(C)[C@@H](O)[C@H](C)CC=CC=C[C@H](CC)CC3)[C@@H]2C)C1,791.06246,Oligomycin A,129010333,Preclinical,ATP synthase inhibitor|ATPase inhibitor,ATP5A1,canonical SMILES,1,32
3654,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1304,C1C[C@@]2(C)C(C(C)=C[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4(OC(C)=O)C(=O)C)=CC1=O,384.50848,Megestrol Acetate,129010002,Launched,progesterone receptor agonist,NR3C1|PGR,InChI key,,32
3654,D16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1488,c1(CCS(NC)(=O)=O)cc2c([nH]cc2C3CCN(C)CC3)cc1.Cl,371.92524,Naratriptan,51371185,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,InChI key,,32
3654,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1342,c1(O)cc(O)c2c(OC=C(c3ccc(O)cc3)C2=O)c1,270.2369,Genistein,5280961,Phase 2/Phase 3,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,InChI key,,32
3654,D18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1504,N1(C)C(=O)c2c(ncn2CC(O)CO)N(C)C1=O,254.24256,Dyphylline,3182,Launched,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B,InChI key,,32
3654,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1364,O1[C@H]([C@]12C)C[C@H](C(=Cc3csc(C)n3)C)OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC2,507.68253,"Epothilone B (EPO906, Patupilone)",129010334,Phase 3,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,canonical SMILES,1,32
3654,D20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1523,c1(nc(Nc2cc(OC)cc(OC)c2)c(NS(=O)(=O)c3ccc(NC(c4cc(OC)c(C)cc4)=O)cc3)n5)c5cccc1,599.65686,SAR245409 (XL765),49867926,Phase 1/Phase 2,PI3K inhibitor,MTOR|PIK3CG,InChI key,1,32
3654,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1380,c1c(C)c(OCC(=O)N[C@H]([C@@H](O)C[C@@H](NC([C@H](C(C)C)N2C(=O)NCCC2)=O)Cc3ccccc3)Cc4ccccc4)c(C)cc1,628.80082,Lopinavir,3817,Launched,HIV protease inhibitor,,InChI key,,32
3654,D22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1532,c1(F)cc(c2cc(NC(=O)N)c(C(=O)N[C@H]3CCCNC3)s2)ccc1,362.42176,AZD7762,16041610,Phase 1,CHK inhibitor,CHEK1|CHEK2,InChI key,,32
3654,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1003,c1([nH]nc2N)c2c(c3ccc(NC(Nc4cc(C)ccc4F)=O)cc3)ccc1,375.39892,Linifanib (ABT-869),11485656,Phase 3,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,InChI key,2,32
3654,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1110,c1(CC)c(C(=O)C(=O)N)c2c(cccc2OCC(O)=O)n1Cc3ccccc3,380.3939,Varespladib (LY315920),155815,Phase 3,secretory phospholipase inhibitor,PLA2G2A,InChI key,,32
3654,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1013,c1nc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)B(O)O)cnc1,384.23719,Bortezomib (PS-341),5213527,Launched,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,InChI key,4,32
3654,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1118,c1cc2c(nc(NS(c3ccc(C)cc3)(=O)=O)c(Nc4ccc5c(nsn5)c4)n2)cc1,448.52074,XL147,1893730,Phase 2,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,InChI key,2,32
3654,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1028,c1cc2c(c(Nc3cc(Cl)c(OCc4cc(F)ccc4)cc3)ncn2)cc1c5ccc(CNCCS(=O)(C)=O)o5.c6cc(S(=O)(=O)O)ccc6C.c7cc(S(=O)(=O)O)ccc7C,925.46078,Lapatinib (GW-572016) Ditosylate,9941095,Launched,EGFR inhibitor,EGFR|ERBB2,InChI key,2,32
3654,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1133,c1c(OC)c(C(c2c(ccc(Cl)c2)c3c(cnc(Nc4ccc(C(=O)O)c(OC)c4)n3)C5)=N5)c(F)cc1,518.9235,Alisertib (MLN8237),24771867,Phase 3,Aurora kinase inhibitor,AURKA,InChI key,1,32
3654,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1038,c(oc1c2cccn1)(c(N3CCOCC3)nc(c4cc(O)ccc4)n5)c25,348.35534,PI-103,9884685,Preclinical,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,InChI key,3,32
3654,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1144,c1c(C(C)(C)C)c(NC(=O)C2=CNc3c(cccc3)C2=O)cc(O)c1C(C)(C)C,392.49071,Ivacaftor (VX-770),16220172,Launched,CFTR channel potentiator,CFTR,InChI key,,32
3654,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1046,c(cc(OCC1CCN(C)CC1)c(OC)c2)(ncnc3Nc4ccc(Br)cc4F)c23,475.35396,Vandetanib (ZD6474),3081361,Launched,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,InChI key,1,32
3654,E12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1156,N(C(=O)N([C@H]1[C@@H](O)[C@H](O)[C@@H](C)O1)C=C2F)=C2NC(=O)OCCCCC,359.35008,Capecitabine,400633,Launched,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,InChI key,,32
3654,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,canonical SMILES,9,32
3654,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1166,[Pt](N)(Cl)(Cl)N,298.02916,Cisplatin,2767,Launched,DNA alkylating agent|DNA synthesis inhibitor,XIAP,InChI key,1,32
3654,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1070,c1c(Cl)c(CS(=O)(=O)c2ccc3c(C(=Cc4[nH]c(C)c(C(=O)N5CCC[C@@H]5CN6CCCC6)c4C)C(=O)N3)c2)c(Cl)cc1,641.60776,PHA-665752,53418393,Preclinical,c-Met inhibitor,MET,chemical name,4,32
3654,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1174,C(Nc1ccc(C#N)c(C(F)(F)F)c1)(=O)[C@](O)(C)COc2ccc(C#N)cc2,389.32796,MK-2866 (GTx-024),11326715,Phase 3,androgen receptor modulator,AR,InChI key,,32
3654,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1082,c1(Cl)ccc(NC(=O)c2c(Cl)cc(S(=O)(=O)C)cc2)cc1c3ccccn3,421.29706,Vismodegib (GDC-0449),24776445,Launched,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,InChI key,,32
3654,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1185,c1c(C[C@H](NC(=O)OCc2scnc2)[C@@H](O)C[C@@H](NC(=O)[C@H](C(C)C)NC(=O)N(C)Cc3nc(C(C)C)sc3)Cc4ccccc4)cccc1,720.94422,Ritonavir,5076,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,InChI key,,32
3654,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1092,c1cc2c(Sc3c(c(C(OC(N4CCOCC4)=CC5=O)=C5)ccc3)S2)cc1,395.49457,KU-55933 (ATM Kinase Inhibitor),5278396,Preclinical,ATM kinase inhibitor,ATM|PRKDC,InChI key,,32
3654,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1196,C1(=O)C=C([C@]2(C)C=C1)C(=C)C[C@]([H])([C@]23[H])[C@@]([H])([C@@]4(C)CC3)CCC4=O,296.40335,Exemestane,129010006,Launched,aromatase inhibitor,CYP19A1,InChI key,1,32
3654,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1101,c1cc2c(c(Cc3ccncc3)nnc2Nc4ccc(Cl)cc4)cc1.Cl.Cl,419.73478,Vatalanib (PTK787) 2HCl,129010335,Phase 3,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB,InChI key,1,32
3654,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1206,c1cc(OCC(CNC(C)C)O)ccc1COCCOC(C)C.OC(=O)C=CC(=O)O,441.51519,Bisoprolol fumarate,53394791,,,,,2,32
3654,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1219,c1nc(N)ccc1C(Nc2cccc(c3nc(N4CCOCC4)c5c(c6c(nccc6)o5)n3)c2)=O,467.47933,YM201636,9956222,Preclinical,PI3K inhibitor,,InChI key,1,32
3654,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1397,[C@H]1(N2CCOCC2)C[C@@]3(C)[C@@]([H])(CC[C@]4([H])[C@@]3([H])CC[C@@]5(C)[C@@]4([H])C[C@H]([N+]6(CC=C)CCCC6)[C@H]5OC(C)=O)C[C@@H]1O.[Br-],609.67822,Rocuronium Bromide,129010336,Launched,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,InChI key,1,32
3654,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1229,n1c(N)c2c(n([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)cn2)nc1F,365.21168,Fludarabine Phosphate,3368,Launched,ribonucleotide reductase inhibitor,DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,InChI key,1,32
3654,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1409,c1(OC)cc2c(nc(N(C)CCCNC(=O)C3OCCC3)nc2N)cc1OC.Cl,425.90971,Alfuzosin HCl,44462223,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2,InChI key,,32
3654,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1247,c1(NC(=O)c2c(C)onc2)ccc(C(F)(F)F)cc1,270.20726,Leflunomide,3899,Launched,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,InChI key,,32
3654,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1439,c1(OC)cc(C=CC(=O)Nc2c(C(=O)O)cccc2)ccc1OC,327.33127,Tranilast,5527,,,,,1,32
3654,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1260,c1ccc(CCCN[C@]([H])(C)c2c3c(cccc3)ccc2)cc1C(F)(F)F.Cl,393.87292,Cinacalcet HCl,123132492,Launched,calcium channel activator,CASR,InChI key,1,32
3654,F10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1455,c1(OC2CCCC2)cc(C3(C#N)CCC([H])(C(O)=O)CC3)ccc1OC,343.41679,Cilomilast,151170,Phase 3,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,InChI key,,32
3654,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1276,c1(C2(CC(CC3C2)CC4C3)C4)cc(c5ccc6c(ccc(C(=O)O)c6)c5)ccc1OC,412.52011,Adapalene,60164,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,InChI key,1,32
3654,F12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1466,[C@@H]1(O)CC(=CC=C2CCC[C@@]3(C)[C@@]2([H])CC[C@H]3[C@H](C)CCCC(O)(C)C)C(=C)[C@@H](O)C1,416.63646,Calcitriol,129010338,Launched,vitamin D receptor agonist,VDR,chemical name,,32
3654,F13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1289,C1(F)=CN(C(=O)NCCCCCC)C(=O)NC1=O,257.26144,Carmofur,2577,Launched,thymidylate synthase inhibitor,TYMS,InChI key,1,32
3654,F14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1481,c(cccn1)(c(OC[C@H](O)CN2CCN([C@H]3c4c(cccc4)[C@H]5[C@H](C5(F)F)c6c3cccc6)CC2)ccc7)c17.Cl.Cl.Cl,636.98706,Zosuquidar (LY335979) 3HCl,129010339,Phase 3,P glycoprotein inhibitor,ABCB1|ABCB4,InChI key,1,32
3654,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1312,[C@H]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O,265.2206,Streptozotocin (STZ),5300,Launched,DNA alkylating agent,SLC2A2,InChI key,,32
3654,F16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1489,c1(Cl)ccc(c2c(C)nc(NC(=O)C)s2)cc1S(NCCO)(=O)=O,389.87753,PIK-93,6852167,Preclinical,PI3K inhibitor,PI4KB|PIK3C3|PIK3CG,InChI key,,32
3654,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1344,c1cc(S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)ccc1CCNC(=O)N3C(=O)C(CC)=C(C)C3,490.61555,Glimepiride,3476,Launched,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,InChI key,,32
3654,F18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1505,[C@H]1(NC(=O)C(c2csc(N)n2)=NOC(C)(C)C(=O)O)[C@@H](C)N(S(=O)(=O)O)C1=O,435.43277,Aztreonam,2274,Launched,bacterial cell wall synthesis inhibitor,,chemical name,2,32
3654,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1366,c1(F)ccc(CNC(=O)C2=C(O)C(=O)N(C)C(N3CCCCS3(=O)=O)=N2)cc1,410.41996,BMS-707035,54682040,Phase 2,HIV integrase inhibitor,,InChI key,,32
3654,F20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1524,c1ccc(Cl)c(C(=O)Nc2c(C(NC3CCNCC3)=O)n[nH]c2)c1Cl,382.24447,AT7519,11338033,Phase 2,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,InChI key,1,32
3654,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1381,N(C(C(=O)O)=C(SC1CNC(C(N(C)C)=O)C1)C2C)(C(=O)C3C(O)C)C23,383.4625,Meropenem,3874387,Launched,bacterial cell wall synthesis inhibitor,,InChI key,4,32
3654,F22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,InChI key,1,32
3654,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1004,c1c(C(=O)N)c2c([nH]c([C@]3(C)CCCN3)n2)cc1,244.29234,Veliparib (ABT-888),11842604,Phase 3,PARP inhibitor,PARP1|PARP2,InChI key,,32
3654,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1111,c1(NC(=O)C2(CC2)C(=O)Nc3ccc(Oc4ccnc5c4cc(OC)c(OCCCN6CCOCC6)c5)c(F)c3)ccc(F)cc1,632.65376,Foretinib (GSK1363089),42642645,Phase 2,VEGFR inhibitor,FLT1|FLT4|KDR|MET,InChI key,1,32
3654,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1017,c1(OC)cc2c(ncnc2Oc3ccc4c(cc(C)[nH]4)c3F)cc1OCCCN5CCCC5,450.50528,Cediranib (AZD2171),9933475,Phase 3,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,InChI key,1,32
3654,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1119,c(cc(OC)c(OC)c1)(nccc2Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3)c12,501.50566,"Cabozantinib (XL184, BMS-907351)",25102847,Launched,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET,InChI key,1,32
3654,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1029,c1cc2c(CN(C3CCC(=O)NC3=O)C2=O)c(N)c1,259.26062,Lenalidomide (CC-5013),216326,Launched,anticancer agent,CDH5|CRBN|PTGS2|TNF|TNFSF11,InChI key,,32
3654,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1134,N(C1CC1)C(Nc2c[nH]nc2c3nc4c(ccc(CN5CCOCC5)c4)[nH]3)=O,381.43161,AT9283,56965909,Phase 2,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,InChI key,,32
3654,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1039,[C@@H]1(O)CC[C@@H](C[C@@H](C)[C@H]2OC(=O)[C@@H](N3C(=O)C(=O)[C@](O)(O[C@@H]4C[C@H](OC)C(C)=CC=CC=C[C@@H](C)C[C@@H](C)C(=O)[C@@H](OC)[C@H](O)C(C)=C[C@@H](C)C(=O)C2)[C@H](C)CC4)CCCC3)C[C@H]1OC,914.17186,Rapamycin (Sirolimus),129010340,,,,,,32
3654,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1145,c1(C(C)(C)C)oc(CSc2sc(NC(C3CCNCC3)=O)nc2)nc1,380.52805,SNS-032 (BMS-387032),3025986,Phase 1,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,CDK2|CDK7|CDK9,InChI key,1,32
3654,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1047,c1cc(NC(CCCCCCC(=O)NO)=O)ccc1,264.3202,"Vorinostat (SAHA, MK0683)",5311,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,InChI key,,32
3654,G12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1157,C(NC(=O)[C@@H](NC(c1nc(c2ccccc2)ccc1)=O)[C@H](O)C)[C@H](B(O)O)C(C)C,413.27512,CEP-18770 (Delanzomib),76635864,,,,,1,32
3654,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1060,c1c2c(C(=O)NN=C2Cc3ccc(F)c(C(=O)N4CCN(C(C5CC5)=O)CC4)c3)ccc1,434.46282,"Olaparib (AZD2281, Ku-0059436)",23725625,Launched,PARP inhibitor,PARP1|PARP2,InChI key,,32
3654,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1167,c1(C=CCNC(=O)COC)cc2c(ncnc2Nc3cc(C)c(Oc4cnc(C)cc4)cc3)cc1,469.53497,CP-724714,53401057,Phase 2,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,chemical name,,32
3654,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1071,c1cc2c([C@@]([H])([C@@H](C(=O)OCC)C#N)C(C(=O)OCC)=C(N)O2)cc1Br,409.23128,HA14-1,129010341,Preclinical,BCL inhibitor,BCL2,InChI key,2,32
3654,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1175,n1c(Cl)c2c(n(Cc3ncc(C)c(OC)c3C)cn2)nc1N,318.76149,BIIB021,16736529,Phase 2,HSP inhibitor,HSP90AA1,InChI key,1,32
3654,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1084,c([nH]c(C)c1)(ccc(Oc2c3n(cc(OC[C@H](O)C)c3C)ncn2)c4F)c14,370.37756,Brivanib (BMS-540215),11451527,Phase 3,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,InChI key,,32
3654,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1186,c1cc2c(ccc(C(C)=CC(=O)Nc3ccccc3C(O)=O)c2)cc1,331.36457,BIBR 1532,53440640,Preclinical,telomerase inhibitor,TERT,canonical SMILES,,32
3654,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1093,c1ccc(F)c(NC(=O)c2cc(c3nc4n(cccc4)c3c5nc(Nc6cc(CC)c(N7CCC(N8CCN(S(=O)(=O)C)CC8)CC7)cc6OC)ncc5)ccc2OC)c1F,851.96308,GSK1904529A,25124816,Preclinical,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR,InChI key,,32
3654,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1197,C1=C[C@@]2(C)[C@@]([H])(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4C(=O)NC(C)(C)C)NC1=O,372.54414,Finasteride,129010342,Launched,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,InChI key,,32
3654,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1102,c1cc(SC(=C(C#N)C(C#N)=C(N)Sc2ccccc2N)N)c(N)cc1.CCO,426.55828,U0126-EtOH,91997702,,,,,1,32
3654,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1207,c1(Oc2c3c(cc(OC)c(OC)c3)ncc2)cc(Cl)c(NC(Nc4noc(C)c4)=O)cc1,454.86305,Tivozanib (AV-951),9911830,Phase 3,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,InChI key,1,32
3654,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1220,c1cc2c(nccc2CNc3ccsc3C(=O)Nc4ccc(OC(F)(F)F)cc4)cc1,443.44154,OSI-930,9868037,Phase 1,KIT inhibitor|VEGFR inhibitor,KDR|KIT,InChI key,1,32
3654,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1398,O1C(CO)C=CC1N2C=C(C)C(=O)NC2=O,224.21328,Stavudine (d4T),5155,Launched,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,InChI key,,32
3654,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1231,c1(O)c(CN(C)C)c2c(nc3c(CN4C3=CC5=C(COC(=O)[C@]5(O)CC)C4=O)c2)cc1.Cl,457.90675,Topotecan HCl,44268668,Launched,topoisomerase inhibitor,TOP1|TOP1MT,InChI key,2,32
3654,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1415,c1c(Cl)c([C@@H](C(OC)=O)N2Cc3c(scc3)CC2)ccc1.OS(=O)(=O)O,419.90021,Clopidogrel,16757820,,,,,,32
3654,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1248,C(c1c(cc(OC)c([C@@]2(C(=O)OC)C[C@](CN3CCc(c24)c(c5[nH]4)cccc5)([H])C[C@](CC)(O)C3)c1)N6C)([C@]6([H])[C@](C(OC)=O)(O)[C@H]7OC(C)=O)(CC8)[C@]([H])([C@@]7(CC)C=CC9)N89,810.97412,Vinblastine,129010343,Launched,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,InChI key,2,32
3654,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1442,c1cc(F)cc(F)c1[C@](O)([C@@H](C)c2c(F)cncn2)Cn3ncnc3,349.31046,Voriconazole,16760226,Launched,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1,InChI key,,32
3654,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1261,c1(n2nc(C(F)(F)F)cc2c3ccc(C)cc3)ccc(S(=O)(=O)N)cc1,381.37216,Celecoxib,2662,Launched,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,InChI key,,32
3654,H10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1456,c1(c2ccc(c3nnco3)cc2)ncccc1S(Nc4ncc(C)nc4OC)(=O)=O,424.43313,Zibotentan (ZD4054),9910224,Phase 3,endothelin receptor antagonist,EDNRA,InChI key,,32
3654,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1278,n1c(N(C)C)nc(N(C)C)nc1N(C)C,210.27941,Altretamine,2123,Launched,DNA synthesis inhibitor,,InChI key,,32
3654,H12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1467,C1[C@@H](O)CC(=CC=C2[C@@]3([H])[C@@](C)([C@]([H])([C@H](C)C=C[C@@H](C)C(C)C)CC3)CCC2)C(=C)[C@H]1O,412.64776,Doxercalciferol,129010344,Launched,vitamin D receptor agonist,VDR,chemical name,1,32
3654,H13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1291,c1c(C(N2CCN(CCOCC(=O)O)CC2)c3ccc(Cl)cc3)cccc1.Cl.Cl,461.80967,Cetirizine DiHCl,45114138,Launched,histamine receptor antagonist,HRH1,InChI key,,32
3654,H14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1482,c1c(c2[nH]c([C@@H]3CCCN3C(=O)[C@@H](NC(=O)OC)C(C)C)nc2)ccc(c4ccc(c5[nH]c([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5)cc4)c1,738.875,Daclatasvir (BMS-790052),74349335,Launched,HCV inhibitor,,InChI key,1,32
3654,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1315,c1c(Cl)c(C(OC(Nc2c(c3ccc(CSCCC(=O)O)cc3)onc2C)=O)C)ccc1,474.95711,Ki16425,10367662,Preclinical,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,InChI key,,32
3654,H16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1490,c1cc2n(c(C#Cc3cc(C(Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)=O)ccc3C)cn2)nc1,532.55948,Ponatinib (AP24534),24826799,Launched,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,InChI key,1,32
3654,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1352,c1(c2cccc(O)c2)nc3c(nc(N)nc3N)nc1c4cc(O)ccc4,346.34276,TG100-115,10427712,Phase 1/Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,,32
3654,H18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1508,[C@@H]1(CCCCCCC(=O)O)C(=O)C[C@H](O)[C@H]1C=C[C@@H](O)CCCCC,354.48096,Alprostadil,214,Launched,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,chemical name,,32
3654,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1367,c1(ccc2)c(c23)c(C(=O)N(CCN(C)C)C3=O)cc(N)c1,283.32508,Amonafide,50515,Phase 3,topoisomerase inhibitor,TOP2A|TOP2B,InChI key,1,32
3654,H20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1525,c1cc(C(C)(C)O)nc(N2c3c(cnc(Nc4ccc(N5CCN(C)CC5)cc4)n3)C(=O)N2CC=C)c1,500.59537,MK-1775,24856436,Phase 2,WEE1 kinase inhibitor,WEE1,InChI key,1,32
3654,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1382,c1(cccc2)c2Cc3c(cccc3)C4N1CCN(C)C4.Cl,300.82574,Mianserin HCl,44269055,Launched,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,InChI key,,32
3654,H22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1536,c1cc2c(nc(n3cnc(c34)cc(OCCOC)cc4)cc2)c(N5CCC(N)CC5)c1,417.50347,CP-673451,10158940,Preclinical,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB,InChI key,,32
3654,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1005,c1(Sc2ccc3c([nH]nc3C=Cc4ncccc4)c2)c(C(NC)=O)cccc1,386.46952,Axitinib,3086685,Launched,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,chemical name,1,32
3654,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1112,c1cc(Sc2nnc3n2nc(c4cn(C)nc4)cc3)cc5c1nccc5,359.40772,SGX-523,24779724,Phase 1,hepatocyte growth factor receptor inhibitor,MET,InChI key,1,32
3654,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1020,c1cc(C(=O)NOCC2CC2)c(Nc3c(Cl)cc(I)cc3)c(F)c1F,478.65953,PD184352 (CI-1040),6918454,Phase 2,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,InChI key,1,32
3654,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1120,C(CO[C@@H]1CC[C@@H](C[C@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@@H](OC)C[C@@H](O[C@@]3(O)C(=O)C(=O)N([C@@H]4C(=O)O2)CCCC4)CC[C@H]3C)C[C@H]1OC)O,958.22442,Everolimus (RAD001),129010345,Launched,mTOR inhibitor,MTOR,canonical SMILES,,32
3654,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1030,c1(CNCCc2c3c(cccc3)[nH]c2C)ccc(C=CC(NO)=O)cc1,349.42622,Panobinostat (LBH589),57519507,Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,canonical SMILES,,32
3654,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1137,C(OC(C)C)(=O)C(=C1SC=CS1)C(OC(C)C)=O,288.38304,Malotilate,4006,Launched,protein synthesis stimulant,,InChI key,,32
3654,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1040,c1(Cl)c(C(F)(F)F)cc(NC(=O)Nc2ccc(Oc3cc(C(=O)NC)ncc3)cc2)cc1.c4c(S(=O)(=O)O)ccc(C)c4,637.02656,Sorafenib Tosylate,406563,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,InChI key,1,32
3654,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1147,c1(OCCCN(CC)CCO)cc2c(c(Nc3cc(CC(=O)Nc4cc(F)ccc4)n[nH]3)ncn2)cc1,507.5599,Barasertib (AZD1152-HQPA),16007391,Phase 2/Phase 3,Aurora kinase inhibitor,AURKB,InChI key,,32
3654,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,InChI key,1,32
3654,I12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1158,n1c(c2onc(N3CCC(Oc4cc(F)ccc4Br)CC3)c2)nnn1CC(O)=O,467.24914,MK-8245,24988881,Phase 2,stearoyl-CoA desaturase inhibitor,SCD,InChI key,,32
3654,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1064,c1(C)ccc(NC(c2ccc(CN3CCN(C)CC3)cc2)=O)cc1Nc4scc(c5cnccc5)n4,498.6424,Masitinib (AB1010),10074640,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,InChI key,2,32
3654,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1168,CCCC(CCC)C(=O)[O-].[Na+],166.19326,Valproic acid sodium salt (Sodium valproate),16760703,,,,,1,32
3654,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1072,n1c(N2CCOCC2)nc(n3c(C(F)F)nc4c3cccc4)nc1N5CCOCC5,417.41254,ZSTK474,11647372,Phase 1/Phase 2,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,InChI key,,32
3654,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1177,c1cc2c(OC(c3c(N)c(OC)ccc3)=CC2=O)cc1,267.27932,PD98059,4713,Preclinical,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,InChI key,2,32
3654,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1085,c1(S(=O)(=O)Nc2ccccc2)cc(C=CC(=O)NO)ccc1,318.34765,Belinostat (PXD101),53437714,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,canonical SMILES,1,32
3654,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1188,c1c(Cn2ncnc2)cc(C(C#N)(C)C)cc1C(C#N)(C)C,293.36625,Anastrozole,2187,Launched,aromatase inhibitor,CYP19A1,InChI key,,32
3654,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1094,c1(cc(Cn2nnc3c2nc(c4cnn(CCO)c4)cn3)cc5)c5nccc1,372.38334,PF-04217903,17754438,Phase 1,c-Met inhibitor,MET,InChI key,,32
3654,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1199,n1c(Cl)nc2c(ncn2[C@@H]3O[C@H](CO)[C@@H](O)C3)c1N,285.68698,Cladribine,1546,Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,InChI key,,32
3654,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1103,O1CCN(CCCOc2cc3c(c(Nc4ccc(NC(c5ccccc5)=O)cc4)ncn3)cc2OC)CC1,513.58753,ZM 447439,9914412,Preclinical,Aurora kinase inhibitor,AURKA|AURKB,InChI key,1,32
3654,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1208,c1c(OC)c2c(C(=O)c3c(c(O)c4c(C[C@@](O)(C(=O)CO)C[C@H]4O[C@]5([H])O[C@@H](C)[C@@H](O)[C@@H](N)C5)c3O)C2=O)cc1.Cl,579.98019,Doxorubicin (Adriamycin),129010225,Launched,topoisomerase inhibitor,TOP2A,InChI key,5,32
3654,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1221,c1[nH]c(N=NN(C)C)c(C(N)=O)n1,182.18319,Dacarbazine,5281007,,,,,,32
3654,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1400,n1c(N)c2c(n(C[C@@H](C)OCP(=O)(OCOC(OC(C)C)=O)OCOC(=O)OC(C)C)cn2)nc1.C(C(O)=O)=CC(O)=O,635.51492,Tenofovir Disoproxil Fumarate,53394991,,,,,,32
3654,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1233,c1(OC)cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4O)cc1O,302.40794,2-Methoxyestradiol (2-MeOE2),129010346,Phase 2,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,InChI key,1,32
3654,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1422,c1cc(OCCCC(=O)NO)c(C)cc1Cl,243.68676,Droxinostat,568416,Preclinical,HDAC inhibitor,HDAC6|HDAC8,InChI key,,32
3654,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1249,c1(S(=O)(=O)N)ccc(Nc2nn(C(=O)c3c(F)cccc3F)c(N)n2)cc1,394.35598,JNJ-7706621,5330790,Preclinical,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,InChI key,,32
3654,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1443,c1cc2c(cc(C(C)N(C(=O)N)O)s2)cc1,236.29018,Zileuton,60490,Launched,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,InChI key,,32
3654,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1262,c1(CN(S(=O)(=O)c2ccc(Cl)cc2)[C@H](CCC(F)(F)F)C(=O)N)ccc(c3nocn3)cc1F,520.88499,Avagacestat (BMS-708163),50941212,Phase 2,gamma secretase inhibitor,PSEN1,InChI key,,32
3654,J10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1457,O(C)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc2ccc(c3ccccn3)cc2)NC(=O)[C@H](C(C)(C)C)NC(=O)OC.S(O)(O)(=O)=O,802.93396,Atazanavir Sulfate,76034172,,,,,,32
3654,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1282,[C@@](C)(OO1)(CC2)O[C@@]([H])(OC(=O)[C@H]3C)[C@]1([C@@]3([H])CC[C@@H]4C)[C@@]24[H],282.33218,Artemisinin,129010347,Launched,DNA synthesis inhibitor,CYP2B6,InChI key,2,32
3654,J12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1470,c1cc2c(NC(=O)C2=Cc3c(C)c(CCC(=O)O)c(C)[nH]3)cc1,310.34711,"TSU-68 (SU6668, Orantinib)",206042,,,,,2,32
3654,J13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1294,C1Cc2c(ccc(OCCCCc3nnnn3C4CCCCC4)c2)NC1=O,369.46068,Cilostazol,2754,Launched,phosphodiesterase inhibitor,PDE3A|PDE3B,InChI key,,32
3654,J14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1483,c1(OC)cc(C(=O)C)ccc1OCCCN2CCC(c3c4c(cc(F)cc4)on3)CC2,426.48058,Iloperidone,71360,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7,InChI key,,32
3654,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1324,c1(nc(N2CCN(C(=O)C3Oc4c(cccc4)OC3)CC2)nc5N)c5cc(OC)c(OC)c1.S(C)(=O)(O)=O,547.58075,Doxazosin Mesylate,62978,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,InChI key,,32
3654,J16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1494,CC(C)(C)c1[nH]c(c2ccc3c(n(CC(C)(C)C)c(N)n3)n2)c(c4ccc(F)cc4)n1.CS(O)(=O)=O.CS(O)(=O)=O,612.73698,LY2228820,11570805,Phase 2,p38 MAPK inhibitor,MAPK14,InChI key,,32
3654,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1354,c1cc2c([nH]c(S(=O)Cc3c(C)c(OCC(F)(F)F)ccn3)n2)cc1,369.36146,Lansoprazole,3883,Launched,ATPase inhibitor,ATP4A|ATP4B,InChI key,,32
3654,J18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1512,N1(C)C(=O)[C@]2([H])N([C@H](c3cc4c(OCO4)cc3)c5c(c6c(cccc6)[nH]5)C2)C(=O)C1,389.40396,Tadalafil,59776653,Launched,phosphodiesterase inhibitor,PDE11A|PDE5A,InChI key,,32
3654,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1368,c1c(C)c(C=CC(C)=CC=CC(C)=CC(=O)O)c(C)c(C)c1OC,326.42933,Acitretin,41317,,,,,2,32
3654,J20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1526,c1cc(c2cn3c(sc4c3ccc(OCCN5CCOCC5)c4)n2)ccc1NC(=O)Nc6noc(C(C)(C)C)c6,560.66717,Quizartinib (AC220),24889392,Phase 3,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,InChI key,1,32
3654,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1386,c1(C(Oc2ccc3c(ccc(C(N)=N)c3)c2)=O)ccc(NC(N)=N)cc1.S(=O)(=O)(C)O.S(=O)(=O)(C)O,539.5819,Nafamostat Mesylate,5311180,Launched,serine protease inhibitor,ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7,InChI key,,32
3654,J22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1537,c(C(=O)c1c(c(C)c(C)cc1)O2)(cccc3CC(=O)O)c23,282.29065,DMXAA (Vadimezan),123964,Phase 3,angiogenesis inhibitor,,InChI key,,32
3654,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1006,c1c(OC2CCOCC2)c3c(ncnc3Nc4c5c(OCO5)ccc4Cl)cc1OCCN6CCN(C)CC6,542.02648,Saracatinib (AZD0530),10302451,Phase 2/Phase 3,src inhibitor,ABL1|LCK|SRC|YES1,InChI key,,32
3654,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1113,c(nc(c1nonc1N)n2CC)(c(C#CC(C)(O)C)ncc3OC[C@H]4CCCNC4)c23,425.48418,GSK690693,16048642,Phase 1,AKT inhibitor,AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX,InChI key,,32
3654,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1021,n1c(Nc2sc(C(=O)Nc3c(C)cccc3Cl)cn2)cc(N4CCN(CCO)CC4)nc1C,488.00553,Dasatinib,3062316,Launched,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,InChI key,,32
3654,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1122,C(Nc1ccccc1N)(=O)c2ccc(CNc3nccc(c4cccnc4)n3)cc2,396.44449,Mocetinostat (MGCD0103),9865515,Phase 2,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3,InChI key,1,32
3654,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1032,c1c(CNc2ncccc2C(Nc3cc4c(C(C)(C)CN4)cc3)=O)ccnc1.P(O)(O)(=O)O.P(O)(O)(=O)O,569.44128,Motesanib Diphosphate (AMG-706),16097729,,,,,,32
3654,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1139,c1c(O)c2c(OC3(CCNCC3)C=C2c4ccc(C(N(CC)CC)=O)cc4)cc1.Cl,428.95166,ADL5859 HCl,129010348,Phase 2,opioid receptor agonist,OPRD1,InChI key,,32
3654,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1041,n1ccc(c2nc(Nc3cc(C)ccc3)sc2)cc1,267.34882,STF-62247,704473,Preclinical,autophagy inducer,,InChI key,2,32
3654,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1150,c1cc(C(N[C@@H](c2ccccc2)[C@@H](O)C(=O)O[C@@H]3C(C)=C4C(C)(C)[C@](O)([C@@H](OC(=O)c5ccccc5)C6[C@@](C)([C@H](O)C[C@@H]7[C@@]6(OC(=O)C)CO7)C(=O)[C@@H]4OC(=O)C)C3)=O)ccc1,853.90614,Paclitaxel,73759704,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1,InChI key,1,32
3654,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1049,[C@@H]1(C(Nc2ccncc2)=O)CC[C@@H]([C@H](N)C)CC1.Cl.Cl,320.25791,Y-27632 2HCl,51371144,Preclinical,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2,InChI key,,32
3654,K12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1159,N1=C(c2cc(C(C)C)c(O)cc2O)N(c3ccc(c4c3)n(C)cc4)C(=O)N1,364.39779,Ganetespib (STA-9090),53629907,Phase 3,HSP inhibitor,HSP90AA1,InChI key,1,32
3654,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1065,c1(c2nc3c(sc(CN4CCN(S(C)(=O)=O)CC4)c3)c(N5CCOCC5)n2)c6c([nH]nc6)ccc1,513.63557,GDC-0941,17755052,Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,1,32
3654,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1169,C(N1C(=NC(N2CCOCC2)=CC1=O)C(C(Nc3ccccc3)C)=C4)=C4C,364.44086,TGX-221,9907093,Preclinical,PI3K inhibitor,PIK3CB|PIK3CD,InChI key,,32
3654,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1075,c1c2c(c(C(C(=O)NC3=O)=C3c4c(Cl)cc(Cl)cc4)cn2C)ccc1,371.21677,SB216763,176158,Preclinical,glycogen synthase kinase inhibitor,CCNA2|CDK2|GSK3A|GSK3B,InChI key,4,32
3654,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1178,c1cc(Oc2ccc(NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3)c(F)c2)cc(C(NC)=O)n1,482.81541,Regorafenib (BAY 73-4506),11167602,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,InChI key,1,32
3654,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,InChI key,1,32
3654,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1190,C(Nc1ccc(C#N)c(C(F)(F)F)c1)(=O)C(O)(C)CS(c2ccc(F)cc2)(=O)=O,430.37337,Bicalutamide,2375,Launched,androgen receptor antagonist,AR,InChI key,,32
3654,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1095,c1(C=CC(=O)NO)ccc(CN(CCc2c3c(cccc3)[nH]c2)CCO)cc1,379.4522,LAQ824 (Dacinostat),216248,Phase 1,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,canonical SMILES,,32
3654,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1200,[C@H]1(N2C(=O)N=C(N)N=C2)C[C@H](O)[C@@H](CO)O1,228.20528,Decitabine,16886,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,InChI key,1,32
3654,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1104,C(O)Cn1cc(c2cc3c(C(=NO)CC3)cc2)c(c4ccncc4)n1,334.37182,GDC-0879,57519545,Preclinical,RAF inhibitor,BRAF,chemical name,1,32
3654,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1209,C1(=O)NC=C(F)C(=O)N1,130.07722,"Fluorouracil (5-Fluoracil, 5-FU)",3385,Launched,thymidylate synthase inhibitor,DPYD|TYMS,InChI key,1,32
3654,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1222,N1C(=O)CN(C[C@H](C)N2CC(=O)NC(=O)C2)CC1=O.Cl,304.73008,"Dexrazoxane HCl (ICRF-187, ADR-529)",129010349,Launched,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,InChI key,,32
3654,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1403,c1(N(C)C)c2c(C(=O)C(=C3O)[C@]([H])(C[C@]4([H])[C@@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H]4N(C)C)C2)c(O)c(NC(=O)CNC(C)(C)C)c1,585.64866,Tigecycline,59979705,Launched,bacterial 30S ribosomal subunit inhibitor,,chemical name,2,32
3654,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1234,C(#N)C(=Cc1cc(C(C)(C)C)c(O)c(Br)c1)C#N,305.16981,AG-1024,2044,Preclinical,insulin growth factor receptor inhibitor,IGF1R,InChI key,1,32
3654,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1425,c1ccc(C)c(NC(CN2CCN(CC(COc3c(OC)cccc3)O)CC2)=O)c1C.Cl.Cl,500.4584,Ranolazine 2HCl,51371259,Launched,sodium channel blocker,SCN10A|SCN4A|SCN5A|SCN9A,InChI key,1,32
3654,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1250,c1(F)cc(N2C(C)(C)C(=O)N(c3cc(C(F)(F)F)c(C#N)cc3)C2=S)ccc1C(=O)NC,464.43595,Enzalutamide (MDV3100),15951529,Launched,androgen receptor antagonist,AR,InChI key,,32
3654,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1450,[O-]C(=O)[C@@H](C)C[C@H](C(=O)C(C)=C[C@H](C)[C@]1([H])[C@@H](C)[C@@H](O)C[C@@]2(O[C@](C)([C@@]3([H])C[C@H](OC4CC[C@H](OC)[C@@H](C)O4)[C@@H](C)[C@@]5(O[C@@]([H])([C@]6([H])[C@H](C)C[C@@H](C)[C@](O)(CO)O6)C[C@@H]5C)O3)CC2)O1)C.[Na+],889.09565,Nanchangmycin,129010350,Preclinical,other antibiotic,,chemical name,2,32
3654,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1264,n1cc2c(nc(NC(=O)NC(C)(C)C)c(c3cc(OC)cc(OC)c3)c2)nc1NCCCCN(CC)CC,523.67023,PD173074,1401,Preclinical,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,InChI key,1,32
3654,L10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1458,c1c(F)c(SC2=NN3C(=C(c4c(Cl)cccc4Cl)C(=O)N=C3)C=C2)ccc1F,436.26206,VX-745,3038525,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,InChI key,1,32
3654,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1283,c(cccc1)(Oc2c(cc(Cl)cc2)[C@]3([H])[C@]4([H])CN(C)C3)c14.C(O)(=O)C=CC(O)=O,401.84019,Asenapine,57354691,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,chemical name,,32
3654,L12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1472,c1(F)cc(COc2ccc(CN[C@@H](C)C(=O)N)cc2)ccc1.CS(O)(=O)=O,398.44902,Safinamide Mesylate,21935083,Launched,dopamine uptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,InChI key,,32
3654,L13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1297,O1[C@H]([C@H]12)C[C@H](C(=Cc3csc(C)n3)C)OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC2,493.65596,Epothilone A,73106690,Preclinical,microtubule stabilizing agent,,canonical SMILES,1,32
3654,L14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1484,c1cc(C(=O)C=Cc2cc(C=CC(=O)NO)n(C)c2)cc(F)c1,314.311,MC1568,71433510,Preclinical,HDAC inhibitor,HDAC2,chemical name,1,32
3654,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1326,C1(C)=NN(c2ccccc2)C(=O)C1,174.1992,Edaravone,4021,Launched,nootropic agent,BCL2,InChI key,,32
3654,L16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1497,n1c(N)c2c(ncc(CC(CC#C)c3ccc(C(=O)N[C@H](C(O)=O)CCC(=O)O)cc3)n2)nc1N,477.47261,Pralatrexate,18350668,Launched,dihydrofolate reductase inhibitor,DHFR|TYMS,InChI key,,32
3654,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1358,C1C(=C2c3c(cc(Cl)cc3)CCc4c2nccc4)CCN(C(OCC)=O)C1,382.88321,Loratadine,3957,Launched,histamine receptor antagonist,HRH1,InChI key,1,32
3654,L18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1514,C1(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N(C)C([C@H](O)[C@H](C)CC=CC)C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N1C,1202.61124,Cyclosporine,2909,Launched,calcineurin inhibitor,PPP3CA,chemical name,,32
3654,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1376,C1C[C@@]2([H])C(CC[C@]3([H])[C@@]2([H])CC[C@@]4(CC)[C@@]3([H])C=C[C@@]4(C#C)O)=CC1=O,310.42994,Gestodene,129009883,Launched,contraceptive agent,,InChI key,,32
3654,L20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1528,c1ncc(c2cc([C@]3(C)CCSC(N)=N3)c(F)cc2F)cn1,320.36026,LY2811376,44251605,Phase 1,beta-secretase inhibitor,BACE1,InChI key,,32
3654,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1387,c1(OCC(O)CN2CCN(c3c(OC)cccc3)CC2)cccc4c1cccc4.Cl.Cl,465.4126,Naftopidil DiHCl,51371242,Launched,adrenergic receptor antagonist,ADRA1A,InChI key,,32
3654,L22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1538,[C@@]([H])(CCC1)([C@H](C(N[C@H](C(C(NC2CC2)=O)=O)CCC)=O)N(C([C@@H](NC([C@H](C3CCCCC3)NC(c4cnccn4)=O)=O)C(C)(C)C)=O)C5)[C@@]15[H],679.84932,Telaprevir (VX-950),68372211,Launched,HCV inhibitor,CTSA|PGR,InChI key,,32
3654,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1007,c(ccc(Oc1ccccc1)c2)(c(O)c(C(=O)NCC(=O)O)nc3C)c23,352.34074,FG-4592,11256664,Phase 3,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2,InChI key,,32
3654,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1114,n1c2c(cc(C(F)(F)c3nnc4n3nc(c5cn(C)nc5)cc4)cc2)ccc1,377.35022,JNJ-38877605,46911863,Phase 1,tyrosine kinase inhibitor,MET,InChI key,1,32
3654,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1022,[C@H]1(OC)[C@@H](OP(C)(=O)C)CC[C@@H](C[C@@H](C)[C@H]2OC(=O)[C@@]3([H])N(CCCC3)C(=O)C(=O)[C@](O)(O[C@@]4([H])C[C@H](OC)C(C)=CC=CC=C[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)C(C)=C[C@@H](C)C(=O)C2)[C@H](C)CC4)C1,990.20612,"Ridaforolimus (Deforolimus, MK-8669)",129010352,Phase 3,mTOR inhibitor,MTOR,canonical SMILES,,32
3654,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1124,c(ccc1)(c(Nc2n[nH]c(C3CC3)c2)nc(N4[C@](C(Nc5cnc(F)cc5)=O)(C)CCC4)n6)n16,461.49476,BMS-754807,124584014,Phase 2,IGF-1 inhibitor,AKT1|IGF1R,InChI key,1,32
3654,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1033,c1(C(Nc2cc(n3cnc(C)c3)cc(C(F)(F)F)c2)=O)cc(Nc4nc(c5cccnc5)ccn4)c(C)cc1,529.51578,Nilotinib (AMN-107),644241,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,InChI key,2,32
3654,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1140,C(Nc1ccc([N+]([O-])=O)c(C(F)(F)F)c1)(=O)[C@](O)(C)COc2ccc(NC(C)=O)cc2,441.35792,Andarine,9824562,Phase 1,androgen receptor modulator,AR,InChI key,1,32
3654,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1042,c1(F)cc2c(NC(=O)C2=Cc3c(C)c(C(=O)NCCN(CC)CC)c(C)[nH]3)cc1.C(=O)(O)C[C@H](O)C(=O)O,532.56122,Sunitinib Malate,53394000,,,,,4,32
3654,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1152,c1(Cl)cc2c([nH]cc2C(c3c(F)ccc(NS(CCC)(=O)=O)c3F)=O)nc1,413.82616,PLX-4720,24180719,Preclinical,RAF inhibitor,BRAF|KDR,InChI key,,32
3654,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1052,c1ccc(C(=S)N(C)NC(=O)CC(=O)NN(C(c2ccccc2)=S)C)cc1,400.51769,Elesclomol (STA-4783),300471,Phase 3,oxidative stress inducer,HSPA1A,InChI key,,32
3654,M12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1162,O1C[C@@H](OCc2ccc(OC(F)(F)F)cc2)Cn3c1nc([N+]([O-])=O)c3,359.25738,PA-824,21062558,Phase 3,nitric oxide donor,FASN,InChI key,,32
3654,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1066,c1c(C(F)(F)F)c(C(C#N)=C(N)Sc2ccc(N)cc2)ccc1,335.34678,SL-327,24906275,,,,,,32
3654,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1170,c1(N2CCN(C)CC2)ccc(Nc3nc(Oc4cccc(NC(=O)C=C)c4)c(Cl)cn3)cc1,464.94729,WZ3146,44607360,Preclinical,EGFR inhibitor,EGFR,InChI key,2,32
3654,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1076,n1ccc(c2[nH]c(c3ccc(S(=O)C)cc3)nc2c4ccc(F)cc4)cc1,377.43464,SB203580,176155,Preclinical,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF,InChI key,,32
3654,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1179,c1(N2CCN(C)CC2)ccc(Nc3nc(Sc4cccc(NC(=O)C=C)c4)c(Cl)cn3)cc1,481.01289,WZ8040,44607531,Preclinical,EGFR inhibitor,EGFR,InChI key,1,32
3654,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1088,c(c(c1cccc(OCc2ccccc2)c1)cn3[C@H]4C[C@H](CN5CCCC5)C4)(c(N)ncn6)c36,453.57863,NVP-ADW742,9825149,Preclinical,insulin growth factor receptor inhibitor,IGF1R,InChI key,,32
3654,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1191,c1(O)cc(c2cc1)C[C@@H](CCCCCCCCCS(CCCC(F)(F)C(F)(F)F)=O)[C@]([H])([C@]23[H])[C@@]([H])([C@@]4(C)CC3)CC[C@@H]4O,606.77079,Fulvestrant,129010353,Launched,estrogen receptor antagonist,ESR1|ESR2|GPER1,InChI key,,32
3654,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1096,c1cc2c(n(C)cc2CNCC3CCN(c4ncc(C(NO)=O)cn4)CC3)cc1,394.47014,Quisinostat (JNJ-26481585),11538455,Phase 2,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,InChI key,2,32
3654,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1201,S(=O)(=O)([O-])CCSSCCS(=O)(=O)[O-].[Na+].[Na+],326.34226,Dimesna,65625,Phase 3,tubulin polymerization inhibitor,,chemical name,,32
3654,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1105,c1cc2c(OC(N3CCOCC3)=CC2=O)c(c4ccccc4)c1,307.34318,LY294002,3973,Preclinical,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1,InChI key,,32
3654,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1210,n1c(N)c2c(ncc(CN(C)c3ccc(C(=O)N[C@H](C(O)=O)CCC(O)=O)cc3)n2)nc1N,454.43927,Methotrexate,4112,Launched,dihydrofolate reductase inhibitor,DHFR,InChI key,1,32
3654,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1224,[Pt+2].[O-]C(=O)C(=O)[O-].C1C[C@@H](N)[C@H](N)CC1,397.28575,Oxaliplatin,77994,Launched,DNA inhibitor,,chemical name,,32
3654,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1404,C(C#N)(C[C@@]1(C)[C@@]2(CC[C@]3([H])[C@@]1([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4O)[C@]5([H])O2)=C5O,329.43328,Trilostane,129010354,Launched,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,ESR1|ESR2|HSD3B1|HSD3B2,chemical name,,32
3654,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1237,N1(C)C(=O)n2c(c(C(=O)N)nc2)N=N1,194.15084,Temozolomide,5394,Launched,DNA alkylating agent,MGMT,InChI key,,32
3654,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1426,c1(OCC)cc(CC(=O)N[C@@H](CC(C)C)c2c(N3CCCCC3)cccc2)ccc1C(=O)O,452.58573,Repaglinide,4547,Launched,insulin secretagogue,ABCC8|KCNJ11|PPARG,InChI key,,32
3654,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1251,C1(=O)C=C(C(=C2[C@]3([H])[C@@]([H])([C@@]4(C)CC2)CC[C@]4(CC#N)O)CC1)CC3,311.418,Dienogest,129009987,Launched,progesterone receptor agonist,PGR,InChI key,,32
3654,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1451,n1c(Nc2ccc(CC(=O)N3CCN(CC)CC3)cc2)nc(Nc4ccc(C(=O)Nc5c(Cl)cccc5)cc4)c(F)c1,588.07494,Aurora A Inhibitor I,44139710,Preclinical,Aurora kinase inhibitor,AURKA,InChI key,1,32
3654,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1266,c1cc(c2nc(N3CCOCC3)c4c(n(C5CCN(C(OC)=O)CC5)nc4)n2)ccc1NC(=O)OC,495.53095,WYE-354,44219749,Preclinical,mTOR inhibitor,MTOR,InChI key,,32
3654,N10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1459,c1(Nc2ncncc2)nc(C(=O)NCc3ccccc3)cs1,311.36162,Thiazovivin,46209426,Preclinical,rho associated kinase inhibitor,,InChI key,,32
3654,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1285,c1cccc(C(O)(C2C(CC3C2)C=C3)CCN4CCCCC4)c1.Cl,347.922,Biperiden HCl,24189163,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,InChI key,,32
3654,N12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1474,C1(=O)NC(C)=C(C(=O)Nc2cc3c([nH]nc3)cc2F)C(c4ccc(C(F)(F)F)cc4)C1,432.37095,GSK429286A,11373846,Preclinical,rho associated kinase inhibitor,ROCK1,InChI key,,32
3654,N13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1299,O1[C@H](N2C(=O)NC(=O)C(F)=C2)C[C@H](O)[C@H]1CO,246.19244,Floxuridine,3363,Launched,DNA synthesis inhibitor,TYMS,InChI key,,32
3654,N14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1485,c1c(N(C(=O)C)S(=O)(=O)c2ccc(OC)cc2)c(C=Cc3cc[n+]([O-])cc3)ccc1,424.46959,HMN-214,54143018,Phase 1,PLK inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,chemical name,2,32
3654,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1329,n1(C(c2ccccc2)C)cncc1C(=O)OCC,244.28903,Etomidate,36339,Launched,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,InChI key,1,32
3654,N16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1500,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@H](C)[C@@]4(O)C(=O)CO)=CC1=O,392.46106,Betamethasone,129010233,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,InChI key,,32
3654,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1360,c1(C=C2SC(=O)NC2=O)cc3c(nccc3c4ccncc4)cc1,333.36384,GSK1059615,71317162,Phase 1,PI3K inhibitor,PIK3CG,chemical name,1,32
3654,N18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1515,c1(C=CC(=O)NO)cc2c(n(CCN(CC)CC)c(CCCC)n2)cc1,358.4778,Pracinostat (SB939),56603532,Phase 2,HDAC inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC5|HDAC9,canonical SMILES,,32
3654,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1377,C1C[C@@]2(C)C([C@@]3([H])[C@]([H])(C3)[C@]4([H])[C@@]2([H])CC[C@@]5(C)[C@@]4([H])[C@@]6([H])[C@]([H])(C6)[C@]57CCC(=O)O7)=CC1=O,366.49319,Drospirenone,129010035,Launched,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,InChI key,,32
3654,N20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1529,c1(NS(=O)(=O)CC)cc2c(NC(=O)C2=C(Nc3ccc(CN4CCCCC4)cc3)c5ccccc5)cc1,516.65437,Hesperadin,66910320,Preclinical,Aurora kinase inhibitor,AURKB,chemical name,3,32
3654,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1390,c1cc2c(n(C)c3c2C(=O)C(Cn4ccnc4C)CC3)cc1.Cl,329.8239,Ondansetron HCl,45114215,Launched,serotonin receptor antagonist,HTR1A|HTR1B|HTR3A|HTR3B|HTR4|OPRM1,InChI key,1,32
3654,N22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1540,C1C(CC(CC2([C@H](N)C(=O)N3[C@@]4([H])[C@@]([H])(C4)C[C@H]3C#N)C5)(O)CC15)C2,315.41,Saxagliptin,129010355,Launched,dipeptidyl peptidase inhibitor,DPP4,InChI key,2,32
3654,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,InChI key,,32
3654,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,InChI key,,32
3654,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1023,c1(N[C](C)(c2c(cc(OCCOC)c(OCCOC)c2)N=C3)=N3)cc(C#C)ccc1.Cl,444.93117,Erlotinib HCl (OSI-744),0,,,,,1,32
3654,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1129,n1c(c2ncc1C(Nc3ccccc3c4cn(c5n4)c(CN6CCNCC6)cs5)=O)cccc2.Cl,506.02236,SRT1720,129010356,Preclinical,SIRT activator,SIRT1,InChI key,,32
3654,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1034,c1cc(OCc2ccccc2)cc(c3c4c(ncnc4N)n([C@H]5C[C@@H](CN6CCC6)C5)c3)c1,439.55205,NVP-AEW541,11476171,Preclinical,IGF-1 inhibitor,IGF1R|INSR,InChI key,1,32
3654,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1141,C(NCC=C)(C1=O)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)C=C(C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2)C(=O)C2=C1,585.68841,17-AAG (Tanespimycin),433449,Phase 3,HSP inhibitor,HSP90AA1,canonical SMILES,4,32
3654,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1043,c1c2c(c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncn2)cc(OC)c1OCCCN5CCCCC5,562.70298,Tandutinib (MLN518),3038522,Phase 2,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,InChI key,,32
3654,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1153,n1c(N[C@H](CC)CO)nc(NCc2ccccc2)c3c1n(C(C)C)cn3,354.44934,"Roscovitine (Seliciclib,CYC202)",5097,Phase 2,CDK inhibitor,CDK2|CDK9,InChI key,,32
3654,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1053,c1cc(C(=O)Nc2c(N)cccc2)ccc1CNC(=O)OCc3cccnc3,376.4085,Entinostat (MS-275),4261,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,InChI key,,32
3654,O12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1163,C(c1cc(C(C)C)c(O)cc1O)(N2Cc(c3C2)cc(CN4CCN(C)CC4)cc3)=O,409.52124,AT13387,11955716,Phase 2,HSP antagonist,HSP90AA1,InChI key,,32
3654,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1067,c1nc(c2c(c3ccc4c(OCO4)c3)nc(c5ccc(C(N)=O)cc5)[nH]2)ccc1,384.38743,SB431542,4521392,Preclinical,TGF beta receptor inhibitor,ACVR1C|TGFBR1,InChI key,1,32
3654,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1171,c1(Nc2ccc(N3CCOCC3)cc2)nc(c4c(C)nc(N)s4)ccn1,368.45599,CYC116,6420138,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|KDR,InChI key,3,32
3654,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1077,c1cc(c2c(c3ccncc3)[nH]c(c4ccc(O)cc4)n2)ccc1F,331.34306,SB202190 (FHPI),5353940,Preclinical,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,InChI key,,32
3654,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1180,c1c(C(F)(F)F)ccc(c2nc3c(CSCC3)c(O)n2)c1,312.31014,XAV-939,2726824,Preclinical,tankyrase inhibitor,TNKS|TNKS2,InChI key,,32
3654,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1089,c1(NS(=O)(=O)C2(CC2)C[C@H](O)CO)c(Nc3c(F)cc(I)cc3)c(F)c(F)cc1OC,572.33717,"Refametinib (RDEA119, Bay 86-9766)",15985330,Phase 2,MEK inhibitor,MAP2K1|MAP2K2,InChI key,1,32
3654,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1192,C(O)(=O)[C@@H](NC(c1sc(N(C)Cc2ccc(c3c2)N=C(C)NC3=O)cc1)=O)CCC(O)=O,458.48758,Raltitrexed,368341,Launched,thymidylate synthase inhibitor,FPGS|TYMS,InChI key,,32
3654,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1097,c1(C(F)(F)F)cc2c(SC(N3CCC4(OC(C)CO4)CC3)=NC2=O)c([N+]([O-])=O)c1,431.38624,BTZ043 Racemate,49769085,Preclinical,DPRE1 inhibitor,,InChI key,2,32
3654,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1202,C1=C[C@@]2(C)[C@@]([H])(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4C(=O)Nc5c(C(F)(F)F)ccc(C(F)(F)F)c5)NC1=O,528.52971,Dutasteride,129010357,Launched,5 alpha reductase inhibitor,SRD5A1|SRD5A2,InChI key,,32
3654,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1106,c(cccc1)(c2c(cc(c3n(c4ccc(NC(=O)CN)cc4)nc(C(F)(F)F)c3)cc2)cc5)c15,460.45046,OSU-03012 (AR-12),10027278,Phase 1,phosphoinositide dependent kinase inhibitor,PDPK1,InChI key,1,32
3654,O22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1212,c1cc2c(nc(CCCC(=O)O)n2C)cc1N(CCCl)CCCl.Cl,394.72378,Bendamustine HCl,51371190,Launched,DNA inhibitor,,InChI key,1,32
3654,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,P03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1225,[C@@]([H])(C(=O)OC1)([C@@H](c2cc(OC)c(O)c(OC)c2)c3c(cc4c(OCO4)c3)[C@H]5O[C@@]6([H])[C@@H](O)[C@@H](O)[C@@]7([H])[C@@]([H])(CO[C@@H](C)O7)O6)[C@]15[H],588.55657,Etoposide,129010358,,,,,2,32
3654,P04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1405,C1CCN([C@H]2C[C@@]3(C)[C@@]([H])(CC[C@]4([H])[C@@]3([H])CC[C@@]5(C)[C@@]4([H])C[C@H]([N+]6(C)CCCCC6)[C@H]5OC(=O)C)C[C@@H]2OC(=O)C)CC1.[Br-],637.73137,Vecuronium Bromide,129010359,Launched,acetylcholine receptor antagonist,CHRNA2,InChI key,1,32
3654,P05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1241,c1(OC)c([C@@]2(C(=O)OC)C[C@@]3([H])CN(C[C@@](CC)(O)C3)CCc4c2[nH]c5c4cccc5)cc6c(N(C=O)[C@]7([H])[C@]6(CC8)[C@@]([H])(N89)[C@@](CC)(C=CC9)[C@@H](OC(C)=O)[C@]7(O)C(=O)OC)c1.S(O)(O)(=O)=O,923.03612,Vincristine,129010361,Launched,tubulin polymerization inhibitor,TUBA4A|TUBB,chemical name,2,32
3654,P06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,InChI key,1,32
3654,P07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1255,C(N)(=O)Cc1cccc(C(=O)c2ccccc2)c1N,254.28386,Nepafenac,151075,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,32
3654,P08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1452,c1cccc(CN2C([C@@H](C(C)C)N(C(=O)c3ccc(C)cc3)CCCN)=Nc4c(ccc(Cl)c4)C2=O)c1,517.06161,Ispinesib (SB-715992),6450817,Phase 2,kinesin inhibitor,KIF11,InChI key,2,32
3654,P09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1267,c1(c2ccc(Cl)cc2)cc3c([nH]cc3C(c4c(F)ccc(NS(CCC)(=O)=O)c4F)=O)nc1,489.92212,"Vemurafenib (PLX4032, RG7204)",42611257,Launched,RAF inhibitor,BRAF|RAF1,InChI key,,32
3654,P10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1460,c1cc2c(c3c(c4[nH]n3)c(ccc4)C2=O)cc1,220.22611,SP600125,8515,Preclinical,JNK inhibitor,MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK,InChI key,2,32
3654,P11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1286,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(=O)CO)O[C@]([H])(CCC)O5)=CC1=O,430.53385,Budesonide,129010363,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,1,32
3654,P12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1475,c1c(F)c(Nc2c(C(=O)NC[C@H](O)CO)ccnc2)ccc1I,431.20077,Pimasertib (AS-703026),11676349,Phase 2,MEK inhibitor,MAP2K1|MAP2K2,InChI key,1,32
3654,P13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1300,N1C(=O)C(F)=CN([C@H]2CCCO2)C1=O,200.16706,FT-207 (NSC 148958),5386,Launched,thymidylate synthase inhibitor,TYMS,InChI key,1,32
3654,P14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1486,c1nc2c(cc(c3ccc(CN4CCN(CC)CC4)cc3)[nH]2)c(N[C@H](C)c5ccccc5)n1,440.58318,AEE788 (NVP-AEE788),11578515,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,InChI key,2,32
3654,P15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1331,c1(C(O)(Cn2cncn2)Cn3cncn3)ccc(F)cc1F,306.27078,Fluconazole,3365,Launched,sterol demethylase inhibitor,CYP51A1,InChI key,1,32
3654,P16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1501,c(C(=O)OC1)(c(O)c(CC=C(C)CCC(=O)OCCN2CCOCC2)c(OC)c3C)c13,433.49473,Mycophenolate Mofetil,4271,,,,,,32
3654,P17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1361,c1(CC(=O)NC(=S)Nc2cc(F)c(Oc3ccnc4c3sc(c5cn(C)cn5)c4)cc2)ccccc1,517.5977,MGCD-265,24901704,Preclinical,VEGFR inhibitor,AXL|MET,InChI key,1,32
3654,P18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1517,[C@@H]1(N)[C@@H](O)[C@]([H])(O[C@@H]2C[C@]([H])(O[C@]3(O)C[C@@H](O)C[C@]4([H])[C@H](O4)C=CC(=O)O[C@H](C)CC=CC=CC=CC=C2)[C@H](C(O)=O)[C@@H](O)C3)O[C@H](C)[C@H]1O,665.72518,Natamycin,129010364,Launched,fungal ergosterol inhibitor,,chemical name,,32
3654,P19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1378,n1c(c2cnn([C@H](C3CCCC3)CC#N)c2)c4c([nH]cc4)nc1,306.36502,Ruxolitinib (INCB018424),17754772,Preclinical,JAK inhibitor,JAK1|JAK2,InChI key,1,32
3654,P20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1530,c1cc2c(NC(=O)C2=C(c3ccccc3)Nc4cccc(CN(C)C)c4)cc1C(=O)NC,426.51023,BIX 02188,68529109,,,,,,32
3654,P21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1392,c1(OCC)cc2c(c(Nc3ccc(F)c(Cl)c3)c(C#N)cn2)cc1NC(=O)C=CCN(C)C,467.92312,Pelitinib (EKB-569),216467,Phase 2,EGFR inhibitor,EGFR,canonical SMILES,,32
3654,P22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1541,[nH]1c2c(cc(Cl)cc2)c3c1C(C(N)=O)CCC3,248.70812,EX 527 (Selisistat),5113032,Phase 2,SIRT inhibitor,SIRT1,InChI key,1,32
3654,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3654,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1545,c1c(F)c2c(c(NC(=O)Nc3ccc(N(C)C)cc3)cc(C)n2)cc1F,356.36922,SB408124,4331799,Preclinical,orexin receptor antagonist,HCRTR1|HCRTR2,InChI key,,32
3655,A04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1712,c1c(C(=O)O)ccc(n2nc(c3c(O)cccc3)nc2c4c(O)cccc4)c1,373.3615,Deferasirox,36687767,Launched,chelating agent,CYP3A4,InChI key,1,32
3655,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1558,c1(Cl)ccc(C2(CCNCC2)c3ccc(c4cn[nH]c4)cc3)cc1,337.84589,AT7867,11175137,Preclinical,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA,InChI key,,32
3655,A06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1725,c1cc2c(cccc2CN(CC=CC#CC(C)(C)C)C)cc1,291.42989,Terbinafine,5402,,,,,,32
3655,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1573,c1ccc(S(=O)(=O)N2CCCNCC2)c3c1cncc3.Cl,327.82962,Fasudil (HA-1077) HCl,44421877,Launched,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,InChI key,1,32
3655,A08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1737,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(O)C(CO)=O)=CC1=O,360.44402,Prednisolone,129010365,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,InChI key,,32
3655,A09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1594,C(C)(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C(=O)N(C)CCc2c1cccc2,361.43537,Semagacestat (LY450139),75632113,Phase 3,gamma secretase inhibitor,PSEN1,InChI key,1,32
3655,A10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1762,c1nc(C(N)=O)cnc1,123.11269,Pyrazinamide,1046,Launched,fatty acid synthase inhibitor,FASN,InChI key,,32
3655,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1618,c1(N)ccc(S(=O)(=O)Nc2ncc(OC)cn2)cc1,280.30298,Sulfameter,5326,Launched,dihydrofolate reductase inhibitor,DHFR,InChI key,,32
3655,A12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1784,c1nc2c(ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)c(N)n1,267.24131,Vidarabine,191,Launched,antiviral,ADA,InChI key,,32
3655,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1629,C1(=O)O[C@@H](C[C@@H](OC([C@@H](NC=O)CC(C)C)=O)CCCCCCCCCCC)[C@@H]1CCCCCC,495.73481,Orlistat,4599,Launched,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,InChI key,1,32
3655,A14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1806,c1nc(C(O)=O)c[n+]([O-])c1C,154.12344,Acipimox,5310993,Launched,cholesterol inhibitor,HCAR2,InChI key,,32
3655,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1644,c1([N+](=O)[O-])oc(C=NNC(=O)N)cc1,198.13624,Nitrofural,1839,,,,,,32
3655,A16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1833,c1c(Cl)c(SC(CCc2ccc(Cl)cc2)Cn3ccnc3)c(Cl)cc1.[N+](O)(=O)[O-],474.78851,Butoconazole nitrate,47471,Launched,bacterial cell wall synthesis inhibitor,,InChI key,1,32
3655,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1658,c1cc(CCN(C)CCOc2ccc(NS(=O)(=O)C)cc2)ccc1NS(=O)(=O)C,441.56477,Dofetilide,71329,Withdrawn,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,InChI key,1,32
3655,A18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1849,c1cc2c(OC=C(c3ccc(O)cc3)C2=O)cc1O,254.2375,Daidzein,5281708,Phase 2,estrogen receptor agonist,ESRRA|ESRRB|ESRRG|TRPC5,InChI key,1,32
3655,A19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1673,NCCN.N1(C)C(=O)c2c(nc[nH]2)N(C)C1=O.N3(C)C(=O)c4c(nc[nH]4)N(C)C3=O,420.42636,Aminophylline,9433,,,,,1,32
3655,A20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1883,C(I)(C(=O)NC(=O)N1[C@H]2C[C@H](O)[C@@H](CO)O2)=C1,354.09851,Idoxuridine,3687,Launched,DNA directed DNA polymerase inhibitor,,InChI key,,32
3655,A21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1692,CS(=O)(=O)OCCCCOS(=O)(=O)C,246.30176,Busulfan,2478,Launched,DNA inhibitor,,InChI key,,32
3655,A22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1903,c1ccc(Cl)c(Nc2ccccc2CC(=O)[O-])c1Cl.[Na+],318.13047,Diclofenac Sodium,5018304,,,,,1,32
3655,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1916,c1cc(S(=O)(=O)Nc2onc(C)c2C)ccc1N,267.30422,Sulfisoxazole,5344,Launched,bacterial antifolate,,InChI key,1,32
3655,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2134,c1c(F)c(NC2=C(C(=O)NOCCO)C=C(C)C(=O)N2C)ccc1I,461.22675,AZD8330,16666708,Phase 1,MEK inhibitor,,InChI key,,32
3655,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1952,C1=Cc2c(c(OC)c3c(cco3)c2)OC1=O,216.18952,Methoxsalen,4114,Launched,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,InChI key,1,32
3655,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2161,c(nc(Nc1ccc(C(F)(F)F)cc1)n2C)(cc(Oc3cc(c4ncc(C(F)(F)F)[nH]4)ncc3)cc5)c25,518.41385,RAF265 (CHIR-265),11656518,Phase 2,RAF inhibitor|VEGFR inhibitor,BRAF,InChI key,1,32
3655,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1974,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,195.21358,Meglumine,4049,Launched,excipient,,InChI key,,32
3655,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2182,c1cccc(CC2=C([C@@H](C(C)C)N(CCCN)C(c3ccc(C)cc3)=O)Oc4c(ccc(Cl)c4)C2=O)c1.Cl,553.51925,SB743921,129010366,Phase 1/Phase 2,kinesin-like spindle protein inhibitor,KIF11,InChI key,2,32
3655,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2005,N1(C)C(=O)C(O)=C(C(=O)NCc2ccc(F)cc2)N=C1C(C)(C)NC(=O)c3oc(C)nn3,444.41634,Raltegravir (MK-0518),54671008,Launched,HIV integrase inhibitor,,InChI key,,32
3655,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2201,n1ccc(Oc2c(F)cc(NC(=O)C(C(=O)C(c3ccc(F)cc3)=CN4)=C4)cc2)c(Cl)c1N,468.84,BMS-794833,44155856,Phase 1,Bcr-Abl kinase inhibitor,ABL1|BCR,InChI key,2,32
3655,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2026,O=C1O[C@]2([H])[C@@](O)([C@]3(O4)C(C([C@]([H])(O)C(=O)O5)([C@H]45)[C@]([H])(C(C)(C)C)C6)([C@]6([H])OC3=O)C2)[C@]1([H])C,408.39915,Ginkgolide A,129010367,Preclinical,GABA receptor antagonist,GLRA1|GLRB,InChI key,,32
3655,B12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2218,n1c(N)c2c(n(C(C)C)nc2c3cc4c(ccc(O)c4)[nH]3)nc1,308.33783,PP242,57347681,Preclinical,mTOR inhibitor,MTOR|PASK,InChI key,,32
3655,B13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2038,c1(cccc(O)c1)N(CC2=NCCN2)c3ccc(C)cc3.CS(=O)(=O)O,377.45792,Phentolamine Mesylate,91430,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,InChI key,,32
3655,B14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2229,c1ccc(c2cc(C(=O)O)ccc2)c(O)c1NN=C3C(C)=NN(c4cc(C)c(C)cc4)C3=O,442.46657,Eltrombopag,66583167,Launched,thrombopoietin receptor agonist,MPL,chemical name,5,32
3655,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2055,C(Cl)(C(O)=CC(=O)N1)=C1,145.54376,Gimeracil,54679224,Launched,dihydropyrimidine dehydrogenase inhibitor,DPYD,InChI key,,32
3655,B16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2244,c1ccc([C@H](C(C)C)C(=O)Nc2ccc(C(=O)NO)cc2)cc1,312.363,AR-42,6918801,Phase 1,HDAC inhibitor,HDAC1,InChI key,,32
3655,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2066,n1c(Cl)c(NC(NCC2)=N2)c(OC)nc1C,241.67748,Moxonidine,4810,Launched,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,InChI key,,32
3655,B18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2261,[C@@H]1(O)CC[C@]2(C)[C@]([H])(CCC(=C)[C@@H]2CC=C3C(O)COC3=O)[C@]1(C)CO,350.4492,Andrographolide,129010368,Phase 2,tumor necrosis factor production inhibitor,NFKB1,chemical name,,32
3655,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2097,[C@H](C(OC)(c1ccccc1)c2ccccc2)(C(=O)O)Oc3nc(C)cc(C)n3,378.42108,Ambrisentan,197712,Launched,endothelin receptor antagonist,EDNRA|EDNRB,InChI key,,32
3655,B20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2269,[C@@H]1(O)[C@H](C(O)=O)O[C@H](Oc2cc3c(C(=O)C=C(c4ccccc4)O3)c(O)c2O)[C@H](O)[C@H]1O,446.36101,Baicalin,3807559,Launched,beta glucuronidase inhibitor,PREP,InChI key,,32
3655,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2120,c1(O)c(CN(C)C)c2c(n(C)c(CSc3ccccc3)c2C(=O)OCC)cc1Br.Cl,513.87543,Arbidol HCl,129010369,Launched,cytochrome P450 inhibitor,CYP3A4,InChI key,,32
3655,B22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2287,C([C@H](C[C@@H]1C2)CNC1)(=CC=CC3=O)N23,190.24166,Cytisine,22407,Launched,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,InChI key,,32
3655,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1547,c1(C#N)cc(c2nc(C)c(C(=O)O)s2)ccc1OCC(C)C,316.37484,Febuxostat,134018,Launched,xanthine oxidase inhibitor,XDH,InChI key,,32
3655,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1713,c1ccc(NC(=O)C2=C(O)c3c(cccc3)S(=O)(=O)N2C)nc1,331.34641,Piroxicam,54676228,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,chemical name,,32
3655,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1561,c1(Cl)c(Oc2c(F)cc(NC(C3=C(OCC)C=CN(c4ccc(F)cc4)C3=O)=O)cc2)ccnc1N,512.89256,BMS-777607,24794418,Phase 1/Phase 2,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,InChI key,1,32
3655,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1729,c1c(C)c(OCCCC(C)(C)C(O)=O)cc(C)c1,250.33338,Gemfibrozil,3463,Launched,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,InChI key,1,32
3655,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1574,c1cc(OCCN2CCOCC2)c3c(cccc3)c1NC(=O)Nc4n(c5ccc(C)cc5)nc(C(C)(C)C)c4,527.65718,BIRB 796 (Doramapimod),156422,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,InChI key,3,32
3655,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1738,c1cccc(c2ccc(Cn3c4c(c(C)cc(c5nc6c(cccc6)n5C)c4)nc3CCC)cc2)c1C(=O)O,514.61689,Telmisartan,65999,Launched,angiotensin receptor antagonist,AGTR1|PPARG,InChI key,,32
3655,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1601,c(c1c(cc(OC)cc1)[nH]2)(CCN3[C@]4([H])C[C@@]5([H])[C@]([H])(C[C@@H](OC(c6cc(OC)c(OC)c(OC)c6)=O)[C@H](OC)[C@H]5C(=O)OC)C3)c24,608.6787,Reserpine,129010370,Launched,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,InChI key,3,32
3655,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1764,c1(C=NN2CCN(C)CC2)c(O)c(c(C(=O)[C@]3(C)O4)c45)c(c(O)c5C)c(O)c1NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO3,822.94022,Rifampin,73759790,Launched,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,chemical name,3,32
3655,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1620,[C@@]([H])(OCC1)(OC[C@@]2(OC(=O)N[C@@]([C@@](O)([H])CN(S(=O)(=O)c3ccc(N)cc3)CC(C)C)([H])Cc4ccccc4)[H])[C@@]12[H].CCO,593.73202,Darunavir Ethanolate,129010371,Launched,HIV protease inhibitor,CYP3A4,InChI key,,32
3655,C12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1787,c1c2c(OCO2)cc3c1[C@@H](O[C@@H]4O[C@H]5[C@@H](O[C@H](c6sccc6)OC5)[C@H](O)[C@H]4O)[C@@H]7[C@]([H])(C(=O)OC7)[C@H]3c8cc(OC)c(O)c(OC)c8,656.65368,Teniposide,129010373,Launched,topoisomerase inhibitor,TOP2A|TOP2B,InChI key,1,32
3655,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1631,C(NC(=O)c1c2[nH]nc1)=N2.[Na+],159.10122,Allopurinol Sodium,16051976,Launched,xanthine oxidase inhibitor,XDH,InChI key,,32
3655,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1807,OCCOCn1cnc2c1N=C(N)NC2=O,225.20464,Aciclovir,2022,Launched,DNA polymerase inhibitor,PNP,InChI key,,32
3655,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1645,c1cc(C(=O)c2cc(C(C)C(=O)O)ccc2)ccc1,254.28056,Ketoprofen,3825,Launched,cyclooxygenase inhibitor,CXCR1|PTGS1|PTGS2|SLC5A8,InChI key,,32
3655,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1835,[C@@H]1(O)[C@@H](C)N(C)C[C@H](C)C[C@](O)(C)[C@H](O[C@H]2[C@@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@](OC)(C)C3)[C@H](C)C(=O)O[C@H](CC)[C@@]1(C)O,748.98448,Azithromycin,129010374,Launched,bacterial 50S ribosomal subunit inhibitor,MLNR,InChI key,5,32
3655,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1662,c1cc2c(non2)c(C3C(C(=O)OC(C)C)=C(C)NC(C)=C3C(OC)=O)c1,371.38713,Isradipine,3784,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2,InChI key,1,32
3655,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1855,c1(F)cc2c(N(CC)C=C(C(O)=O)C2=O)cc1N3CCN(C)CC3.S(O)(=O)(=O)C,429.46306,Pefloxacin Mesylate,119525,Launched,bacterial DNA gyrase inhibitor,TOP2A,InChI key,4,32
3655,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1676,c1cc(CC(C)CN2C[C@@H](C)O[C@@H](C)C2)ccc1C(C)(C)CC.Cl,353.96964,Amorolfine HCl,75633838,Launched,membrane integrity inhibitor,,InChI key,3,32
3655,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1884,[C@@H]1(C)CN(c2c(F)c(N)c3c(N(C4CC4)C=C(C(=O)O)C3=O)c2F)C[C@H](C)N1,392.39978,Sparfloxacin,5257,Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,InChI key,4,32
3655,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1701,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@]5([H])[C@]4(C(=O)CO)OC(C)(C)O5)=CC1=O,416.50727,Desonide,129010375,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,InChI key,,32
3655,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1904,c1cc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)ccc1OC,310.38687,Avobenzone,51040,Launched,UV blocker,TYR,InChI key,,32
3655,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,InChI key,7,32
3655,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2149,c1(c2ccc(S(C)(=O)=O)cc2)ncc(OCC3CCN(c4onc(C(C)C)n4)CC3)cc1,456.55782,GSK1292263,24996872,Phase 2,glucose dependent insulinotropic receptor agonist,GRPR,InChI key,2,32
3655,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1956,c1cc(C(Cn2cncc2)OCc3c(Cl)cc(Cl)cc3)c(Cl)cc1Cl.O[N+]([O-])=O,479.1414,Miconazole Nitrate,68553,Launched,bacterial cell wall synthesis inhibitor,KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5,InChI key,1,32
3655,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,InChI key,,32
3655,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1978,[Br-].[C@@]1([H])(C[C@H](OC(=O)[C@H](CO)c2ccccc2)C3)[N+](C)(C)[C@]3([H])[C@@]4([H])[C@]1([H])O4,398.29146,Methscopolamine,124081959,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,InChI key,,32
3655,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2185,C(Nc1ccc(c2c1)ncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)(=O)C=C.c5c(S(=O)(=O)O)ccc(C)c5,621.07834,AST-1306,25027665,Phase 1,EGFR inhibitor,EGFR|ERBB2,InChI key,,32
3655,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2006,n1c(N)c(c2ccc(Cl)cc2)c(CC)nc1N,248.71141,Pyrimethamine,4993,Launched,dihydrofolate reductase inhibitor,DHFR|SLC47A1,InChI key,1,32
3655,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2202,c(cnn1C)(c(Nc2c(C)ccc(C(=O)Nc3cc(C(F)(F)F)ccc3)c2)nc(c4cnccc4)n5)c15,503.4785,NVP-BHG712,16747388,Preclinical,ephrin inhibitor,EPHB4,InChI key,3,32
3655,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2028,c1cc(C(C#N)c2c(Cl)cc(N3C(=O)NC(=O)C=N3)cc2Cl)ccc1Cl,407.63796,Diclazuril,456389,Launched,antiprotozoal agent,,InChI key,1,32
3655,D12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2219,c1cc(Nc2nc(c3ccc(C(=O)NCC#N)cc3)ccn2)ccc1N4CCOCC4,414.45977,CYT387,25062766,Phase 3,,JAK1|JAK2|JAK3,InChI key,2,32
3655,D13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2040,c1c(NS(C)(=O)=O)c(Oc2ccccc2)cc([N+]([O-])=O)c1,308.30978,Nimesulide,4495,Launched,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,InChI key,,32
3655,D14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2230,c1(C)nc(c2c(c3c4c(ccc(C(N)=O)c4)ncc3)c5n(CCC5)n2)ccc1,369.41915,LY2157299,10090485,Phase 2/Phase 3,TGF beta receptor inhibitor,TGFBR1,InChI key,,32
3655,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2058,c1(cccc(C)c1)N(C)C(=S)Oc2cc3c(cccc3)cc2,307.40938,Tolnaftate,5510,Launched,fungal squalene epoxidase inhibitor,,InChI key,,32
3655,D16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2247,c1c(C(F)(F)F)c(c2cc(N3CCOCC3)nc(N4CCOCC4)n2)cnc1N,410.39354,"BKM120 (NVP-BKM120, Buparlisib)",16654980,Phase 3,PI3K inhibitor,PIK3CA|PIK3CG,InChI key,,32
3655,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2067,c1cc(C=CC(=O)O)ccc1Cn2ccnc2.Cl,264.70752,Ozagrel HCl,71296886,,,,,1,32
3655,D18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2262,c1c(O)cc2c(C(=O)C=C(c3ccc(O)cc3)O2)c1O,270.2369,Apigenin,5280443,Preclinical,casein kinase inhibitor|cell proliferation inhibitor,AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1,InChI key,2,32
3655,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2098,c(C(C)(C)CCC1(C)C)(cc(C)c(C(=C)c2ccc(C(O)=O)cc2)c3)c13,348.47791,Bexarotene,82146,Launched,retinoid receptor agonist,RXRA|RXRB|RXRG,InChI key,,32
3655,D20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2270,[C@H]1(CO)O[C@]2([H])[C@]([H])(OC(=O)c3c2c(O)c(OC)c(O)c3)[C@@H](O)[C@@H]1O,328.27144,Bergenin,16219037,Preclinical,interleukin inhibitor,IL1B|TNF,InChI key,,32
3655,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2121,c1(c(CC(O)=O)n2c(CC(C)(C)C2)c1c3ccccc3)c4ccc(Cl)cc4,379.87928,Licofelone,133021,Phase 3,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5|PLA2G2E|PTGS2,InChI key,2,32
3655,D22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2290,C1[C@H](C)[C@@]2([H])[C@](OO3)([C@]4([H])O[C@@]3(C)CC2)[C@]([H])([C@@H](C)[C@H](O)O4)C1,284.34806,Dihydroartemisinin (DHA),129010376,Launched,antimalarial agent,,InChI key,,32
3655,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1548,c1([C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)cc(Cc3ccc(OCC)cc3)c(Cl)cc1,408.8726,Dapagliflozin,23560495,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,InChI key,,32
3655,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,InChI key,,32
3655,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1565,c(OC(F)(F)O1)(ccc(C2(CC2)C(=O)Nc3ccc(C)c(c4cc(C(=O)O)ccc4)n3)c5)c15,452.40692,VX-809 (Lumacaftor),16678941,Launched,CFTR channel agonist,CFTR,InChI key,,32
3655,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1730,c1cc(Cl)c(S(=O)(=O)N)cc1C(=O)NN2C(C)Cc3c2cccc3,365.83453,Indapamide,3702,Launched,thiazide diuretic,KCNE1|KCNQ1|SLC12A3,InChI key,,32
3655,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1575,O=C1[C@H](NC(=O)C(C)(C)C(=O)NCC(F)(F)C(F)(F)F)c2c(cccc2)c3c(cccc3)N1,469.40451,RO4929097,11351859,,,,,,32
3655,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1739,n1c(c2nc3c(cccc3)[nH]2)csc1,201.24768,Thiabendazole,5430,Launched,angiogenesis inhibitor,,InChI key,1,32
3655,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1603,c1(C(=O)O)c(NCc2occc2)cc(Cl)c(S(=O)(=O)N)c1,330.74413,Furosemide,3440,Launched,diuretic,CA2|GPR35|SLC12A1|SLC12A2,InChI key,,32
3655,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1767,C1C(C)=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(C(C)(C)CCC2)=C2C)C(C)(C)CC1,536.87263,Beta Carotene,573,,,,,,32
3655,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1622,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])C(=O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(O)C(=O)CO)=CC1=O,358.42814,Prednisone,129009910,Launched,glucocorticoid receptor agonist,HSD11B1|NR3C1,InChI key,1,32
3655,E12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1790,[C@@H]1(O)[C@@H](C)[C@@H](O)[C@H](C)C=CC=C(C)C(=O)Nc2c(O)c(c(c(C(=O)[C@]3(C)OC=C[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@@H]1C)c4O3)c5c2n6c(cc(C)cc6)n5)c(O)c4C,785.87854,Rifaximin,129010377,Launched,RNA synthesis inhibitor,NR1I2,chemical name,4,32
3655,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1633,c(n(C)cc1Cc2c(OC)cc(C(NS(=O)(=O)c3c(C)cccc3)=O)cc2)(ccc(NC(=O)OC4CCCC4)c5)c15,575.67522,Zafirlukast,5717,Launched,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,InChI key,,32
3655,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1811,c1(Cl)nc(C(=O)NC(=N)N)c(N)nc1N.Cl,266.08796,Amiloride HCl,23617642,Launched,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,InChI key,,32
3655,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1646,c1ccc(C(=O)c2n3c(C(C(O)=O)CC3)cc2)cc1.OCC(N)(CO)CO,376.40365,Ketorolac,84003,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,32
3655,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1836,c1(S(=O)CCC)cc2c(nc(NC(OC)=O)[nH]2)cc1,281.3308,Albendazole Oxide,83969,Launched,anthelmintic agent,,InChI key,1,32
3655,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1665,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CCC4=O)cc1O,270.36608,Estrone,11869537,Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,InChI key,,32
3655,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1859,c1(O)ccc(C(CC)=C(CC)c2ccc(O)cc2)cc1,268.3502,Diethylstilbestrol,3054,,,,,,32
3655,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1677,c1cc([C@@H](O)[C@@H](CO)NC(C(Cl)Cl)=O)ccc1[N+]([O-])=O,323.12938,Chloramphenicol,298,Launched,bacterial 50S ribosomal subunit inhibitor,CD55,InChI key,1,32
3655,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1889,c1c(O)c2c(C(=O)c3c(c(NCCNCCO)ccc3NCCNCCO)C2=O)c(O)c1,444.48091,Mitoxantrone,4212,Launched,topoisomerase inhibitor,TOP2A,InChI key,6,32
3655,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1702,[C@H]1(CO)O[C@@H](n2cnc3c2N=CNC3=O)CC1,236.22727,Didanosine,3043,Launched,nucleoside reverse transcriptase inhibitor,PNP,InChI key,,32
3655,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1907,n1(c(C)ncc1[N+]([O-])=O)CCO,171.15396,Metronidazole,4173,Launched,DNA inhibitor,CYP2C9|CYP3A4,InChI key,,32
3655,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1928,c1c(CC=C)cc(C(NCCO)=O)c(O)c1OC,251.27838,Alibendol,71916,Launched,antispasmodic,,InChI key,,32
3655,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2151,c1(NC(=O)c2cccc(c3ccc(OC(F)(F)F)cc3)c2C)cnc(N4C[C@@H](C)O[C@@H](C)C4)cc1,485.49814,"LDE225 (NVP-LDE225,Erismodegib)",53396339,Launched,smoothened receptor antagonist,SMO,InChI key,,32
3655,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1957,c1cc(S(=O)(=O)Nc2nnc(C)s2)ccc1N,270.3313,Sulfamethizole,5328,Launched,bacterial antifolate,,InChI key,1,32
3655,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2170,c1c(CN(CC)CC)cc2c(cc(COC(=O)Nc3ccc(C(=O)NO)cc3)cc2)c1.O.Cl,475.96509,Givinostat (ITF2357),129010378,Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,InChI key,3,32
3655,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1979,c1(OCCN(CC)CC)c(I)cc(C(c2c3c(cccc3)oc2CCCC)=O)cc1I.Cl,681.77254,Amiodarone HCl,24189191,Launched,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,InChI key,4,32
3655,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2186,c1(C)nc(c2c(c3ccc4c(OCO4)c3)nc(C(C)(C)C)[nH]2)ccc1,335.39963,SB505124,9858940,Preclinical,ALK tyrosine kinase receptor inhibitor,TGFBR1,InChI key,1,32
3655,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2007,c1c(C=C2C(C)=C(CC(O)=O)c3c2ccc(F)c3)ccc(S(=O)C)c1,356.41058,Sulindac,5352,,,,,,32
3655,F10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2205,c1c(Nc2c3c(cc(OCCOC)c(OCCO)c3)ncn2)cccc1C#C.Cl,415.87007,OSI-420,129010379,Preclinical,EGFR inhibitor,EGFR,InChI key,1,32
3655,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2029,C1=CC(=O)NC(=O)N1[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O2,244.20138,Uridine,1177,Phase 2,dopamine receptor agonist,LSM6|TYMP,InChI key,,32
3655,F12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2220,n1c(c2ccc(OCCN(C)C)cc2)[nH]c(c3cc4c(C(=NO)CC4)cc3)c1c5ccncc5,453.53557,SB590885,53239990,Preclinical,RAF inhibitor,BRAF,canonical SMILES,,32
3655,F13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2042,[C@@H]1(C2)[C@@H]2[C@@]3(C)C(C(Cl)=C[C@]4([H])[C@@]3([H])CC[C@@]5(C)[C@@]4([H])CC[C@@]5(OC(=O)C)C(C)=O)=CC1=O,416.93765,Cyproterone Acetate,129010380,Launched,androgen receptor antagonist,ADORA1|AR,InChI key,,32
3655,F14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2231,n1nc(OCc2ccnc(C(NC)=O)c2)c3c(cco3)c1Nc4ccc(Cl)cc4,409.82574,Telatinib,9808844,Phase 2,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,InChI key,1,32
3655,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2059,c(cc(OC)c(OC)c1)(nc(N2CCN(C(=O)C3OCCC3)CC2)nc4N)c14.Cl.O.O,459.92439,Terazosin HCl,45356864,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,InChI key,,32
3655,F16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2248,c1cc2c(c3c(cc(C(O)=O)cc3)nc2Nc4cccc(Cl)c4)cn1,349.77048,CX-4945 (Silmitasertib),24748573,Phase 1/Phase 2,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,InChI key,3,32
3655,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2074,c1cc2c(c(C(OCC)=O)c(C)n2C)cc1O,233.2631,Mecarbinate,616236,Preclinical,,,InChI key,1,32
3655,F18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2263,[C@H]1(CO)O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,272.25124,Arbutin,346,Phase 2/Phase 3,melanin inhibitor,TYR,InChI key,,32
3655,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2101,c1(OC(CCCCCNC(=N)N)=O)ccc(C(=O)OCC)cc1.O=S(C)(O)=O,417.47718,Gabexate Mesylate,6604561,Launched,serine protease inhibitor,PRSS1|TPSAB1,InChI key,2,32
3655,F20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2271,c1cc2c(c[n+]3c(c4c(cc5c(OCO5)c4)CC3)c2)c(OC)c1OC.[Cl-],371.81421,Berberine HCl,12456,Phase 2/Phase 3,LDL receptor activator,LDLR,InChI key,1,32
3655,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2125,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4(O)C#C)cc1OC,310.42994,Mestranol,12598377,Launched,estrogen receptor agonist,ESR1,InChI key,,32
3655,F22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2292,[C@@H]1(O)[C@H](O)[C@H](C)O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(OC(c5ccc(OC)c(O)c5)=CC4=O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O,608.54468,Diosmin,5353588,Launched,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,InChI key,,32
3655,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1549,c1cc2c(CC[C@]([H])([C@H](O)CNC[C@@H](O)[C@@]3([H])Oc4c(cc(F)cc4)CC3)O2)cc1F.Cl,441.89594,Nebivolol,129010381,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,InChI key,2,32
3655,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1715,c1(S(=O)(=O)NC(=O)NC2CCCCC2)ccc(CCNC(=O)c3ncc(C)nc3)cc1,445.53517,Glipizide,3478,Launched,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,InChI key,1,32
3655,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1567,c1c(N)c2c(C(=O)N(C3CCC(=O)NC3=O)C2=O)cc1,273.24413,Pomalidomide,134780,Launched,angiogenesis inhibitor|tumor necrosis factor production inhibitor,CRBN|PTGS2|TNF,InChI key,3,32
3655,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1732,c1cc(C(C(Cl)Cl)c2ccccc2Cl)ccc1Cl,320.0412,Mitotane,4211,Launched,antineoplastic agent,CYP11A1|CYP11B1|ESR1|FDX1,InChI key,1,32
3655,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1576,c1(ncccc1)NS(=O)(=O)c2ccc(N=Nc3ccc(O)c(C(O)=O)c3)cc2,398.39255,Sulfasalazine,5384001,,,,,,32
3655,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1741,[C@@H]1(C)[C@@H](OC)C=CO[C@]2(C)C(=O)c(c3c4C(=O)C(=C(NC56CCN(CC(C)C)CC5)C3=N6)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(C)=O)c(O2)c(C)c4O,847.00468,Rifabutin,71296898,Launched,protein synthesis inhibitor,HSP90AA1|HSP90B1,chemical name,2,32
3655,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1605,[C@]([H])([C@@](NC(=O)C(=NO)c1csc(N)n1)([H])C2=O)(SCC(C=C)=C3C(=O)O)N23,395.41352,Cefdinir,124930856,,,,,3,32
3655,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1768,N(C(=O)[C@@H]1NC(C(c2nc(N)sc2)=NOC)=O)(C(C(OCOC(=O)C(C)(C)C)=O)=C(C=Cc3c(C)ncs3)CS4)[C@@]14[H],620.72082,Cefditoren Pivoxil,129010382,Launched,bacterial cell wall synthesis inhibitor,,canonical SMILES,1,32
3655,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1623,C(=O)(N[C@@]([H])(CS)C(=O)O)C,163.19485,Acetylcysteine,12035,Launched,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,InChI key,,32
3655,G12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1792,C1[C@@H](OC(C(C)(C)CC)=O)[C@@]2([H])C(C=C[C@H](C)[C@H]2CC[C@]3([H])C[C@@H](O)CC(=O)O3)=C[C@@H]1C,418.56621,Simvastatin,129010383,Launched,HMGCR inhibitor,HMGCR|ITGB2,InChI key,,32
3655,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1635,C1[C@@](O)(C)[C@H](O[C@H]2OC(C)C[C@@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]3O[C@H](C)[C@@H](O)[C@](C)(OC)C3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@@H]1C,733.92678,Erythromycin,129010384,Launched,NFkB pathway inhibitor,MLNR,InChI key,2,32
3655,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1816,c1nc(C(c2ccc(Cl)cc2)CCN(C)C)ccc1.C(=O)(O)C=CC(=O)O,390.86061,Chlorpheniramine Maleate,8231,,,,,1,32
3655,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1647,O1[C@H](n2cnc3c2ncnc3N)[C@H](O)[C@H](O)[C@H]1CO,267.24132,Adenosine,191,Launched,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,InChI key,,32
3655,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1839,c1c(Cl)c(O)c2c(cccn2)c1Cl,214.04809,Chloroxine,2722,Launched,opioid receptor antagonist,OPRK1,InChI key,2,32
3655,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1666,C1(=O)N=C(N)C(F)=CN1,129.09246,Flucytosine,3366,Launched,other antifungal,DNMT1,InChI key,1,32
3655,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1866,c1cccc(C(OCCN(C)C)c2ccccc2)c1.Cl,291.81568,Diphenhydramine HCl,22561460,Launched,histamine receptor antagonist,HRH1,InChI key,,32
3655,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1679,c1(F)cc([C@H](C)C(=O)O)ccc1c2ccccc2,244.26092,Flurbiprofen,3394,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,32
3655,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1891,c1(O)cc(C[C@@](NN)(C)C(=O)O)ccc1O,226.22915,Carbidopa,34359,Launched,aromatic L-amino acid decarboxylase inhibitor,DDC,InChI key,1,32
3655,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1704,N(C(=O)N([C@@H]1CS[C@H](CO)O1)C=C2F)=C2N,247.2467,Emtricitabine,9837769,Launched,nucleoside reverse transcriptase inhibitor,,InChI key,1,32
3655,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1908,c1([N+]([O-])=O)ccc(NC(=O)C(C)C)cc1C(F)(F)F,276.21184,Flutamide,3397,Launched,androgen receptor antagonist,AHR|AR,InChI key,,32
3655,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1929,c1c(Cl)cc(c2nc(N)nc(N)n2)c(Cl)c1,256.09138,Irsogladine,3752,Launched,phosphodiesterase inhibitor,PDE4A,InChI key,,32
3655,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2154,c1(C(N)=NC(=O)OCCCCCC)ccc(NCc2nc3c(ccc(C(=O)N(c4ncccc4)CCC(=O)OCC)c3)n2C)cc1,627.73324,Dabigatran Etexilate,213023,Launched,thrombin inhibitor,F2,InChI key,,32
3655,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,InChI key,2,32
3655,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2177,c1(Cl)cc(S(=O)(=O)N)cc(S(=O)(=O)N)c1Cl,305.15884,Dichlorphenamide,3038,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7,InChI key,,32
3655,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1987,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(Cl)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(OC(c5occc5)=O)C(=O)CCl)=CC1=O,521.42949,Mometasone furoate,129010385,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,,32
3655,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2187,c1c(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)cc1C(C)C,501.72101,Avasimibe,166558,Phase 3,ACAT inhibitor,CES1,InChI key,,32
3655,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2012,n1(Cc2ccc(OC)cc2)c(c3cc1)cc(C(NO)=O)cc3,296.32054,PCI-34051,24753719,Preclinical,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8,InChI key,,32
3655,H10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2207,C1(Cn2c3c(c(N)ncn3)cn2)=Nc4c(c(C)ccc4)C(=O)N1c5ccccc5C,397.43256,PIK-293,53245636,Preclinical,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,,32
3655,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2030,c1(F)ccc(C(c2ccc(F)cc2)N3CCN(CC=Cc4ccccc4)CC3)cc1.Cl.Cl,477.41672,Flunarizine 2HCl,71296962,,,,,2,32
3655,H12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2221,S(=O)(C)(O)=O.c1cc(C(=O)Nc2ccc(C3(C#N)CCCC3)cc2)c(NCc4ccncc4)nc1,493.57797,Apatinib,45139106,Phase 3,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,InChI key,1,32
3655,H13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2043,Cl.C1(C)(CC(C)(CC2C1)CC3(N)C2)C3,215.76278,Memantine HCl,44319334,Launched,glutamate receptor antagonist,CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A,InChI key,,32
3655,H14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2232,c1cc2c(NC(=O)N(CCN3CCC(C(=O)c4ccc(F)cc4)CC3)C2=O)cc1,395.42678,Ketanserin,3822,Launched,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,InChI key,,32
3655,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2060,c1(Br)cc(CN(C2CCCCC2)C)c(N)c(Br)c1.Cl,412.59094,Bromhexine HCl,45114115,Launched,mucolytic agent,,InChI key,,32
3655,H16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2252,C1(C(C)=O)=C(O)[C@]2(C)C(Oc3c2c(O)c(C)c(O)c3C(=O)C)=CC1=O,344.31543,(+)-Usniacin,442614,,,,,,32
3655,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2077,[Ca+2].n1(c(c2ccc(F)cc2)c(c3ccccc3)c(C(Nc4ccccc4)=O)c1C(C)C)CC[C@@H](O)C[C@@H](O)CC(=O)[O-].n5(c(c6ccc(F)cc6)c(c7ccccc7)c(C(Nc8ccccc8)=O)c5C(C)C)CC[C@@H](O)C[C@@H](O)CC(=O)[O-],1155.34172,Atorvastatin Calcium,21862717,,,,,,32
3655,H18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2264,[C@]([H])(CC1)([C@@]([H])(C)CC2)[C@@]([C@]([H])(O[C@@]13C)O[C@H](OC)[C@]4(C)[H])(OO3)[C@@]24[H],298.37464,Artemether,129010386,Launched,antimalarial agent,ATP1A1,InChI key,1,32
3655,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2113,c1(OC)cc2c([C@@H](Cc3cc(OC)c(OC)cc3)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]4(C)CCc(c5[C@H]4Cc6cc(OC)c(OC)cc6)cc(OC)c(OC)c5)CC2)cc1OC.c7c(S(=O)(=O)[O-])cccc7.c8c(S(=O)(=O)[O-])cccc8,1243.47918,Cisatracurium Besylate,129010387,Launched,acetylcholine receptor antagonist,CHRNA2,InChI key,2,32
3655,H20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2276,O1[C@]2([H])C3([C@@H](O)C(=O)O2)[C@@](CC(=O)O4)([C@]4([H])C[C@]3(O)C(C)(C)C)C1=O,326.29861,Bilobalide,129010389,Preclinical,GABA receptor modulator,GLRA1|GLRA2|GLRB|HTR3A|HTR3B,InChI key,1,32
3655,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2126,c1(OCC(O)CN2CCN(c3c(OC)cccc3)CC2)cccc4c1cccc4,392.49072,Naftopidil,4418,Launched,adrenergic receptor antagonist,ADRA1A,InChI key,,32
3655,H22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2295,c(c(O)cc(O)c1)(C(=O)c2c(cc(C)cc2O)C3=O)c13,270.2369,Emodin,3220,Preclinical,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1,InChI key,1,32
3655,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1550,c1c(C2=NNC(=O)CC2C)ccc3c1nc(c4ccc(OC)cc4)[nH]3,334.37181,Pimobendan,4823,Launched,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,InChI key,,32
3655,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1718,c(ncn1CCOCP(OCOC(=O)C(C)(C)C)(=O)OCOC(=O)C(C)(C)C)(c(N)ncn2)c12,501.47054,Adefovir Dipivoxil,60871,Launched,DNA polymerase inhibitor,,InChI key,,32
3655,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1568,c1c(C(=O)NOCC(O)CO)c(Nc2c(F)cc(I)cc2)c(F)c(F)c1Br,561.08909,PD318088,10231331,Preclinical,MEK inhibitor,MAP2K1,InChI key,,32
3655,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1733,C1=C[C@@]2(C)C([C@@H](C)C[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(O)C(=O)CO)=CC1=O,374.4706,Methylprednisolone,129010390,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,1,32
3655,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1577,c(ccc(OC)c1)(cc(c2[nH]c(c3ccc(S(=O)C)cc3)nc2c4ccncc4)cc5)c15,439.52883,Tie2 kinase inhibitor,23625762,Preclinical,TIE tyrosine kinase inhibitor,KDR|MAPK14,InChI key,,32
3655,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1742,N1(c2c(cccn2)C(=O)Nc3c1nccc3C)C4CC4,266.29785,Nevirapine,4463,Launched,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,InChI key,1,32
3655,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1606,c1cc(C(n2ccnc2)(c3ccccc3)c4ccccc4Cl)ccc1,344.83678,Clotrimazole,2812,Launched,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,InChI key,,32
3655,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1770,c1nc(NS(=O)(=O)c2ccc(N)cc2)ncc1,250.277,Sulfadiazine,5215,Launched,bacterial antifolate,,InChI key,,32
3655,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1625,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4(C#C)O)cc1O,296.40336,Ethinyl Estradiol,11914204,Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,InChI key,,32
3655,I12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1793,c1c(CC[C@H](N[C@@H](C)C(=O)N2[C@@H]3[C@@H](CCC3)C[C@@H]2C(=O)O)C(OCC)=O)cccc1,416.51057,Ramipril,5038,Launched,angiotensin converting enzyme inhibitor,ACE,InChI key,,32
3655,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1636,[C@@H]1(C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(O[C@H]2C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@H]1C)C[C@H](O)[C@@H]2C(=O)O,924.07902,Amphotericin B,129010391,Launched,membrane permeability enhancer,,canonical SMILES,2,32
3655,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1825,S1CCC(NC(=O)CSCC(=O)O)C1=O,249.30724,Erdosteine,65632,Launched,mucolytic agent,,InChI key,1,32
3655,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1651,N1C(=O)N([C@H]2O[C@@H](CO)[C@H](O)C2)C=C(C)C1=O,242.22856,Telbivudine,1134,Launched,DNA polymerase inhibitor,TK2,InChI key,,32
3655,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1840,C1CC(NC(=O)N(N=O)CCCl)CCC1,233.69524,Lomustine,3950,Launched,DNA synthesis inhibitor,STMN4,InChI key,1,32
3655,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1667,c1(Cl)cc2c(S(=O)(=O)NC(C(Cl)Cl)N2)cc1S(N)(=O)=O,380.65581,Trichlormethiazide,5560,Launched,chloride channel blocker,ATP1A1|CA1|CA2|CA4|SLC12A1|SLC12A3,InChI key,,32
3655,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1869,c1c(OCC[C@H](N(C)C)c2ccccc2)c3c(cccc3)cc1.Cl,341.87436,Dapoxetine HCl,122177142,Launched,selective serotonin reuptake inhibitor (SSRI),HTR1A|HTR1B|HTR2C|SLC6A4,InChI key,1,32
3655,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1680,CCN(CC)C(=S)SSC(=S)N(CC)CC,296.5392,Disulfiram,3117,Launched,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,InChI key,2,32
3655,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1895,n1c(N2CCCCC2)c3c(c(N4CCCCC4)nc(N(CCO)CCO)n3)nc1N(CCO)CCO,504.62559,Dipyridamole,3108,Launched,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,InChI key,1,32
3655,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1705,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4C(=O)C)=CC1=O,314.4617,Progesterone,129010392,Launched,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,InChI key,,32
3655,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1909,c(c(c1ccc(F)cc1)c(C=C[C@@H](O)C[C@@H](O)CC(=O)[O-])n2C(C)C)(cccc3)c23.[Na+],433.44777,Fluvastatin Sodium,24906289,,,,,,32
3655,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1934,[C@@H]1(C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@H](O)[C@H](O)C[C@]2(O)O[C@H]([C@H](C(O)=O)[C@@H](O)C2)C[C@@H](O[C@H]3O[C@@H](C)[C@H](O)[C@@H](N)[C@H]3O)C=CC=CC=CC=CCCC=CC=C[C@H](C)[C@@H](O)[C@H]1C,926.0949,Nystatin (Fungicidin),129010393,,,,,1,32
3655,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2155,c1cc([C@]2(C(=O)Nc3sc(SCCN4CCCC4)cn3)[C@@H](C5CCCCC5)C2)ccc1S(=O)(=O)C6CC6,559.80668,LY2608204,76844476,Phase 2,glucokinase activator,GCK,InChI key,2,32
3655,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1964,C1C(C(C)N)(CC(CC2C3)CC13)C2,179.30184,Rimantadine,5071,Launched,antiviral|RNA synthesis inhibitor,,InChI key,,32
3655,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2178,c(n1c(c2ccc(CN(C)C)cc2)n3)(c3ccc4)c4C(=O)NCC1,320.3883,AG-14361,9840076,Preclinical,PARP inhibitor,PARP1,InChI key,,32
3655,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1988,C(C(=O)NC(=S)N1)=C1CCC,170.2321,Propylthiouracil,657298,Launched,thyroid peroxidase inhibitor,DIO1|TPO,InChI key,,32
3655,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2192,c1(OC2CCN(CC(=O)NC)CC2)cc3c(ncnc3Nc4cccc(Cl)c4F)cc1OC,473.9277,AZD8931 (Sapitinib),11488320,Phase 2,EGFR inhibitor,EGFR|ERBB2|ERBB3,InChI key,,32
3655,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2014,C(c1cnc2c(cn[nH]2)c1OCCCC)(c3c(F)cc(C)cc3F)=O,345.34328,BMS-265246,5329775,Preclinical,CDK inhibitor,CDK1|CDK2,InChI key,1,32
3655,J10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2208,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CCC4=O)=C(O)C1=O,302.40794,Formestane,29924557,Launched,aromatase inhibitor,CYP19A1,chemical name,,32
3655,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2031,C(Cn1cncc1)(c2c(Cl)cc(Cl)cc2)OCc3ccc(Sc4ccccc4)cc3.[N+](O)(=O)[O-],518.41224,Fenticonazole Nitrate,51754,Launched,bacterial cell wall synthesis inhibitor,,InChI key,,32
3655,J12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2224,c1(onc(C(=O)N)n1)[C@@H](CC(=O)NO)CCCC2CCCCC2,324.37546,UK 383367,22480873,Phase 1,Procollagen C-Endopeptidase Inhibitors,BMP1,InChI key,1,32
3655,J13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2044,C1(c2c(cccc2)C=Cc3c1cccc3)=C4CCN(C)CC4.Cl,323.85908,Cyproheptadine HCl,44299947,Launched,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,InChI key,1,32
3655,J14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2235,[C@H]1(CC)N(C(C)C)c2c(cnc(Nc3c(OC)cc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3)n2)N(C)C1=O,618.8126,Volasertib (BI 6727),71080313,Phase 3,PLK inhibitor,PLK1,InChI key,2,32
3655,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2061,C1[C@@H](OC([C@@H](C)CC)=O)[C@@]2([H])C(C=C[C@H](C)[C@H]2CC[C@@H]3C[C@@H](O)CC(=O)O3)=C[C@@H]1C,404.53963,Lovastatin,129010394,Launched,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,InChI key,,32
3655,J16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2253,c1c2c(c(CCCC(=O)O)c[nH]2)ccc1,203.23712,3-Indolebutyric acid (IBA),8617,Preclinical,,B2M|HLA-A|TRAC|TRBC1,InChI key,,32
3655,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2078,NS(=O)(=O)NC(=N)CCSCc1nc(NC(=N)N)sc1,337.4454,Famotidine,3325,Launched,histamine receptor antagonist,HRH2,InChI key,,32
3655,J18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2265,[C@]([H])(CC1)([C@@]([H])(C)CC2)[C@@]([C@]([H])(O[C@@]13C)O[C@H](OC(CCC(=O)O)=O)[C@]4(C)[H])(OO3)[C@@]24[H],384.42082,Artesunate,129010395,Launched,DNA synthesis inhibitor,,InChI key,1,32
3655,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2114,c1(NS(=O)(C)=O)cc2c(oc(CCCC)c2C(c3ccc(OCCCN(CCCC)CCCC)cc3)=O)cc1.Cl,593.21739,Dronedarone HCl,91885940,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,InChI key,2,32
3655,J20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2277,c1cc(C=CC(=O)O)cc(O)c1O,180.15742,Caffeic Acid,2518,,,,,,32
3655,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2127,c1(OC)ccc([C@@H]2CC(=O)NC2)cc1OC3CCCC3,275.34284,S- (+)-Rolipram,5092,Preclinical,phosphodiesterase inhibitor,,InChI key,,32
3655,J22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2296,C1C[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@@]2([H])C(=O)C=C4[C@@]3(C)CC[C@]5(C)[C@]4([H])C[C@](C(=O)O)(C)CC5)C(C)(C)[C@@]1([H])O,470.68383,Enoxolone,11870423,Launched,gap junction modulator,HSD11B1,InChI key,,32
3655,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1555,c1(CO)cc(c2ccc3c(nc(N4CCOC[C@@H]4C)nc3N5CCOC[C@@H]5C)n2)ccc1OC,465.54473,AZD8055,44200436,Phase 1,mTOR inhibitor,MTOR,InChI key,1,32
3655,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1719,[C@H]1(CO)O[C@@H](N2C=CC(N)=NC2=O)CC1,211.21782,Zalcitabine,5718,Launched,nucleoside reverse transcriptase inhibitor,,InChI key,,32
3655,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1569,C1Sc2c(cc(C#Cc3ccc(C(OCC)=O)cn3)cc2)C(C)(C)C1,351.46193,Tazarotene,5381,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRB,InChI key,1,32
3655,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1734,C1(C(Nc2sc(C)cn2)=O)=C(O)c3c(cccc3)S(=O)(=O)N1C,351.40072,Meloxicam,54677470,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,chemical name,,32
3655,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1582,c1c2c(ccnc2)c(S(=O)(=O)NCCNCC=Cc3ccc(Br)cc3)cc1.Cl.Cl,519.28258,H 89 2HCl,78052496,,,,,,32
3655,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1744,c1cc(C(O)=O)cnc1,123.1094,Nicotinic Acid,938,Launched,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,InChI key,,32
3655,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1607,c1c2c(c(CCN(C)C)c[nH]2)cc(Cn3ncnc3)c1.c4cccc(C(=O)O)c4,391.46619,Rizatriptan Benzoate,77997,,,,,1,32
3655,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1773,C(C(=O)N)(C(=O)[C@]1(O)[C@@]([H])([C@@H](O)[C@@]2([H])C(=C(O)c3c(cccc3O)[C@@]2(C)O)C1=O)[C@@H]4N(C)C)=C4O,460.43395,Oxytetracycline (Terramycin),129010396,,,,,2,32
3655,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1626,c1cc2c(ccc([C@H](C)C(=O)[O-])c2)cc1OC.[Na+],252.24099,Naproxen,1301,,,,,,32
3655,K12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1794,c1cc(C(=O)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2)ccc1Cl,360.83133,Fenofibrate,3339,Launched,PPAR receptor agonist,MMP25|PPARA,InChI key,,32
3655,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1639,c1cc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]3CCOC3)ccc1N,505.62689,Amprenavir,2177,Launched,HIV protease inhibitor,,InChI key,,32
3655,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1828,c1(N)cc(C(=O)OCCN(CC)CC)ccc1OCCC.Cl,330.85018,Proparacaine HCl,45114185,Launched,sodium channel blocker,SCN10A|SCN5A,InChI key,,32
3655,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1652,c1cc(O)ccc1OCc2ccccc2,200.23317,Monobenzone,7638,Launched,melanin inhibitor,TYR,InChI key,,32
3655,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1843,C1C[C@@]2(C)[C@]([H])(C[C@@H](O)[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4([C@H](C)CCC(=O)O)[H])C[C@@H]1O,392.572,Chenodeoxycholic Acid,129010397,Launched,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,InChI key,,32
3655,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1669,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])[C@H](O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(OC(=O)OCC)C(=O)OCCl)=CC1=O,466.95173,Loteprednol etabonate,129010398,Launched,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1,InChI key,,32
3655,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1876,N1C(N)=Nc2c(ncn2COCCOC(=O)[C@@H](N)C(C)C)C1=O.Cl,360.79664,Valaciclovir HCl,71296881,Launched,DNA polymerase inhibitor,,InChI key,,32
3655,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1685,c1(N)ccc(S(=O)(=O)N)cc1,172.20492,Sulfanilamide,5333,Launched,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,InChI key,1,32
3655,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1896,N(O)C(=O)N,76.05466,Hydroxyurea,3657,Launched,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,InChI key,,32
3655,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1706,N(C(=O)N([C@@H]1CS[C@H](CO)O1)C=C2)=C2N,229.25624,Lamivudine,3877,Launched,nucleoside reverse transcriptase inhibitor,,InChI key,1,32
3655,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1910,c1c(Cl)ccc(C(Cn2cncc2)OCc3c(Cl)scc3)c1Cl,387.71122,Tioconazole,5482,Launched,sterol demethylase inhibitor,CYP51A1,InChI key,,32
3655,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1937,c1c(C(=O)NN)ccnc1,137.13927,Isoniazid,3767,Launched,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,InChI key,,32
3655,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2156,c1nc(C(=O)Nc2cc([C@]3(COC4)[C@@]4([H])CSC(N)=N3)c(F)cc2)ccc1F,390.40704,LY2886721,73265271,Phase 1/Phase 2,beta-secretase inhibitor,BACE1,InChI key,,32
3655,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1965,C1NC(=O)C(c2ccccc2)(CC)C(=O)N1,218.25176,Primidone,4909,Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,32
3655,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2179,c1c(CN2CCOCC2)c3n(c(Cc4c(F)cc(Cl)cc4)c(C)n3)nc1Nc5cc(C)n[nH]5,469.9423,LY2784544,46213929,Phase 2,JAK inhibitor,JAK2|JAK3,InChI key,1,32
3655,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1992,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(OC(=O)CC)C(=O)SCF)=CC1=O,500.57084,Fluticasone propionate,129010399,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,InChI key,,32
3655,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2193,C1CN(Cc2ccc3c(n(c4sc(C(N)=O)c(O[C@@H](c5c(C(F)(F)F)cccc5)C)c4)cn3)c2)CCN1C,543.60372,GSK461364,44555147,Phase 1,PLK inhibitor,PLK1,InChI key,3,32
3655,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2015,c1c(NC(=O)CC[S+](C)C)ccc(OCC(COCC)O)c1.c2c(S([O-])(=O)=O)ccc(C)c2,499.64061,Suplatast Tosylate,71773,Launched,histamine release inhibitor|immunoglobulin inhibitor,,InChI key,,32
3655,L10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2214,c1c(F)c(Nc2n[nH]c(C)c2)nc(N[C@@H](C)c3ccc(F)cc3)c1C#N,354.35664,AZ 960,56965903,Preclinical,JAK inhibitor,JAK2,InChI key,,32
3655,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2032,c1(ccc(Cl)cc1)C(=O)NC(C(O)=O)CC(c2c(cccc2)NC3=O)=C3,370.78639,Rebamipide,5042,Launched,free radical scavenger,FPR1,InChI key,,32
3655,L12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2225,c1cc(S(=O)(=O)N[C@@H](CCCNC(N)=N)C(=O)OC)ccc1C,342.41388,TAME,416661,Preclinical,,,InChI key,,32
3655,L13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2045,N1C(=O)N([C@H]2[C@@H](O)[C@H](O)[C@@H](C)O2)C=C(F)C1=O,246.19244,Doxifluridine,3159,Launched,thymidylate synthase inhibitor,TYMS,InChI key,,32
3655,L14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2238,c1cc(COc2cc3c(c4c(cc(C(O)C)cc4)C(=O)O3)cc2OC)ccc1OC,406.42787,Palomid 529 (P529),11998575,Phase 1,AKT inhibitor|mTOR inhibitor,MTOR,InChI key,,32
3655,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2062,C(O)(=O)CNC(=O)C(S)C,163.19486,Tiopronin,5483,Launched,chelating agent|reducing agent,,InChI key,,32
3655,L16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2256,c1c2c(C(C)=CC(=O)O2)ccc1O,176.16871,4-Methylumbelliferone (4-MU),5280567,Phase 2,monoamine oxidase inhibitor,MAOA|MAOB,InChI key,,32
3655,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2086,c1c(OC)c(OC)cc2c1C[C@H]2CN(C)CCCN3C(=O)Cc4c(cc(OC)c(OC)c4)CC3.Cl,505.04607,Ivabradine HCl,129010400,Launched,HCN channel antagonist|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,InChI key,,32
3655,L18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2266,[C@@H]1(O)C[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@@]2([H])CC=C4[C@@]3(C)CC[C@]5(C(=O)O)[C@]4([H])[C@H](C)[C@H](C)CC5)[C@](C)(CO)[C@H]1O,488.69911,Asiatic Acid,129010401,Preclinical,apoptosis stimulant,PYGM,InChI key,1,32
3655,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2116,C(=O)(c1ccccc1c2ccccc2)Nc3ccc(C(=O)N4CCc5c([nH]c(C)n5)c6c4cccc6)cc3.Cl,535.03537,Conivaptan HCl,129010402,Launched,vasopressin receptor antagonist,AVPR1A|AVPR2,InChI key,,32
3655,L20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2281,c1c(O)cc2c(C(=O)C=C(c3ccccc3)O2)c1O,254.2375,Chrysin,5281607,Phase 1,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,InChI key,1,32
3655,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2128,c1(c2ccc(O)cc2)c(C)c(c3n1Cc4ccc(OCCN5CCCCCC5)cc4)cc(O)cc3.Cl,507.06349,Bazedoxifene HCl,129010403,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,InChI key,2,32
3655,L22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2298,c(C(=O)C(O)=C(c1ccc(O)c(O)c1)O2)(ccc(O)c3)c23,286.23629,Fisetin,5281614,Preclinical,Aurora kinase inhibitor,CDK6|FASN,InChI key,3,32
3655,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1556,c1cc(S(=O)(Nc2scnn2)=O)ccc1CCCCCCCCCCCC,409.60903,PHT-427,44240850,Preclinical,AKT inhibitor|pyruvate dehydrogenase inhibitor,AKT2|PDPK1,InChI key,2,32
3655,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1721,n1c(Sc2n(C)cnc2[N+]([O-])=O)c3c(nc[nH]3)nc1,277.26258,Azathioprine,2265,Launched,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,InChI key,,32
3655,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1570,c1c2c(Sc3c(cccc3C(OC(N4CCOCC4)=CC5=O)=C5)C2)ccc1NC(=O)CN6C[C@@H](C)O[C@@H](C)C6,547.66511,KU-60019,16117018,Preclinical,ATM kinase inhibitor,ATM,InChI key,,32
3655,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1735,SCCS(=O)(=O)[O-].[Na+],164.17907,Mesna,23662354,Launched,antioxidant,,chemical name,,32
3655,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1590,c1c(O)cc(Oc2c3c([nH]c(c4cc(N)ccc4)c3)ncn2)cc1,318.32935,TWS119,9549289,Preclinical,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC,InChI key,1,32
3655,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1756,c1(F)cc2c(N(CC)C=C(C(=O)O)C2=O)nc1N3CCNCC3,320.31888,Enoxacin,3229,Launched,topoisomerase inhibitor,TOP2A,InChI key,,32
3655,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1610,c1(Cl)cc2c(C(=O)N(c3c(C)cccc3)C(C)N2)cc1S(N)(=O)=O,365.83453,Metolazone,4170,Launched,carbonic anhydrase inhibitor,SLC12A3,InChI key,1,32
3655,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1777,c1c(C(N)=S)cc(CC)nc1,166.2434,Ethionamide,2761171,Launched,mycolic synthesis inhibitor,,InChI key,,32
3655,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1627,c1c(OC(=O)C)c(C(=O)Nc2sc([N+]([O-])=O)cn2)ccc1,307.28195,Nitazoxanide,41684,Launched,pyruvate ferredoxin oxidoreductase inhibitor,,InChI key,2,32
3655,M12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1799,c1c(C)c(NC(=O)CN2CCN(CC(O)COc3c(OC)cccc3)CC2)c(C)cc1,427.53652,Ranolazine,56959,Launched,sodium channel blocker,SCN10A|SCN4A|SCN5A|SCN9A,InChI key,,32
3655,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1641,c1(Cl)cc2c(S(=O)(=O)NC=N2)cc1S(=O)(=O)N,295.72324,Chlorothiazide,2720,Launched,diuretic,CA1|CA2|CA4|SLC12A3,InChI key,1,32
3655,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1830,S(=O)(c1ccccc1)c2ccc3c([nH]c(NC(=O)OC)n3)c2,315.34702,Oxfendazole,40854,Launched,anthelmintic agent,,InChI key,1,32
3655,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1653,C1C(C)(C)C(C=CC(C)=CC=CC(C)=CC(=O)O)=C(C)CC1,300.43512,Tretinoin,5538,,,,,,32
3655,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1847,c1cc(Cl)ccc1[C@@](C)(c2ccccc2)OCC[C@H]3CCCN3C.OC(=O)C=CC(=O)O,459.9624,Clemastine Fumarate,68911384,,,,,,32
3655,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1671,NCCCCCC(=O)O,131.17292,?6-??-?Aminocaproic acid,564,Launched,plasminogen activator inhibitor,LPA|PLAT|PLG,InChI key,1,32
3655,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1878,N1C(=O)c2c(n(COC(CO)CO)cn2)N=C1N,255.23062,Ganciclovir,3454,Launched,DNA polymerase inhibitor,,InChI key,1,32
3655,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1689,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])C(=O)C[C@@]4(C)[C@@]3([H])C[C@H](C)[C@]4(C(=O)CO)O)=CC1=O,372.45471,Meprednisone,129010404,Launched,,NR3C1,InChI key,1,32
3655,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1899,c1cc(C(=O)N)cnc1,122.12463,Nicotinamide (Vitamin B3),936,Launched,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,InChI key,,32
3655,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1708,c1(Cl)cc2c(S(=O)(=O)NCN2)cc1S(=O)(=O)N,297.73912,Hydrochlorothiazide,3639,Launched,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3,InChI key,,32
3655,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1914,C1C[C@@]2(C)C(=CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4C(C)=O)C[C@H]1O,316.47758,Pregnenolone,70603837,Launched,glutamate receptor modulator,CYP17A1|SULT2B1,InChI key,1,32
3655,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1940,c(N1[C@]([H])(C)CO2)(c2c(N3CCN(C)CC3)c(F)c4)c4C(=O)C(C(O)=O)=C1,361.3675,Levofloxacin,452723,Launched,bacterial DNA gyrase inhibitor,TOP2A,InChI key,5,32
3655,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2158,c1c2c(c(C=Cc3ccc(C(N4CCNCC4)=O)cc3)n[nH]2)ccc1,332.39899,KW-2449,67089852,Phase 1,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,chemical name,2,32
3655,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1969,C(C(=O)Nc1c(C)cccc1C)N2CCCC2=O,246.30491,Nefiracetam,71157,Phase 3,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,InChI key,1,32
3655,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2180,c1c(Cl)c(C(=O)NCC(=O)N[C@@H](CC(C)C)B(O)O)cc(Cl)c1,361.02865,MLN2238,74401387,Launched,proteasome inhibitor,,InChI key,1,32
3655,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2001,c1cc(Cl)c(F)c(Cc2c(OC)cc3c(C(=O)C(C(=O)O)=CN3[C@H](CO)C(C)C)c2)c1,447.88382,"Elvitegravir (GS-9137, JTK-303)",23083982,Launched,HIV integrase inhibitor,,InChI key,2,32
3655,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2195,n1c(c2ccc(NC(NCC)=O)c(OC)c2)nc(N[C@@H](CCC)c3cnccc3)c(C)c1,434.534,CYT997 (Lexibulin),56675648,Phase 2,tubulin polymerization inhibitor,TUBB,InChI key,,32
3655,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2021,c1cc(C2N(C)C(=O)CCS2(=O)=O)ccc1Cl,273.73588,Chlormezanone,2717,Withdrawn,GABA receptor modulator,GABRA1|TSPO,InChI key,,32
3655,N10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2215,c1(F)cc(CC(N[C@H](C(=O)N[C@@H](c2ccccc2)C(OC(C)(C)C)=O)C)=O)cc(F)c1,432.46034,DAPT (GSI-IX),2956,Preclinical,gamma secretase inhibitor,,InChI key,,32
3655,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2035,c1cc(C=C(C)C=C2C(=O)N(CC(=O)O)C(=S)S2)ccc1,319.39862,Epalrestat,3235,Launched,aldose reductase inhibitor,AKR1B1,chemical name,,32
3655,N12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2226,c1c(F)c2c(N=C([C@H](CC)Nc3ncnc4c3nc[nH]4)N(c5ccccc5)C2=O)cc1,415.42302,"CAL-101 (Idelalisib, GS-1101)",11654566,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,1,32
3655,N13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2047,N(C(=O)C1=C(O)c2c(cc(Cl)s2)S(=O)(=O)N1C)c3ccccn3,371.81919,Lornoxicam,54690031,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,chemical name,1,32
3655,N14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2239,[C@@H]1(CSc2nc(c3ccccc3)c(c4ccccc4)o2)O[C@H](c5ccc(NC(CCCCCCC(=O)NO)=O)cc5)O[C@H](c6ccc(CO)cc6)C1,721.86102,Tubacin,3223,,,,,,32
3655,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2064,N1(CCCC(NC)C1)c2c(F)cc3c(N(C4CC4)C=C(C(O)=O)C3=O)c2OC,389.42066,Balofloxacin,65958,Launched,bacterial DNA gyrase inhibitor,,InChI key,3,32
3655,N16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2259,c(C(=O)c1c(cccc1O)C2=O)(c(O)cc(CO)c3)c23,270.2369,Aloe-emodin,10207,Preclinical,anticancer agent,CASP8,InChI key,1,32
3655,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2087,c1(OC(=O)N(CC)C)cc([C@H](C)N(C)C)ccc1.OC(=O)[C@H](O)[C@@H](O)C(=O)O,400.42352,Rivastigmine Tartrate,14254240,,,,,1,32
3655,N18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2267,O=[N+]([O-])c1[nH]ccn1,113.07482,Azomycin,10701,Preclinical,protein synthesis inhibitor,,InChI key,1,32
3655,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2118,CS(Nc1ccc(C(O)CCCN(CC)CCCCCCC)cc1)(=O)=O.C(O)(=O)C=CC(O)=O.CS(Nc2ccc(C(O)CCCN(CC)CCCCCCC)cc2)(=O)=O,885.22504,Ibutilide Fumarate,60752,,,,,,32
3655,N20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2282,c1cccc2c1c([C@@H](O)[C@]3([H])CC([C@@]([H])(C=C)CN34)CC4)ccn2,294.39078,Cinchonidine,66784789,Phase 1,P glycoprotein inhibitor,,InChI key,,32
3655,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2130,OS(=O)(=O)O.O.C(=O)(O[C@@H]1C[C@@]([H])(N(C)[C@@]2([H])C1)CC2)C(CO)c3ccccc3.C(=O)(O[C@@H]4C[C@@]([H])(N(C)[C@@]5([H])C4)CC5)C(CO)c6ccccc6,694.8326,Atropine,656678,,,,,,32
3655,N22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2299,c(C(=O)C(c1ccc(OC)cc1)=CO2)(ccc(O)c3)c23,268.26407,Formononetin,5280378,Preclinical,alcohol dehydrogenase inhibitor,ADH1C|SLC5A2,InChI key,1,32
3655,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1557,c1(OC)cc2c(ncnc2Oc3cc(Cl)c(NC(NCCC)=O)cc3)cc1OC,416.85813,KRN 633,9549295,Preclinical,VEGFR inhibitor,FLT1|FLT4|KDR,InChI key,,32
3655,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,InChI key,,32
3655,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1572,c1(NCc2ccccc2)n3c(c(C(C)C)cn3)nc(NCCCCCCN)c1.Cl,416.99062,BS-181 HCl,129010405,Preclinical,CDK inhibitor,CDK7,InChI key,,32
3655,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,InChI key,,32
3655,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1593,n1n(c2ccc(OC)cc2)c3c(CCN(c4ccc(N5CCCCC5=O)cc4)C3=O)c1C(=O)N,459.49709,Apixaban,10182969,Launched,coagulation factor inhibitor,F10,InChI key,1,32
3655,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1760,c1(C=NN2CCN(C3CCCC3)CC2)c(O)c(c(C(=O)[C@]4(C)O5)c56)c(c(O)c6C)c(O)c1NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO4,877.03066,Rifapentine,71296875,Launched,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4,chemical name,4,32
3655,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1613,c1cc(OCCN[C@@H](Cc2cc(C(=O)N)c3c(CCN3CCCO)c2)C)c(OCC(F)(F)F)cc1,495.53448,Silodosin,9891967,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,InChI key,,32
3655,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1778,N1C(=O)C(C(F)(F)F)=CN([C@@H]2O[C@H](CO)[C@@H](O)C2)C1=O,296.19994,Trifluridine,253083,Launched,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,InChI key,,32
3655,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1628,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(=O)CO)OC(C)(C)O5)=CC1=O,434.49774,Triamcinolone Acetonide,129010406,Launched,glucocorticoid receptor agonist|immunosuppressant,NR3C1,InChI key,,32
3655,O12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1802,[C@@H]1(O)[C@H](CO)O[C@@H](n2c(N)c(C(N)=O)nc2)[C@@H]1O,258.23126,Acadesine,266934,Phase 3,AMPK activator,,InChI key,,32
3655,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1643,C1C[C@@]2(C)[C@]([H])(C[C@H](O)[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4([H])[C@@H](CCC(=O)O)C)C[C@@H]1O,392.572,Ursodiol,129010407,Launched,nuclear factor erythroid derived|like (NRF2) activator,NR1H4,InChI key,,32
3655,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1831,c1([nH]c2c3cccc2)c3c(OCC(O)CNCCOc4c(OC)cccc4)ccc1,406.47423,Carvedilol,2585,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|GJA1|HIF1A|KCNH2|NDUFC2|NPPB|SELE|VCAM1|VEGFA,InChI key,1,32
3655,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1655,c1cc([C@@H](O)CC[C@@H]2[C@H](c3ccc(O)cc3)N(c4ccc(F)cc4)C2=O)ccc1F,409.42524,Ezetimibe,4979942,Launched,cholesterol inhibitor|Niemann-Pick C1-like 1 protein antagonist,ANPEP|NPC1L1|SOAT1,InChI key,,32
3655,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1848,c1(OC)cc(C=CC(=O)C=C(O)C=Cc2cc(OC)c(O)cc2)ccc1O,368.37989,Curcumin,442783,,,,,1,32
3655,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1672,c1(C2(CC)C(=O)NC(=O)CC2)ccc(N)cc1,232.27834,Aminoglutethimide,2145,Launched,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,InChI key,,32
3655,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1881,c1(CCC)cc(C(=S)N)ccn1,180.26998,Protionamide,666418,Launched,,,InChI key,,32
3655,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1691,c1cc2c(CCN3C2CN(C(=O)C4CCCCC4)CC3=O)cc1,312.40605,Praziquantel,4891,Launched,anthelmintic agent,,InChI key,1,32
3655,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1902,[C@H]1(CC(=O)N)[C@]2([H])N=C(C(C)=C(N=C3C=C(N=C4C(C)=C([N-][C@@]25C)[C@@H](CCC(=O)N)[C@]5(C)CC(=O)N)[C@@H](CCC(=O)N)[C@@]4(CC(=O)N)C)[C@@H](CCC(=O)N)C3(C)C)[C@]1(C)CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@@H]6[C@H](CO)O[C@H](n7c8c(cc(C)c(C)c8)nc7)[C@@H]6O.[Co+2]C#N,1355.36518,Vitamin B12,129010408,,,,,4,32
3655,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1709,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4O)cc1O,272.38196,Estradiol,129010410,Launched,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,InChI key,,32
3655,O22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1915,c1cc(S(=O)(=O)Nc2noc(C)c2)ccc1N,253.27764,Sulfamethoxazole,5329,Launched,PABA antagonist,,InChI key,2,32
3655,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,P03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1949,c1cc2c(C(=O)C=C(C)C2=O)cc1,172.18002,Menadione,4055,Launched,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,InChI key,2,32
3655,P04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2159,[C@]1([H])([C@H](O)C)[C@@]2([H])N(C(C(=O)OCOC(=O)C(C)(C)C)=C(SC3CN(C4=NCCS4)C3)[C@H]2C)C1=O,497.62803,Tebipenem Pivoxil,129010411,Launched,bacterial cell wall synthesis inhibitor,CNR1,InChI key,3,32
3655,P05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1971,c1cc(C(NCCO[N+](=O)[O-])=O)cnc1,211.17476,Nicorandil,47528,Launched,nitric oxide donor|potassium channel activator,KCNJ11,InChI key,1,32
3655,P06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2181,c1c(Cl)c(C(=O)NCC(=O)N[C@@H](CC(C)C)B2OC(=O)CC(CC(O)=O)(C(O)=O)O2)cc(Cl)c1,517.12161,MLN9708,75310475,Launched,proteasome inhibitor,,InChI key,1,32
3655,P07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2003,c1cc([C@@H](NC(=O)C2CCC(F)(F)CC2)CCN(C3CC4)C4CC(n5c(C(C)C)nnc5C)C3)ccc1,513.66554,Maraviroc,22570509,Launched,CC chemokine receptor antagonist,CCR5,InChI key,,32
3655,P08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2198,c1cc2n(c(c3cc(OC(F)(F)F)ccc3)cn2)nc1NCC4CCN(C)CC4,405.41678,SGI-1776 free base,24795070,Phase 1,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,InChI key,,32
3655,P09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2024,c1(scc2)c2C(=C3CCN(C)CC3)c4c(cccc4)CC1=O.C(=O)(O)C=CC(=O)O,425.49742,Ketotifen Fumarate,36856,,,,,,32
3655,P10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2216,c1cc(C=Cc2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)ccc1C(F)(F)F,468.47092,Mubritinib (TAK 165),204100,,,,,1,32
3655,P11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2036,C(=O)(O)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC,294.30312,Aspartame,2242,Launched,,TAS1R2|TRPV1,InChI key,,32
3655,P12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2227,n1c(N)c2c(n(CC3=Nc4c(c(C)ccc4)C(=O)N3c5ccccc5C)nc2c6cccc(O)c6)nc1,489.52791,PIK-294,24905149,Preclinical,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,InChI key,,32
3655,P13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2053,C1(=O)N=C(N)C=CN1[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O2,243.21662,Cytidine,596,Launched,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,InChI key,,32
3655,P14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2243,c1(Br)nc(C=C(C#N)C(=O)N[C@@H](CCC)c2ccccc2)ccc1,384.26972,Degrasyn (WP1130),72757535,Preclinical,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X,canonical SMILES,,32
3655,P15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2065,c1c(CN2CCCCC2)ccnc1OCC=CCNC(=O)CS(Cc3occc3)=O,431.54836,Lafutidine,3873,Launched,histamine receptor antagonist,HRH2,chemical name,1,32
3655,P16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2260,[C@H]1(O)[C@@H](O)[C@@H](CO)O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O,457.42848,Laetrile,2180,Phase 2,caspase activator,CASP3,InChI key,,32
3655,P17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2091,c1c(CCOCC2CC2)ccc(OCC(O)CNC(C)C)c1,307.42776,Betaxolol,2369,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,InChI key,,32
3655,P18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2268,c1(O)cc2c(C(=O)C=C(c3ccccc3)O2)c(O)c1O,270.2369,Baicalein,5281605,Preclinical,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH,InChI key,4,32
3655,P19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2119,c1(C(C)(C)C)cc(SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O,516.84161,Probucol,4912,Launched,atherogenesis inhibitor,ABCA1|ABCB11|CES1,InChI key,1,32
3655,P20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2285,C1Cc2c(ccc3c2C(=O)C(=O)C4=C3OC[C@H]4C)C(C)(C)C1,296.36029,Cryptotanshinone,496348,Preclinical,acetylcholinesterase inhibitor|STAT inhibitor,STAT3,InChI key,2,32
3655,P21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2131,n1cc(Cl)c(NC(=O)c2cc(OCC3CC3)c(OC(F)F)cc2)c(Cl)c1,403.20746,Roflumilast,449193,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,InChI key,,32
3655,P22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2300,c1cc(C=CC(=O)O)cc(OC)c1O,194.184,Ferulic Acid,709,,,,,1,32
3655,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3655,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2302,C1C[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@@]2([H])C(=O)C=C4[C@@]3(C)CC[C@]5(C)[C@]4([H])C[C@@](C)(C(=O)O)CC5)C(C)(C)[C@H]1O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](C(=O)O)O7)[C@@H](O)[C@H](O)[C@@H](C(=O)O)O6,822.93208,Glycyrrhizic Acid,129010412,Launched,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,InChI key,2,33
3656,A04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2467,n1cc2c(n(CCC(COC(=O)C)COC(C)=O)cn2)nc1N,321.33176,Famciclovir,3324,Launched,DNA polymerase inhibitor,,InChI key,1,33
3656,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2320,c1(O)cc2c(C(=O)C=C(c3cc(O)c(O)cc3)O2)c(O)c1,286.23629,Luteolin,5280445,Phase 2,glucosidase inhibitor,TOP1,InChI key,2,33
3656,A06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2480,c1cc(C2(O)CCN(CCC(c3ccccc3)(c4ccccc4)C(N(C)C)=O)CC2)ccc1Cl.Cl,513.49846,Loperamide HCl,22269559,Launched,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,InChI key,1,33
3656,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,InChI key,1,33
3656,A08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2492,[C@H]1(OC)C(C)(C)O[C@@H](Oc2c(C)c3c(C(O)=C(NC(c4cc(CC=C(C)C)c([O-])cc4)=O)C(=O)O3)cc2)[C@H](O)[C@@H]1OC(=O)N.[Na+],634.60617,Novobiocin Sodium,54730021,,,,,5,33
3656,A09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2347,c1(O)cc2c(C(=O)C(O)=C(c3cc(O)c(O)cc3)O2)c(O)c1.O.O,338.26625,Quercetin Dihydrate,5284452,Launched,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,InChI key,3,33
3656,A10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2502,c1c(OC)cc2c(nccc2[C@H](O)[C@]3([H])C[C@@]([H])([C@@H](C=C)CN34)CC4)c1.Cl.O.O,396.90826,Quinine HCl Dihydrate,129010413,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4,InChI key,1,33
3656,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2364,c1c(C)c2c(c3c(c4c(c(C)co4)C(=O)C3=O)cc2)cc1,276.28607,Tanshinone I,114917,Phase 2,AP inhibitor,IFNG,InChI key,,33
3656,A12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2515,C1CN(S(=O)(=O)c2cc(C(NC(=O)c3n4c(CCC)nc3C)=N4)c(OCC)cc2)CCN1CC.Cl.O.O.O,579.10975,Vardenafil HCl Trihydrate,129010414,Launched,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,InChI key,3,33
3656,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2377,c1(O)cc2c(C(=O)C(c3ccc(OC)cc3)=CO2)c(O)c1,284.26347,Biochanin A,5280373,Preclinical,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN,InChI key,,33
3656,A14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2534,c1cc(C(Cn2cncc2)OCc3c(Cl)cccc3Cl)c(Cl)cc1Cl.[N+](O)(=O)[O-],479.1414,Isoconazole nitrate,159968,Launched,fungal lanosterol demethylase inhibitor,CYP17A1,InChI key,,33
3656,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2390,[C@@H]1(O)[C@H](O)[C@H](Oc2cc(C=Cc3ccc(O)cc3)cc(O)c2)O[C@H](CO)[C@H]1O,390.38388,Polydatin,393787,Phase 2,ICAM1 expression inhibitor,ICAM1,chemical name,,33
3656,A16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2548,Cl.[C@@]1([H])(C[C@@H](O)C2)N(C)[C@]2([H])[C@@]3([H])[C@]1([H])O3,191.65526,Scopine HCl,129010415,Launched,,,InChI key,,33
3656,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2403,c1c(OC)c(OC)c2c([C@H]3Cc(cc4Oc5ccc(cc5)C[C@H]6c(cc7O2)c(CCN6C)cc7OC)ccc4OC)c1CCN3C,622.74987,Tetrandrine,5422,Preclinical,calcium channel blocker,SLC6A3,InChI key,,33
3656,A18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2561,c1cc(C(Cl)=C(c2ccc(OCCN(CC)CC)cc2)c3ccccc3)ccc1.OC(=O)CC(O)(C(O)=O)CC(=O)O,598.08313,Clomifene citrate,60974,,,,,2,33
3656,A19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2412,O1[C@H](O)[C@@]2([H])[C@]([H])(CC=C2CO)C(C(OC)=O)=C1,226.22586,Genipin,6325197,Preclinical,choleretic agent,,InChI key,2,33
3656,A20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2579,N1C(=O)C(C)=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C1=O,267.24132,Zidovudine,5726,Launched,nucleoside reverse transcriptase inhibitor,TERT,InChI key,,33
3656,A21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2446,C(#N)C(=NNc1ccc(C2=NNC(=O)C[C@H]2C)cc1)C#N,280.28468,Levosimendan,60867,Launched,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,InChI key,3,33
3656,A22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2599,c1(O)c(I)cc(Oc2c(I)cc(C[C@H](N)C(=O)O)cc2I)cc1I,776.87002,L-Thyroxine,853,Launched,thyroid hormone stimulant,THRA|THRB,InChI key,,33
3656,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2608,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(=O)COC(=O)C)OC(C)(C)O5)=CC1=O,494.52488,Fluocinonide,129010416,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,InChI key,,33
3656,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2752,n1c(c2c(Nc3ccc(Oc4ccn5c(ncn5)c4)c(C)c3)nc1)ccc(c6ccc(CNCCS(C)(=O)=O)o6)c2,569.63418,HER2-Inhibitor-1,42598643,Preclinical,EGFR inhibitor,,InChI key,3,33
3656,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2621,c1cc(Nc2nc(c3n(C(C)C)c(C)nc3)ccn2)ccc1S(=O)(C)=O,371.45663,AZD5438,16747683,Phase 1,CDK inhibitor,KCNH2,InChI key,1,33
3656,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2768,C1CCN(c2nc3n(ncc3CC)c(NCc4c[n+]([O-])ccc4)c2)[C@H](CCO)C1,396.48601,Dinaciclib (SCH727965),16048554,Phase 3,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,InChI key,,33
3656,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2631,c1ccc(OC(=O)NC2CCCCC2)cc1c3cc(C(=O)N)ccc3,338.40028,URB597,1383884,Phase 1,FAAH inhibitor,FAAH|FAAH2|TRPA1,InChI key,,33
3656,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2779,c1(N(C)C)ccc(C(=O)NCCCCCCC(=O)NO)cc1,307.388,M344,3994,Preclinical,HDAC inhibitor,,InChI key,,33
3656,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2656,n1(c2cc(N[C@H]3CC[C@H](OC(=O)CN)CC3)c(C(N)=O)cc2)nc(C(F)(F)F)c4c1CC(C)(C)CC4=O,521.532,PF-04929113 (SNX-5422),44195571,Phase 1/Phase 2,HSP inhibitor,HSP90AA1,InChI key,2,33
3656,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2790,n1(C)c(c2nc1C=Cc3ccc(OC)c(OC)c3)C(=O)N(CC)C(=O)N2CC,384.42895,Istradefylline,198792,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,chemical name,1,33
3656,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2666,c1(C(F)(F)F)ccc(Oc2cccc(CC3CCN(C(=O)Nc4cccnc4)CC3)c2)nc1,456.46022,PF-3845,25154867,Preclinical,FAAH inhibitor,FAAH,InChI key,,33
3656,B12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2803,[C@](C)(C(n1cnc2c1cccc2)=CC3)(CCC4C5CC=C6[C@]4(C)CC[C@H](O)C6)C35,388.54508,Galeterone,129010417,Phase 3,androgen receptor modulator,AR|CYP17A1,InChI key,2,33
3656,B13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2681,c(OC(F)(F)O1)(cc(C=C2C(=O)NC(=O)S2)cc3)c13,285.2235,AS-604850,53394675,,,,,1,33
3656,B14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2924,c1(NCCNc2ccc(C#N)cn2)nc(c3c(Cl)cc(Cl)cc3)c(c4nc(C)c[nH]4)cn1.Cl,501.79886,CHIR-99021 (CT99021) HCl,129010418,Preclinical,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1,InChI key,3,33
3656,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2692,c1ccc(Nc2c(C)cnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)cc1S(=O)(=O)NC(C)(C)C,509.66679,TG101209,16722832,Preclinical,JAK inhibitor,JAK2|JAK3,InChI key,,33
3656,B16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3019,C(C(=O)N(O)C(C1CCCCC1)=C2)=C2C.NCCO,268.35196,Ciclopirox ethanolamine,38911,Launched,membrane integrity inhibitor,ATP1A1,InChI key,2,33
3656,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2714,c1(F)cc([C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]2C(=O)N(C)c3c(cccc3)c4c2cccc4)cc(F)c1,479.47532,LY411575,10205993,Preclinical,gamma secretase inhibitor,,InChI key,,33
3656,B18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3061,c1(O)ccc([C@@H](O)CNC)cc1O.Cl,219.66536,Epinephrine HCl,51371171,Launched,adrenergic receptor agonist|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,InChI key,,33
3656,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2728,c1c(OC)c(OC)cc2c1ncnc2Nc3cccc(Cl)c3,315.75425,AG-1478 (Tyrphostin AG-1478),2051,Preclinical,EGFR inhibitor,EGFR|MAPK14,InChI key,2,33
3656,B20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S5002,c1(CCC(CO)(N)CO)ccc(CCCCCCCC)cc1.Cl,343.93176,Fingolimod (FTY720) HCl,44266389,Launched,immunosuppressant|sphingosine phosphate receptor agonist,S1PR1|S1PR5,InChI key,4,33
3656,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2743,n1c(C)c2c(N([C@@H]3CC[C@@H](OCCO)CC3)C(=O)C(c4cnc(OC)cc4)=C2)nc1N,425.48088,PF-04691502,25033539,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,InChI key,,33
3656,B22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,InChI key,,33
3656,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2468,c1ccc(Sc2ccc3c([nH]c(NC(=O)OC)n3)c2)cc1,299.34761,Fenbendazole,3334,Launched,tubulin polymerization inhibitor,TUBB,InChI key,,33
3656,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2322,C1[C@@]2([H])[C@@]([H])([C@]3([H])[C@]4([H])N(C(=O)CCC4)C2)N(CCC3)CC1,248.36386,(+)-Matrine,7075140,Phase 2,opioid receptor agonist,OPRK1,InChI key,1,33
3656,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,InChI key,2,33
3656,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2338,C1[C@@]2([H])[C@@]([H])([C@]3([H])[C@]4([H])N(C(=O)CCC4)C2)[N+]([O-])(CCC3)CC1,264.36326,Oxymatrine,7082413,Launched,,,InChI key,,33
3656,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2494,C1(c2c(cccc2)COc3c1cc(CC(=O)O)cc3)=CCCN(C)C.Cl,373.87316,Olopatadine HCl,71296935,,,,,,33
3656,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2349,N(CCc1c2[nH]c3c1cccc3)(C(=O)c4c5cccc4)C2=N5,287.31532,Rutaecarpine,65752,Preclinical,cyclooxygenase inhibitor,PTGS2,InChI key,1,33
3656,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2503,c1ccc(COC(=O)CNC(=O)C(Cc2ccccc2)CSC(C)=O)cc1,385.47662,Racecadotril,107751,Launched,enkephalinase inhibitor,MME,InChI key,,33
3656,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2365,C1Cc2c(ccc3c2C(=O)C(=O)c4c3occ4C)C(C)(C)C1,294.34441,Tanshinone IIA,164676,Phase 2/Phase 3,anti-inflammatory agent|interleukin inhibitor,IL1B|NR1I2|TNF,InChI key,,33
3656,C12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2517,c1cc2c(C3c4c(cccc4)C2(CCCNC)CC3)cc1.Cl,313.86426,Maprotiline HCl,45114088,Launched,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2,InChI key,1,33
3656,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2378,[Br-].c1ccccc1[C@H](CO)C(=O)O[C@@H]2C[C@@]([H])([N+](C)(CCCC)[C@@]3([H])C2)[C@]4([H])[C@@]3([H])O4,440.37119,Butylscopolamine Bromide,12358890,Launched,cholinergic receptor antagonist,,InChI key,,33
3656,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,InChI key,,33
3656,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2391,c1(O)cc2c(C(=O)C(O)=C(c3cc(O)c(O)cc3)O2)c(O)c1,302.2357,Quercetin,5280343,Launched,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,InChI key,3,33
3656,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2549,[Cl-].[C@@]1([H])(C[C@@H](OC(=O)C(O)(c2ccccc2)c3ccccc3)C4)[N+]5(CCCC5)[C@]4([H])CC1,427.9636,Trospium chloride,5284631,Launched,acetylcholine receptor antagonist,CHRM1,InChI key,,33
3656,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2404,c1cc(C=CC(=O)c2ccc(O)cc2O)ccc1O,256.25338,Isoliquiritigenin,425,,,,,,33
3656,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2564,[C@H]1(NC(c2c(c3c(Cl)cccc3)noc2C)=O)[C@@]4([H])N([C@@H](C([O-])=O)C(C)(C)S4)C1=O.[Na+].O,475.87842,Cloxacillin Sodium,129010419,,,,,1,33
3656,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2413,C1=C(C(O)=O)[C@]2([H])[C@@]([H])(C(CO)=CC2)[C@H](O[C@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)O1,374.33987,Geniposidic acid,129010420,Preclinical,cyclooxygenase inhibitor,,InChI key,,33
3656,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2583,c1cc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)ccc1S(=O)(=O)C,356.2222,Thiamphenicol,5433,Launched,bacterial 50S ribosomal subunit inhibitor,,InChI key,2,33
3656,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2451,C1(CC(N)(CC2C1)CC3C2)C3.Cl,187.70962,Amantadine HCl,44430195,Launched,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,InChI key,,33
3656,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2601,c1cc(S(=O)(=O)NC(=O)NN2CC3C(CCC3)C2)ccc1C,323.41054,Gliclazide,3475,Launched,ATP channel blocker|insulin secretagogue,ABCC8|VEGFA,InChI key,,33
3656,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2612,OC[C@@H](O)[C@@H](O)[C@@H](O)CO,152.14577,Ribitol,827,Preclinical,,,InChI key,1,33
3656,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2755,c(ccc(NC1=N[C@H](C)CO1)c2)(ncnc3Nc4ccc(OCc5nccs5)c(Cl)c4)c23,466.94326,Varlitinib,11655699,Phase 2,EGFR inhibitor,ERBB2,InChI key,,33
3656,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2622,c1(c2c3c(ncnc3N)n(C4CCCC4)n2)cc5c([nH]cc5)nc1,319.36377,PP121,24905142,Preclinical,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC,InChI key,1,33
3656,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2770,n1c(C[C@]2(C(O)=O)CC[C@H](Oc3cccc(Cl)c3F)CC2)cccc1Nc4nccs4,461.93684,MK-5108 (VX-689),24748204,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,InChI key,2,33
3656,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2632,c1c(OC)c2c(ncc2C(=O)C(=O)N3CCN(C(c4ccccc4)=O)C[C@H]3C)[nH]c1,406.43447,BMS-378806,5495820,Phase 1,HIV attachment inhibitor,,InChI key,,33
3656,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,InChI key,1,33
3656,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2658,c1(S(Nc2cc(c3ccc(c4c3)nccc4c5ccnnc5)cnc2OC)(=O)=O)ccc(F)cc1F,505.49598,GSK2126458 (GSK458),25167777,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,1,33
3656,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2791,N1C(=O)C(c2c(c3nc(N4CCN(C)CC4)n2)cccc3)=C(c5c(c6[nH]c5)cccc6)C1=O,438.48117,Sotrastaurin,10296883,Phase 2,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,InChI key,3,33
3656,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2667,c1(F)ccc(CNC(=O)C(C(=O)C(O)=C2N3C[C@@]4([H])N([C@@H](C)CCO4)C2=O)=C3)c(F)c1,419.37876,Dolutegravir (GSK1349572),129010421,Launched,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,InChI key,,33
3656,D12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2807,c1(S(Nc2cccc(c3c(c4ccnc(N)n4)sc(C(C)(C)C)n3)c2F)(=O)=O)c(F)cccc1F,519.5624,Dabrafenib (GSK2118436),44462760,Launched,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,InChI key,2,33
3656,D13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2682,c1(F)ccc(c2ccc(C=C3SC(=O)NC3=O)o2)cc1,289.28162,CAY10505,2844288,Preclinical,PI3K inhibitor,PIK3CG,chemical name,1,33
3656,D14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3000,N1(C)C(C(=C2)CC1S([O-])(=O)=O)=CC(=O)C2=NNC(N)=O.[Na+],322.2729,Carbazochrome sodium sulfonate (AC-17),53395145,,,,,2,33
3656,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2696,c1(c2nc3c(sc(CN4CCN(C(=O)[C@H](C)O)CC4)c3C)c(N5CCOCC5)n2)cnc(N)nc1,498.60109,GDC-0980 (RG7422),66694608,Phase 2,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,InChI key,2,33
3656,D16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3020,S1CCC=C[C@@H]2CC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(=O)NC(=CC)C(=O)N[C@@H](C(C)C)C(=O)O2)CS1,540.69584,"Romidepsin (FK228, Depsipeptide)",3425,,,,,,33
3656,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2717,c1(Cl)cc2c([nH]c(C(=O)N[C@@H](Cc3ccccc3)[C@@H](O)C(N(C)C)=O)c2)cc1,399.87068,CP-91149,69621061,Preclinical,glycogen phosphorylase inhibitor,PYGL,InChI key,,33
3656,D18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3062,c1cc(CC([O-])=O)c(Nc2c(Cl)cccc2Cl)cc1.[K+],334.23899,Diclofenac Potassium,23667642,,,,,,33
3656,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2729,C1(=O)NC(=O)C(Nc2ccc(O)c(Cl)c2)=C1c3ccccc3[N+]([O-])=O,359.72069,SB415286,4210951,Preclinical,glycogen synthase kinase inhibitor,GSK3A|GSK3B|RPS6KB1,InChI key,1,33
3656,D20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S5003,[C@H]1(OC)[C@@H](O)CC[C@@H](C=C(C)[C@H]2OC(=O)[C@@]3([H])N(CCCC3)C(=O)C(=O)[C@](O)(O[C@H]4[C@@H](OC)C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)[C@H](C)C[C@@H]4OC)C1,804.01816,Tacrolimus (FK506),129010422,,,,,,33
3656,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2744,c1(Br)c(N2CCN(Cc3noc(C)c3)CC2)c4c([nH]c(c5ccc(N6CCN(C)CC6)cc5)n4)nc1,551.48134,CCT137690,25154041,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,InChI key,,33
3656,D22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2309,[C@H]1(CO[C@@H]2O[C@@H](C)[C@H](O)[C@H](O)[C@H]2O)O[C@@H](Oc3cc4c(C(=O)C[C@@H](c5cc(O)c(OC)cc5)O4)c(O)c3)[C@H](O)[C@@H](O)[C@@H]1O,610.56056,Hesperidin,3594,Launched,flavanone glycoside,CACNA1B,InChI key,,33
3656,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2470,C1=C[C@@]2(C)C([C@](F)([H])C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@]5([H])[C@]4(C(=O)CO)OC(C)(C)O5)=CC1=O,452.4882,Fluocinolone Acetonide,129010423,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,InChI key,1,33
3656,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2323,[C@H]1(O)[C@@H](C)O[C@@H](OC[C@H]2O[C@@H](Oc3cc4c(C(=O)C[C@@H](c5cc(O)c(OC)cc5)O4)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H]1O.CO,642.60241,Methyl-Hesperidin,129010424,,,,,,33
3656,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2482,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1.Cl.Cl,683.6213,Manidipine 2HCl,129010425,Launched,calcium channel blocker,CACNA1C|CACNA1D,InChI key,2,33
3656,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2339,c1(C(C)=O)ccc(OC)cc1O,166.1739,Paeonol,11092,Preclinical,anti-inflammatory agent,,InChI key,,33
3656,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2495,c1(C(C)(C)C)cc(C)c(CC2=NCCN2)c(C)c1O.Cl,296.83549,Oxymetazoline HCl,21114704,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,InChI key,,33
3656,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2351,[C@H]1(CO)O[C@@H](Oc2c(CO)cccc2)[C@H](O)[C@@H](O)[C@@H]1O,286.27781,Salicin,5145,Phase 1,anti-inflammatory agent,,InChI key,,33
3656,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2504,O1[C@H](n2nc(C(=O)N)nc2)[C@H](O)[C@H](O)[C@H]1CO,244.20468,Ribavirin,5064,Launched,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,InChI key,,33
3656,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2366,c1(O)cc2c(C(=O)[C@H](O)[C@@H](c3ccc(O)c(O)c3)O2)c(O)c1,304.25158,Taxifolin (Dihydroquercetin),471,Phase 2,opioid receptor antagonist,ADIPOR2,InChI key,,33
3656,E12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2522,c1(O)cc([C@H](CNC)O)ccc1O,183.20441,L-Adrenaline,838,Launched,adrenergic receptor agonist|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,InChI key,,33
3656,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2379,[C@H]1(O)[C@H](O)[C@]([H])(O[C@@H]2[C@H](CO)O[C@@]([H])(O[C@@H]3CC[C@@]4(C)C(=CC[C@]5([H])[C@@]4([H])CC[C@@]6(C)[C@@]5([H])C[C@@]7([H])[C@@]6([H])[C@@H](C)[C@@]8(CC[C@@H](C)CO8)O7)C3)[C@H](O[C@]9([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O)[C@H]2O)O[C@@H](C)[C@@H]1O,869.04358,Dioscin,129010426,Preclinical,apoptosis stimulant,CXCR3,InChI key,,33
3656,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2536,c1(Cl)cc(Cl)c(COC(Cn2cncc2)c3ccc(Cl)cc3Cl)cc1,416.12856,Miconazole,4189,Launched,bacterial cell wall synthesis inhibitor,KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5,InChI key,,33
3656,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2392,c(OCO1)(cc([C@@H]2[C@@]3([H])[C@@]([H])([C@@H](c4ccc5c(OCO5)c4)OC3)CO2)cc6)c16,354.35331,Sesamin,12308623,Preclinical,NFkB pathway inhibitor,,InChI key,,33
3656,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2552,c1cc2c(C(Cc3ccc(Cl)cc3)=NN(C4CCCN(C)CC4)C2=O)cc1.Cl,418.35939,Azelastine HCl,45114135,Launched,histamine receptor antagonist,HRH1,InChI key,1,33
3656,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2405,C(C[C@@]1([H])N(C[C@@]2([H])[C@]([H])(N3CCC2)[C@@]1([H])CCC3)C4=O)=C4,246.34798,Sophocarpine,1772221,Phase 3,,,InChI key,1,33
3656,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2565,c1(O)ccc([C@@H](N)C(=O)N[C@@H]2C(=O)N3[C@]2([H])SC(C)(C)[C@H]3C([O-])=O)cc1.[Na+],387.38599,Amoxicillin Sodium,129010427,,,,,3,33
3656,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2415,[C@@H]1(O)CO[C@@H](O[C@H]2CC[C@](C3)([C@@]3(CC[C@@]4(C)[C@@]5(C)C[C@H](O)[C@@]4([H])[C@@]6(C)O[C@@H](C(O)(C)C)CC6)[C@]57[H])[C@@]([H])([C@@H](O[C@H]8[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O8)C7)C2(C)C)[C@H](O)[C@H]1O,784.97022,Astragaloside A,129010428,Preclinical,antiinflammatory agent,,InChI key,,33
3656,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2584,C1=C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@]([H])(O)C[C@@]4(C)[C@@]3([H])C[C@]([H])(C)[C@@]4(OC(=O)CC)C(=O)CCl)=CC1=O,466.96998,Clobetasol propionate,129009878,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,InChI key,,33
3656,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2453,c1(O)ccc(CNNC(=O)C(CO)N)c(O)c1O.Cl,293.70414,Benserazide HCl,45114081,Launched,DOPA decarboxylase inhibitor,DDC,InChI key,,33
3656,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2602,Cc1c(CC(=O)OCC(=O)O)c2c(ccc(OC)c2)n1C(c3ccc(Cl)cc3)=O,415.82372,Acemetacin,1981,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,InChI key,,33
3656,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2613,c1(C(=C(Cl)Cl)Cl)cc(N)c(S(=O)(=O)N)cc1S(=O)(=O)N,380.65582,Clorsulon,43231,Launched,glycolysis inhibitor,,InChI key,,33
3656,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2758,C1(=O)O[C@H](COC)[C@@]2(C)c(c3C(=O)C4=C2[C@@H](OC(C)=O)C[C@@](C)([C@]45[H])C(=O)CC5)c1co3,428.43185,Wortmannin,129010429,Preclinical,PI3K inhibitor,PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC,InChI key,1,33
3656,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2623,c1(C)ccc(NC(=O)Nc2cccc(CN3CCN(C(OC)=O)CC3)c2F)cn1,401.43466,Omecamtiv mecarbil (CK-1827452),11689883,Phase 2,cardiac myosin activator,MYBPC3,InChI key,,33
3656,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2772,c1c(NC(=O)C2(CC(CC)CC)CCCCC2)c(SC(=O)C(C)C)ccc1,389.5945,"Dalcetrapib (JTT-705, RO4607381)",6918540,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,InChI key,1,33
3656,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2633,c1(Cl)c(C#N)c(OC[C@H](O)CNC(C)(C)Cc2cc3c(cccc3)cc2)ccc1,408.9205,NPS-2143,20812747,Preclinical,calcium receptor antagonist,CASR,InChI key,1,33
3656,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2781,o1c(c2sc(CO)cc2)ccc1c3sc(CO)cc3,292.37327,RITA (NSC 652287),374536,Preclinical,MDM inhibitor,MDM2,InChI key,,33
3656,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2659,c1c([C@@H](CCN(C(C)C)C(C)C)c2cc(CO)ccc2O)cccc1,341.48704,"5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)",9927971,Phase 1,acetylcholine receptor antagonist,CHRM3,InChI key,,33
3656,F10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,InChI key,,33
3656,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2670,c1cc(C[C@H](N)COc2cncc(c3ccc4c(c(C)n[nH]4)c3)c2)ccc1,358.43627,A-674563,20744853,Preclinical,AKT inhibitor,AKT1|PKIA|PRKACA,InChI key,1,33
3656,F12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2808,C1N(C(=O)[C@H](CNC(C)C)c2ccc(Cl)cc2)CCN(c3ncnc4c3[C@H](C)C[C@@H]4O)C1,457.99617,GDC-0068,74078320,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,InChI key,,33
3656,F13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2683,C1(=O)Nc2c(cc(Cl)cc2)C(N[C@@H]3CN(CCC34)CC4)=C1c5[nH]c6c(cccc6)n5,419.90667,CHIR-124,22664665,Preclinical,CHK inhibitor,CHEK1,InChI key,2,33
3656,F14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3001,N1C(=O)N([C@@H]2[C@@H](F)[C@@H](O)[C@H](CO)O2)C=C(C)C1=O,260.21902,Clevudine,352992,Launched,DNA polymerase inhibitor,,InChI key,,33
3656,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2697,c1(c2c(O)cccc2)ccc(c3c4c(NC(=O)C(C#N)=C4O)sc3)cc1,360.38588,A-769662,54708532,Preclinical,AMPK activator,,InChI key,1,33
3656,F16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3022,[C@@](C)(C(=O)[C@H](OC)C(C(C)(C)[C@@]1(O)[C@@H]2OC(c3ccccc3)=O)=C(C)[C@@H](OC(=O)[C@H](O)[C@H](c4ccccc4)NC(=O)OC(C)(C)C)C1)([C@H](OC)C[C@]5([H])[C@@]6(OC(C)=O)CO5)[C@]26[H],835.93238,Cabazitaxel,129010430,Launched,microtubule inhibitor,TUBA4A|TUBB|TUBB1,InChI key,1,33
3656,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2718,C1CC(NC(=O)c2cc(c3cccc(S(=O)(=O)CC)c3)c4c([nH]c5c4cc(C)cn5)c2C)CCN1C,504.64367,TAK-901,16124208,Phase 1,Aurora kinase inhibitor,AURKB,InChI key,1,33
3656,F18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3117,c1c(C(O)(C(=O)OCC#CCN(CC)CC)C2CCCCC2)cccc1.Cl,393.94738,Oxybutynin chloride,21935077,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,InChI key,,33
3656,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2730,c1cc2c(nc(n3c4c(cc(OCC5(C)COC5)cc4)nc3)cc2)c(N6CCC(N)CC6)c1,443.54075,Crenolanib (CP-868596),10366136,Phase 2,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,InChI key,1,33
3656,F20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S6002,c1(C=[N+]([O-])C(C)(C)C)c(S([O-])(=O)=O)cc(S(=O)(=O)[O-])cc1.[Na+].[Na+],381.33295,NXY-059,151178,Phase 3,free radical scavenger,,chemical name,,33
3656,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2746,c1(C(C)(C)C#N)cc(C(=O)Nc2cc(Nc3ccc4c(C(=O)N(C)C=N4)c3)c(C)cc2)ccc1,451.51969,AZ 628,11676786,Preclinical,RAF inhibitor,BRAF|RAF1,InChI key,3,33
3656,F22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2310,c1(O)ccc(c2c(O)ccc(CC=C)c2)cc1CC=C,266.33432,Honokiol,72303,Phase 3,AKT inhibitor,ALOX5|PTGS1|PTGS2,InChI key,,33
3656,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2471,c1(OCC[N+](CC)(CC)CC)c(OCC[N+](CC)(CC)CC)c(OCC[N+](CC)(CC)CC)ccc1.[I-].[I-].[I-],891.5291,Gallamine Triethiodide,6172,Launched,acetylcholine receptor antagonist,ACHE|CHRM2|CHRNA1|CHRNA2,InChI key,1,33
3656,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2325,c1(O)cc2c(C(=O)C(O)=C(c3c(O)cc(O)cc3)O2)c(O)c1.O,320.25097,Morin Hydrate,16219651,Preclinical,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12,InChI key,1,33
3656,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2484,n1ccc(C(C=C(C#N)C(=O)N2)=C2C)cc1,211.21936,Milrinone,4197,Launched,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,InChI key,,33
3656,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2341,C1C=C(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@H]3[C@](C)(O3)C1,248.3175,(-)-Parthenolide,73759808,Preclinical,NFkB pathway inhibitor,HDAC1,canonical SMILES,1,33
3656,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2496,c1cc(C=CC(=O)O)ccc1Cn2ccnc2,228.24657,Ozagrel,4646,,,,,,33
3656,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2355,[C@@]([H])(CC(=O)O1)([C@@]2(C)[C@]([H])(C(C)(C)CCC2)CC3)[C@]13C,250.37643,Sclareolide,11870380,Launched,other antifungal,,InChI key,,33
3656,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2506,[C@@]1(C)(O)[C@H](O)[C@@H](C)C(=NOCOCCOC)[C@H](C)C[C@](O)(C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@@H](O[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@@H]1CC,837.04654,Roxithromycin,73759751,Launched,bacterial 50S ribosomal subunit inhibitor,ABCB1|MLNR,chemical name,4,33
3656,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2367,c1(OC)cc2c(C(Cc3cc(OC)c(OC)cc3)NCC2)cc1OC.Cl,379.87773,Tetrahydropapaverine HCl,129010431,Preclinical,,,InChI key,,33
3656,G12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2527,c1cc2c(C(=O)C(=C3O)[C@]([H])([C@@H](O)[C@]4([H])[C@@]3(O)C(=O)C(C(=O)N)=C(O)[C@@H]4N(C)C)C2=C)c(O)c1.Cl,478.87962,Methacycline HCl,129010432,,,,,4,33
3656,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2380,c1(O)cc2c(C(=O)C=C(c3cc(O)c(OC)cc3)O2)c(O)c1,300.26287,Diosmetin,5281612,Launched,aryl hydrocarbon receptor agonist,CYP1B1,InChI key,1,33
3656,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2537,n1(c(C)ncc1[N+](=O)[O-])CC(O)C,185.18054,Secnidazole,71815,Launched,acetylcholinesterase inhibitor|microtubule inhibitor,,InChI key,,33
3656,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2394,c1(O)cc2c(C(=O)C[C@@H](c3ccc(O)cc3)O2)c(O)c1,272.25278,Naringenin,932,Phase 1,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,InChI key,,33
3656,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2554,c1(O)c(O)c2c(C=CC(=O)O2)cc1,178.14154,Daphnetin,5280569,Preclinical,protein kinase inhibitor,,InChI key,1,33
3656,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2406,c1cc2c(C(=O)c3c(cc(C)cc3O)C2=O)c(O)c1,254.2375,Chrysophanic Acid,10208,Preclinical,EGFR inhibitor,EGFR|MTOR,InChI key,1,33
3656,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2566,c1cc(C(CNC(C)C)O)cc(O)c1O.Cl,247.71851,Isoprenaline HCl,23616062,Launched,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|MAPK1|PIK3R1|PIK3R2|PIK3R3,InChI key,,33
3656,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2417,[C@H]1(O)C[C@@]2(C)[C@]([H])(C(=O)C=C3[C@@]2([H])CC[C@@]4(C)[C@@]3(O)CC[C@H]4[C@](O)(C)[C@H](O)CCC(C)(O)C)C[C@H]1O,480.63406,20-Hydroxyecdysone,129010434,Preclinical,ecdysone receptor modulator,,InChI key,,33
3656,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2586,C(OC)(=O)C=CC(OC)=O,144.12531,Dimethyl Fumarate,12215,,,,,1,33
3656,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2455,[N+](C)(C)(C)CC(C)OC(=O)N.[Cl-],196.67507,Bethanechol chloride,11548,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,InChI key,,33
3656,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2603,c1(O)cc2c(SC(=O)O2)cc1,168.16986,Tioxolone,72139,Preclinical,carbonic anhydrase inhibitor,CA2,InChI key,,33
3656,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2614,N1(C)CC(C(=O)OC)=CCC1.Br,236.10626,Arecoline,5351517,Phase 1,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,InChI key,,33
3656,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2759,c1c(C(=O)NO)cnc(N(Cc2sc3c(nc(c4cnc(OC)cc4)nc3N5CCOCC5)c2)C)n1,508.55285,CUDC-907,54575456,Phase 2,PI3K inhibitor,HDAC2|PIK3R1,InChI key,1,33
3656,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2624,n1c(N)c2n(c([C@H]3CC[C@H](C(O)=O)CC3)nc2c4cc5c(c(OC)ccc5)[nH]4)nc1,406.43778,OSI-027,56965966,Phase 1,mTOR inhibitor,MTOR,InChI key,1,33
3656,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2773,N(c1ccccc1Br)C(N[C@@H]2CCN(c3ncc(C(F)(F)F)cc3)C2)=O,429.23434,SB705498,57404073,Phase 2,TRPV antagonist,TRPV1,InChI key,,33
3656,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2634,c1(NC(=O)Nc2cc(C(C)(C)C)nn2c3ccc4c(cccn4)c3)ccc(Oc5ccnc(C(=O)NC)c5)cc1F,553.58682,DCC-2036 (Rebastinib),25066467,Phase 1,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BCR|FGR|FLT3|HCK|LYN|SRC,InChI key,1,33
3656,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2783,c1cc2c(nc(N3CCOC[C@@H]3C)nc2N4CCOC[C@@H]4C)nc1c5cccc(C(=O)NC)c5,462.54409,AZD2014,44200550,Phase 2,mTOR inhibitor,MTOR,InChI key,1,33
3656,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2660,c1c(Cl)ccc(S(=O)(=O)[C@]2(c3cc(F)ccc3F)CC[C@H](CCC(O)=O)CC2)c1,442.90384,MK-0752,9803433,Phase 1/Phase 2,gamma secretase inhibitor,,InChI key,,33
3656,H10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2794,[C@H]1(CO[P@](=O)(Oc2ccccc2)N[C@@H](C)C(=O)OC(C)C)O[C@@H](N3C=CC(=O)NC3=O)[C@@](F)(C)[C@@H]1O,529.45252,"Sofosbuvir (PSI-7977, GS-7977)",129010435,,,,,,33
3656,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2671,c1(F)ccc(c2ccc(C=C3C(=O)NC(=O)S3)o2)c(O)c1,305.28102,AS-252424,56965900,,,,,2,33
3656,H12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2811,n1c(N)c2c(n(C(C)C)nc2c3ccc4c(nc(N)o4)c3)nc1,309.32589,INK 128 (MLN0128),45375953,Phase 2,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,InChI key,,33
3656,H13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2685,c1c(O)c(C(=O)c2cc(OC)c(OCCN3CCOCC3)cc2)c(CC(=O)N(CCOC)CCOC)c(CC)c1O,574.66247,KW-2478,23116322,Phase 1/Phase 2,HSP inhibitor,,InChI key,,33
3656,H14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3007,[C@@H]1(NC(N)=N)[C@H](NC(=O)C)[C@]([H])([C@@H]([C@@H](CO)O)O)OC(C(O)=O)=C1,332.3098,Zanamivir,44386082,Launched,neuraminidase inhibitor,NEU2,InChI key,,33
3656,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2699,n1cc(c2nc(N3CCOCC3)nc4c2CCN4S(=O)(=O)C)cnc1N,377.42145,CH5132799,49784945,Phase 1,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,,33
3656,H16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3023,c1(CC(NO)=O)ccc(OCCCC)cc1,223.26828,Bufexamac,2466,Withdrawn,cyclooxygenase inhibitor,HDAC10|HDAC6,InChI key,,33
3656,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2719,c1cnc(Oc2ccc(Nc3nnc(c4cc(C)cs4)c5c3cccc5)cc2)c(c6ccnc(N)n6)c1,503.57763,AMG-900,24856041,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,InChI key,2,33
3656,H18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4001,c(cc(OC)c(OC)c1)(nccc2Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3)c12.C(O)(=O)C[C@@H](C(O)=O)O,635.5931,Cabozantinib malate (XL184),46830297,,,,,1,33
3656,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2731,c1(OC2CCN(C)CC2)ccc(Nc3ncc4c(N(C5CCCC5)C(=O)N4C)n3)c(OC)c1,452.54927,AZ 3146,56973724,Preclinical,monopolar spindle 1 kinase inhibitor,,InChI key,1,33
3656,H20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S6003,c1c(C(O)=O)cccc1c2nc(c3c(F)cccc3)on2,284.24196,Ataluren (PTC124),11219835,Launched,CFTR channel agonist|dystrophin stimulant,DMD,InChI key,,33
3656,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2747,N1(CC(O)(C)C)C(C)=C(C(Nc2ncc(Oc3c(c4ncc3)ccc(OC)c4)cc2)=O)C(=O)N1c5ccccc5,539.58175,AMG-458,24764449,Preclinical,MET inhibitor,MET,InChI key,2,33
3656,H22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2311,C1C[C@@]2(C)[C@]([H])([C@@H](O)C[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@H]4[C@@H](CCC(=O)O)C)C[C@@H]1O,392.572,Hyodeoxycholic acid (HDCA),129010436,Phase 1,atherosclerosis formation inhibitor,,InChI key,,33
3656,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2473,c1c(O)ccc([C@H](CC)[C@@H](c2ccc(O)cc2)CC)c1,270.36608,Hexestrol,3606,Launched,synthetic estrogen,AKR1C1|ESR1|ESR2,InChI key,,33
3656,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2326,c1(O)cc2c(C(=O)C(O)=C(c3cc(O)c(O)c(O)c3)O2)c(O)c1,318.2351,Myricetin,5281672,Preclinical,androgen receptor agonist|cytochrome P450 inhibitor,PIK3CG,InChI key,1,33
3656,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2485,c1c(O)c2c(C(=O)c3c(c(NCCNCCO)ccc3NCCNCCO)C2=O)c(O)c1.Cl.Cl,517.40279,Mitoxantrone HCl,45114134,Launched,topoisomerase inhibitor,TOP2A,InChI key,7,33
3656,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2342,c1(O)cc(O)c(C(=O)CCc2ccc(O)cc2)c(O)c1,274.26866,Phloretin,4788,Launched,sodium/glucose cotransporter inhibitor,AQP9|CLCN3|SLC23A1,InChI key,1,33
3656,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2497,[C@H]1([N+]2(C)CCCCC2)C[C@@]3(C)[C@@]([H])(CC[C@]4([H])[C@@]3([H])CC[C@@]5(C)[C@@]4([H])C[C@H]([N+]6(C)CCCCC6)[C@H]5OC(=O)C)C[C@@H]1OC(=O)C.[Br-].[Br-],732.6699,Pancuronium dibromide,129010437,Launched,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,InChI key,1,33
3656,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2356,C1=C(C(O)=O)C[C@@H](O)C(O)C1O,174.15129,Shikimic Acid,1094,Preclinical,,,InChI key,,33
3656,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2508,O([C@@H]1C[C@@]([H])(N(C)[C@@]2([H])C1)[C@]3([H])[C@@]2([H])O3)C(=O)[C@H](CO)c4ccccc4.Br,384.26488,Scopolamine HBr,129010439,Launched,acetylcholine receptor antagonist,,InChI key,,33
3656,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2370,C1C[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@@]2([H])CC=C4[C@@]3(C)CCC5[C@]4([H])[C@H](C)[C@H](C)C[C@H]5C(O)=O)C(C)(C)[C@H]1O,456.70032,Ursolic Acid,129010441,Phase 1,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,InChI key,,33
3656,I12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2528,C1CC(C2=CC(C)=CC(=O)N2O)CCC1,207.26888,Ciclopirox,2749,Launched,membrane integrity inhibitor,ATP1A1,InChI key,2,33
3656,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2381,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,182.17175,D-Mannitol,453,Launched,diuretic,,InChI key,1,33
3656,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2542,c1ccc(CCNC(=N)NC(N)=N)cc1.Cl,241.72053,Phenformin HCl,24183041,Withdrawn,AMPK activator,KCNJ8|PRKAA1,InChI key,,33
3656,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2395,c1(C)cc2c(C(=O)c3c(cc(OC)cc3O)C2=O)c(O)c1,284.26348,Rheochrysidin,10639,Preclinical,protein tyrosine kinase inhibitor,PTPN1,InChI key,,33
3656,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2555,[C@@]1(C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@H](O[C@H]2[C@@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[C@@H](C)[C@@H](O[C@H]3O[C@@H](C)[C@H](O)[C@@](OC)(C)C3)[C@@H](C)C(=O)O[C@@H]1CC,747.95336,Clarithromycin,71296890,Launched,bacterial 50S ribosomal subunit inhibitor,CYP3A4,InChI key,4,33
3656,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2407,C1(=C)C[C@](O[C@]23[C@@]1([H])CC[C@H]2C)(O)[C@H](C(C)C)C3,236.34986,Curcumol,129010442,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,InChI key,,33
3656,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2567,C1C[C@@]2(C)C([C@@H](C)C[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4(OC(=O)C)C(C)=O)=CC1=O,386.52435,Medroxyprogesterone acetate,129010443,Launched,progesterone receptor agonist,,InChI key,,33
3656,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2420,C1N2[C@@]([H])([C@]3([H])C[C@@]([H])([C@@]4([H])C(CCCN4)=C3)C2)CCC1,232.36445,Aloperine,162147,Preclinical,,,InChI key,,33
3656,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2589,[C@@H]1(O)[C@H](O)[C@H](O)[C@@H](CO)N(CCO)C1,207.22428,Miglitol,51577,Launched,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,InChI key,,33
3656,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2457,[C@H]1(O)[C@H](SC)O[C@H]([C@@H](NC([C@@H]2C[C@@H](CCC)CN2C)=O)C(Cl)C)[C@H](O)[C@@H]1O.Cl,461.44395,Clindamycin HCl,73759861,Launched,protein synthesis inhibitor,,InChI key,3,33
3656,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2604,C1C[C@@]2(C)C(=CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])CCC4=O)C[C@H]1O,288.42442,Dehydroepiandrosterone (DHEA),57256396,Launched,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,InChI key,,33
3656,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2615,c1(O)cc([C@@]([H])(O)CN)ccc1O.OC(=O)[C@]([H])(O)[C@@]([H])(O)C(=O)O.O,337.27995,Noradrenaline bitartrate monohydrate,3047796,,,,,,33
3656,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2760,[C@H]1(CO)O[C@@H](c2ccc(C)c(Cc3ccc(c4ccc(F)cc4)s3)c2)[C@H](O)[C@@H](O)[C@@H]1O,444.5157,Canagliflozin,74323022,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,InChI key,,33
3656,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2626,c1c(OC[C@H]2OCCNC2)c(NC(=O)Nc3ncc(C)nc3)cc(Br)c1C,436.30298,LY2603618,57731899,Phase 2,CHK inhibitor,CHEK1,InChI key,1,33
3656,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2775,C(OC)(=O)Nc1[nH]c2c(ccc(C(c3sccc3)=O)c2)n1,301.32043,Nocodazole,4122,Preclinical,tubulin polymerization inhibitor,HPGDS,InChI key,2,33
3656,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2635,n1c(N2CCC(Cc3ccc(Cl)cc3)(N)CC2)c4c([nH]cc4)nc1,341.8379,CCT128930,17751819,Preclinical,AKT inhibitor,PKIA|PRKACA,InChI key,2,33
3656,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2784,c(ccn1CCNC(CC(C)(C)O)=O)(ncnc2Nc3cc(Cl)c(Oc4cc(C(F)(F)F)ccc4)cc3)c12,547.9566,TAK-285,11620908,Phase 1,EGFR inhibitor,ERBB2,InChI key,,33
3656,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2661,c1(N2CC(OC3C2)CC3)c4c(n(C5CCC6(OCCO6)CC5)nc4)nc(c7ccc(NC(NC)=O)cc7)n1,519.59542,WYE-125132 (WYE-132),25260757,Preclinical,mTOR inhibitor,MTOR,InChI key,,33
3656,J10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2795,c1cc(C(=O)Nc2ccc(F)cc2F)ccc1OCCCC,305.31918,VU 0357121,2296132,Preclinical,glutamate receptor positive allosteric modulator,GRM5,InChI key,,33
3656,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2673,C1(=O)C(C)=C2C(C(=O)N(C3CC3)C(=O)N2c4cccc(NC(=O)C)c4)=C(Nc5c(F)cc(I)cc5)N1C,615.39479,Trametinib (GSK1120212),11707110,Launched,MEK inhibitor,MAP2K1|MAP2K2,InChI key,1,33
3656,J12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2814,N1(C(Nc2nc(C)c(c3ccnc(C(C)(C)C(F)(F)F)c3)s2)=O)CCC[C@H]1C(N)=O,441.47048,BYL719,75163532,Phase 3,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,InChI key,1,33
3656,J13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2686,c1c(c2cc(F)c(CN3CCOCC3)c(F)c2)c4c(ncc(c5cnn(C6CCNCC6)c5)n4)cc1.Cl.Cl,563.4695,NVP-BSK805 2HCl,129010444,Preclinical,JAK inhibitor,JAK2,InChI key,1,33
3656,J14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3008,c1cc2c(Sc3c(cc(C(C(O)=O)C)cc3)CC2=O)cc1,298.35625,Zaltoprofen,5720,Launched,cyclooxygenase inhibitor,,InChI key,,33
3656,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2700,c1cc(c2cnc(CC(=O)NCc3ccccc3)cc2)ccc1OCCN4CCOCC4,431.52675,KX2-391,23635314,Phase 2,src inhibitor|tubulin polymerization inhibitor,SRC,InChI key,1,33
3656,J16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3025,c1(CS(F)(=O)=O)ccccc1,174.19268,PMSF,4784,Preclinical,serine protease inhibitor,,InChI key,,33
3656,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2720,c1(N(C)C)cc(C(=O)Nc2ccc(C)c(NC(=O)c3ccc(O)cc3)c2)ccc1,389.44701,ZM 336372,5730,Preclinical,RAF inhibitor,BRAF|LCK|MAPK14|RAF1,InChI key,1,33
3656,J18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4002,c1c(F)c(C[C@@H](N)CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)cc(F)c1F.P(OO)(=O)=O.[H].O,523.32408,Sitagliptin phosphate monohydrate,78053673,,,,,,33
3656,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2735,c1(c(c2cnn(C)c2)cn3)n3c(N)c(Br)c([C@@H]4CCCNC4)n1,376.25431,MK-8776 (SCH 900776),16224745,Phase 2,CHK inhibitor,CDK2|CHEK1,InChI key,,33
3656,J20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S6005,c1cc(F)c(N(C(N)=O)c2ccc(C(=O)N)c(c3ccc(F)cc3F)n2)c(F)c1,404.31779,VX-702,10341154,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,InChI key,1,33
3656,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2748,c1cc(c2c(OC)cc(F)c(C(C)C)c2)c(CN3[C@H](C)[C@@H](c4cc(C(F)(F)F)cc(C(F)(F)F)c4)OC3=O)cc1C(F)(F)F,637.50843,Anacetrapib (MK-0859),49849451,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,InChI key,,33
3656,J22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2312,[C@H]1(CO)OC(Oc2c(CC=C(C)C)c3c(C(=O)C(OC4[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O4)=C(c5ccc(OC)cc5)O3)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O,676.6617,Icariin,5471129,Phase 3,phosphodiesterase inhibitor,PDE5A,InChI key,1,33
3656,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2475,n1ccc(c2cnccc2)nc1Nc3c(C)ccc(NC(c4ccc(CN5CCN(C)CC5)cc4)=O)c3,493.60273,Imatinib (STI571),5291,Launched,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,InChI key,2,33
3656,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2328,C(N(CC)c1c(ccc(C)n1)C2=O)=C2C(=O)O,232.23528,Nalidixic acid,4421,Launched,bacterial DNA gyrase inhibitor,,InChI key,4,33
3656,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2486,C1CN(C(=N)NC(=N)N)CCO1.Cl,207.66125,Moroxydine HCl,21177116,Launched,antiviral,,InChI key,1,33
3656,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2343,c1(O)c(C(=O)CCc2ccc(O)cc2)c(O[C@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)cc(O)c1,436.40926,Phlorizin,4789,Preclinical,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3,InChI key,,33
3656,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2498,OCC(C)(C)[C@@]([H])(O)C(=O)NCCC(=O)O,219.23497,D-Pantothenic acid,6613,Launched,coenzyme A precursor,,InChI key,1,33
3656,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2357,[C@H]1(CO)Oc2c(cc([C@@H]3Oc4c(c(O)cc(O)c4)C(=O)[C@@H]3O)cc2)O[C@@H]1c5cc(OC)c(O)cc5,482.43617,Silibinin,5213,Launched,cytochrome P450 inhibitor,ALOX5,InChI key,,33
3656,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2509,c1(C(O)CNC(C)C)ccc(NS(=O)(=O)C)cc1.Cl,308.82474,Sotalol,44336998,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,InChI key,,33
3656,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2373,[nH]1c2c(cccc2)c3c1[C@@]4([H])N(C[C@@]5([H])[C@@]([H])([C@@H](C(=O)OC)[C@@H](O)CC5)C4)CC3.Cl,390.90368,Yohimbine HCl,129010445,Launched,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8,InChI key,,33
3656,K12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2529,c1(O)cc(CCN)ccc1O.Cl,189.63937,Dopamine HCl,43822543,Launched,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,InChI key,,33
3656,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2384,[C@](O)(Cc1c2cc(O)c(O)c1)(COc3c4ccc(O)c3O)[C@]24[H],302.27875,Hematoxylin,442514,Preclinical,,,InChI key,3,33
3656,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2543,N(C(=O)[C@@]1(NC(=O)C(c2csc(N)n2)=NOC)[H])(C(C(=O)O)=C(CSC(=O)c3ccco3)CS4)[C@@]14[H].Cl,560.02351,Ceftiofur HCl,129010446,Launched,bacterial cell wall synthesis inhibitor,,canonical SMILES,6,33
3656,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2396,[C@H]1(CO)O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,300.30439,Salidroside,4961358,Preclinical,beta amyloid protein neurotoxicity inhibitor,APP,InChI key,,33
3656,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2556,c1cc(N(C)CCOc2ccc(CC3C(=O)NC(=O)S3)cc2)ncc1,357.42675,Rosiglitazone,77999,Withdrawn,insulin sensitizer|PPAR receptor agonist,ACSL4|FFAR1|PPARG|TRPC5|TRPM3,InChI key,,33
3656,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2408,c1cc([C@H](NC(=O)C(C)=CC)[C@@H](O)C(=O)O[C@@H]2C(C)=C3C(C)(C)[C@](O)([C@@H](OC(=O)c4ccccc4)[C@@]5([H])[C@@](C)([C@H](O)C[C@@H]6[C@@]5(OC(C)=O)CO6)C(=O)[C@H]3OC(C)=O)C2)ccc1,831.90062,Cephalomannine,129010447,Preclinical,DNA polymerase inhibitor,,chemical name,1,33
3656,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2569,c1(O)cc([C@@]([H])(O)CNC)ccc1.Cl,203.66596,Phenylephrine HCl,45114086,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,InChI key,,33
3656,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2422,c1cc2c(OC=C(c3ccccc3)C2=O)cc1OC(C)C,280.31784,Ipriflavone (Osteofix),3747,Launched,bone resorption inhibitor,,InChI key,,33
3656,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2593,C(N1c2c(cc(Cl)cc2)C(O)CCC1)(=O)c3ccc(NC(c4c(C)cccc4)=O)cc3C,448.94129,Tolvaptan,216237,Launched,vasopressin receptor antagonist,AVPR1A|AVPR2,InChI key,,33
3656,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2458,c1c(Cl)c(NC2=NCCN2)c(Cl)cc1.Cl,266.5548,Clonidine HCl,21178463,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,InChI key,,33
3656,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2605,C1(=O)C(C)=C(CCCCCCCCCCO)C(=O)C(OC)=C1OC,338.4385,Idebenone,3686,Launched,calcium channel modulator,,InChI key,,33
3656,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2617,N1(C[C@H](CO)O)C(=O)C2=C(N(C)C(=O)C(F)=C2Nc3c(F)cc(I)cc3)N=C1,504.22667,TAK-733,67065878,Phase 1,MEK inhibitor,MAP2K1,InChI key,1,33
3656,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2761,c1cc2n(c(Cc3cc4c(nccc4)cc3)cn2)nc1c5cn(C)nc5,340.38124,NVP-BVU972,44206063,Preclinical,MET inhibitor,MET,InChI key,,33
3656,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2627,c1cc(Cn2c3c(cccc3)c4c2CCN(C)C4)ccc1C(=O)NO.Cl,371.86058,Tubastatin A HCl,129010448,Preclinical,HDAC inhibitor,HDAC6,InChI key,1,33
3656,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2776,S(Cc1ccccc1)CCC(CCCCC(=O)O)SCc2ccccc2,388.58652,CPI-613,24770514,Phase 2,pyruvate dehydrogenase inhibitor,PDHA1,InChI key,,33
3656,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2636,c1c(c2c(C)nc(NC(=O)N3CCC[C@H]3C(N)=O)s2)nc(C(C)(C)C)s1,393.52681,A66,74832860,Preclinical,PI3K inhibitor,PIK3CA,InChI key,,33
3656,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2785,o1c(c2ccc(Cl)cc2)ccc1C(Nc3cc(OC)cc(OC)c3)=O,357.78763,A-803467,16038374,Preclinical,sodium channel blocker,SCN10A,InChI key,,33
3656,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2663,c1(ccccc1OC)N2CCN(CCN(C(=O)C3CCCCC3)c4ncccc4)CC2.Cl.Cl.Cl,531.94587,WAY-100635 Maleate,44388603,Phase 1,serotonin receptor antagonist,HTR1A,InChI key,,33
3656,L10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2796,C(N[C@H](c1ccccc1)C)(=O)C(C#N)=Cc2nc(Br)ccc2,356.21655,WP1066,72752238,Phase 1,STAT inhibitor,STAT3,chemical name,,33
3656,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2674,c1ccc(NC(=O)Nc2ccc(c3ccc(C([C@H]4[C@@H](C(=O)O)CCC4)=O)cc3)cc2)cc1,428.47975,A922500,53394059,Preclinical,diacylglycerol O acyltransferase inhibitor,DGAT1,InChI key,,33
3656,L12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2820,c1(N2CCOCC2)ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)c(OC)c1,468.93599,TAE226 (NVP-TAE226),9934347,Preclinical,protein tyrosine kinase inhibitor,PTK2,InChI key,1,33
3656,L13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2688,n1c(N)c(C(=O)c2c(OC)ccc(F)c2F)cnc1NC3CCN(S(=O)(C)=O)CC3,441.45224,R547,6918852,Phase 1,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,InChI key,,33
3656,L14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3012,c1(S(N)(=O)=O)cc(Nc2nccc(N(c3cc(c4cc3)nn(C)c4C)C)n2)ccc1C,437.51801,Pazopanib,10113978,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,InChI key,1,33
3656,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2703,n1c(Nc2c(C(NC)=O)c(F)ccc2)c3c([nH]cc3)nc1Nc4cc5c(CCN5C(CN(C)C)=O)cc4OC,532.56936,GSK1838705A,25182616,Preclinical,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1,InChI key,,33
3656,L16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3026,c1(O)ccc(C=Cc2cc(O)cc(O)c2)cc1O,244.24267,Piceatannol,4813,,,,,2,33
3656,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2722,c1cc(C(Nc2ccc3c(c(N)cc(C)n3)c2)=O)c(COc4ccc(CC)cc4)cc1.Cl,447.95653,JTC-801,71297147,Phase 2,opioid receptor antagonist,OPRL1,InChI key,2,33
3656,L18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4075,c1c[n+]2c([S-][Zn+2]3([S-]c4[n+](cccc4)[O-]3)[O-]2)cc1,317.72172,Zinc Pyrithione,0,,,,,8,33
3656,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2736,c1(OCCN2CCCC2)ccc(Nc3ncc(C)c(Nc4cc(S(=O)(=O)NC(C)(C)C)ccc4)n3)cc1,524.67813,TG101348 (SAR302503),16722836,Phase 3,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,InChI key,,33
3656,L20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7046,C1CC=C[C@@]2([H])[C@@]([H])(C[C@@H](O)C2)[C@H](O)C=CC(=O)O[C@@H](C)C1,280.35936,Brefeldin A,129010449,Preclinical,protein synthesis inhibitor,ARF1|CYTH2,canonical SMILES,,33
3656,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2749,C(O)(=O)C=CC(O)=O.n1c(c2c3c(N(C)C(=O)N3c4ccc(N5CCNCC5)c(C(F)(F)F)c4)c1)ccc(c6ccc(OC)nc6)c2,650.60446,BGT226 (NVP-BGT226),66870970,,,,,,33
3656,L22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2314,c1(O)cc2c(C(=O)C(O)=C(c3ccc(O)cc3)O2)c(O)c1,286.2363,Kaempferol,5280863,Preclinical,bone resorption inhibitor|estrogen-related receptor inverse agonist,AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1,InChI key,3,33
3656,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2476,c1c(N2CCN(c3ccc(N4C=NN(C(C)CC)C4=O)cc3)CC2)ccc(OC[C@H]5CO[C@@](c6c(Cl)cc(Cl)cc6)(Cn7ncnc7)O5)c1,705.63341,Itraconazole,58612883,Launched,cytochrome P450 inhibitor,CYP51A1,InChI key,1,33
3656,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2334,C1C[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@@]2([H])CC=C4[C@@]3(C)CCC5[C@]4([H])CC(C)(C)C[C@H]5C(O)=O)C(C)(C)[C@H]1O,456.70031,Oleanolic Acid,129010450,,,,,,33
3656,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2487,c(C(=O)OC1)(c(O)c(CC=C(CCC(O)=O)C)c(OC)c2C)c12,320.33709,Mycophenolic acid,4272,,,,,1,33
3656,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2344,C1CCCN(C(=O)C=CC=Cc2ccc3c(OCO3)c2)C1,285.33765,Piperine,4840,,,,,,33
3656,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2499,c1ccc(OCC(C)N(Cc2ccccc2)CCCl)cc1.Cl,340.28732,Phenoxybenzamine HCl,45114167,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB2|CALM1,InChI key,3,33
3656,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2359,c1(OC)ccc2c([C@@]34[C@]([H])(C=C(OC)C(=O)C3)[C@@H](N(C)CC4)C2)c1O,329.39022,Sinomenine,16394562,Preclinical,angiogenesis inhibitor,,InChI key,,33
3656,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2510,[C@H]1(NC)[C@@H](O)[C@]2([H])[C@]([H])(O[C@]3(O)[C@@]([H])(O[C@H](C)CC3=O)O2)[C@@H](NC)[C@H]1O.Cl.Cl,405.27144,Spectinomycin HCl,129010451,Launched,bacterial 30S ribosomal subunit inhibitor,,InChI key,3,33
3656,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2374,c1(O)cc2c([nH]cc2CC(N)C(=O)O)cc1,220.22458,5-hydroxytryptophan (5-HTP),144,Launched,neurotransmitter,SLC36A1|SLC36A2,InChI key,1,33
3656,M12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2531,c1(OC)cc(C=O)c(OC)cc1OC,196.19988,Asaraldehyde,20525,Preclinical,cyclooxygenase inhibitor,PTGS2,InChI key,1,33
3656,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2385,c1cc(CCN(C)C)ccc1O,165.23219,Hordenine,68313,Preclinical,,,InChI key,,33
3656,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2545,[C@@]1([H])(C[C@@H](O)C2)N(C)[C@]2([H])[C@@]3([H])[C@]1([H])O3,155.19431,Scopine,1274465,Launched,,,InChI key,1,33
3656,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2399,c1(O)cc2c(C(=O)[C@H](O)[C@@H](c3cc(O)c(O)c(O)c3)O2)c(O)c1,320.25097,Dihydromyricetin,5153580,Preclinical,,,InChI key,1,33
3656,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2557,c1ccc2c(cccc2CN(C)CC=CC#CC(C)(C)C)c1.Cl,327.89083,Terbinafine HCl,71296891,,,,,,33
3656,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2409,[C@@](C)(C(=O)[C@H](O)C(=C1C)C(C)(C)[C@@](O)(C[C@@H]1O)[C@H]2OC(c3ccccc3)=O)([C@H](O)C[C@]4([H])[C@@]5(OC(=O)C)CO4)[C@]25[H],544.59013,10-Deacetylbaccatin-III,129010453,Preclinical,antitumor agent,,InChI key,1,33
3656,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2574,c1c(O)c2c([C@](O)(C)[C@@](C(=C3O)C2=O)([H])C[C@]4([H])[C@@]3(O)C(=O)C(C(=O)N)=C(O)[C@@]4([H])N(C)C)cc1.Cl,480.89549,Tetracycline HCl,54724370,,,,,4,33
3656,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2437,c1cc2c(CN3[C@]([H])(c4c(cc(OC)c(OC)c4)CC3)C2)c(OC)c1OC,355.42749,Rotundine,72301,Launched,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,InChI key,1,33
3656,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2594,C(N1CCCC1=O)C(NCCN(C(C)C)C(C)C)=O,269.38308,Pramiracetam,51712,Launched,acetylcholine receptor agonist,,InChI key,1,33
3656,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2461,C(N1c2c(cccc2)NC1=O)CCN3CCC(N4C(=O)Nc5c4ccc(Cl)c5)CC3,425.91126,Domperidone,3151,Launched,dopamine receptor antagonist,DRD2|DRD3,InChI key,,33
3656,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2606,C1CC(=C([C@H](c2ccc(N(C)C)cc2)C[C@@]3(C)[C@@]4([H])CC[C@@]3(C#CC)O)[C@]45[H])C(CC5)=CC1=O,429.59369,Mifepristone,13080184,Launched,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,InChI key,1,33
3656,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2619,c1ccc(COC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CC(C)C)cc1,475.62083,MG-132,6914692,Preclinical,proteasome inhibitor,PSMB1,InChI key,1,33
3656,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2765,N1=C(C(NC)=O)c2c(c(O)c3n2[C@H](C)CN(CC)C3=O)C(=O)N1Cc4cc(Cl)c(F)cc4,461.87394,MK-2048,68116543,Preclinical,HIV integrase inhibitor,,InChI key,,33
3656,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2629,c1(OC)cc(OC)c(Cl)cc1NC(=O)Nc2cc(C)on2,311.72095,PNU-120596,311434,Preclinical,acetylcholine receptor agonist,CHRNA7,InChI key,,33
3656,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2777,c1(C)cnc(c2c(Cl)cnc(N3CCN(C(CCS(=O)(=O)C)=O)CC3)c2)c(C)c1,436.95549,PF-5274857,56956240,Preclinical,smoothened receptor antagonist,SMO,InChI key,1,33
3656,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,InChI key,,33
3656,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2787,N1(C)c(c2C(O)=C(C(N(CC)c3ccccc3)=O)C1=O)cccc2Cl,356.80287,Laquinimod,54677946,Phase 3,immunosuppressant,CXCL2,InChI key,1,33
3656,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2664,C1CCCC(c2ccc(OC(C(O)=O)(C)CC)cc2)(c3ccc(OC(C(=O)O)(C)CC)cc3)C1,468.58183,Clinofibrate,2787,Launched,lipase clearing factor inhibitor,LPL,InChI key,1,33
3656,N10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2797,C1c2c(ncc(Br)c2)[C@H](C3CCN(C(=O)CC4CCN(C(=O)N)CC4)CC3)c5c(cc(Cl)cc5Br)C1,638.82163,Lonafarnib,9852353,Phase 3,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,InChI key,,33
3656,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2677,c1ccc(C(c2ccccc2)C(O)CN3CCN(c4cccc(Cl)c4)CC3)cc1.Cl.Cl,479.86956,BRL-15572,129010454,Preclinical,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,InChI key,1,33
3656,N12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2840,S=C1N(c2cc(F)c(C(=O)NC)cc2)C3(CCC3)C(=O)N1c4cc(C(F)(F)F)c(C#N)nc4,477.43471,ARN-509,24872560,Phase 3,androgen receptor antagonist,AR,InChI key,,33
3656,N13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2689,c(cc[nH]1)(cc(c2nc(N3CCOCC3)c4c(n(C5CCN(Cc6cnccc6)CC5)nc4)n2)cc7)c17,494.5908,WAY-600,25229526,Preclinical,mTOR inhibitor,MTOR,InChI key,5,33
3656,N14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3017,c1c(C(O)=O)c(OC(=O)C)ccc1,180.15741,Aspirin,2244,Launched,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,InChI key,,33
3656,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2711,c1(F)cc(CC(=O)N[C@@H](C)C(=O)N[C@@H]2C(=O)N(C)c3c(cccc3)c4c2cccc4)cc(F)c1,463.47592,YO-01027,10115684,Preclinical,gamma secretase inhibitor,,InChI key,,33
3656,N16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3031,c1cc2c(c(C)nc(CN3C(=O)c4c(nc(N5CCC[C@@H](N)C5)n4CC#CC)N(C)C3=O)n2)cc1,472.54221,Linagliptin,57389748,Launched,dipeptidyl peptidase inhibitor,DPP4,InChI key,,33
3656,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2726,c1(N2C(=O)C(Br)=C(OCc3c(F)cc(F)cc3)C=C2C)cc(C(NC)=O)ccc1C,477.29866,PH-797804,22049997,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK14,InChI key,1,33
3656,N18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4119,c(cc(N1CCN(C)CC1)c(F)c2)(N(CC)C=C(C(=O)O)C3=O)c23.S(=O)(=O)(O)C.O.O,465.49362,Pefloxacin Mesylate Dihydrate,6917670,Launched,bacterial DNA gyrase inhibitor,TOP2A,InChI key,6,33
3656,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2738,c1(ccccc1)CN2CCN(CC(=O)NN=Cc3c(O)c(CC=C)ccc3)CC2,392.49401,PAC-1,6753378,,,,,4,33
3656,N20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7397,c1(cc(NC(=O)Nc2ccc(Oc3ccnc(C(NC)=O)c3)cc2)ccc1Cl)C(F)(F)F,464.82494,Sorafenib,216239,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,InChI key,1,33
3656,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2750,C(NC1CCOCC1)(=O)c2ccc(c3nccc(c4c[nH]nc4c5ncccc5)c3)cc2,425.48241,GW788388,10202642,Preclinical,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1,InChI key,2,33
3656,N22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2319,C1(=O)[C@H]2[C@@]3(O2)[C@@](C)(CC[C@@]4([H])[C@]3(C)C(=O)C[C@]5([H])[C@]4(COC(=O)C6)[C@@]6([H])OC5(C)C)[C@H](c7ccoc7)O1,470.51159,Limonin,129010455,Preclinical,HIV protease inhibitor,,InChI key,1,33
3656,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2479,[C@@H]1(O)[C@]([H])([C@H](NC([C@H]2N(C)C[C@H](CCC)C2)=O)[C@H](O)C)O[C@H](SC)[C@H](O)[C@H]1O.Cl,442.99829,Lincomycin HCl,129010456,Launched,bacterial 30S ribosomal subunit inhibitor,,InChI key,2,33
3656,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2335,[C@@]1([H])([C@H]2O)[C@@](CO3)(C(CC4)[C@]5([C@@]23O)[C@H](O)[C@]4([H])C(=C)C5=O)[C@@H](O)CCC1(C)C,364.43271,Oridonin,129010458,Preclinical,BCL inhibitor,BCL2,InChI key,1,33
3656,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2489,C1C[C@@H](C(=O)N[C@@H](C(O)=O)Cc2ccccc2)CC[C@@H]1C(C)C,317.42258,Nateglinide,4443,Launched,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,InChI key,,33
3656,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2346,c(C(=O)C(c1ccc(O)cc1)=CO2)(ccc(O)c3O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c23,432.37749,Puerarin,6166169,Phase 2,serotonin receptor antagonist,,chemical name,,33
3656,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2500,c1cc(CCC(=O)c2c(OCC(CNCCC)O)cccc2)ccc1,341.44397,Propafenone HCl,4932,Launched,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2|SCN5A,InChI key,1,33
3656,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2362,c1cc(C(CNC)O)ccc1O,167.20501,Synephrine,7172,Launched,adrenergic receptor agonist,ADRA1A,InChI key,,33
3656,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2512,c1cnc(NC(C2=C(O)c3c(ccs3)S(=O)(=O)N2C)=O)cc1,337.37413,Tenoxicam,54677971,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,chemical name,1,33
3656,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2375,[C@@H]1(CO)[C@H](O)[C@H](O)[C@@H](O)[C@]([H])([C@]2([H])c3c(c(O)cc(CO)c3)C(=O)c4c2cccc4O)O1,418.39397,Aloin,129010459,Preclinical,angiogenesis inhibitor,,chemical name,1,33
3656,O12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2533,c1cc([C@@](O)([H])[C@](C)([H])NCCc2ccc(O)cc2)ccc1O.Cl,323.81448,Ritodrine HCl,51371387,Launched,adrenergic receptor agonist,ADRB2,InChI key,,33
3656,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2386,c1cc2c(C(=C3C(=O)c4c(cccc4)N3)C(=O)N2)cc1,262.2628,Indirubin,5380743,,,,,1,33
3656,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2547,[Br-].O.[C@@]1([H])(C[C@@H](OC(=O)C(O)(c2sccc2)c3sccc3)C4)[N+](C)(C)[C@]4([H])[C@H]5[C@@H]1O5,490.43156,Tiotropium Bromide hydrate,656610,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,InChI key,,33
3656,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2401,c1(O)cc(CC(O)C([O-])=O)ccc1O.[Na+],220.15453,Sodium Danshensu,23711819,,,,,1,33
3656,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2559,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2([H])C(=O)C[C@@]4(C)[C@@]3([H])CC[C@@]4(O)C(=O)COC(=O)C)=CC1=O,402.48069,Cortisone acetate,129009885,Launched,glucocorticoid receptor agonist,NR3C1,InChI key,,33
3656,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2410,[C@H]1(CO)O[C@@H](O[C@]23C[C@]([H])([C@]24COC(=O)c5ccccc5)[C@](O)(O[C@]46[H])C[C@@]3(C)O6)[C@H](O)[C@@H](O)[C@@H]1O,480.46181,Paeoniflorin,129010460,Preclinical,anticonvulsant,,InChI key,,33
3656,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,InChI key,,33
3656,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2438,c1cc(C(O)CNC)ccc1O.Cl,203.66596,Synephrine HCl,129010461,Launched,adrenergic receptor agonist,ADRA1A,InChI key,,33
3656,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2596,C1(O)C(O)C(OC(=O)CCCCCCCCCCCCCCC)C(SC)OC1C(NC(C2CC(CCC)CN2C)=O)C(Cl)C.Cl,699.85276,Clindamycin palmitate HCl,75094277,Launched,bacterial 50S ribosomal subunit inhibitor,,InChI key,1,33
3656,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2466,c1cc2c(CC[C@]3([H])[C@@]2([H])CC[C@@]4(C)[C@@]3([H])C[C@@H](O)[C@H]4O)cc1O,288.38136,Estriol,129010462,Launched,estrogen receptor agonist,ESR1|ESR2,InChI key,,33
3656,O22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2607,c1(OC)cc(OC)c(C(CCCN2CCCC2)=O)c(OC)c1.Cl,343.84564,Buflomedil HCl,45114227,Launched,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,InChI key,,33
3656,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,P03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,InChI key,2,33
3656,P04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2767,n1c(c2nc1)c(N)ncn2C,149.15328,3-Methyladenine,1673,Preclinical,PI3K inhibitor,PI3,chemical name,1,33
3656,P05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2630,c1ccc(OCCCN(CC(c2ccccc2)c3ccccc3)Cc4c(Cl)c(C(F)(F)F)ccc4)cc1CC(O)=O.Cl,618.51328,GW3965 HCl,71297144,Preclinical,LXR agonist,NR1H2|NR1H3,InChI key,5,33
3656,P06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2778,c1(Nc2ccc(Cl)cc2Cl)ncc(C(NCC3CCOCC3)=O)c(C(F)(F)F)n1,449.25438,GW842166X,10253143,Phase 2,cannabinoid receptor agonist,CNR2,InChI key,,33
3656,P07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2639,c1c(C(=O)N)c(N[C@H]2CC[C@H](O)CC2)cc(n3c4c(C(=O)CC(C)(C)C4)c(C(F)(F)F)n3)c1,464.48068,SNX-2112 (PF-04928473),24772860,Phase 1,HSP inhibitor,,InChI key,1,33
3656,P08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2789,n1c(N([C@@H]2[C@@H](C)CCN(C(CC#N)=O)C2)C)c3c([nH]cc3)nc1,312.3696,"Tofacitinib (CP-690550,Tasocitinib)",9818231,Launched,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,InChI key,,33
3656,P09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2665,c1cc(OC(C)(C)C(=O)O)ccc1C2CC2(Cl)Cl,289.15445,Ciprofibrate,2763,Launched,PPAR receptor agonist,PPARA,InChI key,,33
3656,P10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2801,c1(OC)cc(CCc2[nH]nc(NC(c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)=O)c2)cc(OC)c1,463.57191,AZD4547,57430866,Phase 2/Phase 3,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,InChI key,1,33
3656,P11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2680,c1nc2c(c(c3ccc(Oc4ccccc4)cc3)nn2[C@@H]5CCCN(C(=O)C=C)C5)c(N)n1,440.49705,Ibrutinib (PCI-32765),16126651,Launched,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,InChI key,,33
3656,P12,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2853,C1OCCN(CC(=O)N[C@@H](CCc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4)C1,719.90988,Carfilzomib (PR-171),91820608,Launched,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,InChI key,2,33
3656,P13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2690,c1(F)ccc(C(=O)N2C[C@@H](c3onc(c4ccc(F)cc4)n3)CCC2)cc1,369.36468,ADX-47273,3602027,Preclinical,glutamate receptor modulator,GRM5,InChI key,,33
3656,P14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3018,c1(Nc2cccc(C(F)(F)F)c2)ncccc1C(O)=O,282.21796,Niflumic acid,4488,Launched,cyclooxygenase inhibitor,ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9,InChI key,1,33
3656,P15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2713,C1(OC)=C(C(=O)C2=CC1=O)C[C@H](C)C[C@@H](OC)[C@H](O)[C@H](C)C=C(C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,560.6359,Geldanamycin,3460,Preclinical,HSP inhibitor,HSP90AA1|HSP90AB1,chemical name,1,33
3656,P16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3032,C(O)(=O)C(C)(OCc1c(c2n(Cc3ccccc3)n1)cccc2)C,324.3737,Bindarit,71354,Phase 2,NFkB pathway inhibitor,CCL2|CCL7|CCL8,InChI key,,33
3656,P17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2727,C(N1CCCCC1)C=CC(=O)Nc2cc3c(ncnc3Nc4ccc(F)c(Cl)c4)cc2OC,469.939,"Dacomitinib (PF299804, PF299)",57519532,Phase 3,EGFR inhibitor,EGFR|ERBB2|ERBB4,canonical SMILES,1,33
3656,P18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4273,C(N)(=O)c1cccc(N)c1,136.15122,3-Aminobenzamide,1645,Phase 2,PARP inhibitor,PARP1,InChI key,,33
3656,P19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2742,c1cc(c2cc3c(CCNC3=O)[nH]2)ccn1,213.23524,PHA-767491,11715767,Preclinical,CDC inhibitor,CDK1|RPS6KB1,InChI key,1,33
3656,P20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8049,c1cc(Cn2c3c(cccc3)c4c2CCN(C)C4)ccc1C(=O)NO,335.39963,Tubastatin A,49850262,Preclinical,HDAC inhibitor,HDAC6,InChI key,1,33
3656,P21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2751,c1(c2c3c(c(C(=O)NC)nn3C)C(C)(C)C1)cnc(Nc4ccc(N5CCN(C)CC5)cc4)n2,460.57457,Milciclib (PHA-848125),16718576,Phase 2,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,InChI key,,33
3656,P22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3656,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1333,c1(C(F)(F)F)ccc(OC(c2ccccc2)CCNC)cc1.Cl,345.78706,Fluoxetine HCl,44669843,Launched,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,InChI key,2,21
3657,A04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3070,N1(CC(N)=O)CCCC1=O,142.1558,Piracetam,4843,Launched,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,InChI key,,21
3657,A06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4256,c1nc(N2CCN(CCCCN3C(=O)CC4(CCCC4)CC3=O)CC2)ncc1.Cl,421.96407,Buspirone HCl,45114160,Launched,serotonin receptor agonist,DRD2|HTR1A,InChI key,1,21
3657,A08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1189,N1=C(CN2CCO[C@H](O[C@H](c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C)[C@@H]2c4ccc(F)cc4)NC(=O)N1,534.42666,Aprepitant,21923359,Launched,tachykinin antagonist,TACR1,InChI key,,21
3657,A12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1441,C1C(O)(C(c2ccc(OC)cc2)CN(C)C)CCCC1.Cl,313.86271,Venlafaxine,45114212,Launched,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,InChI key,,21
3657,A14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2103,c1cc2c([C@@]3([C@H]45)[C@@](O)(CCC4=O)[C@H](N(CC6CC6)CC3)C2)c(O5)c1O.Cl,377.86186,Naltrexone HCl,129010463,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,InChI key,,21
3657,A16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3024,n1c(c2cccc(Cl)c2Cl)c(N)nc(N)n1,256.09138,Lamotrigine,3878,Launched,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,21
3657,A18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,A24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,B24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1438,[C@@H](OC(C)(C)O1)(CO[C@]2(COS(=O)(=O)N)[C@H]3OC(C)(C)O2)[C@@H]13,339.36203,Topiramate,71296901,Launched,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,21
3657,C04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3175,C(NC)C[C@@H](Oc1ccccc1C)c2ccccc2.Cl,291.81568,Atomoxetine HCl,71296888,Launched,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,InChI key,,21
3657,C06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4283,c(cccc1)(C=Cc2c(cccc2)C3=CCCN(C)C)c13.Cl,311.84838,Cyclobenzaprine HCl,5351883,Launched,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,InChI key,1,21
3657,C08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1259,c1cc2c([C@H](CCNC(=O)CC)CC2)c3c1OCC3,259.34344,Ramelteon,9881626,Launched,melatonin receptor agonist,MTNR1A|MTNR1B,InChI key,,21
3657,C12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1444,c1c2c(snc2N3CCN(CCc4cc5c(NC(=O)C5)cc4Cl)CC3)ccc1.Cl,449.39658,Ziprasidone HCl,44326969,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,InChI key,,21
3657,C14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2452,c1(C(C(NC(C)(C)C)C)=O)cc(Cl)ccc1.Cl,276.20206,Amfebutamone HCl,44319775,Launched,dopamine uptake inhibitor,CHRNA3|SLC6A2|SLC6A3,InChI key,,21
3657,C16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,C24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,D24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1445,c1(c(CS(=O)(=O)N)no2)c2cccc1,212.22572,Zonisamide,5734,Launched,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,21
3657,E04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3180,[nH]1c(c2c(C[C@H]3CCCN3C)c1)ccc(CCS(c4ccccc4)(=O)=O)c2.Br,463.43098,Eletriptan HBr,75633796,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,InChI key,,21
3657,E06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4289,c1(Cl)cc(C(=O)NCCN(CC)CC)c(OC)cc1N.Cl,336.25732,MetoclopraMide HCl,45114070,Launched,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,InChI key,,21
3657,E08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1280,C1CCN(CC)C1CNC(=O)c2c(OC)cc(N)c(S(=O)(=O)CC)c2,369.47897,Amisulpride,2159,Launched,dopamine receptor antagonist,DRD2|DRD3|HTR2A|HTR7,InChI key,,21
3657,E12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1614,c(sc(N)n1)(cc(OC(F)(F)F)cc2)c12,234.1983,Riluzole,5070,Launched,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,InChI key,,21
3657,E14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2459,N1c2c(cc(Cl)cc2)N=C(N3CCN(C)CC3)c4c1cccc4,326.82326,Clozapine,2818,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,InChI key,,21
3657,E16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,E24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,F24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1693,N1(c2c(cccc2)C=Cc3c1cccc3)C(N)=O,236.26858,Carbamazepine,2554,Launched,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,21
3657,G04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3189,N1c(c2CC1=O)cccc2CCN(CCC)CCC.Cl,296.8355,Ropinirole HCl,51371289,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,InChI key,,21
3657,G06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1281,c1(OC)ccc(C(=O)N2CCCC2=O)cc1,219.23652,Aniracetam,2196,Launched,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,InChI key,,21
3657,G12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1615,C(C)(N=C1N(CCCC1)C2=O)=C2CCN3CCC(c4noc5c4ccc(F)c5)CC3,410.48448,Risperidone,5073,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,InChI key,2,21
3657,G14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2460,[C@@H]1(NCCC)Cc2c(nc(N)s2)CC1,211.32708,Pramipexole,4885,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,InChI key,,21
3657,G16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,G24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,H24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1747,C(C)(NC(C)=C(C(=O)OCCOC)C1c2cc([N+]([O-])=O)ccc2)=C1C(=O)OC(C)C,418.44033,Nimodipine,4497,Launched,calcium channel blocker,AHR|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR|NR3C2,InChI key,,21
3657,I04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3199,c1ccc(O[C@@H]([C@@]2([H])CNCCO2)c3ccccc3)c(OCC)c1.CS(=O)(O)=O,409.49647,Reboxetine mesylate,129010464,Launched,adrenergic receptor antagonist,SLC6A2,InChI key,,21
3657,I06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1330,c1c(C(COC(=O)N)COC(=O)N)cccc1,238.23986,Felbamate,3331,Launched,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,InChI key,,21
3657,I12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1920,c1(F)ccc(C(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)=O)cc1,375.86422,Haloperidol,3559,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,InChI key,,21
3657,I14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2493,N1c2c(cccc2)N=C(N3CCN(C)CC3)c4c1sc(C)c4,312.4325,Olanzapine,4585,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,InChI key,1,21
3657,I16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,I24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,J24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1898,c1cc2c(N=CC2C(=O)OC3C[C@]([H])(N(C)[C@]4([H])C3)CC4)cc1.Cl,320.81384,Tropisetron,51371400,Launched,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,InChI key,,21
3657,K04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3212,C(NCCN1CCOCC1)(=O)c2ccc(Cl)cc2,268.73928,Moclobemide (Ro 111163),4235,Launched,monoamine oxidase inhibitor,MAOA|MAOB,InChI key,,21
3657,K06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1332,c1cc2c(C(=O)N(C)Cc3n2cnc3C(OCC)=O)cc1F,303.28836,Flumazenil,3373,Launched,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,InChI key,,21
3657,K12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1975,c1cc2c(NC(=O)CC2)cc1OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3,448.38537,Aripiprazole,60795,Launched,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,InChI key,1,21
3657,K14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2541,C(CCN(C)C)N1c2c(cccc2)CCc3c1cc(Cl)cc3.Cl,351.31325,Clomipramine HCl,22734989,Launched,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,InChI key,1,21
3657,K16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,K24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,L24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2456,c1ccc2c(Sc3c(cc(Cl)cc3)N2CCCN(C)C)c1.Cl,355.3251,Chlorpromazine HCl,21943423,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,InChI key,2,21
3657,M04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4058,C1CN(CCC)[C@H](C(Nc2c(C)cccc2C)=O)CC1.Cl,310.86207,Ropivacaine HCl,71296930,Launched,sodium channel blocker,SCN10A,InChI key,,21
3657,M06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1356,C1(=O)CCCN1[C@@H](CC)C(=O)N,170.20896,Levetiracetam,59708,Launched,calcium channel blocker,CACNA1B|SCN1A|SV2A,InChI key,,21
3657,M12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2016,C1c2c(cccc2)C3N(CCN(C)C3)c4c1cccn4,265.35286,Mirtazapine,4205,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2A|HTR2B|HTR2C|HTR3A|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,InChI key,1,21
3657,M14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3005,[C@@H]1(c2ccc(F)cc2)CCNC[C@H]1COc3ccc4c(OCO4)c3.Cl,365.82634,Paroxetine HCl,22935257,Launched,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,InChI key,,21
3657,M16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,M24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,N24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2525,C1(c2ccccc2)(c3ccccc3)C(=O)NC(=O)N1,252.26798,Phenytoin,1775,Launched,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,21
3657,O04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4202,Cl.c1cc(OC)c(OC)cc1C(C(C)C)(C#N)CCCN(CCc2cc(OC)c(OC)cc2)C,491.06255,Verapamil HCl,19760873,Launched,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,InChI key,,21
3657,O06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1391,N1(C(=O)N)c2c(cccc2)CC(=O)c3c1cccc3,252.26798,Oxcarbazepine,34312,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,InChI key,,21
3657,O12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O13,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2084,c1cc2c(cccc2)c(O[C@H](c3cccs3)CCNC)c1.Cl,333.8755,Duloxetine HCl,71296926,Launched,norepinephrine reuptake inhibitor|serotonin�norepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,InChI key,1,21
3657,O14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S3021,n1(c2ccc(Cl)cc2Cl)c(c3ccc(Cl)cc3)c(C)c(C(NN4CCCCC4)=O)n1,463.78733,Rimonabant,104850,Withdrawn,cannabinoid receptor antagonist,CNR1|GPR55,InChI key,,21
3657,O16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,O24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P01,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P02,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P03,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P04,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P05,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P06,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P07,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P08,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P09,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P10,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P11,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P12,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P13,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P14,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P15,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P16,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P17,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P18,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P19,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P20,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P21,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P22,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P23,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
3657,P24,Selleck Bioactive Compound Library - 10mM,empty,,,,,,,,,,,,
8888,B02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,not available,0,0
8888,B03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,not available,0,0
8888,B04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,not available,0,0
8888,B05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,not available,0,0
8888,B06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,not available,0,0
8888,B07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2864,c1c(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(Cl)c1,383.67293,IMD 0354,5081913,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,not available,0,0
8888,B08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,not available,0,0
8888,B09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,not available,0,0
8888,B10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,not available,0,0
8888,B11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,not available,0,0
8888,B14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,not available,0,0
8888,B15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7110,n1nc2n(c3c(c(C)c(C)s3)C(c4ccc(Cl)cc4)=N[C@@H]2CC(=O)OC(C)(C)C)c1C,456.98819,(+)-JQ1,49871817,,,,not available,0,0
8888,B16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,not available,0,0
8888,B17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,not available,0,0
8888,B18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,not available,0,0
8888,B19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,not available,0,0
8888,B20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,not available,0,0
8888,B21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1115,c1cc(c2ccc([C@@H](C(F)(F)F)N[C@@H](CC(F)(C)C)C(NC3(CC3)C#N)=O)cc2)ccc1S(C)(=O)=O,525.55879,Odanacatib (MK-0822),57459022,Phase 3,cathepsin inhibitor,CTSK,not available,0,0
8888,B22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,not available,0,0
8888,C22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,not available,0,0
8888,D22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,not available,0,0
8888,E22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,not available,0,0
8888,F22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,not available,0,0
8888,G22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2638,C(C(=O)c1c(c(c2c3c(c4c(cccc4)s3)ccc2)ccc1)O5)=C5N6CCOCC6,413.48825,NU7441 (KU-57788),11327430,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,not available,0,0
8888,B23,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,not available,0,0
8888,C23,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,not available,0,0
8888,D23,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,not available,0,0
8888,E23,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,not available,0,0
8888,F23,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,not available,0,0
8888,G23,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2620,c1cc(S(=O)(=O)c2cc3c(ncc(C(N)=O)c3Nc4cccc(OC)c4)c(C)c2)cc(C(=O)N(C)C)c1,518.58413,GSK256066,9827968,Phase 2,phosphodiesterase inhibitor,PDE4A,not available,0,0
8888,C02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,not available,0,0
8888,C03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,not available,0,0
8888,C04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,not available,0,0
8888,C05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,not available,0,0
8888,C06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,not available,0,0
8888,C07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2897,c(c(Nc1ccc(Cl)cc1F)ncn2)(cc(OC)c(OC)c3)c23,333.74472,ZM 306416,5329006,Preclinical,Abl kinase inhibitor|src inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,not available,0,0
8888,C08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,not available,0,0
8888,C09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,not available,0,0
8888,C10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,not available,0,0
8888,C11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,not available,0,0
8888,C14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,not available,0,0
8888,C15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8038,c1cc2c(C=CNC2=O)c(OCC(=O)c3ccccc3)c1,279.29002,UPF 1069,25015515,Preclinical,PARP inhibitor,PARP2,not available,0,0
8888,C16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,not available,0,0
8888,C17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,not available,0,0
8888,C18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,not available,0,0
8888,C19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,not available,0,0
8888,C20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,not available,0,0
8888,C21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1430,c1(OC2CCCC2)cc(C3CC(=O)NC3)ccc1OC,275.34284,Rolipram,5092,Phase 3,phosphodiesterase inhibitor,,not available,0,0
8888,D02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,not available,0,0
8888,D03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,not available,0,0
8888,D04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,not available,0,0
8888,D05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,not available,0,0
8888,D06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,not available,0,0
8888,D07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4078,C(O)(=O)c1ccccc1Nc2cccc(C)c2C,241.2851,Mefenamic Acid,4044,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,not available,0,0
8888,D08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,D09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,D10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,D11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,D14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,D15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7189,n(c(C)nn1)(c2c(cc(OC)cc2)C(c3ccc(Cl)cc3)=N[C@H]4CC(=O)NCC)c14,423.89537,I-BET-762,52934829,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,D16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,not available,0,0
8888,D17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,not available,0,0
8888,D18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,not available,0,0
8888,D19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,not available,0,0
8888,D20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,not available,0,0
8888,D21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2162,c1(Nc2cc(C)[nH]n2)c(Cl)cnc(N[C@@H](C)c3ncc(F)cn3)n1,348.76596,AZD1480,46861588,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,not available,0,0
8888,E02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,not available,0,0
8888,E03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,not available,0,0
8888,E04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,not available,0,0
8888,E05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,not available,0,0
8888,E06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,not available,0,0
8888,E07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4088,C1=C[C@@]2(C)C([C@@H](F)C[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(=O)CO)O)=CC1=O,410.45152,Flumethasone,129010255,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,not available,0,0
8888,E08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,not available,0,0
8888,E09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,not available,0,0
8888,E10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,not available,0,0
8888,E11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,not available,0,0
8888,E14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,not available,0,0
8888,E15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7207,c1cccc2c1n(CCCSC(N)=N)cc2C3=C(c4c(c5n(C)c4)cccc5)C(=O)NC3=O.CS(O)(=O)=O,553.65308,Ro 31-8220 Mesylate,11628205,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,not available,0,0
8888,E16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,not available,0,0
8888,E17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,not available,0,0
8888,E18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,not available,0,0
8888,E19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,not available,0,0
8888,E20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,not available,0,0
8888,E21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1714,N(C(=O)N([C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1)C=C2)=C2N,263.19814,Gemcitabine,3461,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,not available,0,0
8888,F02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,not available,0,0
8888,F03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,not available,0,0
8888,F04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,not available,0,0
8888,F05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,not available,0,0
8888,F06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,not available,0,0
8888,F07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4098,C1C[C@@]2(C)C(CC[C@]3([H])[C@@]2(F)[C@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H]5[C@]4(C(CCl)=O)OC(C)(C)O5)=CC1=O,454.95928,Halcinonide,129010256,Launched,glucocorticoid receptor agonist,NR3C1,not available,0,0
8888,F08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,not available,0,0
8888,F09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,not available,0,0
8888,F10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,not available,0,0
8888,F11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,not available,0,0
8888,F14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,not available,0,0
8888,F15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8039,n1c(N)c2c(n(CCCNC(C)C)c(Sc3c(I)cc4c(OCO4)c3)n2)nc1,512.36781,PU-H71,9549213,Phase 1,HSP inhibitor,HSP90AA1,not available,0,0
8888,F16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,not available,0,0
8888,F17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,not available,0,0
8888,F18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,not available,0,0
8888,F19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,not available,0,0
8888,F20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,not available,0,0
8888,F21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1962,N(S(=O)(=O)c1ccc(N)cc1)c2cc(OC)nc(OC)n2,310.32895,Sulphadimethoxine,5323,Launched,dihydropteroate synthetase inhibitor,,not available,0,0
8888,G02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,not available,0,0
8888,G03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,not available,0,0
8888,G04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,not available,0,0
8888,G05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,not available,0,0
8888,G06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,not available,0,0
8888,G07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4118,c1(nc[nH]c1)CCN.Cl.Cl,184.06694,Histamine 2HCl,18377385,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,not available,0,0
8888,G08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,not available,0,0
8888,G09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,not available,0,0
8888,G10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,not available,0,0
8888,G11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,not available,0,0
8888,G14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,not available,0,0
8888,G15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8076,c1nccc(C(NNc2ccccc2)=O)c1,213.23523,PluriSIn #1 (NSC 14613),225362,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,not available,0,0
8888,G16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,not available,0,0
8888,G17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,not available,0,0
8888,G18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,not available,0,0
8888,G19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,not available,0,0
8888,G20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,not available,0,0
8888,G21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1723,c1cc2c(c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3)cc1OC,357.78763,Indomethacin,3715,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,not available,0,0
8888,H02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,not available,0,0
8888,H03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,not available,0,0
8888,H04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,not available,0,0
8888,H05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,not available,0,0
8888,H06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,not available,0,0
8888,H07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7016,n1c(N)ncc(c2c3c(n(C(C)C)c(C)n3)nc(N4CCOCC4)n2)c1,354.40957,VS-5584 (SB2343),46912230,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,not available,0,0
8888,H08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,not available,0,0
8888,H09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,not available,0,0
8888,H10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,not available,0,0
8888,H11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,not available,0,0
8888,H14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,not available,0,0
8888,H15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7501,C1(=Cc2ccc(F)cc2)C(=O)C(=Cc3ccc(F)cc3)CN(CC4=CC(C)(C)N(O[H])C4(C)C)C1,464.5468,HO-3867,66852381,,,,not available,0,0
8888,H16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,not available,0,0
8888,H17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,not available,0,0
8888,H18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,not available,0,0
8888,H19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,not available,0,0
8888,H20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,not available,0,0
8888,H21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1736,c1c(OC)c(OCC(COC(=O)N)O)ccc1,241.2405,Methocarbamol,4107,Launched,muscle relaxant,CA1,not available,0,0
8888,H22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,not available,0,0
8888,I22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,not available,0,0
8888,J22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,not available,0,0
8888,K22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,not available,0,0
8888,L22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,not available,0,0
8888,M22,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2576,c1c(C)c(CC2=NCCN2)c(C)cc1C(C)(C)C.Cl,280.83609,Xylometazoline HCl,45114096,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,not available,0,0
8888,I02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,not available,0,0
8888,I03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,not available,0,0
8888,I04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,not available,0,0
8888,I05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,not available,0,0
8888,I06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,not available,0,0
8888,I07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S4902,n1c(c2c(NCCc3ccc(Oc4ccccc4)cc3)nc1)ccc(N)c2,356.4204,QNZ (EVP4593),509554,Preclinical,NFkB pathway inhibitor,,not available,0,0
8888,I08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,not available,0,0
8888,I09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,not available,0,0
8888,I10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,not available,0,0
8888,I11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,not available,0,0
8888,I14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,not available,0,0
8888,I15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1164,c1(C(=O)N)cc2c(nccc2Oc3ccc(NC(NC4CC4)=O)c(Cl)c3)cc1OC,426.85295,Lenvatinib (E7080),9823820,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,not available,0,0
8888,I16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,not available,0,0
8888,I17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,not available,0,0
8888,I18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,not available,0,0
8888,I19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,not available,0,0
8888,I20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,not available,0,0
8888,I21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1917,c1c(N(C)C)ccc(C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(N(C)C)cc3)c1.[Cl-],407.97879,Crystal Violet,11057,Launched,other antibiotic,,not available,0,0
8888,J02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,not available,0,0
8888,J03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,not available,0,0
8888,J04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,not available,0,0
8888,J05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,not available,0,0
8888,J06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,not available,0,0
8888,J07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7327,n1(c2ccc(OC)cc2)c(c3c([N+]([O-])=O)c1C)cc(O)cc3,298.29335,ID-8,791637,Preclinical,,,not available,0,0
8888,J08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,not available,0,0
8888,J09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,not available,0,0
8888,J10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,not available,0,0
8888,J11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,not available,0,0
8888,J14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,not available,0,0
8888,J15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1090,c1cc2c(c(CN(C)C)c(C(NCCOc3ccc(C(NO)=O)cc3)=O)o2)cc1,397.42442,PCI-24781 (Abexinostat),11749858,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,not available,0,0
8888,J16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,not available,0,0
8888,J17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,not available,0,0
8888,J18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,not available,0,0
8888,J19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,not available,0,0
8888,J20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,not available,0,0
8888,J21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2337,c1(OC)c(CC=C(C)C)c2c(C=CC(=O)O2)cc1,244.28574,Osthole,10228,Preclinical,calcium channel blocker,,not available,0,0
8888,K02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,not available,0,0
8888,K03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,not available,0,0
8888,K04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,not available,0,0
8888,K05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,not available,0,0
8888,K06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,not available,0,0
8888,K07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8032,n1cc(C(=O)N)c(Nc2cccc(n3nccn3)c2)nc1N[C@H]4[C@H](N)CCCC4.Cl,429.90655,"PRT062607 (P505-15, BIIB057) HCl",129010314,Phase 2,syk inhibitor,FGR|MAP3K9|SYK,not available,0,0
8888,K08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,not available,0,0
8888,K09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,not available,0,0
8888,K10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,not available,0,0
8888,K11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,not available,0,0
8888,K14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,not available,0,0
8888,K15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1057,c1cc2c([nH]c(C3=NC(=Cc4[nH]c(C)cc4C)C(OC)=C3)c2)cc1.CS(O)(=O)=O,413.49001,Obatoclax Mesylate (GX15-070),70700268,Phase 3,BCL inhibitor,BCL2,not available,0,0
8888,K16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,not available,0,0
8888,K17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,not available,0,0
8888,K18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,not available,0,0
8888,K19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,not available,0,0
8888,K20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,not available,0,0
8888,K21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2308,c1(O)cc2c(C(=O)C[C@@H](c3cc(O)c(OC)cc3)O2)c(O)c1,302.27875,Hesperetin,3593,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,not available,0,0
8888,L02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,not available,0,0
8888,L03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,not available,0,0
8888,L04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,not available,0,0
8888,L05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,not available,0,0
8888,L06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,not available,0,0
8888,L07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8034,c1cc(NC(=O)C)c2c(C(=O)N([C@H](CS(=O)(C)=O)c3ccc(OC)c(OCC)c3)C2=O)c1,460.50015,Apremilast (CC-10004),10151715,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,not available,0,0
8888,L08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,not available,0,0
8888,L09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,not available,0,0
8888,L10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,not available,0,0
8888,L11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,not available,0,0
8888,L14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,not available,0,0
8888,L15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1533,c1(OC)c(OC)cc(Nc2ncc(F)c(Nc3ccc4c(NC(=O)C(C)(C)O4)n3)n2)cc1OC,470.45362,R406 (free base),11213558,Phase 3,SYK inhibitor,RET|SYK,not available,0,0
8888,L16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,not available,0,0
8888,L17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,not available,0,0
8888,L18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,not available,0,0
8888,L19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,not available,0,0
8888,L20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,not available,0,0
8888,L21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2481,c1([N+](=O)[O-])cccc(C2C(C(=O)OCCN3CCN(C(c4ccccc4)c5ccccc5)CC3)=C(C)NC(C)=C2C(OC)=O)c1,610.69942,Manidipine,4008,Launched,calcium channel blocker,CACNA1C|CACNA1D,not available,0,0
8888,M02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,not available,0,0
8888,M03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,not available,0,0
8888,M04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,not available,0,0
8888,M05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,not available,0,0
8888,M06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,not available,0,0
8888,M07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S8078,C1[C@@]([H])([C@]2(C(OC)=O)CCC1(C)C)[C@@]([H])([C@@]3(C)CC2)C(=O)C=C([C@]34C)[C@@](C)([C@@]5([H])CC4)C=C(C#N)C(=O)C5(C)C,505.68811,Bardoxolone Methyl,124918974,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,not available,0,0
8888,M08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,not available,0,0
8888,M09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,not available,0,0
8888,M10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,not available,0,0
8888,M11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,not available,0,0
8888,M14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,not available,0,0
8888,M15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1048,c1(Nc2n[nH]c(C)c2)nc(Sc3ccc(NC(C4CC4)=O)cc3)nc(N5CCN(C)CC5)c1,464.58642,"VX-680 (Tozasertib, MK-0457)",5494449,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,not available,0,0
8888,M16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,not available,0,0
8888,M17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,not available,0,0
8888,M18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,not available,0,0
8888,M19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,not available,0,0
8888,M20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,not available,0,0
8888,M21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2535,c1cc(C(OCc2ccc(Cl)cc2)Cn3cncc3)c(Cl)cc1Cl.[N+](O)(=O)[O-],444.69634,Econazole nitrate,68589,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,not available,0,0
8888,N02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,not available,0,0
8888,N03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,not available,0,0
8888,N04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,not available,0,0
8888,N05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,not available,0,0
8888,N06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,not available,0,0
8888,N07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7509,Cc1oc(CNc2c3c(ccc(c4oc(CO)cc4)c3)ncn2)cc1,335.35657,ML167,44968231,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,not available,0,0
8888,N08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,not available,0,0
8888,N09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,not available,0,0
8888,N10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,not available,0,0
8888,N11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,not available,0,0
8888,N14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,not available,0,0
8888,N15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1087,c1c(C(=O)N)cc([N+]([O-])=O)c(I)c1,292.03067,Iniparib (BSI-201),9796068,Phase 3,PARP inhibitor,PARP1,not available,0,0
8888,N16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,N17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,N18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,N19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,N20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,N21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2780,c1(OC)cc2c(ncc3c2N([C@@H](c4ncccc4)C)C(=O)N3)cc1c5c(C)noc5C,415.44453,I-BET151 (GSK1210151A),52934274,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,not available,0,0
8888,O02,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,not available,0,0
8888,O03,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,not available,0,0
8888,O04,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,not available,0,0
8888,O05,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,not available,0,0
8888,O06,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,not available,0,0
8888,O07,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S7436,CCCCCCCCCCCCCCCCn1c(C)[n+](Cc2ccccc2)cc1.[I-],524.56407,NH125,10436839,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,not available,0,0
8888,O08,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,not available,0,0
8888,O09,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,not available,0,0
8888,O10,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,not available,0,0
8888,O11,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,not available,0,0
8888,O14,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,not available,0,0
8888,O15,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S1008,c1c(C(=O)NOCCO)c(Nc2c(Cl)cc(Br)cc2)c(F)c3c1n(C)cn3,457.6814,Selumetinib (AZD6244),10127622,Phase 3,MEK inhibitor,MAP2K1,not available,0,0
8888,O16,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,not available,0,0
8888,O17,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,not available,0,0
8888,O18,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,not available,0,0
8888,O19,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,not available,0,0
8888,O20,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,not available,0,0
8888,O21,Selleck Bioactive Compound Library - 10mM,experimental,Selleck Chemicals,S2792,c(cc(C(F)(F)F)cc1)([C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(OC)=O)C[C@@H](CC)N3C(=O)OCC)c13,600.47332,Torcetrapib,9851652,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,not available,0,0